- Staat
- TX
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 12.12.2023
- Impfdatum
- 10.02.2021
- Beginn
- 17.01.2022
- Tage bis Beginn
- 341,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
COVID-19 pneumonia
Cough
Decreased appetite
Diarrhoea
Dyspnoea
Hypoxia
Nausea
Pyrexia
Vomiting
Symptomtext
Presents with anorexia, nausea, vomiting, diarrhea, cough, fevers, sob and found to have covid pneumonia with acute respiratory failure with hypoxia, Treated with remdesivir and steroids and back on room air and doing well on discharge
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 04.12.2023
- Impfdatum
- 02.02.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 58,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Biopsy
Fibrosarcoma
Pathology test
Symptomtext
developed spindle cell neoplasm consistent with fibroblastic sarcoma grade2/3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fibrosarcoma
- Hospital-Tage
- 10,0
- Labordaten
- needle core biopsy surgical pathology report 8/22/22
- Aktuelle Erkrankungen
- chronic but stable heart disease but no history of any form of cancer ever.
- Vorgeschichte
- heart disease
- Andere Medikamente
- atorvastatin 40mg alprazolam .25mg 2x carvedilol 12.5mg 2x eliquist 2.5mg 2x levothyroxine 25mg losartan 50mg ezetimibide 10mg welexa 200mcg Tramadol as needed
- Allergien
- norvastin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 07.11.2023
- Impfdatum
- 12.02.2021
- Beginn
- 25.01.2022
- Tage bis Beginn
- 347,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Dyspnoea
Hypophagia
Lethargy
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
Presents to the ED c/o SOB. Positive for Covid on day of admission 1/25/22. History is obtained from daughter at bedside. She says her mom has been feeling SOB for the past 5 days, along with lethargy and poor po intake. She has not been having any coughs, fevers, chills. She has supplemental O2 at home that she does not use. She has been vaccinated against COVIDx2. She was unable to come off of BIPAP. I did have a long discussion with the family. They would like to make the patient hospice and initate CMO. She has transferred and made CMO. Patient passed comfortably.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 28.08.2023
- Impfdatum
- 05.02.2021
- Beginn
- 02.12.2022
- Tage bis Beginn
- 665,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breakthrough COVID-19
COVID-19
Death
Pneumonia
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Covid-19 Breakthrough Infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, HLD, CAD, AFIB
- Andere Medikamente
- Apixaban, ASA, Atorvastatin, Diltiazem, Lisinopril, Mirtazapine.
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 28.08.2023
- Impfdatum
- 05.02.2021
- Beginn
- 02.12.2022
- Tage bis Beginn
- 665,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breakthrough COVID-19
COVID-19
Death
Pneumonia
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Covid-19 Breakthrough Infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, HLD, CAD, AFIB
- Andere Medikamente
- Apixaban, ASA, Atorvastatin, Diltiazem, Lisinopril, Mirtazapine.
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 12.08.2023
- Impfdatum
- 08.02.2021
- Beginn
- 02.01.2023
- Tage bis Beginn
- 693,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Angiogram cerebral
Carotid artery thrombosis
Cerebral infarction
Cerebrovascular accident
Computerised tomogram head abnormal
Echocardiogram
Facial paralysis
Headache
Hemiparesis
Laboratory test
Magnetic resonance imaging head
Migraine
Subarachnoid haemorrhage
Swallow study
Symptomtext
12-24-22 was having migraine that got worse of the past 2 days with headache in right occipital region. Had a stroke early morning 1-2-23. In ED at 0817 with left-sided weakness, left face droop. Noncontrast CT of head - SAH blood on CT. Primary diagnosis of stroke. Facial palsy, subacute right MCA infart secondary to right carotid thrombus with extension to R M1. Hospitalized from 1-2-23 to 1-18-23. Discharged to acute rehab, then skilled nursing, then assisted living. No evidence of atrial arrhythmia during hospitalization. Hospitalized at a local Clinic Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- 4 CT scans, MRI Brain, IR cerebral artery angiogram, echo transthoracic, swallow function. Standard hospital lab tests done. Summary - R MCA infarct involving opercular cortex and i
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- hypothyroidism
- Andere Medikamente
- D3, CoQ10, fish oil, B complex, spirulina, WPThyroid
- Allergien
- shellfish
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 25.07.2023
- Impfdatum
- 11.02.2021
- Beginn
- 04.04.2023
- Tage bis Beginn
- 782,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient Deceased
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Carotid Stenosis, DM Type II, CAD, Hypothyroidism, Dyslipidemia, GERD, HTN, AVB, PVD, ESRD.
- Andere Medikamente
- Tylenol, B complex, Prevacid, Midodrine, Renvela, Ultram
- Allergien
- Amoxicillin, Levofloxacin, Simvastatin, PCN
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 21.07.2023
- Impfdatum
- 09.02.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 336,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Cardio-respiratory arrest
Chronic obstructive pulmonary disease
Condition aggravated
Symptomtext
Admitted for COVID-19 infection, COPD exacerbation; tx w/O2, abx, steroids; pt had epsidoe of code blue 1/16. d/t multiple readmissions and extensive medical problems, family expressed goals to keep pt comfortable and pt dc'd to IP hospice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 18.07.2023
- Impfdatum
- 09.02.2021
- Beginn
- 15.01.2022
- Tage bis Beginn
- 340,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Fatigue
Nausea
SARS-CoV-2 test positive
Symptomtext
Presented to ED w c/o nausea, fatigue x 2 days; COVID+ 1/6 but Z-pak, steroids & Tessalon Perles ineffective; admitted for acute resp failure w/hypoxemia d/t COVID-19 pna; tx w/steroids, zinc, remdesivir, O2; weaned to RA prior to dc.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 06.07.2023
- Impfdatum
- 05.02.2021
- Beginn
- 15.01.2022
- Tage bis Beginn
- 344,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Brain injury
COVID-19
COVID-19 pneumonia
Cerebral ischaemia
Dyspnoea
Mental status changes
SARS-CoV-2 test positive
Symptomtext
Presented to ED for worsening SOB, COVID+ x 2 wks; admitted for COVID-19 pna and acute resp failure; tx w/O2, abx, steroids, zinc, Vit-C; pt developed hypoxic ischemic brain injury; he maintained his saturations off ventilatory support with no improvement in his mental status and was discharged to hospice
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 17,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 29.06.2023
- Impfdatum
- 09.02.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 333,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Death
Encephalopathy
Endotracheal intubation
Hypercapnia
Mechanical ventilation
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Admitted for acute on chronic hypoxic respiratory failure, tested positive for COVID-19 , also was noted to be encephalopathic initially attributed to hypercapnia. Tx w/abx, steroids & pulm support w/noninvasive ventilation but hypercapnia and encephalopathy did not improve hence patient was intubated. Due to lack of improvement family decided to withdraw care, patient was extubated, placed on comfort measures and expired on 01/27.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 20,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 19.06.2023
- Impfdatum
- 22.02.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 161,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Asthenia
Cerebellar stroke
Cerebrovascular accident
Computerised tomogram
Laboratory test
Magnetic resonance imaging
Symptomtext
Multiple debilitating strokes in the cerebellum and cerebrum.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 30,0
- Labordaten
- Multiple MRIs, CT scans, and others
- Aktuelle Erkrankungen
- Diabetes Meletus Type 2
- Vorgeschichte
- None
- Andere Medikamente
- Adderall
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- M
- Eingang
- 21.04.2023
- Impfdatum
- 15.02.2021
- Beginn
- 01.10.2022
- Tage bis Beginn
- 593,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Atelectasis
COVID-19
Chest X-ray abnormal
Death
General physical health deterioration
Hypoxia
Malaise
Pyrexia
SARS-CoV-2 test positive
Symptomtext
pt had a positive COVID test at home; to ED with c/o fever, malaise; COVID test positive; CXR showed left basilar atelectasis; pt O2 saturation 94% on RA; given Vitamins C, D, and zinc; DNR/DNI; pt had rapid response due to hypoxia; O2 supplementation; pt deteriorated and transitioned to comfort measures; he passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HFrEF, paroxysmal Atrial Fibrillation; asthma, COPD, OSA - on CPAP, hypothyroidism, CKD stage IV
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 25.02.2021
- Beginn
- 01.08.2022
- Tage bis Beginn
- 522,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Hypoxia
Intensive care
Pneumonia bacterial
SARS-CoV-2 test positive
Symptomtext
3RD PFIZER COVID VACCINE DOSE GIVEN 10/9/21 #FE3592; pt had a positive COVID test on 8/28/22; hospitalized on 9/22/22 with worsening SOB, COVID pneumonia; dc'd to SNF; 10/14/22 rehospitalized for SOB and hypoxia; O2 supplementation; AHRF; ICU; started on ABX and later stopped them due to lack of infectious bacterial pneumonia; placed on steroids and CellCept; DNR/DNI; pt transitioned to comfort measures; O2 supplementation removed and pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- GERD, HTN, HLD, DVT, SVT, BRAIN CANCER, PERIPHERAL NEUROPATHY
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 29.03.2023
- Impfdatum
- 24.02.2021
- Beginn
- 01.09.2022
- Tage bis Beginn
- 554,0
- Dosis
- 3
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Bronchoscopy
COVID-19
Cough
Cystitis
Death
Dyspnoea
Dysuria
Hypotension
Intensive care
SARS-CoV-2 test positive
Suprapubic pain
Urinary tract infection
Symptomtext
3RD DOSE OF COVID VACCINE GIVEN 5/4/22, MODERNA, #056M21A; pt to ED 9/25/22 with suprapubic pain and difficulty urinating; acute cystitis; pt tested positive earlier in the week for COVID after 2-3 wks of cough; no dyspnea; no other complaints; ABX for UTI; O2 supplementation; Dexamethasone; on dialysis; during hospitalization, pt had low blood pressures; transferred to ICU; worsening oxygenation; bronchoscopy done with slight improvement in oxygenation; during dialysis pt experienced dyspnea and decompensation with hypoxia and hypotension; rapid response called; DNR/DNI; transitioned to comfort care and pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 12,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ON DIALYSIS
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 24.03.2023
- Impfdatum
- 06.10.2021
- Beginn
- 06.12.2022
- Tage bis Beginn
- 426,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had a breakthrough infection and expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 8,0
- Labordaten
- Positive COVID test on 11/28/2022.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Uterine cancer CAD HTN AAA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 17.03.2023
- Impfdatum
- 07.10.2021
- Beginn
- 04.11.2022
- Tage bis Beginn
- 393,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had a breakthrough infection and passed away..
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID test on 9/7/2022.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- DM2 HTN Ischemic Stroke
- Andere Medikamente
- Citalopram Memantine XR Donepezil Cholecalciferol Cyanocobalamin Valsartan Aspirin Nifedipine XL Mirtazapine Quetiapine Macrobid Isosorbide Mononitrate
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 23.02.2023
- Impfdatum
- 28.09.2021
- Beginn
- 06.09.2022
- Tage bis Beginn
- 343,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
PATIENT PASSED ON 06/06/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- UNKNOWN
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- CAD A FIB HTN
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 20.02.2023
- Impfdatum
- 05.02.2021
- Beginn
- 20.05.2022
- Tage bis Beginn
- 469,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- SPECIMEN COLLECTION FOR COVID-19 PCR TESTING ON 5/9/2022 - POSITIVE ON 5/11/2022 FOR COVID-19 RNA.
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN; WAS AT A LTCF AT TIME OF DEATH
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 04.02.2023
- Impfdatum
- 15.01.2021
- Beginn
- 01.05.2022
- Tage bis Beginn
- 471,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Death
Symptomtext
CAUSE OF DEATH LISTED ON DEATH CERTIFICATE: COVID PNEUMONIA, LUNG CARCINOMA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- UNKNOWN
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- LUNG CARCINOMA;
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 25.01.2023
- Impfdatum
- 21.11.2021
- Beginn
- 13.08.2022
- Tage bis Beginn
- 265,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had a breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- Positive COVID test on 9/8/2022.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- SAH COPD CAD HTN Hyperlipidemia
- Andere Medikamente
- Finasteride Atorvastatin Ferrous sulfate Pantoprazole Acetaminophen Aluminum-mag hydroxide-simethicone Bisacodyl Hydroxyzine HCL Melatonin Metoprolol tartrate Nystatin Ranolazine Warfarin
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 25.01.2023
- Impfdatum
- 19.10.2021
- Beginn
- 08.08.2022
- Tage bis Beginn
- 293,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- Positive COVID test on 7/28/2022 and 8/5/2022.
- Aktuelle Erkrankungen
- Unknow
- Vorgeschichte
- Dementia DM 2 HTN Dyslipidemia
- Andere Medikamente
- Metformin Lisinopril Estradiol Pravastatin Sodium Gabapentin Mirabegron Metoprolol Tartrate Amlodipine Aspirin Ascorbic Acid Cholecalciferol Cyanocobalamin
- Allergien
- Adhesive tape Latex
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 24.01.2023
- Impfdatum
- 15.01.2021
- Beginn
- 18.10.2021
- Tage bis Beginn
- 276,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
PERSON HAD BEEN AT LTCF PRIOR AND AT TIME OF DEATH; LIMITED NOTES AVAILABLE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- TESTED POSITIVE FOR COVID-19 WITH SPECIMEN COLLECTION ON 8/29/2021 AND 8/30/2021 VIA PCR.
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 11.02.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 475,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
Death
Diarrhoea
Dyspnoea
Hypoxia
Intensive care
Positive airway pressure therapy
Symptomtext
MODERNA COVID VACCINE #3 GIVEN 5/28/22, LOT #058A22-2A; pt admitted to hospital with worsening SOB; hypoxia; c/o diarrhea and generalized weakness; 1 wk ago pt dx with COVID, started on Paxlovid, completed the course; diarrhea has continued; placed in ICU; required vasopressors, ABX, steroids, BiPAP; didn't respond to tx in ICU; pt found passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD on home O2, CKD2, heart valve replacements
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 13.02.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 473,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Fraction of inspired oxygen
General physical health deterioration
Intensive care
Renal impairment
SARS-CoV-2 test positive
Symptomtext
pt had a positive COVID test at Center for Rehab on 6/28/22; pt brought to hospital on 7/6/22 with worsening SOB secondary to COVID pneumonia; worsening respiratory requirements; 100% FiO2 via mask; ICU; worsening renal function; pt's condition continued to deteriorate; poor prognosis; steroids and ABX given; family requested comfort care; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 11.10.2022
- Impfdatum
- 23.02.2021
- Beginn
- 19.08.2022
- Tage bis Beginn
- 542,0
- Dosis
- UNK
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebral haemorrhage
Confusional state
Death
Fall
Gait disturbance
Hypoaesthesia
Symptomtext
Had 2nd dose 3-19-21 Pfizer Lot#EN6204 3rd dose 10-28-21 Pfizer Lot #FF2593 Experienced numbness in leg and could not walk and confusion 7-2022. Fell at hospital 8-19-2022 due to brain hemorrhage. Patient died 8-30-2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 12,0
- Labordaten
- Brain hemorrhage 8-19-2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High blood pressure, enlarged prostate, high cholesterol, glaucoma
- Andere Medikamente
- Aspirin-81mg Amlodipine-10mg Lisinopril-10mg Tradjenta-5mg Finistride-5mg Metoprolol-25mg Atoruastatin-40mg Latanoprost-0.005%
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 05.10.2022
- Impfdatum
- 27.04.2021
- Beginn
- 23.03.2022
- Tage bis Beginn
- 330,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cerebrovascular accident
Computerised tomogram
Ischaemia
Magnetic resonance imaging head
Scan with contrast
Symptomtext
Stroke,3mm focu of ischemia, subacutet CVA in right frontal gyrus. No obvious outward symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- CT Scan, MRI of brain w/wo contrast
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Amlodipine-Benazepril 10/40, Gabapentin, 800 mg daily, Ezetimibe (Zetia) 10 mg daily, Asprin 83 mg daily, Multi Vitamin Vit. D3 250 mcg, Vit. B12 5000 mcg, L0Methyl Folate800 mg, Krill Oil 1000 mg, CO Q-10 200 mg, Mgnesium 250 mg, Zinc Su
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 27.10.2021
- Beginn
- 22.09.2022
- Tage bis Beginn
- 330,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrial fibrillation
Blood lactic acid
COVID-19
Computerised tomogram head normal
Death
Hypophagia
Hypoxia
Mental status changes
SARS-CoV-2 test positive
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer BioNTech vaccine on 2/9/2021, 3/2/21 and 10/27/21. Presented to ED from rehab yesterday w/AMS and decreased PO intake. Prior admission to rehab after being hospitalized and tx'd for COVID, discharged 9/8/22. COVID + this admission as well. She was hypoxic on arrival to ED and placed on supplemental O2. Head CT negative for acute process. Lactate was 4.0. Admitted to the medical floor and started on decadron and Zosyn. That evening she went into Afib RVR. Transitioned to comfort care and expired on 9/22/22. Tx'd with cefepime, decadron, vancomycin, metronidazole, and zosyn.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- covid + 9/3/22, 9/13/22/ and 9/15/22. This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Dementia, Parkinson's, DM, HTN, and HLD
- Andere Medikamente
- tylenol, carbidopa/levodopa, vitamin d3, cranberry/vit C, dexamethasone, divalproex, donepezil, memantine, metoprolol succinate, multivitamin, omega 3, pantoprazole, pioglitazone, psyllium husk, rosuvastatin, venlafaxine
- Allergien
- codeine, iodine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.09.2022
- Impfdatum
- 02.02.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 333,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Device intolerance
General physical health deterioration
Intensive care
Multiple organ dysfunction syndrome
Positive airway pressure therapy
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
PFIZER COVID VACCINE #3 GIVEN 10/1/21, LOT #FF8839; pt transported from a residential facility to hospital due to not tolerating BiPAP well; when EMS arrived O2 saturation was 70%; placed on NRB 15L O2; found to be positive for COVID; given ABX and IVFs; ICU; respiratory failure; condition worsened; multiorgan failure; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, ATRIAL FIBRILLATION, CHRONIC RESPIRATORY FAILURE, CHRONIC PACEMAKER, CAD, BPH, GERD, CHF, CARDIOMYOPATHY, ANEMIA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 16.09.2022
- Impfdatum
- 21.01.2021
- Beginn
- 13.08.2022
- Tage bis Beginn
- 569,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Death from COVID S/P COVID vaccination ? Vaccines o 01/21/2021 Pfizer Lot EL9291 o 02/11/2021 Pfizer Lot EL9269 o 02/19/2022 Pfizer Lot FM0698
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- Positive COVID Test 08/13/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes mellitus, Hypertension, Dyslipidemia CAD W/HX stents, chronic hypoxic/hypercarbic respiratory failure, HTN, DMT2, hypothyroidism, CO2 narcosis, COPD
- Andere Medikamente
- Duoneb Alfuzosin Methocarbamol Atorvastatin Irbesartan Metoprolol succinate XL Acetaminophen Aspirin Sertraline Trazodone Potassium Chloride Levothyroxine Metformin Cholecalciferol Cyanocobalamin Ocuvite with leutein Allopurinol Finasteri
- Allergien
- Penicillins and oxycodone
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 08.02.2021
- Beginn
- 22.08.2022
- Tage bis Beginn
- 560,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Chest tube insertion
Death
Dyspnoea
Endotracheal intubation
Haemodynamic instability
Hypoxia
Mechanical ventilation
Oxygen saturation decreased
Pneumothorax
Respiratory distress
SARS-CoV-2 antibody test
SARS-CoV-2 antibody test positive
Symptomtext
68y.o. female with PMH pertinent for seronegative RA on chronic prednisone recent COVID PNA presented for worsening SOB. In the ER, patient was hypoxic requiring HFNC 100% FiO2/50 L and a nonrebreather maintaining SPO2 in the early 90s. Significant increase in work of breathing. Patient was intubated. On 8/28, the patient developed resp distress. Patient had a needle decompression and then chest tube placement for right sided tension pneumothorax. Patient was unable to be weaned off ventilator and on 9/5 had a drop in SpO2 with increased WOB. Patient required multiple pressors for hemodynamic instability. Patient transitioned to comfort care, and passed peacefully that evening.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- 8/23/22 SARS-CoV-2 IgG (Anti-Spike) -- positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 15.02.2021
- Beginn
- 06.02.2022
- Tage bis Beginn
- 356,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Asthenia
COVID-19
Cough
Death
Dyspnoea
Hypophagia
Mental status changes
Nausea
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
2/6 - 2/7/22 pt in Hospital with sx of cough, congestion, poor oral intake, SOB, weakness, AMS, nausea, body aches; positive COVID test, acute renal failure; DNR/DNI; family decided to transition pt to hospice; dc'd to home where pt passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Metastatic carcinoid tumor s/p metastasis to liver, lungs, bones; CKD stage IV, hypothyroidism, gout
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 29.08.2022
- Impfdatum
- 05.02.2021
- Beginn
- 07.01.2022
- Tage bis Beginn
- 336,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Disease complication
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away due to complications
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 20,0
- Labordaten
- Positive COVID test on 8/21/2021
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- Alzheimer's DM2 CAD hypertension
- Andere Medikamente
- Clopidogrel furosemide insulin simvastatin ferrous sulfate carvedilol donepezil duloxetine gabapentin hydrocodone memantine metformin midodrine warfarin
- Allergien
- heparin tamsulosin promethazine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 24.12.2021
- Beginn
- 09.08.2022
- Tage bis Beginn
- 228,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19 pneumonia
Hypotension
Metabolic encephalopathy
Symptomtext
Patient admitted for COVID-19 pneumonia, hypotension, metabolic encephalopathy, acute hypoxemic respiratory failure. Treated with decadron and remdesivir and inhalers. Once stable pt d/c home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, hyperlipidemia, coronary artery disease status post 5 stents, status post CABG x5, 3 years ago, depressi
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 13.02.2021
- Beginn
- 22.02.2022
- Tage bis Beginn
- 374,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Basal ganglia haemorrhage
COVID-19
Cerebral haematoma
Computerised tomogram head abnormal
Computerised tomogram thorax abnormal
Death
Endotracheal intubation
Fall
Haemorrhage
Head injury
Hypertension
Intensive care
Pneumonia
SARS-CoV-2 test positive
Unresponsive to stimuli
Symptomtext
PFIZER COVID VACCINE #3 GIVEN 9/23/21, LOT #30145BA; limited medical records received on pt; 2/22/22 pt to ED via EMS after hitting head during a fall; pt became unresponsive en route to hospital; intubated in ED; CT head showed right basal ganglia hemorrhage and right occipital hematoma; hypertensive bleed; CT chest showed bilateral pneumonia; positive COVID test; pt transferred to ICU; 5 days later pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 01.07.2022
- Impfdatum
- 03.02.2021
- Beginn
- 31.01.2022
- Tage bis Beginn
- 362,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Pateint had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID test on 1/1/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM type 2 chronic kidney disease Atherosclerotic heart disease of native coronary artery without angina pectoris
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 19.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Chest X-ray abnormal
Death
Dyspnoea
Loss of consciousness
Lung opacity
Pneumonia
SARS-CoV-2 test positive
Thrombocytopenia
Symptomtext
Pt had a positive COVID test on 8/27/21 at a pharmacy; was admitted to hospital from 8/27/21 - 9/17/21; he was treated with remdesivir, baricitinib, dexamethasone; dc'd; back to hosp on 10/17/21 with worsening SOB; on 4 L O2 via NC; CXR showed worsening pulmonary opacities; treated with ABX; admitted with pneumonia; COVID test was now negative; respiratory status did not improve; treated with steroids; developed acute respiratory needs, transitioned to Vapotherm and transferred to PCU; weaned from Vapotherm to O2 via NC; worsening thrombocytopenia; PT worked with patient and he passed out from being to weak to do PT; planned to send pt home with hospice, but pt expired in the hosp before able to go home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 34,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, HL, CKD STAGE III, BPH, BRADYCARDIA, ABDOMINAL AORITIC ANEURYSM,
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 06.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac stress test
Cerebrovascular accident
Computerised tomogram
Investigation
Thrombosis
Weight decreased
Symptomtext
STROKE; This is a spontaneous report received from contactable reporters (Consumers or other non HCPs) from License Party. Other Case identifiers: US-BRISTOL-MYERS SQUIBB COMPANY-2022-037994 (Company), BMS-2022-024502 (Company). This case was received via Company (Reference number: 202200269859) on 28-Mar-2022. Information was received from a Consumer/other non health professional concerning a 63 Year(s) old Male patient, who received Suspect product APIXABAN for drug use for unknown indication, lot number: Unknown; Suspect product COVID-19 VACCINE for Drug use for unknown indication (from 06-Feb-2021), lot numbers: EL9269 and EN6203. On an unknown date, the patient experienced cerebrovascular accident(stroke) which was considered serious due to the following criteria: hospitalization and medical significance. Treatment included surgery. The outcome of the event is unknown. The status of APIXABAN medication is unknown. The status of COVID-19 VACCINE medication is unknown. Concomitant medications were not reported. Relevant Laboratory & other Diagnostic Tests On an unknown date, CAT SCAN: Blood clot in brain. The reporter did not provide a causal assessment for event cerebrovascular accident to product APIXABAN. The reporter did not provide a causal assessment for event cerebrovascular accident to product COVID-19 VACCINE. The patient had COVID-19 shot, clarifies the product as the Pfizer COVID-19 vaccine and 3 weeks after caller got the second dose, caller had a blood clot in the brain, had a stroke, was rushed to the hospital and had brain surgery. They were able to do a cat scan and found the blood clot, did surgery, went through the groin area to get to the blood clot. The patient was taken no medication before, now on Eliquis. Tracking of Changes: 28-Mar-2022: Initial information was received. APIXABAN (ELIQUIS) is under agreement with Company.; Sender's Comments: Company Comment: This patient had cerebrovascular accident(stroke) requiring surgery who was on therapy with apixaban and COVID-19 vaccination. Based on the limited information regarding nature of stroke (ischemic or hemorrhagic), relevant medical history and therapy details, it cannot be ascertained with reasonable possibility that suspect drugs caused or contributed to stroke.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- Test Name: CAT scan; Result Unstructured Data: Test Result:Blood clot in brain
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Eliquis
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Asthenia
Autopsy
Communication disorder
Death
Chills
Disturbance in attention
Interchange of vaccine products
Feeding disorder
Fluid intake reduced
Gait inability
Hypersomnia
Incoherent
Mobility decreased
Pyrexia
Respiratory arrest
Resuscitation
Tremor
Symptomtext
Pfizer-BioNTech and Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 1/20/2021 and 2/8/2021. Per report, after second vaccine, patient experienced chillls, shaking, fever of 102.6, could not focus, and low energy. Patient received Moderna Vaccine on 12/10/2021. Per patient's daughter, patient had a lowgrade fever on 12/10/21. Patient's fever then broke on 12/11/2021. Patient stopped breathing on the way to the emergency department and the patient expired on 12/12/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diverticulitis, hypercholesterolemia, aderenocortical insufficiency, Gastro-esophageal reflux disease, osteoporosis, Vitamin D deficiency, Small lymphocytic lymphoma, Hiatal hernia, monoclonal gammopathy of unknown significance, insomnia, iron deficiency
- Andere Medikamente
- Tylenol #3, fosamax, colace, florinef, cortef, melatonin, crestor, multivitamin, desyrel, vitamin C, vitamin D3, calcium
- Allergien
- Pravastain
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 27.05.2022
- Impfdatum
- 15.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 167,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
pt had a positive COVID test on 8/23/21 from a facility; pt passed away in the facility; DC and med records sent to vaers website
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 23.05.2022
- Impfdatum
- 23.02.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 312,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Hypoxia
SARS-CoV-2 test positive
Symptomtext
pt had been at home on hospice; had a positive COVID test on 1/8/22; came to hospital on 1/9/22 for sever hypoxia; family elected to restart GIP hospice due to poor prognosis; pt passed away in the hospital; med records and agency sent to specific website per VAERS request
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Advanced Pulmonary Fibrosis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 22.02.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 192,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute myocardial infarction
Acute respiratory distress syndrome
Acute respiratory failure
Aortic stenosis
COVID-19
Computerised tomogram head abnormal
Confusional state
Death
Disorientation
Hypotension
Lung consolidation
Meningioma
Pneumonia bacterial
SARS-CoV-2 test positive
Speech disorder
Symptomtext
Patient is a 93 year-old male, with past medical history significant for HTN, prior ICH, suspected CKD, meningioma and recent SARS Covid 19 infection. Prior to his hospitalization, patient was hospitalized, early September, 2021 when tested positive for COVID on admission on 09/02/21 . Reportedly his symptoms started on 08/30/21. He was found to have right upper lobe consolidation. He was treated With Rerndesivi rand ceftriaxone, which was transitioned to Cefdinir upon transfer to skilled nursing facility on 09/08/2021.. At that time, he was fully oriented and able to talk over the phone. Since then, he reportedly became increasingly confused. disoriented, with nonsensical speech without focal deficits. While at hospital, he was incidentally noted to have meningioma on head CT. Patient was seen at ED on 09/19/21 for reported acute respiratory distress. His oxygen saturation was reported to be in the 60% range. He was on NRB, which was slowly titrated down to 6L via NC. He was also hypotensive. Patient died 9/23/2021 at 2: 19 AM. Cause of death acute hypoxemic respiratory failure, bacterial pneumonia; nonSTEMI, severe aortic stenosis, recent COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 30.04.2022
- Beginn
- 07.05.2022
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Anticoagulant therapy
Blood electrolytes
C-reactive protein
COVID-19
Chest X-ray
Chronic kidney disease
Coagulation test
Confusional state
Deep vein thrombosis
Diarrhoea
Failure to thrive
Fibrin D dimer
Hypoglycaemia
Hypophagia
Illness
Inflammatory marker increased
Metabolic function test
Symptomtext
Symptoms of confusion and hypoglycemia associated with poor oral intake associated with acute illness with positive COVID-19 PCR test 6 days previously prompted presentation to hospital emergency department. Diagnoses included acute hypoxemic respiratory insufficiency, acute on chronic CKD, diarrhea, deep vein thrombosis, and failure to thrive in setting of increased inflammatory markers. in addition to antidiabetic medication management, patient received remdesivir, dexamethasone, and anticoagulation X 4 days. Patient was discharged medically stable to his routine home care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- Chest Xray Comprehensive Electrolyte Panel D dimer CRP Anti Xa
- Aktuelle Erkrankungen
- Type 2 diabetes Coronary heart disease Systolic heart failure Hyperlipidemia Chronic kidney disease Pseudophakia bilateral Hypertension
- Vorgeschichte
- Above
- Andere Medikamente
- Insulin degludec Alendronate Aspirin Atorvastatin Carvedilol Cholecalciferol Furosemide Diclofenac gel
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 13.05.2022
- Impfdatum
- 26.08.2021
- Beginn
- 14.02.2022
- Tage bis Beginn
- 172,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID-29 test on 1/28/2022.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 26.10.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 98,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- Positive COVID-19 test on 2/1/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Advance dementia rheumatoid arthritis supraventricular tachycardia
- Andere Medikamente
- Methotrexate levothyroxine multivitamin omeprazole methylcellulose Cymbalta Vitamin D3 Folic acid Orencia Tylenol Colace Plaquenil Neurontin Ferrous sulfate plavix toprol XL Amiodarone Lipitor Albuteral Melatonin
- Allergien
- Penicillins codeine red dye horse/equine containing products
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 04.05.2022
- Impfdatum
- 09.02.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 211,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Cough
Critical illness
Death
Dyspnoea
Endotracheal intubation
Immunoglobulin therapy
Intensive care
Renal impairment
SARS-CoV-2 test positive
Therapy cessation
Symptomtext
Presented with SOB, cough x 1 week; Covid + ED; admitted to ICU with Covid PNA; tx with zithromax, rocephin, steroids, remdesivir, singulair, zinc, maxipime, supplemental O2; intubated 9/11; IgG infusion;currently remains intubated with worsening renal function; on pressors; critically ill; After discussions with the husband, he expressed that she would not have wanted dialysis. Palliative care assisted in family meetings and the family elected to transition to comfort measures. She was made DNR and therapy was discontinued. She was declared deceased on 9/29/21 at 11:09.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 22,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 03.05.2022
- Impfdatum
- 13.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Coronary arterial stent insertion
Feeling hot
Gait disturbance
Hypoaesthesia
Magnetic resonance imaging head abnormal
Magnetic resonance imaging neck
Symptomtext
On February 10, 2021, I saw my PCP at the time. Then in March, I saw him again and he was talking about referring me to the neurologist. April 2, 2021, I had a stent placed in a heart artery. Between the time that I talked to the PCP in March for a referral to the neurologist and seeing my new PCP in June was when I began experiencing different symptoms than what I was getting sent to the neurologist for. It started with a slight numbness on the left side which was the result of prior back surgery years ago. Original symptoms were slight numbness on the left side. In June, new PCP referred me to the doctor the original PCP had suggested. In June I was experiencing more symptoms and I had little events where I would be sitting and from the center of my back to my head would be a warm sensation coming up then it would go away. And that happened 2-3 different times. After that feeling, I noticed increased and more pronounced numbness and my ability to walk decreased. I went to the neurologist in August 2021 and she suggested getting an MRI done of my neck and brain. MRI done on August 30, 2021. The MRI came back that I had a lacunar stroke event and we didn't know when this occurred. Currently doing physical therapy right now. Neurologist is considering doing another MRI. Have another follow up later this year 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- MRI - August 30, 2021 - indicated a Lacunar stroke event; Possible future MRI later this year
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Cardiovascular issues - high cholesterol, clogged arteries; Type 2 Diabetes; Neuropathy
- Andere Medikamente
- Allegra; Alprazolam; Amlodipine; Atorvastatin; Cialis; Coreg; Famotidine; Prandin; Telmisartan; Zinc; Zyrtec
- Allergien
- Hydrocodone; Oxycontin; Codeine; Specific brand of eye drops (unknown at this time)
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 28.04.2022
- Impfdatum
- 05.02.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 238,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Blood glucose increased
COVID-19
Death
Dyspnoea
Hypoxia
Mental status changes
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
10/4/21 pt transferred from ER for a higher level of care; went to ER on 10/3/21 with dyspnea and altered mental state; found to be positive for COVID; hypoxic (O2 sats 80% on RA); placed on O2; elevated glucose; transferred to Facility; quickly became BiPAP dependent, but still hypoxemic; pt transitioned to comfort care, and passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM, dyslipidemia, OSA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 13.04.2022
- Impfdatum
- 27.02.2021
- Beginn
- 07.04.2022
- Tage bis Beginn
- 404,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Asthenia
Blood lactic acid
Brain natriuretic peptide increased
COVID-19
Cardiac arrest
Death
Dyspnoea
Endotracheal intubation
Pulseless electrical activity
SARS-CoV-2 test positive
Troponin I increased
White blood cell count increased
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death Received Pfizer Vaccine 2/06/21 and 02/27/21. Presented to ED 04/06/22 via EMS after cardiac arrest 15 min prior. According to the patient's family he has been feeling week for several days, today he seemed more SOB. Upon EMS arrival the patient was in PEA, placed on Lucas device, administered 1 round epinephrine and intubated. ROSC was achieved after total of 5 min. down time estimated by EMS. Intubated and sedated upon arrival to ED. Workup in ED showed AKI, lactic acid 8.3, Trop I HS 90, BNP 618, WBC 19.4 and is Covid-19 positive. Family decided on comfort measure only. Pt expired on 4/7/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 1,0
- Labordaten
- 4/06/22- This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, aortic and mitral regurgitation, BPH, HLD
- Andere Medikamente
- albuterol, amlodipine, atorvastatin, cetirizine, clonidine, diclofenac, fluticasone, hydralazine, patiromer, primidone
- Allergien
- Penicillin V, Lasix
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 12.04.2022
- Impfdatum
- 25.10.2021
- Beginn
- 05.04.2022
- Tage bis Beginn
- 162,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Chest X-ray normal
Chronic obstructive pulmonary disease
Condition aggravated
Influenza A virus test negative
Influenza B virus test
Obesity
SARS-CoV-2 test positive
Sepsis
Systemic inflammatory response syndrome
Tachycardia
Tachypnoea
White blood cell count normal
Symptomtext
Pfizer 2/10/21, 3/4/21 & 10/25/21. admitted for sepsis secondary to COVID-19 pneumonia causing acute hypoxemic respiratory failure, COPD exacerbation, obesity all these diagnosis present on admission. chest x-ray showed no acute infiltrates, independently reviewed. COVID-19 test is positive. Influenza a and B negative. sirs criteria positive including tachycardia and tachypnea, sepsis focused exam performed, appropriate IV hydration given in the emergency room. Avoid aggressive IV hydration due to risk of worsening outcomes in COVID. Currently afebrile, white count is 7, Blood pressure acceptable. Pt discharged 4/10/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- COVID 19 PCR + 4/5/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, hypertension, hyperlipidemia, pre-diabetes; obesity
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 31.03.2022
- Impfdatum
- 13.02.2021
- Beginn
- 22.09.2021
- Tage bis Beginn
- 221,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
pt passed away in the nursing home; cause of death was COVID 19 per death certificate; pt had a positive COVID test on 9/22/21 in Hospital; pt was transferred from the hospital to the nursing home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 23.03.2022
- Impfdatum
- 01.03.2021
- Beginn
- 25.03.2021
- Tage bis Beginn
- 24,0
- Dosis
- 1
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Death
Dysstasia
Fall
General physical health deterioration
Influenza like illness
Oedema peripheral
Urinary incontinence
Symptomtext
He felt like he was having flu-like symptoms and his primary care physician gave him vitamin B. His health began to decline and on his birthday he had begun to have fluid build-up in the legs. Shortly thereafter he complained of urinating himself. He was taken to the hospital when he fell and could not get up. My husband knows more about the symptoms because he carried him into several hospitals which all discharged him until he finally died in the third hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- Trying to pull together medical records.
- Aktuelle Erkrankungen
- Was overall in good health as the conditions he had were under control.
- Vorgeschichte
- Diabetes and he had a stent in his heart.
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 22.03.2022
- Impfdatum
- 17.03.2021
- Beginn
- 04.01.2022
- Tage bis Beginn
- 293,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acquired diaphragmatic eventration
Acute respiratory failure
Alanine aminotransferase increased
Albumin globulin ratio
Allen's test
Anion gap
Aspartate aminotransferase increased
Base excess
Basophil count decreased
Basophil percentage decreased
Blood albumin normal
Blood alkaline phosphatase normal
Blood bicarbonate increased
Blood bilirubin normal
Blood calcium normal
Blood chloride decreased
Blood creatinine normal
Blood culture
Symptomtext
1/4/22 86-year-old male with a history of ILD with chronic respiratory failure presented with acute on chronic hypoxemic respiratory failure secondary to COVID-19 pneumonia. He declined rapidly. We were unable to achieve SPO2 greater than 80 to 100% FiO2 with nonrebreather. Family did not wish to escalate care further and preferred to proceed with comfort focused care. Spoke with daughter, POA, and she informed me that the plan was to maintain full treatment until family could arrive. Family arrived on 1/5 and we initiated comfort focused treatment. Hospice was consulted. Consents were signed for inpatient scatter bed. Patient to be discharged/readmitted to scatter bed. Hospice following His symptoms were treated. He appeared to remain comfortable. The patient expired secondary to acute on chronic hypoxemic respiratory failure secondary to covid 19 pneumonia in the setting of advanced interstitial lung disease @ 0203 hours 1/7/2022 REVIEW OF SYSTEMS Review of Systems Constitutional: Negative for chills and fever. HENT: Negative for sore throat and neck pain. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for chest tightness. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative. Musculoskeletal: Positive for myalgias. Skin: Negative for rash. Neurological: Negative for dizziness, syncope and headaches. Psychiatric/Behavioral: Negative for agitation and behavioral problems. CBC W/DIFF - Abnormal White Blood Count 6.16 4.5 - 11.0 10*3/uL Red Blood Count 4.50 4.5 - 5.9 10*6/uL Hemoglobin 13.4 (*) 13.5 - 17.5 g/dL Hematocrit 43.0 41.0 - 53.0 % Mean Corpuscular Volume 95.6 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.8 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.2 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 12.9 12.0 - 16.8 % Platelet Count 160 140 - 440 10*3/uL Mean Platelet Volume 11.3 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 71.2 45 - 80 % Lymphocyte % 14.3 (*) 15 - 50 % Monocyte % 13.8 0 - 15 % Eosinophil% 0.0 0 - 7 % BASO% 0.2 0 - 2 % Immature Granulocyte% 0.5 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 4.39 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.88 0.7 - 5.5 10*3/uL Monocyte Absolute 0.85 0.0 - 1.7 10*3/uL EOS-Absolute 0.00 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.03 0.00 - 0.10 10*3/uL COMPREHENSIVE METABOLIC PANEL (CMP) - Abnormal Sodium 138 136 - 145 mmol/L Potassium 4.6 3.5 - 5.1 mmol/L Chloride 94 (*) 98 - 107 mmol/L Carbon Dioxide 30 (*) 22 - 29 mmol/L Anion Gap 14 (*) 5 - 13 (arb'U) Glucose 97 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 26 8 - 26 mg/dL Creatinine-Blood 1.20 (*) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 21.7 RATIO Estimated GFR 57 (*) >60 /1.73 m2 Estimated GFR if (Privacy) >60 >60 /1.73 m2 Total Protein 6.3 6.2 - 8.0 g/dL Albumin 3.6 3.2 - 4.6 g/dL Globulin 2.7 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.3 1.1 - 2.5 RATIO Calcium 9.0 8.4 - 10.2 mg/dL Total Bilirubin 0.7 0.2 - 1.2 mg/dL AST/SGOT 88 (*) 5 - 34 U/L ALT/SGPT 67 (*) 0 - 55 U/L Alkaline Phosphatase 57 40 - 150 U/L TROPONIN - Abnormal Troponin 0.039 (*) 0.000 - 0.034 ng/mL ARTERIAL BLOOD GAS - Abnormal Allen Test POSITIVE (arb'U) Temperature-ABG 37.0 37.0 Cel pH-ABG 7.45 7.35 - 7.45 PH PCO2-ABG 47 35 - 48 mm(Hg) PO2-ABG 56 (*) 83 - 108 mm(Hg) HCO3-ABG 33 (*) 22 - 30 mmol/L TC02-ABG 34 (*) 22 - 30 mmol/L Base Excess-ABG 7.5 (*) 0 - 3 mmol/L O2 Sat-ABG 90.6 (*) 95.0 - 98.0 % FIO2-ABG 60.0 20 - 100 % CULTURE, BLOOD CULTURE, BLOOD B-TYPE NATRIURETIC PEPTIDE B-Type Natriuretic Peptide 111.2 4 - 254 pg/mL LACTIC ACID Lactic Acid 1.3 0.7 - 2.0 mmol/L 1/4/22 Chest xray IMPRESSION: Right greater than left patchy infiltrate which could represent pulmonary edema and/or multifocal pneumonia superimposed on chronic volume loss and scarring of the prominently elevated right lung base/hemidiaphragm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 1,0
- Labordaten
- 1/4/22 COVID-19 Result Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- history of metastatic prostate cancer, restrictive lung disease, Chronic Resp failure, Diastolic Dysfunction, HTN, Obesity Anxiety o Arthritis OSTEO/FEET o Cancer (CMS/HCC) PROSTATE o Compression fracture of L1 lumbar vertebra (CMS/HCC) o Compression fracture of L3 lumbar vertebra o Compression fracture of L5 lumbar vertebra o Compression fracture of T12 vertebra (CMS/HCC) o Depression o Difficulty walking use of cane for ambulation o ED (erectile dysfunction) o GERD (gastroesophageal reflux disease) o H/O prostatectomy 1993 o History of cholecystectomy 1992 o History of hip surgery 1998 hip replacement right hip o Hyperlipidemia o Hypertension o Kidney stone o Metastasis to bone (CMS/HCC) 11/6/2017 o Midline low back pain o Neuropathy N/T BILAT FEET o Pathologic fracture Pathologic fx probably secondary to prostate cancer of T11, T12, L1, L3, L5 and possibly L4. o Renal insufficiency
- Andere Medikamente
- albuterol-ipratropium 0.5-2.5 mg/3 mL nebulizer albuterol-ipratropium 0.5-2.5 mg/3 mL nebulizer Take 1 ampule by nebulization every 4 (four) hours as needed for Wheezing or Shortness of Air Dx: R06.02, R06.2, J44.1. ALPRAZolam 0.25 MG tab
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 17.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 165,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
Chronic kidney disease
Death
Fall
General physical health deterioration
Hypoxia
Positive airway pressure therapy
SARS-CoV-2 test positive
Sepsis
Symptomtext
pt to ED after a fall at home; c/o weakness; tested positive or COVID 3 dys earlier per pt; admitted to hosp for management of sepsis and hypoxia; given dexamethasone; O2 supplementation; experienced acute on chronic kidney disease; O2 requirements increased to BiPAP; pt's condition worsened; unable to wean off of BiPAP; pt transitioned into comfort care and died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 11.02.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 331,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
Cardiac failure acute
Cardiogenic shock
Confusional state
Death
Vaccine breakthrough infection
General physical health deterioration
Hypotension
Neurological symptom
Pulmonary oedema
SARS-CoV-2 test positive
Symptomtext
pt brought to ED with stroke-like sx, increase weakness, hypotension, increased confusion; placed on 100% NRB mask; cardiogenic shock secondary to acute heart failure in the setting of pulmonary edema; found to be positive for COVID; comfort measures; pt's condition rapidly declined and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Alzheimer's , HTN, hyperlipidemia, generalized weakness
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 11.02.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 331,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
Cardiac failure acute
Cardiogenic shock
Confusional state
Death
Vaccine breakthrough infection
General physical health deterioration
Hypotension
Neurological symptom
Pulmonary oedema
SARS-CoV-2 test positive
Symptomtext
pt brought to ED with stroke-like sx, increase weakness, hypotension, increased confusion; placed on 100% NRB mask; cardiogenic shock secondary to acute heart failure in the setting of pulmonary edema; found to be positive for COVID; comfort measures; pt's condition rapidly declined and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Alzheimer's , HTN, hyperlipidemia, generalized weakness
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 05.03.2022
- Impfdatum
- 17.03.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 294,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood sodium
Haematocrit
Haemoglobin
Plasma cell myeloma
Pulmonary embolism
White blood cell count
Symptomtext
pulmonary embolism; multiple myeloma; This is a spontaneous report received from contactable reporter(s) (Physician). A 80 year-old male patient received bnt162b2 (BNT162B2), administration date 17Mar2021 (Lot number: EL9269) at the age of 80 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "TIA", start date: 30Nov2021 (unspecified if ongoing); "Late onset Alziemers", start date: 28Dec2021 (unspecified if ongoing); "chronic leukemia", start date: 04Aug2020 (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot number: EL9265), administration date: 23Feb2021, when the patient was 80 years old, for COVID-19 Immunization, reaction(s): "pressure in his head", "Dizzy", "nausea", "Headache", "Vomiting", "waves of vertigo/ dizziness", "not feeling well", "achy", "first week he had a typical virus like the flu", "tired", "chills", "sick", "he couldn't stand"; Zoster, administration date: 01Oct2006, when the patient was 66 years old, for Immunization; Flu, administration date: 25Aug2020, when the patient was 80 years old, for Immunization. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "pulmonary embolism"; PLASMA CELL MYELOMA (medically significant) with onset 05Jan2022, outcome "unknown", described as "multiple myeloma". The patient underwent the following laboratory tests and procedures: blood sodium (136-145): (07Feb2022) 135 MiU/L; haematocrit (39.0-53.0): (07Feb2022) 36.5 %; haemoglobin (14.0-17.5): (07Feb2022) 12.3 g/l; white blood cell count (4.8-10.8): (07Feb2022) 4.0 10*9/uL. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the description given in the narrative, there is reasonable possibility of causal association between the events and the suspect BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220207; Test Name: sodium; Result Unstructured Data: Test Result:135 MiU/L; Test Date: 20220207; Test Name: HCT; Test Result: 36.5 %; Test Date: 20220207; Test Name: Haemoglobin; Result Unstructured Data: Test Result:12.3 g/l; Test Date: 20220207; Test Name: WBC; Result Unstructured Data: Test Result:4.0 10*9/uL
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Alzheimer's disease; Chronic leukemia; Hyperlipidemia; TIA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 03.03.2022
- Impfdatum
- 07.10.2021
- Beginn
- 22.01.2022
- Tage bis Beginn
- 107,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Aggression
Alanine aminotransferase normal
Anion gap
Anticoagulation drug level above therapeutic
Aspartate aminotransferase normal
Asthenia
Basophil count
Blood albumin decreased
Blood alkaline phosphatase normal
Blood bicarbonate increased
Blood bilirubin normal
Blood calcium decreased
Blood chloride normal
Blood creatinine decreased
Blood glucose normal
Blood lactic acid
Symptomtext
1/22/22 80 yr/o male who presents to the Emergency Department complaining of vomiting blood. Patient is unable to provide any history at this time as he has garbled speech and is combative. Per report EMS was called for the patient either coughing or vomiting blood. He noticed his oxygen levels were low in route. His daughter arrived shortly after began my evaluation at the bedside. She provides majority of the history. She states that he was diagnosed with cancer of his gastroesophageal junction at the end of November. He subsequently developed COVID which he was exposed at the end of December and was in the hospital at an outside facility until the 16th of this month with COVID-pneumonia. He was discharged home on 2 L of oxygen which the daughter states was adequate when he was awake and sitting upright but at night his oxygen would drop and she would have to turn it up to 4 to 5 L. States over the past 2 days he has been complaining of feeling nauseous and not wanting to eat and feeling weak. She states today he was able to take 2 of his morning medications but when attempting to take more he declined stating he did not feel like he could swallow. She states shortly thereafter he began regurgitating a pink-colored fluid. She did not note any cough when this was occurring and states it appeared to be "reflux". This prompted her to call EMS. He has had episodes of regurgitation in the past but has never been discolored. She is not aware of any black or tarry stools. She does note he did not take his Lasix this morning and she has noticed some intermittent swelling of his ankles. She notes that she is the second designee for his medical power of attorney his wife being the first. She is unsure if he has an advanced directive or living well. She will attempt to obtain these or get a hold of the patient's wife so we can discuss his wishes. Physical Exam Constitutional: Appearance: He is underweight. He is ill-appearing. HENT: Head: Comments: There is bright red saliva present in the patient's mouth and face. Neck: Thyroid: No thyroid mass. Cardiovascular: Rate and Rhythm: Normal rate. Rhythm irregular. Pulses: Radial pulses are 1+ on the right side and 1+ on the left side. Pulmonary: Comments: Mildly tachypneic, there is rhonchi at the right middle and lower lobes. Chest: Chest wall: No deformity or crepitus. Abdominal: General: Abdomen is flat. Bowel sounds are decreased. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: Cervical back: Neck supple. Skin: General: Skin is warm. Capillary Refill: Capillary refill takes less than 2 seconds. Coloration: Skin is pale. Neurological: Mental Status: He is easily aroused. He is lethargic and confused. GCS: GCS eye subscore is 3. GCS verbal subscore is 2. GCS motor subscore is 6. Psychiatric: Behavior: Behavior is uncooperative. Hospital Problems: Principal Problem: Acute blood loss anemia (1/22/2022) Active Problems: Pneumonia of both lower lobes due to infectious organism Hemoptysis Discharge Diagnoses: Acute blood loss anemia, hemorrhagic shock, septic shock, sepsis due to aspiration pneumonia, acute respiratory failure with hypoxia, coagulopathy, acute renal failure likely due to ATN Hospital Course: Patient was admitted with impression of acute blood loss anemia due to upper GI bleeding likely from known esophageal cancer exacerbated by anticoagulation on Coumadin with supratherapeutic INR. INR was reversed with Kcentra and IV vitamin K, he received blood product and IV fluids. He was treated for aspiration pneumonia with Zosyn and required intubation for hypoxia and airway protection. Intensivist and GI service manage alongside, however patient's hemodynamic stability declined and he required up to 4 vasopressors. His course was further complicated by AKI suspected to be due to ATN in setting of hypotension/anemia. Patient's family opted to make patient comfort care. Patient expired at 13:14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- 1/22/22 COVID-19 Result Detected Abnormal Laboratory Results: Recent Results (from the past 24 hour(s)) CBC w/Diff Collection Time: 01/22/22 9:56 AM Result Value Ref Range White Blood Count 17.89 (H) 4.5 - 11.0 10*3/uL Red Blood Count 2.78 (L) 4.5 - 5.9 10*6/uL Hemoglobin 8.2 (L) 13.5 - 17.5 g/dL Hematocrit 25.9 (L) 41.0 - 53.0 % Mean Corpuscular Volume 93.2 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.5 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.7 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.1 12.0 - 16.8 % Platelet Count 403 140 - 440 10*3/uL Mean Platelet Volume 9.0 8.4 - 12.4 fL Diff Type CBC w/Manual Differential (arb'U) Neutrophils % 88.2 (H) 45 - 80 % Lymphocyte % 3.6 (L) 15 - 50 % Monocyte % 5.5 0 - 15 % Eosinophil% 2.7 0 - 7 % Nucleated RBC % 0 0 /100(WBC) Absolute Neutrophil Count 15.78 (H) 1.5 - 7.5 /uL Neutrophil Abs 15.78 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.64 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.98 0.0 - 1.7 10*3/uL EOS-Absolute 0.48 0.0 - 0.8 10*3/uL Poikilocytosis 2+ (A) None Seen (arb'U) Anisocytosis 1+ (A) None Seen (arb'U) Microcytosis 1+ (A) None Seen (arb'U) Acanthocytes 2+ (A) None Seen (arb'U) Platelet Estimate Adequate Adequate (arb'U) Comprehensive Metabolic Panel(CMP) Collection Time: 01/22/22 9:56 AM Result Value Ref Range Sodium 140 136 - 145 mmol/L Potassium 4.4 3.5 - 5.1 mmol/L Chloride 106 98 - 107 mmol/L Carbon Dioxide 28 22 - 29 mmol/L Anion Gap 6 5 - 13 (arb'U) Glucose 101 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 28 (H) 8 - 26 mg/dL Creatinine-Blood 0.50 (L) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 56.0 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 4.8 (L) 6.2 - 8.0 g/dL Albumin 2.3 (L) 3.2 - 4.6 g/dL Globulin 2.5 1.5 - 4.5 g/dL Albumin/Globulin Ratio 0.9 (L) 1.1 - 2.5 RATIO Calcium 7.8 (L) 8.4 - 10.2 mg/dL Total Bilirubin 0.9 0.2 - 1.2 mg/dL AST/SGOT 28 5 - 34 U/L ALT/SGPT 15 0 - 55 U/L Alkaline Phosphatase 77 40 - 150 U/L B-Type Natriuretic Peptide Collection Time: 01/22/22 9:56 AM Result Value Ref Range B-Type Natriuretic Peptide 217.4 4 - 254 pg/mL Troponin Collection Time: 01/22/22 9:56 AM Result Value Ref Range Troponin 0.037 (H) 0.000 - 0.034 ng/mL Protime-INR Collection Time: 01/22/22 9:56 AM Result Value Ref Range Prothrombin Time >110.0 (H) 10.3 - 13.3 s INR >11.0 (HH) INR .Partial Thromboplastin Time Collection Time: 01/22/22 9:56 AM Result Value Ref Range Partial Thromboplastin Time 55.6 (H) 25.1 - 36.5 s Type and Screen Collection Time: 01/22/22 10:07 AM Result Value Ref Range ABO/Rh(D) A Positive Antibody Screen Negative Crossmatch Expiration 01/25/2022,2359 Arterial Blood Gas Collection Time: 01/22/22 10:07 AM Result Value Ref Range Allen Test POSITIVE (arb'U) Temperature-ABG 37.0 37.0 Cel pH-ABG 7.49 (H) 7.35 - 7.45 PH PCO2-ABG 39 35 - 48 mm(Hg) PO2-ABG 60 (L) 83 - 108 mm(Hg) HCO3-ABG 30 22 - 30 mmol/L TC02-ABG 31 (H) 22 - 30 mmol/L Base Excess-ABG 6.1 (H) 0 - 3 mmol/L O2 Sat-ABG 93.7 (L) 95.0 - 98.0 % FIO2-ABG 100.0 20 - 100 % Digoxin Collection Time: 01/22/22 10:29 AM Result Value Ref Range Digoxin 0.50 (L) 0.8 - 1.8 ng/mL Lactic Acid Collection Time: 01/22/22 10:51 AM Result Value Ref Range Lactic Acid 2.7 (H) 0.7 - 2.0 mmol/L Lactic Acid Collection Time: 01/22/22 12:08 PM Result Value Ref Range Lactic Acid 2.0 0.7 - 2.0 mmol/L Protime-INR Collection Time: 01/22/22 12:39 PM Result Value Ref Range Prothrombin Time 25.6 (H) 10.3 - 13.3 s INR 2.2 INR CBC w/Diff Collection Time: 01/22/22 12:39 PM Result Value Ref Range White Blood Count 28.64 (H) 4.5 - 11.0 10*3/uL Red Blood Count 2.87 (L) 4.5 - 5.9 10*6/uL Hemoglobin 8.5 (L) 13.5 - 17.5 g/dL Hematocrit 27.4 (L) 41.0 - 53.0 % Mean Corpuscular Volume 95.5 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.6 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.0 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.0 12.0 - 16.8 % Platelet Count 546 (H) 140 - 440 10*3/uL Mean Platelet Volume 9.0 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 87.4 (H) 45 - 80 % Lymphocyte % 5.9 (L) 15 - 50 % Monocyte % 4.5 0 - 15 % Eosinophil% 0.7 0 - 7 % BASO% 0.2 0 - 2 % Immature Granulocyte% 1.3 (H) 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 25.04 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.70 0.7 - 5.5 10*3/uL Monocyte Absolute 1.30 0.0 - 1.7 10*3/uL EOS-Absolute 0.19 0.0 - 0.8 10*3/uL Basophil Abs 0.05 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.36 (H) 0.00 - 0.10 10*3/uL 1/22/22 XR Chest 1 Vw IMPRESSION: Placement of enteric tube with tip projecting over the distal thoracic esophagus, recommend advancement for more optimal positioning. Placement of endotracheal tube in satisfactory position. Moderate to severe right greater than left airspace disease and effusions concerning for pulmonary edema and/or multifocal pneumonia.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Adenocarcinoma of duodenum 11/10/2021 o Adenocarcinoma of gastroesophageal junction 11/10/2021 o Anemia o Anemia 6/11/2014 o Atrial fibrillation o BPH (benign prostatic hypertrophy) o CAD (coronary artery disease) o CPAP (continuous positive airway pressure) dependence o H/O mitral valve repair o Hyperlipidemia o IFG (impaired fasting glucose) o Iron deficiency anemia 4/13/2015 o Left bundle-branch block o Mitral insufficiency o Normocytic anemia 3/27/2017 o Obstructive sleep apnea o Rectal bleeding 6/13/2016 o Sleep apnea o Throat cancer (CMS/HCC) 01/2021 o Tricuspid regurgitation o Unspecified intestinal malabsorption 8/31/2015 o Vitamin D deficiency
- Andere Medikamente
- atorvastatin (LIPITOR) 10 MG tablet Take 10 mg by mouth daily. digoxin (LANOXIN) 0.125 MG tablet Take 1 tablet (125 mcg total) by mouth daily. diltiazem (CARDIZEM CD) 240 MG 24 hr capsule 1 by mouth twice a day 7/17/13 ferrous sulfat
- Allergien
- Benzocaine
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 96,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 02.03.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 301,0
- Dosis
- 1
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Activated partial thromboplastin time
Acute respiratory failure
Alanine aminotransferase normal
Angiogram pulmonary abnormal
Aortic stenosis
Aphasia
Aspartate aminotransferase increased
Aspiration
Blood albumin decreased
Blood calcium decreased
Blood creatinine normal
Blood glucose increased
Blood sodium decreased
Blood urea increased
Bronchial secretion retention
Complication associated with device
Death
Facial wasting
Symptomtext
12/29/21 96 yr/o female with a history of aspiration PNA with sepsis and prolonged hospitalization complicated by COVID pneumonia. The was then discharge dto a subacute rehab but returned to the hospital on 12/26/2021 with concern for infected Gtube as well as being found supine with tube feeds in progress and additional aspiration. She had a CTA of the chest at time of evaluation with lateral lung consolidation in LLL and bilateral lower lung mucous plugging. She had desaturations and acute hypoxic respiratory failure. Initially she was placed on IV antibiotics including vancomycin and zosyn. The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for possible upper GI bleed as well. The pt remained non-verbal and did not have any significant changes/improvements while at the hospital. Family elected to forego further aggressive interventions and decided to focus on comfort as the primary goal. All aggressive interventions, including antibiotics were discontinued. She was transferred to Facility for further symptom management as she was requiring parenteral lorazepam and morphine. The pt is unresponsive at this time but family present at bedside. Spoke with sisters and brother at the bedside and they recounted the previously 2 months of medical issues that have led the pt to where she is currently. They remain focused on comfort as the primary goal and don't have any acute questions at this time. Physical Exam Constitutional: General: She is not in acute distress. Appearance: She is ill-appearing. She is not diaphoretic. Comments: Unresponsive to verbal or tactile stimuli, lying in bed in recovery position; NAD HENT: Head: Comments: Mild temporal wasting present Mouth/Throat: Mouth: Mucous membranes are moist. Pharynx: No oropharyngeal exudate. Comments: No drainage noted Eyes: General: No scleral icterus. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: No murmur heard. No friction rub. No gallop. Pulmonary: Comments: Short, shallow breathing pattern present with rhonchi noted throughout Abdominal: General: There is no distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. Comments: Absent bowel sounds Musculoskeletal: General: No swelling or tenderness. Skin: General: Skin is warm and dry. Neurological: Comments: Unresponsive to verbal or tactile stimuli, no myoclonus 1/2/22 Cause of death: aspiration pneumonia SECONDARY DIAGNOSES: 1. COVID 19 2. Aortic stenosis 3. HTN 4. Possible GI bleed HOSPITAL COURSE: The patient was a 96 yr/o-year-old female with a history of aspiration PNA with sepsis and prolonged hospitalization complicated by COVID pneumonia. She was then discharged to subacute rehab but returned to the hospital on 12/26/2021 with concern for infected Gtube as well as being found supine with tube feeds in progress and additional aspiration. She had a CTA of the chest at time of evaluation with lateral lung consolidation in LLL and bilateral lower lung mucous plugging. She had desaturations and acute hypoxic respiratory failure. Initially she was placed on IV antibiotics including vancomycin and zosyn. The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for possible upper GI bleed as well. The pt remained non-verbal and did not have any significant changes/improvements while at the hospital. Family elected to forego further aggressive interventions and decided to focus on comfort as the primary goal. All aggressive interventions, including antibiotics were discontinued. She was transferred the Inpatient Care Center for further symptom management as she was requiring parenteral lorazepam and morphine. At time of admission to the Facility the pt had a PPS of 10% and prognosis judged to be limited to days. Parenteral medications were ordered for comfort including morphine, ativan and haldol. She continued to decline and died 1/2/22 @ 1759
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- 12/28/21 COVID-19 Result Detected Abnormal; Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/27/21 1300 12/28/21 0323 WBC 26.63* 18.19* 20.91* -- 23.18* HGB 10.3* 10.0* 8.4* 7.7* 7.7* HCT 31.1* 32.1* 26.8* 24.0* 23.8* MCV 93.4 96.4 96.1 -- 95.2 Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/28/21 0323 NA 134* 134* 132* 132* CO2 22 27 25 23 BUN 34* 38* 38* 26* CREATININE 0.66 0.80 0.80 0.81 GLUCOSE 218* 160* 177* 100* Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/28/21 0323 CALCIUM 8.7 9.0 8.3* 7.7* No results for input(s): INR, PROTIME, PTT in the last 168 hours. Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 ALT 24 34 30 AST 20 36* 35* ALBUMIN 2.3* 2.5* 2.3* Recent Labs Lab 12/26/21 2354 COLORU Yellow CLARITYU Clear PH 8.0 LEUKOCYTESUR Negative RBCUA 2 WBCUA 4* CTA chest, 12/26/2021: 1. Bilateral lung consolidation most pronounced in the left lung base with bilateral lower lobe mucous plugging representing pneumonia likely secondary to aspiration, which is favored over COVID-19 pneumonia. Trace left-sided pleural effusion. 2. 7 mm cyst in the pancreas. Yearly follow-up can be obtained as clinically warranted. 3. Findings stercoral colitis. 4. Asymmetric fat stranding in the left lateral abdominal wall at the level gastrostomy tube insertion, which may represent cellulitis in the proper clinical setting. The gastrostomy tube is in proper position and there is no drainable fluid collection. 5. Unchanged T7 compression fracture.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Aortic stenosis o Benign essential HTN o Bilateral leg edema o Bleeding 12/26/2021 Gtube site o History of rectal fissure o Varicose veins of both lower extremities
- Andere Medikamente
- acetaminophen (TYLENOL) 650 MG suppository; LORazepam (ATIVAN) 2 MG/ML injection Infuse 1 mL into the vein every 2 (two) hours as needed (anxiety/agitation). morphine 2 MG/ML injection Infuse 1 mL into the vein every 2 (two) hours as n
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 19.02.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 223,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Patient staying in nursing home; positive test for COVID-19 on 9/30/21; O2 supplementation and antibiotics; DNR; comfort measures; patient died in the facility.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 02.03.2022
- Impfdatum
- 26.02.2021
- Beginn
- 01.09.2021
- Tage bis Beginn
- 187,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Death
Decreased appetite
Productive cough
SARS-CoV-2 test positive
Symptomtext
pt spent a few days in the hospital with c/o weakness, poor appetite, productive cough; positive test for COVID; no hypoxia; was released after observation to HCF - healthcare facility where medical records show he passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 29.10.2021
- Beginn
- 10.01.2022
- Tage bis Beginn
- 73,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Activated partial thromboplastin time
Acute kidney injury
Acute respiratory failure
Alanine aminotransferase normal
Albumin globulin ratio
Angiogram pulmonary abnormal
Anion gap
Aspartate aminotransferase increased
Asthenia
Basophil count decreased
Basophil percentage decreased
Blood albumin normal
Blood alkaline phosphatase normal
Blood bicarbonate normal
Blood bilirubin normal
Blood calcium increased
Blood chloride decreased
Blood creatinine normal
Symptomtext
1/12/22 68 yr/o female past medical history of anemia hypertension multiple myeloma her hematologist is Dr., she is fully vaccinated and boosted against COVID Has been feeling badly for a few days tested positive for COVID on January 10 2 days previously, woke up this morning feeling awfully weak tired short of breath and so called EMS Her shortness of breath limits history EMS reports finding her satting 70% on room air tachycardic but normotensive on their arrival, but time I evaluate patient she is on nasal cannula satting in low 90s but tachypneic to the 30s She denies chest pain ROS Gen: Negative except as in HPI Eyes: no redness and no drainage ENT: no rhinorrhea and no congestion ROS CV: no murmur and no chest pain Resp: Negative except as in HPI GI: no nausea , no vomiting and no diarrhea GU: good UOP MSK: no back pain, no joint swelling, no myalgias Neuro: no weakness, no numbness, no headache Hem: no bruising and no bleeding Skin: no rash Admit date: 1/12/2022 Discharge date and time: 1/17/2022, 5:07 PM Discharge Diagnoses: Principal Problem: Acute respiratory failure due to COVID-19 (CMS/HCC) (1/12/2022) Active Problems: Multiple Myeloma of 2016 (7/25/2016) Hyperlipidemia (9/25/2017) Chronic pain (5/30/2020) Followed by palliative care service (5/30/2020) Multiple myeloma in relapse (CMS/HCC) (1/19/2021) Cardiomyopathy (CMS/HCC) (1/14/2022) LV dysfunction: EF=26% (1/17/2022) Hypotension (arterial) (1/17/2022) Discharge Condition: deceased Consults: INPATIENT CONSULT TO PHARMACY IP CONSULT TO HOSPITALIST IP CONSULT TO PULMONOLOGY IP CONSULT TO CARDIOLOGY IP CONSULT TO HEMATOLOGY IP CONSULT TO PALLIATIVE CARE INPATIENT CONSULT TO PHARMACY IP CONSULT TO PALLIATIVE CARE Hospital Course: Acute hypoxic Resp failure Covid + Vaccinated yet compromised status - Multiple Myeloma CTA noted Bipap-O2 support -> intubation and Vent today pulm tx Steroids remdesivir Empiric abx's initiated Now on baricitinib Check procal Ok Tenuous status throughout Monitored closely - inflam markers pulm CC followed Hypotension Post intubation Pressor support -IVF's- along with Amio ->ST Wean New Onset Sys HF -CM Elevated Trop BNP + Echo EF 26% Cards eval-mgmt Med rx - IV diuresis Cards initiated Isordil ,hydralaine, note BB allergy Lisinopril , aldactone Hep gtt AKI Rising Bun/Cr Setting of diuresis Concern with possible ATN - hypotension Hyperglycemia -sec steroids and TF's Added Basal SS a1c -6.6 Trend MM Followed by hematology Asked to see Cont same - add followed by Palliative care - ask to see apprec input HLD Was On statin Nut - NPO DHT-TF DVT ppx- AC Code Status-DNR Clinical course worsened throughout the day As above - now intubated -Required multiple pressors - Pulmonary Critical Care spoke with family - now at bedside - along with Palliative service - > family opted to pursue terminal / compassionate extubation with comfort measures- with subsequent death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- COVID Result IPOC PCR Detected Abnormal CBC w/Diff Collection Time: 01/12/22 1:49 PM Result Value Ref Range White Blood Count 10.44 4.5 - 11.0 10*3/uL Red Blood Count 4.25 4.0 - 5.2 10*6/uL Hemoglobin 13.4 12.0 - 16.0 g/dL Hematocrit 39.1 36.0 - 46.0 % Mean Corpuscular Volume 92.0 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 31.5 26.0 - 34.0 pg Mean Corpuscular HGB Conc 34.3 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 13.9 12.0 - 16.8 % Platelet Count 279 140 - 440 10*3/uL Mean Platelet Volume 10.2 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 84.7 (H) 45 - 80 % Lymphocyte % 3.3 (L) 15 - 50 % Monocyte % 10.3 0 - 15 % Eosinophil% 0.0 0 - 7 % BASO% 0.1 0 - 2 % Immature Granulocyte% 1.6 (H) 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 8.84 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.34 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 1.08 0.0 - 1.7 10*3/uL EOS-Absolute 0.00 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.17 (H) 0.00 - 0.10 10*3/uL CMP Collection Time: 01/12/22 1:49 PM Result Value Ref Range Sodium 129 (L) 136 - 145 mmol/L Potassium 3.6 3.5 - 5.1 mmol/L Chloride 93 (L) 98 - 107 mmol/L Carbon Dioxide 21 (L) 22 - 29 mmol/L Anion Gap 15 (H) 5 - 13 (arb'U) Glucose 206 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 29 (H) 10 - 20 mg/dL Creatinine-Blood 0.78 0.55 - 1.02 mg/dL BUN/Creatinine Ratio 37.2 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 6.9 6.2 - 8.0 g/dL Albumin 3.9 3.2 - 4.6 g/dL Globulin 3.0 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.3 1.1 - 2.5 RATIO Calcium 9.2 8.4 - 10.2 mg/dL Total Bilirubin 0.5 0.2 - 1.2 mg/dL AST/SGOT 39 (H) 5 - 34 U/L ALT/SGPT 19 0 - 55 U/L Alkaline Phosphatase 73 40 - 150 U/L Troponin I Collection Time: 01/12/22 1:49 PM Result Value Ref Range Troponin 0.290 (HH) 0.000 - 0.034 ng/mL Arterial Blood Gas Collection Time: 01/12/22 1:49 PM Result Value Ref Range Allen Test POSITIVE (arb'U) Temperature-ABG 37.0 37.0 Cel pH-ABG 7.40 7.35 - 7.45 PH PCO2-ABG 36 32 - 45 mm(Hg) PO2-ABG 95 83 - 108 mm(Hg) HCO3-ABG 22 22 - 30 mmol/L TC02-ABG 24 22 - 30 mmol/L Base Deficit-ABG 1.9 0 - 3 mmol/L O2 Sat-ABG 96.7 95.0 - 98.0 % FIO2-ABG 100.0 20 - 100 % .Partial Thromboplastin Time Collection Time: 01/12/22 3:40 PM Result Value Ref Range Partial Thromboplastin Time 20.1 (L) 25.1 - 36.5 s 1/12/22 XR Chest 1 Vw IMPRESSION: 1. Patchy peripheral bilateral airspace disease can be seen with Covid pneumonia. CT Angiogram Chest For PE IMPRESSION: 1.No central or proximal segmental pulmonary embolism. Distal evaluation limited by motion. 2.Extensive patchy and confluent groundglass airspace disease likely due to COVID pneumonia, given clinical history. ARDS would have a similar imaging appearance. 3.The tip of the left chest port catheter extends through the tricuspid valve and is just inside the right ventricle. No change from the prior. 4.Extensive chronic osseous abnormalities, stable.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anemia 2020 o Arthritis o Blood transfusion without reported diagnosis 2/2017 Received blood and platelets o GERD o GERD (gastroesophageal reflux disease) 2005,2017 o Hyperlipidemia o Hypertension o Multiple myeloma (CMS/HCC) DX 7/2016 Hematologist o Osteoporosis
- Andere Medikamente
- acyclovir 200 MG capsule acyclovir 200 MG capsule albuterol HFA 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet atorvastatin 20 MG tablet Caltrate 600+D 600-400 MG-UNIT DARZALEX IV dexamethasone 4 MG tablet fluticasone 27.5
- Allergien
- Bisoprolol, Talwin, Amlodipine
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 11.03.2021
- Beginn
- 02.01.2022
- Tage bis Beginn
- 297,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Alanine aminotransferase normal
Albumin globulin ratio decreased
Anion gap
Aspartate aminotransferase normal
Asthenia
Back pain
Basophil count decreased
Basophil percentage decreased
Bilirubin urine
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium decreased
Blood chloride increased
Blood creatinine increased
Blood culture
Symptomtext
1/2/22 86 yr/o male who presents with low blood pressure which began yesterday. History is obtained through the son who is translating for the patient. The son states that the patient has baseline confusion and is unable to contribute to the history. The son reports that yesterday his blood pressure was in the 50s systolic and this morning it was in the 70s systolic. Son relates that the patient vomited yesterday. He has been generally weak and unable to walk since yesterday. He had a fall 2 days ago but the son reports that it was not a bad fall. Son reports that he is complaining of low back pain. But he has not complained of any chest or abdominal pain headache or other complaints. But has not he has not complained of any chest or abdominal pain headache or other complaints. He has had a cough. There is no report of fever. Patient has had 2 Covid vaccinations. Review of Systems: Respiratory: Positive for cough. Gastrointestinal: Positive for vomiting. Musculoskeletal: Positive for back pain. Neurological: Positive for weakness. Psychiatric/Behavioral: Positive for confusion. ROS is limited in this patient who has baseline confusion and does not speak English, CBC W/DIFF - Abnormal, White Blood Count 9.45 4.5 - 11.0 10*3/uL, Red Blood Count 4.10 (*) 4.5 - 5.9 10*6/uL, Hemoglobin 12.6 (*) 13.5 - 17.5 g/dL, Hematocrit 39.3 (*) 41.0 - 53.0 %, Mean Corpuscular Volume 95.9 80.0 - 100.0 fL, Mean Corpuscular Hemoglobin 30.7 26.0 - 34.0 pg, Mean Corpuscular HGB Conc 32.1 31.0 - 37.0 g/dL, Red Cell Distribution Width-CV 12.5 12.0 - 16.8 %, Platelet Count 170 140 - 440 10*3/uL, Mean Platelet Volume 10.0 8.4 - 12.4 fL, Diff Type Hospital CBC w/AutoDiff (arb'U), Neutrophils % 82.0 (*) 45 - 80 %, Lymphocyte % 9.5 (*) 15 - 50 %, Monocyte % 6.1 0 - 15 %, Eosinophil% 1.8 0 - 7 %, BASO% 0.2 0 - 2 %Immature Granulocyte% 0.4 0.0 - 1.0 %, Nucleated RBC % 0 0 /10, 0(WBC), Neutrophil Abs 7.74 2.0 - 8.8 10*3/uL, Lymphocyte-Absolute 0.90 0.7 - 5.5 10*3/uL, Monocyte Absolute 0.58 0.0 - 1.7 10*3/uL, EOS-Absolute 0.17 0.0 - 0.8 10*3/uL, Basophil Abs 0.02 0.0 - 0.2 10*3/uL, Immature Granulocyte Abs 0.04 0.00 - 0.10 10*3/uL. COMPREHENSIVE METABOLIC PANEL (CMP) - Abnormal, Sodium 137 136 - 145 mmol/L, Potassium 4.8 3.5 - 5.1 mmol/L, Chloride 110 (*) 98 - 107 mmol/L, Carbon Dioxide 14 (*) 22 - 29 mmol/L, Anion Gap 13 5 - 13 (arb'U), Glucose 141 (*) 74 - 99 mg/dL, Blood Urea Nitrogen (BUN) 49 (*) 8 - 26 mg/dL, Creatinine-Blood 2.69 (*) 0.73 - 1.18 mg/dL, BUN/Creatinine Ratio 18.2 RATIO, Estimated GFR 23 (*) >60 /1.73 m2, Estimated GFR if African-American 27 (*) >60 /1.73 m2, Total Protein 7.4 6.2 - 8.0 g/dL, Albumin 3.6 3.2 - 4.6 g/dL, Globulin 3.8 1.5 - 4.5 g/dL, Albumin/Globulin Ratio 0.9 (*) 1.1 - 2.5 RATIO, Calcium 8.2 (*) 8.4 - 10.2 mg/dL, Total Bilirubin 0.7 0.2 - 1.2 mg/dL, AST/SGOT 35 (*) 5 - 34 U/L, ALT/SGPT 20 0 - 55 U/L, Alkaline Phosphatase 58 40 - 150 U/L. LACTIC ACID - Abnormal, Lactic Acid 2.1 (*) 0.7 - 2.0 mmol/L. CULTURE, URINE, CULTURE, BLOOD. TROPONIN, Troponin <0.010 0.000 - 0.034 ng/mL. B-TYPE NATRIURETIC PEPTIDE, B-Type Natriuretic Peptide 28.0 4 - 254 pg/mL. LIPASE, Lipase 33 4 - 39 U/L. URINALYSIS, Color-Urine Yellow, Clarity-Urine Clear. Specific Gravity Urine 1.010 1.005 - 1.030 (arb'U), pH-Urine 5.0 5.0 - 9.0 (pH), Protein-Urine Negative Negative mg/dL, Glucose-Urine Negative Negative mg/dL, Ketone-Urine Negative Negative mg/dL, Bilirubin-Urine Negative Negative mg/dL. Occult Blood-Urine Negative Negative (arb'U), Nitrite-Urine Negative Negative (arb'U), Urobilinogen-Urine Normal Normal (EhrlichU)/dL, Leukocyte Esterase-Urine Negative Negative (arb'U), Source-Urine Urine Midstream. Reflex Microscopic? Macroscopic only performed. 1/2/22 XR Chest 1 Vw IMPRESSION: 1. Extensive airspace disease in the right lung may represent pneumonia. Would recommend radiographic follow-up to resolution. 2. Patchy airspace disease in the left lung base may represent atelectasis and/or pneumonia. Discharge Diagnoses: Principal Problem: Pneumonia due to COVID-19 virus (1/2/2022). Active Problems: AKI (acute kidney injury) (1/2/2022), Severe sepsis (1/2/2022), Metabolic acidosis (1/2/2022), BPH (benign prostatic hyperplasia) (6/1/2015), Vascular dementia (6/10/2015), Type 2 diabetes mellitus without complication, without long-term current use of insulin (8/18/2020). H/O: CVA (cerebrovascular accident) (1/2/2022), Acute respiratory failure with hypoxia (1/3/2022). History of Present Illness: Patient is not a good historian. History taken from son who speaks some English and the ED staff. This is an 86 yr/o male who presents with low blood pressure which began yesterday PTA. History is obtained through the son who is translating for the patient. The son states that the patient has baseline confusion and is unable to contribute to the history. The son reports that yesterday his blood pressure was in the 50s systolic and this morning it was in the 70s systolic. Son relates that the patient vomited yesterday. He has been generally weak and unable to walk since yesterday. He had a fall 2 days ago but the son reports that it was not a bad fall. Son reports that he is complaining of low back pain. But has not he has not complained of any chest or abdominal pain headache or other complaints. He has had a cough. There is no report of fever. Patient has had 2 Covid vaccinations. 1/11/22 Hospital Course: Pneumonia due to COVID-19 virus/Acute Hypoxic Respiratory Failure, Inflammatory markers improving, Started IV Decadron and Remdesivir - continue same, Baricitinib added 1/4 after transfer to ICU, CAP/aspiration antibiotics to continue - day 8 of 10, Pulm on consult - appreciate assistance, Back on BiPap - D-dimer notable jump 10k to 21k. AKI with metabolic acidosis and hypernatremia. Hx of BPH and urinary retention, Likely pre-renal ATN. Renal US with no hydro, Monitor UOP and serial labs, Continue Flomax, Renal consulted - appreciate assistance, Creatinine overall mildly improved but not at baseline. Continuing FW for hypernatremia and adding D5W IVF. Severe sepsis, POA, From COVID and likely underlying aspiration pneumonia. IVF, supportive care, and treat underlying infections, Back on Pressors as of 1/10 - likely r/t sedation. Vascular dementia/H/o CVA. Delirium vs metabolic encephalopathy, PT/OT when appropriate. Continue aspirin, Minimizing sedating meds as able. Correct metabolic derangements. Type 2 diabetes mellitus without complication, without long-term current use of insulin, Mildly uncontrolled. Was on adjusted Lantus and ISS. Patient was made DNR/DNI during his admission by family, and today his respiratory status worsened to the point he could no longer sustain himself. He passed naturally at 13:50 on 1/11/2022. Cause of death is acute respiratory failure from COVID pneumonia and a possible secondary bacterial pneumonia. I have spoken to the patient's son today, he understands his hospitalization course.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- 1/2/22 COVID-19 Result Detected Abnormal.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- AKI (acute kidney injury) 1/2/2022, BPH (benign prostatic hyperplasia), Gout, Hypertension
- Andere Medikamente
- amLODIPine (NORVASC) 10 mg tablet Take 1 tablet by mouth daily, ASPIRIN 81 PO Take by mouth, finasteride (PROSCAR) 5 MG tablet Take 1 tablet by mouth daily, metFORMIN (GLUCOPHAGE-XR) 500 MG Tablet Extended Release 24 Hour Take 2 tablets by
- Allergien
- Bactrim
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 22.10.2021
- Beginn
- 23.02.2022
- Tage bis Beginn
- 124,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Basal ganglia stroke
COVID-19
Computerised tomogram head abnormal
Death
Depressed level of consciousness
Dyspnoea
Inappropriate schedule of product administration
Mental status changes
Oxygen saturation decreased
Positive airway pressure therapy
SARS-CoV-2 test positive
Unresponsive to stimuli
Symptomtext
Moderna and Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 2/22/21 and Pfizer Vaccine on 3/15/21 and 10/22/21. Presented to ED on 2/11/22 Covid+, d/c'd 2/12/22. Reported sats of 88-94% Presented to ED 2/16/22 w/increasing SOB and AMS. Placed on BiPAP. 2/23/22 not arousable. Pt began to desaturate and unresponsive. CT head with Acute left basal ganglia stroke. Transitioned to comfort care only, expired on 2/23/22. Treated with medrol dosepack, decadron, zosyn, and ceftriaxone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- 2/11/22: This sample was analyzed on the (Privacy) platform using RT-PCR technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hx of CLL, CKD4, RA
- Andere Medikamente
- albuterol, amlodipine, benzonatate,calcium polycarbophil, vitamin D3, codeine/guaifenesin, dronedarone, ferrous sulfate, fluticasone, fluticasone/vilanterol, folic acid, guaifenesin, hydroxychloroquine, ibrutinib, L.acid/B.bifiddum, metopro
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 25.02.2021
- Beginn
- 09.02.2022
- Tage bis Beginn
- 349,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Acute respiratory failure
Atrial fibrillation
COVID-19
Death
Distributive shock
Dyspnoea
Endotracheal intubation
Pleural effusion
Pyrexia
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/4/21 and 2/25/21. Presented to ED 2/6/22 with SOB and sxs worsened over 3 weeks. Previous Friday to admission began having fevers, prescribed azithromycin and inhalers. Tested negative for covid 2-3 times. Admitted for A-fib and acute hypoxic resp failure 2/2 Covid. Required HFNC during admission, intubated 2/8. STEMI 2/9 c/b distributive shock and bil. pleural effusions. Transitioned to comfort care. Tx'd with decadron, solumedrol, baricitinib,cefepime and vancomycin. Expired 02/09/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Afib, HLD, OA
- Andere Medikamente
- tylenol, chlorhexidine, docusate, ezetimibe, finasteride, gabapentin, HC/tylenol, hydromorphone,medrol dose pack, mupirocin, pantoprazole, xarelto, tapentadol, trazodone
- Allergien
- atorvastatin
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 22.10.2021
- Beginn
- 13.02.2022
- Tage bis Beginn
- 114,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
pt admitted to hospital after having covid 19, with possible stroke. pt expired 2/13/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 04.02.2021
- Beginn
- 30.01.2022
- Tage bis Beginn
- 360,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Cough
Death
Dyspnoea
Fatigue
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/14/2021 and 2/4/2021. Telehealth visit 1/21/2022 c/o sore throat and persistent cough, declined COVID testing, given prescriptions for azithromycin and guaifenesin AC syrup. Presented to ED 1/30/2022 c/o of SOB, fatigue, fever and positive home COVID test on 1/24/2022. On presentation respiratory rate of 24 with an SpO2 of 81%. Admitted for acute hypoxic resp failure 2/2 Covid PNA. Treated with methylprednisolone, tocilizumab, and Max HF of 60L 95% FiO2 with O2 sat down to 86%. 2/4/2022 expressed desire to cease all Covid treatment, remove HFNC, w/comfort measures only. Expired 2/5/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- Positive COVID-19 on 1/30/2022 using the BioFire FilmArray
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, Myasthenia gravis in remission after thymectomy, hx of right hemidiaphragm paralysis due to phrenic nerve damage from previous right lower lobectomy, Sleep Apnea, BPH.
- Andere Medikamente
- Atorvastatin, Colestipol, Guaifenesin with codeine, Tamsulosin, Trazodone.
- Allergien
- Ciprofloxacin, Penicillin, Grass Pollen
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 26.02.2021
- Beginn
- 16.01.2022
- Tage bis Beginn
- 324,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Blood creatinine increased
Blood lactic acid decreased
Blood potassium normal
Blood sodium increased
Blood urea increased
COVID-19
COVID-19 pneumonia
Carbon dioxide decreased
Computerised tomogram thorax abnormal
Death
Dyspnoea
Hypotension
Hypoxia
Lung opacity
Positive airway pressure therapy
Rectal haemorrhage
Respiratory distress
SARS-CoV-2 test positive
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021 and 2/26/2021. Presented to ED on 1/15/2022 with complaints of rectal bleeding and SOB. Admited for acute hypoxemic respiratory distress due to Covid PNA. In ED, noted to be borderline hypotensive and hypoxic at 87%. Placed on BiPAP and his O2 improved. Labs revealed significant metabolic derangements including creatinine 6.24, BUN 120, CO2 18, sodium 160 but K was normal. Lactate was 1.1 and WBC was 5.9. Non-contrast CT chest confirms GGO consistent with Covid pneumonia. Treated with azithromycin, rocephin, and decadron. DNAR status. Expired on 1/26/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- 1/15/22 Covid + : This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, CKD 3 with recent AKI, prostate cancer s/p radiation tx severe diverticulitis requiring right hemicolectomy, advanced non-verbal dementia,
- Andere Medikamente
- alprazolam, amlodipine, memantine, quetiapine, synthroid
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 17.11.2021
- Beginn
- 13.01.2022
- Tage bis Beginn
- 57,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Acute respiratory failure
COVID-19
Death
Hypoxia
Renal failure
SARS-CoV-2 test positive
Septic shock
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/3/2021, 2/24/2021, and 11/17/2021. Patient tested positive at nursing home on 1/13/2022. Presented to ED on 1/20/22 for abdominal pain and hypoxia. Admitted for septic shock, acute respiratory failure, and renal failure. Received oxygen supplementation, dexamethasone, antibiotics, and pressors. On 1/21/2021, patient requested comfort care. Family in agreement. Expired 1/21/2022 at 1255.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 1,0
- Labordaten
- 1/13/2022: COVID positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, dyslipidemia CAD, history of colon cancer, fatty liver disease, mitral regurgitation, gout
- Andere Medikamente
- allopurinol, aspirin, lipitor, lisinopril, metoprolol, ursodiol, multivitamin
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 30.08.2021
- Beginn
- 02.01.2022
- Tage bis Beginn
- 125,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Anxiety
Aortic valve incompetence
COVID-19
COVID-19 pneumonia
Computerised tomogram thorax abnormal
Constipation
Cough
Echocardiogram abnormal
Hypertension
Hypoxia
Lumbar radiculopathy
Lung opacity
Mitral valve incompetence
Muscle spasms
Osteopenia
Osteoporosis
Pathological fracture
Symptomtext
86 year old female with pmh htn who was admitted for covid 19, acute respiratory failure. Please see h and p for details. The following issues were addressed: 1. Covid 19 virus infection/viral pneumonia - vaccinated - ct chest shows ground glass pulmonary infiltrates in a pattern highly suggestive of Covid 19 pneumonitis - status post remdesivir - received iv hydrocortisone, transitioned to iv decadron while in hospital - will discharge on oral decadron to complete course - continue zinc, vit c - needs repeat imaging as outpatient with pcp to ensure resolution 2. Viral sepsis (temp 95.7, respiratory rate 25), poa - afebrile > past 24 hours 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 4L with ambulation as determined by walking oximetry 4. Polymyalgia rheumatica - on prednisone at time of admission - resume 1/16/22 5. Hypertension, uncontrolled - continue hydralazine, metoprolol, lisinopril, hctz - continue prn clonidine as outlined below - patient to monitor blood pressure at home - record, bring to appointment with pcp/discuss with virtual hospital - may need further adjustment of medications as outpatient with pcp 6. Anxiety - started prn hydroxyzine as outlined below Dispo - PT recommends home health, will be arranged prior to discharge as well as virtual hospital START taking these medications Details benzonatate (TESSALON) 100 MG capsule Take 1 capsule by mouth 3 (three) times daily as needed for Cough. cloNIDine (CATAPRES) 0.1 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed (sbp >170 or dbp >100). dexamethasone (DECADRON) 6 MG tablet Take 1 tablet by mouth daily with breakfast Take last dose on 1/15/22. dextromethorphan polistirex ER (DELSYM) 30 MG/5ML liquid Take 5 mLs by mouth every 12 (twelve) hours as needed for Cough. hydroCHLOROthiazide (HYDRODIURIL) 12.5 MG tablet Take 1 tablet by mouth daily. hydrOXYzine (ATARAX) 10 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed for Anxiety. lisinopril (PRINIVIL) 40 MG tablet Take 1 tablet by mouth daily. sennosides (SENOKOT) 8.6 MG TABS Take 1 tablet by mouth daily as needed (constipation). vitamin C (VITAMIN C) 500 MG tablet Take 1 tablet by mouth daily. zinc sulfate (ZINCATE) 220 (50 Zn) MG capsule Take 1 capsule by mouth daily. CONTINUE these medications which have CHANGED Details hydrALAZINE (APRESOLINE) 100 MG tablet Take 1 tablet by mouth every 8 (eight) hours. metoprolol, TOPROL-XL, 25 MG 24 hr tablet Take 3 tablets by mouth daily. predniSONE (DELTASONE) 1 MG tablet Take 6 tablets by mouth daily Resume 1/16/22. CONTINUE these medications which have NOT CHANGED B Complex CAPS Take 1 tablet by mouth daily. Calcium Citrate-Vitamin D (CALCIUM CITRATE + D PO) Take 1 tablet by mouth daily Cholecalciferol (VITAMIN D3) 2000 UNITS capsule Take 2,000 Units by mouth daily. FIBER ADULT GUMMIES PO Take by mouth daily ibandronate (BONIVA) 150 MG tablet Take 1 tablet by mouth every 30 (thirty) days. Associated Diagnoses: Age-related osteoporosis with current pathological fracture, initial encounter MAGNESIUM PO Take 1 tablet by mouth. Multiple Vitamin (MULTIVITAMIN) tablet Take 1 tablet by mouth daily. Omega-3 Fatty Acids (FISH OIL) 1000 MG CAPS Take 2,000 mg by mouth daily Arthritis NECK Frequent PVCs 06/2018 Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by biopsy. PATIENT DENIES THYROID ISSUES H/O cardiovascular stress test 7/2012 DR. History of chicken pox MEASLES, MUMPS AS A CHILD History of fracture RIGHT SMALL FINGER History of pleurisy 1/9/14 Hypertension Left bundle branch block (LBBB) 06/2018 Lumbar radiculopathy LVH (left ventricular hypertrophy) 06/2018 Echocardiogram mild mitral aortic regurgitation Mobitz type 1 second degree AV block 06/2018 Nocturnal leg cramps Obstructive sleep apnea Hypoxia uses CPAP Osteopenia PVC (premature ventricular contraction) 03/2017 Renal cell cancer (CMS/HCC) 2014 Varicose veins
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Arthritis NECK o Frequent PVCs 06/2018 o Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by
- Andere Medikamente
- START taking these medications Detailsbenzonatate (TESSALON)
- Allergien
- Codeine, Cardura, Morphine, Sulfa, Penicillin, Norvasc
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 01.02.2022
- Impfdatum
- 04.03.2021
- Beginn
- 16.10.2021
- Tage bis Beginn
- 226,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Confusional state
Death
Dyspnoea
Cough
Delirium
Mental status changes
Pyrexia
SARS-CoV-2 test positive
Pulmonary oedema
Symptomtext
pt brought to ED from SNF after being diagnosed positive for COVID 4 days prior; c/o SOB and more confused than normal; has taken antibiotic and prednisone since COVID diagnosis; came to hospital with 3 L O2 via NC; DNR/DNI; found to have pulmonary edema and acute respiratory failure; treated with dexamethasone, redesivir, baricitinib; poor prognosis; maxed out on Vapotherm with O2 sats in the 80s%; transitioned to comfort care and died shortly afterwards in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- metastatic prostate CA, DMTW, HLD, HTN, COPD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 31.01.2022
- Impfdatum
- 04.03.2021
- Beginn
- 18.01.2022
- Tage bis Beginn
- 320,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Cardiomegaly
Chest X-ray abnormal
Dyspnoea
Lung infiltration
SARS-CoV-2 test positive
Sepsis
Symptomtext
Came to the ED for worsening SOB for the past few days. Tested + for COVID one week ago (1/18/22). XR Chest 1V [Auth (Verified)] (01/26 1418): FINAL IMPRESSION: Stable scattered perihilar and lower lobe interstitial infiltrates with stable cardiomegaly. Evidence of prior sternotomy. Admitted to inpatient for COVID infection with sepsis with acute hypoxic respiratory failure. Patient had been previously vaccinated but not boosted Pfizer 2/10/21 & 3/4/21. Discharged 1/31/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- COVID 19 + 1/18/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma, A-fib, Hypertension, CAD, hyperlipidemia, skin cancer, COPD on home O2; CABG x4
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 31.01.2022
- Impfdatum
- 10.02.2021
- Beginn
- 24.01.2022
- Tage bis Beginn
- 348,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute myeloid leukaemia
Arthralgia
COVID-19
COVID-19 pneumonia
Confusional state
Death
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Received Pfizer vaccines on 1/20/21, 2/10/21 positive for COVID by PCR on 1/24/22 admitted to hospital 1/24/22-1/30/22 for bilateral hip pain, confusion, underlying AML Expired 1/30/22 d/t hypoxic respiratory failure, COVID-19 pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 96,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 25.02.2021
- Beginn
- 18.12.2021
- Tage bis Beginn
- 296,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Atrial fibrillation
Cough
Death
Dyspnoea
General physical health deterioration
Hypotension
Hypoxia
Myalgia
Symptomtext
pt brought to ED with c/o SOB, cough, and myalgias; found to be hypoxic; started on O2 via NC; hypotensive; AKI; started on dexamethasone and bronchodilators; developed A Fib with rapid ventricular rate; continued to hypotensive and condition declined requiring high flow O2 and NRB mask; DNR/DNI; condition deteriorated; placed on comfort based care and died in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 02.02.2021
- Beginn
- 26.09.2021
- Tage bis Beginn
- 236,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Endotracheal intubation
General physical health deterioration
Positive end-expiratory pressure
Renal failure
Respiratory distress
SARS-CoV-2 test positive
Symptomtext
pt brought to ED via EMS with c/o O2 sats at home in the 60s; positive for COVID; EMS placed pt on O2 via NC and 100% NRB mask; O2 sats 80%; respiratory distress and kidney failure; intubated and admitted to hosp; too unstable for dialysis; O2 in 70s% on high PEEP and 100% FIO2; condition drastically worsened; pt passed away before family made it to the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 24.01.2022
- Impfdatum
- 10.02.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 191,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Symptomtext
Admit for COVID infection. Fully vaccinated. Steroids, remdesivir, O2, vit-c, nebs. Condition stable, pt discharged with home O2.01b701b701b701b701b701b701b701b701b7Acute respiratory failure with hypoxia secondary to COVID-19. Currently the patient is on 3 L nasal cannula. Continue dexamethasone, remdesivir.Remdesivir was completed on 08/25/2021.Continue vitamin-C and zinc supplementation. Continue the enhanced isolation protocol Pneumonia due to COVID-19. As above. Interstitial lung disease.No pulmonary follow-up for the last 2 years.Continue the DuoNebs and Pulmicort. Hypertension. Continue Norvasc. Blood pressure is stable. Patient may probably need to go home with home oxygen
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 09.02.2021
- Beginn
- 17.08.2021
- Tage bis Beginn
- 189,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Endotracheal intubation
Intensive care
Positive airway pressure therapy
Symptomtext
Admit for COVID infection with poss superimposed bacterial pna. Fully vaccinated. Rocephin, zithromax, steroids, remdesivir, zinc, HFNC, intermittent Bipap, singulair. Unfortunately patients never really improved during her long and complicated course. She was made DNR and decision made to withdraw care by palliative care, icu team in discussion with family. She was extubated on 9/6 and pronounced dead.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 21,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 10.02.2021
- Beginn
- 11.10.2021
- Tage bis Beginn
- 243,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Atrial fibrillation
Bradycardia
COVID-19
Cardiac arrest
Cardiac failure acute
Cardiac failure congestive
Condition aggravated
Cough
Death
Dyspnoea
Hypoxia
Intensive care
Multiple organ dysfunction syndrome
Oedema peripheral
Renal failure
Resuscitation
SARS-CoV-2 test positive
Symptomtext
Patient admitted to hospital with c/o increasing SOB, increase in LE edema, weight gain, cough; CHF exacerbation; acute heart failure; positive for COVID; A Fib; AKI and worsening renal failure; CHF exacerbation worsened; increase for O2 therapy; multiorgan failure; transferred to ICU; worsening hypoxia, bradycardia, asystole; ACLS protocols with chest compressions performed; family decided to stop compressions and patient died at the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD, COPD, HTN, DM, hyperlipidemia
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 13.01.2022
- Impfdatum
- 22.02.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 320,0
- Dosis
- 1
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bradycardia
Cardio-respiratory arrest
Death
Life support
Multiple organ dysfunction syndrome
Symptomtext
Pt died 1/8/22. He was in multi system organ failure. On the 8th, he developed bradycardia and arrested. ACLS provided but ROSC was not achieved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Unknown. Pt vaccinated before hospitalization.
- Vorgeschichte
- COPD DMII OSA, CPAP ESRD Hypertension Prostate cancer Gout Hyperlipidemia Depression Peripheral neuropathy
- Andere Medikamente
- Unknown
- Allergien
- Iodinated Diagnostic Agents Lisinopril
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 28.09.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 102,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Angiogram pulmonary abnormal
COVID-19
Chest X-ray abnormal
Death
Hypoxia
Lung consolidation
Lung opacity
Mental status changes
Multiple organ dysfunction syndrome
Respiratory failure
SARS-CoV-2 test positive
Septic shock
Urinary tract infection
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/3/2021, 3/3/2021, and 9/28/2021. Bedbound s/p stroke presented to the emergency department for altered mental status and hypoxemia. Amitted for respiratory failure with COVID-19, septic shock, UTI, and altered mental status. Patient received antibiotics, dexamethasone, and remdesivir. Status declined rapidly with multiorgan failure w/increasing O2 demands. Expired 1/9/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- 1/8/2022: COVID positive; 1/8/2022: Chest x-ray revealed left suprahilar and right basilar opacities may reflect pneumonia; 1/8/2022: CTA Chest found no evidence of pulmonary; embolism. Bilateral patchy consolidation within the left greater than right upper lobes and lower lobes.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cancer hypertension, bilateral macular degeneration, subdural hematoma, thyroid disease, stroke
- Andere Medikamente
- amlodipine 5 mg daily, aspirin 81 mg daily, baclofen 5 mg, twice daily, citalopram 20 mg daily, gabapentin 100 mg nightly, levothyroxine 100 mcg daily, liothyronine 5 mcg daily, melatonin 10 mg nightly, toprol XL 25 mg daily, entresto 24-26
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 16.11.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 46,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Death
Diarrhoea
General physical health deterioration
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/19/2021, 2/9/2021, and 11/16/2021. Patient presented to ED on 1/1/2022 with complaints of diarrhea that has been progressively getting worse for the past two days. Patient had been previously diagnosed with COVID and had received bamlanivimab and etesevimab on 12/24/2021. On 1/5/2022 patient decompensated and expired on 1/7/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, Hyperlipidemia, BPH, Waldenstrom's, Anxiety
- Andere Medikamente
- Aspirin 81 mg QD, Desvenlafaxine 100 mg QD, Adderall 20 mg TID, Enalapril 10 mg QD, Hydrochlorothiazide 25 mg QD, Lorazepam 0.5 mg BID, Metoprolol 50 mg QD, Mirtazepine 30 mg QD, Olanzepine 7.5 mg QD, Simvastatin 40 mg QD, Tamsulosin 0.4 mg
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 25.08.2021
- Beginn
- 23.12.2021
- Tage bis Beginn
- 120,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Chest X-ray abnormal
Death
Lung opacity
Pneumonia
Pulmonary oedema
Respiratory disorder
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/7/2021, 2/28/2021, and 8/25/2021. Patient received bamlanivimab/etesevimab on 12/23/2021. Patient received at hospital - as a transfer from outside hospital for continued care of acute hypoxic respiratory failure due to COVID-19. Patient received oxygen supplementation, dexamethasone, and remdesivir. Patient's respiratory status continued to decompensate and patient was transitioned to comfort care. Patient expired on 1/8/2022 at 1520.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- 1/3/2021: Chest x-ray revealed mixed interstitial and alveolar opacities noted throughout both lungs which may be due to edema or multifocal pneumonia
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Non-hodgkin lymphoma, bladder cancer, hypertension, hyperlipidemia
- Andere Medikamente
- -
- Allergien
- Amiodarone, gabapentin, pregablin, levofloxacin, penicillin, diphenhydramine, tetanus vaccines and toxoid
- Vorherige Impfungen
- tetanus vaccine and toxoid causing itching and rash
- Staat
- TX
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 02.03.2021
- Beginn
- 26.12.2021
- Tage bis Beginn
- 299,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Angiogram pulmonary normal
COVID-19
Cardiac arrest
Chest X-ray abnormal
Chest pain
Computerised tomogram head normal
Death
Dyspnoea
Gastrostomy
Lung opacity
Mental status changes
Pneumonia
Pyelonephritis
SARS-CoV-2 test positive
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/9/2021 and 3/2/2021. Patient received sotrovimab on 12/26/2021. Patient was hospitalized for COVID-19 on 12/27/2021 to 1/1/2022 and treated with dexamethasone and remdesivir. Patient presented to the ED on 1/2/2022 with complaints of chest pain, altered mental status, and shortness of breath. Patient was admitted to the hospital for acute respiratory failure, multifocal pneumonia, and pyelonephritis. Patient received oxygen supplementation, antibiotics, dexamethasone, and had PEG tub placed. On 1/8/2022, the patient went into cardiac arrest and expired at 10:05.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- 12/26/2021 COVID positive; 1/2/2022: Chest x-ray revealed worsened patchy and confluent bilateral lung opacities concerning for multifocal pneumonia. 1/3/2022: CT head no acute abnormality: 1/3/2022 CTA chest no acute pulmonary embolism.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma, congestive heart failure, chronic obstructive pulmonary disease, hypertension, diabetes, hyperlipidemia, thyroid disease, chronic kidney failure requiring dialysis, history of stroke
- Andere Medikamente
- Tylenol #3 one every 4 hours PRN, brompheniramine/pseudoephed, DM 2-30-10 mg/5 mL 5 mLs Oral Every 4 hours PRN, aspirin 81 MG 1 tablet Oral Daily, bupropion HCl 150 mg Oral 2 times daily, carvedilol 25 MG 1 tablet Oral 2 times daily, finast
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 27.02.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 308,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Asthenia
COVID-19
Cough
Death
Decreased appetite
Dyspnoea
Endotracheal intubation
Fatigue
Headache
Influenza B virus test positive
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Sinus pain
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to physician office on 12/29/2021 complaining of shortness of breath, congestion, cough, body aches, headaches, fatigue and sinus pain x4-5 days. Rapid influenza screen was positive for Influenza B, and patient prescribed oseltamivir, while awaiting COVID PCR results which later resulted as positive as well. Patient presented to ED on 1/2/2022 with increased weakness, dyspnea, and decreased appetite with an SpO2 of 80%. Patient admitted, and continued to decompensate requiring intubation on 1/4/2022. Patient status was DNAR/COT and patient expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- COVID positive on 12/29/2021 using the Hologic Panther platform using PCR or equivalent Nucleic Acid Amplification(NAA) technology
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, CKD stage 3, Dyslipidemia, Tachycardia, Emphysema, GERD, Hypertension, OSA, Pulmonary hypertension, Rheumatoid arthritis, Rheumatoid lung disease.
- Andere Medikamente
- Albuterol Nebs/MDI Q6H PRN, Amlodipine 2.5 mg QD, Atorvastatin 40 mg QD, Doxycycline 100 mg BID, Furosemide 40 mg QD, Hydroxychloroquine 200 mg BID, Latanoprost 1 drop QD, Losartan 100 mg QD, Metoprolol 50 mg QD, Omeprazole 50 mg QD, Oselt
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 30.12.2021
- Impfdatum
- 25.02.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 244,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID test on 8/18/2021.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Dementia Dysphagia Acute Kidney Failure Schizophrenia Anxiety Depression Hypertension Hypothyroidism Osteoarthritis
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 29.12.2021
- Impfdatum
- 17.08.2021
- Beginn
- 05.12.2021
- Tage bis Beginn
- 110,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
COVID-19
Death
Endotracheal intubation
Pneumonia
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021, 2/26/2021, and 8/17/2021. PMHx ESRD s/p renal transplant on hemodialysis, dx'd w/Covid 13 days prior to admission on 12/5/2021. Admitted for acute respiratory failure w/hypoxia, PNA and acute on chronic renal failure. Tx'd w/steroids, bactrim, vancomycin and Cefepime. Was not a candidate for remdesivir, tocilizumab/baricitinib. Intubated 12/11/21. Expired12/16/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Renal transplant in 2019 due to IgA nephropathy, Anemia, Anxiety, ESRD, GERD, GOUT, Hypertension, hypercholesterolemia
- Andere Medikamente
- Cyanocobalamin 100 mcg QD, Dexlansoprazole 60 mg QD, Diazepam 5 mg Q8H prn Anxiety, Famotidine 10 mg QD, Norco 5/325 mg Q6H prn, Labetalol 150 mg BID PRN SBP >150, Mycophenolate 360 mg QID, Rosuvastatin 10 mg QD, Bactrim 400/80 mg QD, Tacro
- Allergien
- Pantoprazole (Headache)
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 29.12.2021
- Impfdatum
- 01.03.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 256,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Death
Endotracheal intubation
SARS-CoV-2 test positive
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/8/2021, and 3/1/2021. PMHx of DMII, HTN, CKD s/p kidney transplant on immunosuppression. Covid+ 11/13/21, hospitalizd x3days. D/c'd home on O2. Readmitted 11/18/21 for worsening symptoms, intubated 11/20. Transferred to Medical Center on 11/24/21 for higher level of care due to acute hypoxemic respiratory failure 2/2 Covid-19. Tx'd steroids, nitric oxide, diuresed, merrem, vancomycin and cresemba. Continued to get worse and expired 12/13/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 31,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic pain, Renal transplant, Diabetes, Hypertension, Peripheral neuropathy
- Andere Medikamente
- Albuterol MDI Q6H prn, Aspirin 81 mg QD, Benzonatate 100 mgTID prn, Calcium carbonate 2000 mg TID prn, Cellcept 250 mg BID, Dexamethasone 6 mg QD, Doxycycline 100 mgBID, Folic Acid 1 mg QD, Gabapentin 300 mg QD, Furosemide 40 mg QD, Levemir
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 23.12.2021
- Impfdatum
- 03.03.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 180,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- Positive COVID test on 8/1/2021.
- Aktuelle Erkrankungen
- Peripheral neuropathy Vertigo HTN Hyperlipidemia Hypothyroidism Anemia (megaloblastic anemia) Anxiety Depression
- Vorgeschichte
- -
- Andere Medikamente
- Miralax Super B Complex-Vitamin C Vitamin D3 Escitalopram oxalate Levothyroxine Melatonin Metoprolol tartrate Pregabalin Simvastatin
- Allergien
- Allopurinol Doxycycline
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 16.12.2021
- Impfdatum
- 23.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weight decreased
Symptomtext
Severe weight loss - 02/25/2021 Patients weight was 136 lbs. 03/25/2021 Patients weight was 127 lbs. 04/01/2021 patients weight was 110 lbs. Death Occurred: 05/02/2021 Documentation (if needed) is available in the form of medical notes from ER & office visits & a death certificate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 08.12.2021
- Impfdatum
- 15.02.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 242,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Case died of Covid following Covid vaccination. No symptom or treatment information available.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Ordered Test: SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay Ordered Test Codes: 94558-4 (LN LOINC)/ Status: Final Accession Number: POC-C6DB1947-5F22-41B9-A81D-CE4985D0B7D6 Specimen Source: Respiratory Sample Specimen Site: Anterior nares swab(697989009) Specimen Collection Date/Time: 2021-10-12 00:00:00.0 Results: * Resulted Test: SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay Coded Result: Positive Numeric Result: Units: Text Result: Reference Range From: negative Reference Range To: Performing Facility Details: Date/Time: 2021-10-12 00:00:00.0 Interpretation: Result Method: Status: Final Test Code: 94558-4 (LN LOINC)/ Result Code: 10828004 (SCT/
- Aktuelle Erkrankungen
- Emphysema Impaired cognition Mixed anxiety and depressive disorder Alzheimers Unintentional weight loss
- Vorgeschichte
- Emphysema Impaired cognition Mixed anxiety and depressive disorder Alzheimers Unintentional weight loss
- Andere Medikamente
- fluoxetine 10 mg capsule Take 1 capsule every day by oral route. fluoxetine 20 mg capsule Take 1 capsule every day by oral route. lorazepam 0.5 mg tablet TAKE 1 TABLET BY MOUTH TWICE DAILY AS NEEDED promethazine-phenylephrine-codeine 6.25 m
- Allergien
- Non known allergies
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 05.02.2021
- Beginn
- 06.12.2021
- Tage bis Beginn
- 304,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Chest X-ray abnormal
Computerised tomogram thorax abnormal
Pulmonary embolism
SARS-CoV-2 test
Symptomtext
Approximately three weeks after second Pfizer COVID-19 vaccine, I was diagnosed with two pulmonary embolisms, one in each lung. I was hospitalized for four days and was on oxygen for two months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- Tested for COVID Chest XRay Pulmonary CatScan
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hoshimoto's
- Andere Medikamente
- Synthroid, Vitamin C, Zinc
- Allergien
- Shrimp, Scallops, Aspirin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 30.11.2021
- Impfdatum
- 24.02.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 266,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Atrial fibrillation
Bronchoscopy
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Endotracheal intubation
Hypoxia
Lactic acidosis
SARS-CoV-2 test positive
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient rec'd Pfizer Vaccines on 2/3/2021 and 2/24/2021. PMHx of cirrhosis, COPD, CAD w/stent, osteoarthritis sepsis and repiratory failure requiring tracheostomy in the past. Presented to ED one week ago c/o SOB. COVID negative, s/p bronchoscopy on 11/12, tx'd w/abx, d/c'd home on O2 via NC. Per pt. 2nd Covid test + prior to d/c. Presented to ED on 11/17 w/SPO2 in the 30s on NC. Admitted for ACRF w/hypoxia, Covid pneumonia, A-fib, and lactic acidosis. Intubated on 11/22. Tx'd w/dexamethasone, tocilizumab, inhaled epoprostenol. Remained severely hypoxic and expired 11/26/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- COVID-19 Positive test on 11/17/2021 analyzed on the Luminex Aries platform using RT-PCR technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cirrhosis, COPD, CAD, Dysrhythmia, H/O Angioplasty, Hepatitis C, History of MI, Osteoarthritis
- Andere Medikamente
- Albuterol MDI PRN, Apixaban 5 mg BID, Aspirin 81 mg QD, Symbicort 160/4.5 mcg BID, Cetirizine 10 mg QD, Cholecalciferol 125 mcg QD, Cyanocobalamin 100 mcg QD, Norco 10/325 PRN, Probiotic QD, Multivitamin QD, Potassium Chloride 10 mEq QD, Qu
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 30.11.2021
- Impfdatum
- 24.02.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 266,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Atrial fibrillation
Bronchoscopy
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Endotracheal intubation
Hypoxia
Lactic acidosis
SARS-CoV-2 test positive
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient rec'd Pfizer Vaccines on 2/3/2021 and 2/24/2021. PMHx of cirrhosis, COPD, CAD w/stent, osteoarthritis sepsis and repiratory failure requiring tracheostomy in the past. Presented to ED one week ago c/o SOB. COVID negative, s/p bronchoscopy on 11/12, tx'd w/abx, d/c'd home on O2 via NC. Per pt. 2nd Covid test + prior to d/c. Presented to ED on 11/17 w/SPO2 in the 30s on NC. Admitted for ACRF w/hypoxia, Covid pneumonia, A-fib, and lactic acidosis. Intubated on 11/22. Tx'd w/dexamethasone, tocilizumab, inhaled epoprostenol. Remained severely hypoxic and expired 11/26/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- COVID-19 Positive test on 11/17/2021 analyzed on the Luminex Aries platform using RT-PCR technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cirrhosis, COPD, CAD, Dysrhythmia, H/O Angioplasty, Hepatitis C, History of MI, Osteoarthritis
- Andere Medikamente
- Albuterol MDI PRN, Apixaban 5 mg BID, Aspirin 81 mg QD, Symbicort 160/4.5 mcg BID, Cetirizine 10 mg QD, Cholecalciferol 125 mcg QD, Cyanocobalamin 100 mcg QD, Norco 10/325 PRN, Probiotic QD, Multivitamin QD, Potassium Chloride 10 mEq QD, Qu
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 24.11.2021
- Impfdatum
- 06.02.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 177,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Case died of Covid 6 months after being vaccinated for it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- dered Test: SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by Lab with probe detection (SARS Coronavirus 2) Ordered Test Codes: (LN LOINC)/2019nCoV (L LOCAL) Status: Final Accession Number: Specimen Source: Other Specimen Site: Specimen Collection Date/Time: 2021-07-27 00:00:00.0 Results: * Resulted Test: SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection (SARS Coronavirus 2 RNA) Coded Result: Detected Numeric Result: Units: Text Result: Reference Range From: NOT Detected Reference Range To: Performing Facility Details: Date/Time: 2021-07-28 14:40:34.0 Performing Facility:PUBLIC HEALTH LABORATORY Facility ID:MT PHL (FI) Interpretation: Abnormal Result Method: Status: Final Test Code: (LN LOINC)/2019nCoV (L LOCAL) Result Code: (SCT/
- Aktuelle Erkrankungen
- Parkinson's Dementia due to Parkinson's Benign Hypertension
- Vorgeschichte
- Parkinson's Dementia due to Parkinson's Benign Hypertension
- Andere Medikamente
- carbidopa-levodopa (SINEMET) 25-100 mg per tablet carbidopa-levodopa (SINEMET) 25-100 mg per tablet Dosage: Please take 2 tablets in the morning, 1.5 at noon, 2 in the evening and 1.5 at bedtime for one week then increase to 2 tablets 4 t
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 24.11.2021
- Impfdatum
- 11.03.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 251,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cardiac arrest
SARS-CoV-2 test positive
Symptomtext
HOSPITAL VISIT, CARDIAC ARREST
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 1,0
- Labordaten
- COVID POSITIVE TEST
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HYPERTENSION, KIDNEY STONES, PNEUMONIA, PULMONARY EMBOLISM
- Andere Medikamente
- ALBUTEROL, APIXABAN, AUGMENTIN, AZITHROMYCIN, DOCUSATE SODIUM, DRONABINOL, LASIX, METOPROLOL, MIRTAZAPINE, PREDNISONE, PROTONIX, SERTRALINE, SIMVASTATIN
- Allergien
- ASA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 24.11.2021
- Impfdatum
- 11.03.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 251,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cardiac arrest
SARS-CoV-2 test positive
Symptomtext
HOSPITAL VISIT, CARDIAC ARREST
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 1,0
- Labordaten
- COVID POSITIVE TEST
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HYPERTENSION, KIDNEY STONES, PNEUMONIA, PULMONARY EMBOLISM
- Andere Medikamente
- ALBUTEROL, APIXABAN, AUGMENTIN, AZITHROMYCIN, DOCUSATE SODIUM, DRONABINOL, LASIX, METOPROLOL, MIRTAZAPINE, PREDNISONE, PROTONIX, SERTRALINE, SIMVASTATIN
- Allergien
- ASA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- 21.10.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 19,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acidosis
Acute kidney injury
Acute respiratory failure
Blood bilirubin increased
Bronchial secretion retention
Bronchoalveolar lavage
Bronchoscopy
Computerised tomogram head
Computerised tomogram spine
Computerised tomogram thorax
Culture positive
Dizziness
Dyspnoea
Echocardiogram
Endotracheal intubation
General physical health deterioration
Gram stain
Haemofiltration
Symptomtext
11/8/2021 1. Community-acquired pneumonia 2. Severe sepsis 3. Acute respiratory failure 4. Acute on chronic kidney failure 5. Elevated LFTs and bilirubin
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 1,0
- Labordaten
- 11/8/21 RPP Comment Negative Legionella Antigen Urine POSITIVE Abnormal Culture, Bronchial Washing Status: Final result-Gram stain-rare squamous epithelial cells, WBC
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 1. Community-acquired pneumonia 2. Severe sepsis 3. Acute respiratory failure 4. Acute on chronic kidney failure
- Andere Medikamente
- Apixaban 5 mg Oral 2 times daily Ascorbic Acid 250 MG
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 18.11.2021
- Impfdatum
- 19.03.2021
- Beginn
- 30.10.2021
- Tage bis Beginn
- 225,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Patient death 10/30/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 21,0
- Labordaten
- Positive COVID test 10/10/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Aphasia
Cerebrovascular accident
Cerebral thrombosis
Headache
Musculoskeletal disorder
Speech disorder
Confusional state
Dysgraphia
Hypoacusis
Symptomtext
suffering from a stroke; couldn't talk for over a week; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), both via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was suffering from a stroke and couldn't talk for over a week on an unspecified date after having both shots. The events resulted in Physician Office visit (neurologist). The outcome of the event suffering from a stroke was not recovered, and the outcome of the other event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Aphasia
Cerebrovascular accident
Cerebral thrombosis
Headache
Musculoskeletal disorder
Speech disorder
Confusional state
Dysgraphia
Hypoacusis
Symptomtext
suffering from a stroke; couldn't talk for over a week; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), both via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was suffering from a stroke and couldn't talk for over a week on an unspecified date after having both shots. The events resulted in Physician Office visit (neurologist). The outcome of the event suffering from a stroke was not recovered, and the outcome of the other event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 17.11.2021
- Impfdatum
- 03.03.2021
- Beginn
- 22.05.2021
- Tage bis Beginn
- 80,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient deceased. Unsure of cause of death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Cardiovascular and Mediastinum Chronic atrial fibrillation Essential hypertension Chronic systolic heart failure Coronary artery disease involving native coronary artery of native heart without angina pectoris Respiratory Sleep apnea Digestive Intestinal malabsorption, unspecified GI bleed Radiation proctitis Musculoskeletal and Integument Osteoarthritis of left hip Genitourinary Chronic renal failure, stage 4 (severe) Prostate cancer Other Essential familial hypercholesterolemia History of colon cancer Status post left hip replacement Anemia, iron deficiency Symptomatic anemia Anemia due to chronic blood loss S/P right colectomy
- Andere Medikamente
- allopurinol (ZYLOPRIM) 100 MG tablet aspirin EC 81 MG EC tablet atorvastatin (LIPITOR) 80 MG tablet benazepril (LOTENSIN) 5 MG tablet Bimatoprost 0.01 % SOLN brinzolamide (AZOPT) 1 % ophthalmic suspension budesonide-formoterol (SYMBIC
- Allergien
- Nitroglycerin
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 17.11.2021
- Impfdatum
- 26.02.2021
- Beginn
- 18.09.2021
- Tage bis Beginn
- 204,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebral haemorrhage
Condition aggravated
Death
Symptomtext
Brain bleed resulting in death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- "Brain Bleed"
- Vorgeschichte
- Cardiovascular and Mediastinum HTN (hypertension) Atrial fibrillation CAD in native artery Respiratory OSA on CPAP Digestive Gastric polyp Other History of right thalamic and right occipital stroke Pure hypercholesterolemia Routine general medical examination at a health care facility
- Andere Medikamente
- amLODIPine (NORVASC) 2.5 MG tablet aspirin 81 MG chewable tablet Cholecalciferol (VITAMIN D) 1000 units tablet lisinopril (PRINIVIL) 40 MG tablet Omega-3 Fatty Acids (FISH OIL) 1000 MG capsule simvastatin (ZOCOR) 40 MG tablet spironol
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 11.11.2021
- Impfdatum
- 19.02.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 201,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had breakthrough infection and expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- Positive COVID-19 PCR test on 8/25/2021
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Dementia
- Andere Medikamente
- Atorvastain Tamsulosin
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 09.11.2021
- Impfdatum
- 22.01.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 266,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Encephalopathy
Symptomtext
Hospitilization, resulting in palliative care and death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Arterial ischemic stroke, MCA (middle cerebral artery), left, acute (HCC)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 05.11.2021
- Impfdatum
- 23.02.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 188,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Individual had a breakthrough infection and expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 6,0
- Labordaten
- Positive COVID-19 lab on 08/24/2021.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- COPD Hypertension Diabetes mellitus Hyperlipidemia
- Andere Medikamente
- Lipitor Byetta Pen Glucotrol Aspirin Glucophage Multivitamin-Centrum Insulin Glargine Ocuvite with Lutein
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 04.11.2021
- Impfdatum
- 13.02.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 213,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Dyspnoea
General physical health deterioration
Hypoxia
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
pt seen at ED for dyspnea and hypoxia; positive for COVID; transferred to another hospital for advanced care; on 4 - 8 L O2 via NC; PMH: HTN, OSA; started on decadron, remdisivir, Lovenox, Baricitinib; eventually required Vapotherm then full BiPAP support; transitioned to comfort care due to worsening condition; pt died in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 03.11.2021
- Impfdatum
- 30.03.2021
- Beginn
- 12.09.2021
- Tage bis Beginn
- 166,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Confusional state
Cough
Death
Encephalopathy
General physical health deterioration
Mental status changes
SARS-CoV-2 test positive
Symptomtext
Hx of dementia and recent pneumonia; diagnosed positive for COVID 1 wk ago in nursing facility; has been in isolation in the facility; presents to ED with cough; on 4 L O2 via NC, sats in the 90s; increased confusion during the course of hospitalization; condition worsened; encephalopathy; antibiotics and O2 supplementation given; mental status never recovered; comfort care measures in place; pt died in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 23,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 02.03.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 233,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient had a breakthrough infection and deceased.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 6,0
- Labordaten
- Positive COVID-19 PCR test on 10/15/2021.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Atorvastatin, lisinopril, omeprazole, oxybutynin
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 28.10.2021
- Impfdatum
- 07.02.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 202,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
They had a breakthrough infection and deceased.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID-19 PCR Test on 8/20/201
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 18.08.2021
- Beginn
- 18.10.2021
- Tage bis Beginn
- 61,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
C-reactive protein abnormal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Fibrin D dimer increased
Lung opacity
Malaise
SARS-CoV-2 test positive
Symptomtext
Pt received 3 doses of the Pfizer COVID-19 vaccine (initial 2 dose series and immunocompromised 3rd dose. Received on 2/4/2021, 2/24/2021, and 8/18/2021 respectively). Pt still contracted COVID and was ill enough to be hospitalized. Symptom onset of 10/13/2021, tested positive 10/18/2021 and admitted to hospital. **Acute hypoxic respiratory failure secondary to COVID-19 pneumonia: Patient with symptom onset 10/13/2021 with positive Covid test 10/18/2021. Patient is up-to-date on SARS-CoV-2 mRNA vaccine series including recent booster dose, but notably patient is immunosuppressed on chronic immunosuppressive medications. Patient with rapid respiratory decline, initially on room air, progressed rapidly to higher needs. Initial chest x-ray with bilateral opacities, right greater than left with progressive bilateral airspace opacities on repeat chest x-ray 10/20/2021. -Started on dexamethasone 6 mg daily on 10/18/2021, but with progressive respiratory decline, increased to 10 mg twice daily 10/20/2021. Decreased to 6mg twice daily, by mouth, on 10/27. -Remdesivir initiated 10/18, completed 5-day course on 10/22/2021 -Continue baricitinib, started 10/20/2021 with progressive respiratory decline. Plan for 14-day course or until discharge (whichever shorter) -prone positioning as tolerated -Continue supplemental O2. If progressive O2 requirements, would likely need transition to PAP therapy, but not agreeable to intubation if needed for further respiratory decline. -Symptomatic therapies with as needed Tylenol, albuterol -CRP and D-dimer have down trended. No ongoing monitoring needed at this time. -Saline nebulizer treatments, Aerobika, and guaifenesin for mucolytics
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- allergic rhinitis, anxiety, asthma, bronchiectasis, bursitis, cervical ddd, depression, eosinophilia, GERD, HTN, hyperlipidemia, IBS, left carotid bruit, osteoporosis, pulmonary nodules, sciatica, syncope, umbilical hernia
- Andere Medikamente
- azelastine nasal spray, calcium citrate w/ vitamin D, denosumab, diclofenac, dicyclomine, fluticasone-salmeterol, gabapentin, levoceterizine, losartan, mycophenolate, omalizumab, sertraline, trazodone, vitamin D
- Allergien
- Melon, Niacin, Cilantro, Fire ants, pineapple, wasp venom, tramadol, papaya derivatives, sulfa antibiotics, amoxicillin-pot clavulanate, fosamax, hydroxyzine, lotensin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 05.02.2021
- Beginn
- 06.09.2021
- Tage bis Beginn
- 213,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Chest pain
Confusional state
Cough
Death
SARS-CoV-2 test positive
Dyspnoea
General physical health deterioration
Nausea
Vomiting
Symptomtext
seen in ED on 9/5 and dx with COVID; c/o cough, dyspnea, confusion, N/V, chest pain; admitted to hosp with COVID pneumonia; pt's condition deteriorated; O2 needs increased despite O2 being given; pt's condition worsened and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 05.02.2021
- Beginn
- 06.09.2021
- Tage bis Beginn
- 213,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Chest pain
Confusional state
Cough
Death
SARS-CoV-2 test positive
Dyspnoea
General physical health deterioration
Nausea
Vomiting
Symptomtext
seen in ED on 9/5 and dx with COVID; c/o cough, dyspnea, confusion, N/V, chest pain; admitted to hosp with COVID pneumonia; pt's condition deteriorated; O2 needs increased despite O2 being given; pt's condition worsened and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 15.10.2021
- Impfdatum
- 01.02.2021
- Beginn
- 27.09.2021
- Tage bis Beginn
- 238,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Adrenal disorder
Adrenal mass
Alanine aminotransferase normal
Aspartate aminotransferase normal
Aspiration pleural cavity
Asthenia
Atelectasis
Bladder scan
Blood alkaline phosphatase increased
Blood bilirubin decreased
Blood calcium normal
Blood chloride normal
Blood creatinine normal
Blood folate normal
Blood iron decreased
Blood lactic acid decreased
Blood potassium decreased
Symptomtext
Telephone Encounter - RN - 09/27/2021 2:38 PM Formatting of this note might be different from the original. Spoke with daughter, pt feeling more exhausted and getting sob with activity since las OV. Feels like she can not function and is very pale per daughter. These s/s have gotten worse since last OV , not new. PO running 93-94% today , has not smoked for 2 months no respiratory s/s at all, her chronic smokers cough has resolved. Has been taking iron supplement as instructed at last OV with no improvement in s/s. Pt daughter does not want to take to ED unless emergent as they simply tell her she is anemic, give IV fluids and send her home to f/u with PCP. Pt scheduled appt tomorrow in office Electronically signed by RN at 09/27/2021 2:42 PM Back to top of Miscellaneous Notes Telephone Encounter - MA - 09/27/2021 1:12 PM Formatting of this note might be different from the original. Patient's daughter states that the patient has been seen several times in recent months for ongoing symptoms and they would like to know if something else is recommended. She states that the patient had back surgery and feels worse now then she did prior to the surgery. She states that the patient complains of being exhausted and SOB. She states that the last time the patient was in the office she had swollen ankles that has gotten smaller, but not by a lot. She states that the patient complains that her "legs feel like rubber." She states that they bought a home pulse ox and today the patient's reading is 91 but it has been running in the 80s. She states that the patient's pulse reading has been "high." Please advise. Electronically signed by MA at 09/27/2021 1:15 PM Back to top of Miscellaneous Notes Admission Current 9/28/2021 - present (17 days) Hospital Chronic obstructive pulmonary disease, unspecified COPD type Depression Other hyperlipidemia Severe sepsis Lesion of adrenal gland Compression fracture of T5 vertebra Pathological fracture of vertebra due to neoplastic disease, initial encounter Iron deficiency anemia Elevated alkaline phosphatase level History of alcohol abuse Urinary retention Hilar lymphadenopathy Adenocarcinoma of lung, stage 4, right Bone metastasis Adrenal nodule S/P kyphoplasty Acute respiratory insufficiency Leukocytosis Pleural effusion on right COVID-19 virus infection COPD exacerbation (CMS/HCC) #Compression fracture of T5 vertebrae possibly secondary to neoplastic process vs injury vs osteopenia? -CT thoracic spine: At T5, there is a vertebroplasty with vertebral plana type appearance of the vertebral body with prevertebral swelling and soft tissue density as well as lucency through the bilateral pedicles and posterior elements, consistent with neoplasm. Presumed pathologic fracture. There appears to be some fragment of calcium or bone in the spinal column at the T5 level. There is loss of the fat planes around the central canal and foramen at this level as well as just above and below the compressed segment. Presumed cord compression although this is not certain and MRI would be helpful better evaluate this region. -MRI thoracic spine: Rredemonstration of a severe pathologic compression fracture of the T5 vertebral body, likely secondary to neoplastic process. As stated, there is soft tissue extending into the spinal canal from the posterior aspect of the T5 vertebral body and also from the pedicles and posterior elements of T5. As a result, there is severe cord compression at the T5 level.There is also evidence of anterior subluxation of T4 and T5 secondary to tumor infiltration of the left and right superior articulating facets of T5. Therefore I believe there is evidence of instability of the thoracic spine at the T5 4-T5 level. There is 4 mm of anterior subluxation of T4 and T5 and some focal kyphosis of the thoracic spine at the T5 level.Bulky right hilar soft tissue mass or lymphadenopathy is partially seen on the sagittal images. This is probably due to neoplastic process. Plan: -Neurosurgery consulted: They are planning to complete a T2-T8/9 decompression and instrumented fusion on 9/30 or 9/31. They will be ordering a CT of the T-spine for preoperative planning -We will continue to monitor neurological status closely -Bladder scans q2 shift -Dilaudid for pain -Follow-up MRI of the brain -Oncology consulted -Radiation oncology consulted #Severe sepsis [leukocytosis, tachycardia, tachypnea, hypoxia] possibly secondary to unknown source DDx: less likely surgical site infection [site is intact, no erythema or fluctuance] Tachycardia could be 2/2 pain -WBC 16.4, troponin <0.03, lactate 1.4 -WBC 12.1, lactate 0.6, procalcitonin <0.05 -Urinalysis negative, RSV panel negative Plan: -Started on cefepime and vancomycin (day 1) -Follow-up blood cultures and urine culture -Follow-up lactic, troponin, and procalcitonin -CBC and CMP daily -Continue to monitor on telemetry #Lesion of the adrenal gland and hilar lymphadenopathy -CTA PE: Bulky right hilar and subcarinal lymphadenopathy. Left adrenal lesion measures 2 cm. The thoracic lymphadenopathy in the right hilum narrows the pulmonary arteries however no embolism is appreciated. -CT abdomen/pelvis: 2 cm left adrenal lesion as seen on the chest CT is concerning for neoplasm #Elevated alkaline phosphatase -ALK 133, GGT 16 #Iron deficiency anemia -Follows started her on iron supplementation -Iron <10, transferrin 299.2, ferritin 29, folate 9.4, B12 348 -H/H 8.4/28.6 > 7.6/26.1 -No signs of bleeding on physical examination -Transfuse if less than 7 #COPD -Continue with Breo Ellipta daily and albuterol as needed -Continue with Singulair 10 mg daily #Hyperlipidemia -On atorvastatin 20 mg nightly at home #Depression/anxiety -On venlafaxine at home, dose needs to be verified #History of alcohol abuse -Sober for the past 15 years Patient is a 70 y.o. female with PMHx of COPD, iron deficiency anemia, hyperlipidemia, history of alcohol abuse, and depression/anxiety who presented to Hospital on 9/28/2021 as a direct transfer from Hospital. Per the patient, she began to experience symptoms after she had spinal surgery done on 8/2/2021 for a fracture of her T6 vertebrae. Since her surgery, she has felt extremely weak and fatigued, and has had minimal to no energy. She endorses progressively worsening pain near the original spinal surgical site. She said that the pain normally radiates down and out, following along the edges of her ribs to her sternal area. She described the pain as burning in nature and said it is very intense. She said that the pain generally comes and goes and is usually worse with movement. She stated that she has tried ice, heat, and was prescribed naproxen for the pain without any relief. Her symptoms are associated with severe weakness in her legs, which she described this as having "spaghetti legs" and numbness of her groin area. At this time, she denies any bladder or bowel incontinence.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 17,0
- Labordaten
- 10/07/2021 1426 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 10/07/21 1426 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result Detected Critical 10/07/2021 1426 COVID-19 PCR - Communal Living / SNF Placement (Asymptomatic) Collected: 10/07/21 1426 | Final result | Specimen: Swab from Nasopharynx Labs: Results from last 7 days Lab Units 09/28/21 1817 09/28/21 0033 09/28/21 0033 WBC AUTO K/mcL 12.1* < > 16.4* HEMOGLOBIN g/dL 7.6* < > 8.4* HEMATOCRIT % 26.1* < > 28.6* PLATELETS K/mcL 546* < > 631* NEUTROS PCT AUTO % -- -- 73 LYMPHS PCT AUTO % -- -- 19 MONOS PCT AUTO % -- -- 6 EOS PCT AUTO % -- -- 1 < > = values in this interval not displayed. Results from last 7 days Lab Units 09/28/21 0033 SODIUM mmol/L 139 POTASSIUM mmol/L 3.4* CHLORIDE mmol/L 103 CO2 mmol/L 26 BUN mg/dL 30* CREATININE mg/dL 0.77 CALCIUM mg/dL 9.1 TOTAL PROTEIN gm/dL 6.7 BILIRUBIN TOTAL mg/dL 0.2* ALK PHOS IU/L 133* ALT IU/L 9 AST IU/L 11* Results from last 7 days Lab Units 09/28/21 0033 TROPONIN I ng/mL <0.03 Results from last 7 days Lab Units 09/28/21 0033 LACTATE mmol/L 1.4 Procedure Component Value Ref Range Date/Time CT angiogram chest pulmonary embolism with and without contrast Resulted: 10/14/21 2029 Order Status: Completed Updated: 10/14/21 2029 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: There is no evidence of pulmonary arterial embolism. There is large irregular right central hilar mass measuring 4.5 x 5.5 cm strongly suggest neoplasm and multiple enlarged mediastinal lymph nodes and postobstructive consolidation and atelectasis right lower lobe superior segment and basilar segments and right pleural effusion with some loculation identified. Pulmonary Artery Embolism: None. Cardiomegaly: None. RV/LV ratio: N/A END OF IMPRESSION: INDICATION: Covid pneumonia, please eval for pulmonary embolism. Shortness of breath. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CTA scan of the chest was performed from the lung apices to below the diaphragm, including the pulmonary artery. 2 mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D post processing imaging were obtained and stored. CONTRAST: 60mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was adequate. COMPARISON: 10/9/2021 FINDINGS: There are no intraluminal defects in the central main and visualized segmental branches of pulmonary arteries in both lungs. There is no intimal tear, dissection or aneurysm of thoracic aorta identified. There is large irregular right central hilar mass measuring 4.5 x 5.5 cm strongly suggest neoplasm and multiple enlarged mediastinal lymph nodes and postobstructive consolidation and atelectasis right lower lobe superior segment and basilar segments and right pleural effusion with some loculation identified. There is small 6 mm peripheral pulmonary nodule right upper lobe identified. Evidence of chronic emphysematous and bullous changes in both lungs Upper Abdomen: No abnormalities identified. Bones: Unremarkable. Insert DST sentence This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Resulted: 10/14/21 0741 Order Status: Completed Updated: 10/14/21 0741 Narrative: XR CHEST 1 VW PORT IMPRESSION: Continued small right effusion, right hilar mass, and background COPD. END OF IMPRESSION: INDICATION: increasing O2 requirements. TECHNIQUE: Portable AP upright projection of the chest is acquired. COMPARISON: 10/2/2021 FINDINGS: we again identify effusion small on the right and right hilar mass. Background marked COPD. No significant interval change This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT chest with contrast (Abnormal) Resulted: 10/09/21 0828 Order Status: Completed Updated: 10/09/21 0828 Narrative: PROCEDURE INFORMATION: Exam: CT Chest With Contrast; Diagnostic Exam date and time: 10/9/2021 12:08 AM Age: 70 years old Clinical indication: Other: Na; Additional info: Covid positive, assess lung parenchyma. TECHNIQUE: Imaging protocol: Diagnostic computed tomography of the chest with contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. Contrast material: OMNI 350; Contrast volume: 76 ml; Contrast route: INTRAVENOUS (IV); COMPARISON: CT CHEST WO CONTRAST 10/4/2021 8:01 AM FINDINGS: Lungs: Severe panlobular emphysematous changes. 1 cm spiculated mass redemonstrated within the right upper lobe. Peribronchial thickening redemonstrated. Slight improvement in the infiltrate involving the posterior aspect of the right upper lobe since the prior examination. No new ground-glass infiltrates. Pleural spaces: Small right pleural effusion slightly smaller than on prior exam. Heart: Unremarkable. No cardiomegaly. No pericardial effusion. Mediastinal space: Large right hilar mass redemonstrated. The right hilar mass extends into the mediastinum Pulmonary arteries: There is attenuation of the right main pulmonary artery by the hilar mass. Aorta: Unremarkable. No aortic aneurysm. Lymph nodes: Subcarinal lymphadenopathy is identified. Multiple mediastinal and prevascular lymph nodes Adrenal glands: 2.4 x 2.2 cm left adrenal mass redemonstrated. Bones/joints: Status post thoracic fusion. Soft tissues: Unremarkable. IMPRESSION: 1. Large right hilar mass redemonstrated. 2. 2.4 x 2.2 cm left adrenal mass redemonstrated. 3. 1 cm spiculated mass redemonstrated within the right upper lobe worrisome for neoplasia 4. Slight improvement in the infiltrate involving the posterior aspect of the right upper lobe since the prior examination. 5. No new ground-glass infiltrates. In the setting of metastatic disease as demonstrated on this examination, recommendations for follow-up incidental pulmonary nodules are not applicable. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD Ultrasound guided thoracentesis right Resulted: 10/05/21 1318 Order Status: Completed Updated: 10/05/21 1318 Narrative: US-GUIDED THORACENTESIS RIGHT IMPRESSION: Successful ultrasound-guided right-sided therapeutic and diagnostic thoracentesis. 320 mL of pleural fluid was removed. END OF IMPRESSION: INDICATION: Right-sided pleural effusion. Pleural fluid seen on x-ray. PERFORMING PROVIDER: MD. TECHNIQUE: Informed consent was obtained. The patient was placed in the sitting upright position. A time out was taken prior to the procedure. Sonography of the right posterior chest was performed showing a small amount of pleural fluid. Ultrasound guidance was used and sonographic images were obtained and permanently stored. The preferred skin entry site for thoracentesis was prepped and draped in sterile fashion. Local anesthetic was administered. Access was obtained to the pleural space using ultrasound guidance with a 5-French catheter and 320 mL of clear straw-colored pleural fluid was removed. The patient tolerated the procedure well without immediate complication. ESTIMATED BLOOD LOSS: None. SPECIMENS OBTAINED: Yes. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT chest without contrast Resulted: 10/04/21 0945 Order Status: Completed Updated: 10/04/21 0945 Narrative: CT CHEST WO CONTRAST IMPRESSION: 1. A small to moderate-sized right pleural effusion with mild compressive atelectasis. Compared to prior CT thoracic spine 9/30/2021, there has been interval increase in size. 2. Interval increase in infiltrate in the posterior segment of right lower lobe with airspace opacity and peribronchial thickening, worrisome for bronchiolitis and developing pneumonia. Followup with CT chest is recommended. 3. A 1 cm spiculated lung nodule in right upper lobe may represent primary lung carcinoma. 4. Unchanged extensive right hilar and mediastinal adenopathy. 5. Extensive postoperative changes of the thoracic spine from T3 to T9 with pedicle screws in place. Paraspinal soft tissue swelling at T4 to T6 level has not significantly changed since the prior study. END OF IMPRESSION: INDICATION: Increasing O2 requirements, assess for fluid overload vs PNA. TECHNIQUE: Helical CT scan of the chest without contrast was performed from the lung apices to below the diaphragm. 3 mm axial reconstruction with MPR coronal and sagittal images were created. CONTRAST: No contrast was administered. COMPARISON: CTA chest 9/28/2021 report. The images were not available for comparison at the time of dictation. Postoperative CT thoracic spine 9/30/2021. FINDINGS: CT CHEST: THYROID: Unremarkable. LUNG/PLEURAL: There is a small to moderate-sized right pleural effusion with compressive atelectasis of right lower lobe. There is infiltrate in the posterior aspect of the right upper lobe. There is a 1 cm spiculated lung mass in right upper lobe laterally on CT image. There is extensive emphysema with architectural distortion and destruction. There is peribronchial thickening of the right upper lobe, indicating chronic bronchitis or bronchiolitis. There is mild left basilar atelectasis. MEDIASTINUM/HILA/AXILLA/SUPRACLAVICULAR: The large right hilar mass is again identified with extension into the mediastinum. There is an enlarged subcarinal lymph node. PULMONARY ARTERIES: Unremarkable. HEART: Unremarkable. No coronary artery calcification noted. AORTA: No aneurysm or dissection. There is minimal atherosclerotic plaque noted. UPPER ABDOMEN: The 2 cm left adrenal mass is again identified. BONES: Extensive postoperative changes in the thoracic spine, T3 to T9 with pedicle screws in place, soft tissue swelling and extensive streaky artifacts. The right-sided paraspinal soft tissue swelling at T4 to T6 level is again identified. There are mild degenerative changes of the thoracic spine. SOFT TISSUE: Unremarkable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Resulted: 10/03/21 0701 Order Status: Completed Updated: 10/03/21 0701 Narrative: XR CHEST 1 VW PORT IMPRESSION: Some diffuse interstitial vascular congestion or infiltrates noted. END OF IMPRESSION: INDICATION: Assess for post-obstructive PNA. TECHNIQUE: Single AP projection of the chest is acquired. COMPARISON: None available. FINDINGS: Hardware fusion changes of the upper thoracic and mid thoracic spine are noted. Heart size is within normal limits. Diffuse interstitial vascular congestion changes or infiltrates may be present. No definitive effusion, pneumothorax or consolidation is identified. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Transthoracic echo (TTE) complete Bubble Resulted: 10/01/21 1039 Order Status: Completed Updated: 10/01/21 1044 LVIDd 3.70 3.7 - 5.6 cm LVIDs 2.40 2 - 3.8 cm IVSd 0.85 0.6 - 1.1 cm LVPWd 0.85 0.6 - 1.1 cm LADs 3.00 1.9 - 4 cm LVOT diameter 1.90 cm Left Atrial Index 20.4 mL/m2 Aortic Root (2.0-3.7) 3.00 cm Aortic valve area 2.80 cm2 AoV peak gradient 8.70 mmHg AoV mean gradient 5.00 mmHg TR max PG 46.00 mmHg TR max vel 339.10 cm/sec Narrative: FINALIZED REPORT Transthoracic Echocardiogram *Study Conclusions* Summary: 1. Left ventricle: The cavity size was normal. Wall thickness was normal. Systolic function was normal. The estimated ejection fraction was 55-60%. There were no regional wall motion abnormalities. Some parameters suggest diastolic dysfunction (grade 1). 2. Right ventricle: The cavity size was normal. Wall thickness was normal. Systolic function was normal. 3. Pulmonary systolic pressure was mildly increased, estimated to be 45-50 mm Hg. 4. Inferior vena cava: The vessel was normal in size. The respirophasic diameter changes were normal, consistent with normal central venous pressure. --------------------------------------------------------------------------- --------------------------------------------------------------------------- ----- *Cardiac Anatomy* Left ventricle: The cavity size was normal. Wall thickness was normal. Systolic function was normal. The estimated ejection fraction was 55-60%. There were no regional wall motion abnormalities. Some parameters suggest diastolic dysfunction (grade 1). Right ventricle: The cavity size was normal. Wall thickness was normal. Systolic function was normal. Left atrium: The cavity size was normal. Right atrium: The cavity size was normal. Aortic valve: Mildly hickened, calcified leaflets. Doppler: Transvalvular velocity was within the normal range. There was no stenosis. There was no regurgitation. Aortic root: The aortic root was normal in size. Mitral valve: Structurally mildly thickened leaflets. Mobility was not restricted. Doppler: There was no stenosis. There was no regurgitation. Tricuspid valve: Grossly normal. Doppler: There was no stenosis. There was mild regurgitation. Pulmonic valve: Not well visualized. Doppler: There was no stenosis. There was no regurgitation. Pulmonary artery: The main pulmonary artery was not well visualized. Pulmonary systolic pressure was mildly increased, estimated to be 45-50 mm Hg. Inferior vena cava: The vessel was normal in size. The respirophasic diameter changes were normal, consistent with normal central venous pressure. Pericardium: There was no pericardial effusion. CT thoracic spine without contrast (Abnormal) Resulted: 10/01/21 0017 Order Status: Completed Updated: 10/01/21 0018 Narrative: PROCEDURE INFORMATION: Exam: CT Thoracic Spine Without Contrast Exam date and time: 9/30/2021 6:14 PM Age: 70 years old Clinical indication: Other: Na; Additional info: Post op evaluation TECHNIQUE: Imaging protocol: Computed tomography images of the thoracic spine without contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: CT NAVI THORACIC SPINE WO CONTRAST 9/29/2021 4:36 AM FINDINGS: Vertebrae: Status post postop changes identified with fusion from T2-T8 with transpedicular screw placement. Prior kyphoplasty changes of T5. There is again noted a lytic process involving T5 vertebral body. Limitedly seen due to presence of streak artifact from metallic hardware. Discs/Spinal canal/Neural foramina: Mild multilevel degenerative changes. No evidence of spinal canal narrowing. Soft tissues: Paravertebral postsurgical changes. Again noted a infiltrative right hilar mass. IMPRESSION: Status post thoracic spinal fusion changes as described above as well as kyphoplasty. Postsurgical changes are noted. Infiltrative right hilar mass, unchanged. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD X-ray thoracic spine 2 views Resulted: 09/30/21 1845 Order Status: Completed Updated: 09/30/21 1845 Narrative: XR SPINE THORACIC 2 VW IMPRESSION: Midthoracic spine fixation with evidence of prior vertebroplasty or kyphoplasty. Intraoperative imaging. Radiographic guidance is provided for the surgical staff. Please refer to the operative notes for full details. END OF IMPRESSION: INDICATION: invasive surgical procedure. ARTHRODESIS, POSTERIOR OR POST LATERAL TECHNIQUE, SINGLE LEVEL; THORACIC (WITH LATERAL TRANSVERSE TECHNIQUE, WHEN PERFORMED) T2-T8 fusion, OR. TECHNIQUE: AP and lateral C-arm images of the thoracic spine. Intraoperative imaging. COMPARISON: Prior imaging from MRI of the thoracic spine of September 28, 2021. FINDINGS: Radiographic guidance is provided for the surgical staff for mid thoracic spine fixation with evidence of prior vertebroplasty or kyphoplasty. Please refer to the operative notes for full details. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT exam in OR Resulted: 09/30/21 1756 Order Status: Completed Updated: 09/30/21 1756 Narrative: This is a limited study that will be used for surgical guidance only. This is not a diagnostic study, no diagnostic interpretation will be performed and no diagnostic report will be generated. A full diagnostic study should be ordered if you require diagnostic information. MRI brain with and without contrast (Abnormal) Resulted: 09/30/21 0013 Order Status: Completed Updated: 09/30/21 0013 Narrative: PROCEDURE INFORMATION: Exam: MR Head Without and With Contrast Exam date and time: 9/29/2021 10:14 PM Age: 70 years old Clinical indication: Other: Na; Additional info: Assess for brain mets TECHNIQUE: Imaging protocol: MR of the head without and with intravenous contrast. Contrast material: MULTIHANCE; Contrast volume: 10 ml; Contrast route: INTRAVENOUS (IV); COMPARISON: SR NM BONE SCAN WHOLE BODY 7/14/2021 5:13 PM FINDINGS: Brain: There is moderate prominence of ventricles and sulci, compatible with moderate atrophy. There is no abnormal diffusion weighted signal intensity to suggest an acute ischemic event. The midline structures have a normal configuration. There is minimal FLAIR signal abnormality in the periventricular, deep and subcortical white matter regions compatible with minimal microangiopathy. There is no signal abnormality on the susceptibility weighted imaging to suggest intracranial hemorrhage. There are no regions of abnormal enhancement to suggest mass. Cerebral ventricles: Normal. No ventriculomegaly. Bones/joints: Unremarkable. Paranasal sinuses: Normal as visualized. No acute sinusitis. Mastoid air cells: Normal as visualized. No mastoid effusion. Orbital cavity: Unremarkable. Soft tissues: Unremarkable. Other vasculature: Normal vascular flow voids are present. IMPRESSION: 1. There are no regions of abnormal enhancement to suggest mass. 2. No evidence for acute intracranial abnormality or displaced calvarial fracture. 3. Additional incidental and/or chronic findings as described. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD CT navi thoracic spine without contrast (Abnormal) Resulted: 09/29/21 0552 Order Status: Completed Updated: 09/29/21 0552 Narrative: PROCEDURE INFORMATION: Exam: CT Thoracic Spine Without Contrast Exam date and time: 9/29/2021 4:36 AM Age: 70 years old Clinical indication: Other: N/a; Additional info: Pre-op TECHNIQUE: Imaging protocol: Computed tomography images of the thoracic spine without contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: SR MRI THORACIC SPINE W WO CONTRAST 9/28/2021 10:15 AM FINDINGS: Vertebrae: T5 compression fractures again visualized. The patient is status post kyphoplasty. There is acute kyphosis at this level. There is a grade 1 anterolisthesis of L4 over L5. Discs/Spinal canal/Neural foramina: There is lytic changes to the lamina and posterior facets consistent with underlying neoplasm. Some bony fragments are seen in the canal. Soft tissues: Unremarkable. Lungs: Some postobstructive changes are seen in the lungs. Mediastinum: Extensive right hilar mass is noted but not fully evaluated on the examination. IMPRESSION: 1. T5 fracture status post kyphoplasty with associated underlying bony lytic process likely neoplasm as described. Bony fragments in the canal as noted on recent MRI. 2. Infiltrating right hilar mass.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Non-Hospital Allergic rhinitis due to pollen Dry eye Unspecified glaucoma Compression fracture of T6 vertebra, initial encounter Personal history of tobacco use Medication management S/P vertebroplasty Other hemoglobinopathies
- Andere Medikamente
- Outpatient Medications albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler atorvastatin (LIPITOR) 20 mg tablet brimonidine (ALPHAGAN) 0.2 % ophthalmic solution ferrous sulfate 325 mg (65 mg iron) tablet fluticasone propion-salm
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 08.10.2021
- Impfdatum
- 09.02.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 167,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19 pneumonia
Cough
Craniotomy
Dyspnoea
Haematoma evacuation
Subdural haematoma
Symptomtext
History of recent subdural hematoma status post evacuation/craniotomy and subsequent admission to rehab who was discharged nearly 1 week ago to home presented complaining of worsening shortness of breath and cough. Hx of CHF. COVID-19 PNA w/ acute hypoxemic respiratory failure at presentation. Tx w/ steroids, remdesivir and supportive therapy. Weaned off oxygen, on RA at time of DC.DC'd to home w/home health.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 11.02.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 81,0
- Dosis
- 1
- Route/Site
- SYR / AR
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebral haemorrhage
Computerised tomogram abnormal
Death
Symptomtext
My mom received her first dose feb 11, 2021 and second dose of the pfizer covid vaccine on Mar 4, 2021. She experienced two brain bleeds, one after the first shot and the second brain bleed after the second dose. Both brain bleeds were detected by hospital's CAT scan. The emergency room neurosurgeon indicated that he saw evidence of the old brain bleed that happened several months back and this new one that brought her into the emergency room on july 17, 2021. My mom died of this brain bleed on july 22, 2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 7,0
- Labordaten
- Hospital has them
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Deep leg thrombosis, asthma
- Andere Medikamente
- -
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 06.10.2021
- Impfdatum
- 03.03.2021
- Beginn
- 21.08.2021
- Tage bis Beginn
- 171,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory distress syndrome
Acute respiratory failure
Angiogram pulmonary abnormal
Anticoagulant therapy
COVID-19
Diarrhoea
Dyspnoea
Emphysema
Endotracheal intubation
Intensive care
Lung disorder
Lung opacity
Mechanical ventilation
Oxygen saturation decreased
SARS-CoV-2 test positive
Symptomtext
81 y.o. female with PAD s/p aortobifem bypass, Atrial fibrillation on xarelto who presents to Medical Center with COVID19. Spoke with patient and daughter briefly at bedside prior to emergent intubation. Patient and daughter report that patient tested positive for COVID19 about 10 days ago. Patient has been at home on nasal cannula. Patient reports that today she felt as though she could not breathe. Daughter reports that saturations had dropped at home. Patient reports that otherwise she has felt ok in the last ten days, has had diarrhea that has been bothering her more in the last few days prior to presentation. Of note patient is vaccinated with Pfizer. In the emergency room, patient was requiring HFNC. CTPE showed no pulmonary embolism and moderate bilateral airspace disease consistent with COVID19. Patient also has advanced emphysema. She has a past medical history of CHF (congestive heart failure), Chronic renal failure, Compression fracture of fourth lumbar vertebra with routine healing (11/2020), COPD (chronic obstructive pulmonary disease), Hyperlipidemia, unspecified, Hypertensive heart disease without congestive heart failure, PAD (peripheral artery disease), and Personal history of other diseases of the digestive system. #Acute Hypoxic Respiratory failure secondary to COVID19 infection - Patient's CTPE negative of PE, did show bilateral GGO c/w COVID and some concern for underlying lung disease. No concern for concurrent bacterial pneumonia. PLAN - DEXA ARDS started 8/23 - a.m. gas was borderline requiring proning- will reevaluate this afternoon - Ongoing ICU level care given hypoxic respiratory failure #Acute Hypoxic Respiratory failure secondary to COVID19 infection- worsened - Required increased PEEP for recruitment, paralytic, and increasing to FiO2 100% overnight. This a.m. remains hypoxic despite being on 100% FiO2. Differential includes PE, pneumonia, progression of COVID19 infection. Initially started antibiotics, however as goals are now to keep the patient alive until family arrives, are minimizing treatment to only what is sustaining her life for the next 24 hours. PLAN - Continue steroids - Not proning due to multiple comorbidity and poor prognosis - Cont vent settings. - Heparin drip for possible PE, will not pursue imaging to confirm Patient was unable to be weaned down on her ventilator settings despite dexamethasone and attempts to optimize patient's fluid status. Patient's family elected to have no escalation of care on 8/28, and ultimately decided on comfort care with terminal extubation on 8/30.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 10,0
- Labordaten
- COVID-19 PCR positive on 08/21/21
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- PMH includes CHF (congestive heart failure), Chronic renal failure, Compression fracture of fourth lumbar vertebra with routine healing (11/2020), COPD (chronic obstructive pulmonary disease), Hyperlipidemia, unspecified, Hypertensive heart disease without congestive heart failure, PAD (peripheral artery disease), and Personal history of other diseases of the digestive system.
- Andere Medikamente
- albuterol atorvastatin budesonide-formoterol calcitonin cefadroxil docusate furosemide hydrocodone-acetaminophen levothyroxine loratadine-pseudoephedine metoprolol tartrate pantoprazole rivaroxaban
- Allergien
- Chlorhexidine Chlorhexidine Itching Medium Allergy 1/29/2018 Oxycodone-acetaminophen Oxycodone-acetaminophen Itching Medium Allergy 1/27/2018 Cephalexin Unknown reaction Low Allergy 3/7/2016 Doxycycline Unknown reaction Low Allergy 3/7/2016 Nafcillin Nafcillin Unknown reaction Low Allergy 3/7/2016
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 29.09.2021
- Impfdatum
- 15.02.2021
- Beginn
- 07.09.2021
- Tage bis Beginn
- 204,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Symptomtext
Hospice patient. Died due to COVID-19. Was fully vaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic Lung Disease, Chronic Renal Disease, Hypertension, Autoimmune Condition, Obese
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 21.03.2021
- Beginn
- 07.09.2021
- Tage bis Beginn
- 170,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Death
Laboratory test
SARS-CoV-2 test positive
Symptomtext
Patient admitted to hospital via ED 9/7/21. COVID test positive 9/7/21. Deceased 9/15/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Covid Test 9/7/21, RPP 9/8/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 28.02.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 177,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
SARS-CoV-2 test
Symptomtext
Patient admitted to hospital and tested for COVID 8/24/21. Discharged 8/28/21. Deceased 9/7/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- COVID19 test 8/24/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 23.09.2021
- Impfdatum
- 02.03.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 176,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute hepatic failure
Acute kidney injury
Ammonia normal
Arthralgia
Arthritis bacterial
Asthenia
Asymptomatic COVID-19
Bacteraemia
Blindness
Blindness unilateral
Blood bilirubin abnormal
COVID-19
Cerebrovascular accident
Computerised tomogram head normal
Confusional state
Death
Dyspnoea
Echocardiogram
Symptomtext
Hospitalized (9.2.21); Deceased (9.17.21); COVID-19 positive; Fully Vaccinated Discharge Provider Primary Care Physician at Discharge Admission Date: 9/2/2021 Date of Death: 9/17/21 Time of Death: 3:30 PM Preliminary Cause of Death: Bacteremia Discharge Disposition: death DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyponatremia Loss of vision AKI (acute kidney injury) HOSPITAL COURSE: Patient is a 70 y.o. male with a pertinent past medical history for chronic diastolic heart failure, cirrhosis, non-insulin-dependent type 2 diabetes, who presented to the ED primarily with generalized weakness and left vision sided loss. The patient's wife is at bedside and provides aspects of history. 8/19 he started having some confusion and generalized weakness and went to the ED due to wife concern for hepatic encephalopathy, however ammonia normal. He went back to the ED 8/25 and was found to be COVID positive but did not have any symptoms, he received monoclonal antibodies the next day. He presented to the ED again 8/31 for right knee pain and swelling and thought that he may have twisted his knee, he has had a prior arthroplasty there. Radiograph was negative for fracture or other acute abnormality at that time. He then returned with left eye vision loss that started 5-6 days prior to admission that he had never mentioned until day of admission. He was noted to have hyponatremia and mild AKI both of which corrected while hospitalized. CT orbits negative for globe issue. Ophthalmology evaluated him and stated this was Iritis and started patient on prednisolone and atropine drops (the atropine caused left eye pupillary dilation). He was evaluated by ortho and had his right knee tapped which returned septic and grew MSSA. On Ancef with plan to continue 6 weeks course. His hospitalization was complicated by his lethargy and confusion likely related to pain medications and liver function. He had a stroke rap called which did not show concern for a stroke. He was found to have MSSA bacteremia as well and was seen by ID. TTE negative for vegetations. Unfortunately patient developed worsening LFTs and bilirubin. Gastroenterology was consulted. It is noted that patient had cirrhosis have baseline etiology unclear. Hepatitis-C and hepatitis-B workup were negative. Imaging did not show thrombus. Acute liver failure was initially attributed to recent anesthesia exposure and Ancef use as well as Tylenol. These medications were discontinued but LFTs continue to trend up. There was also concern for Bilateral endogenous endophthalmitis. IV Ancef was discontinued and patient was started on IV vancomycin and linezolid. Unfortunately this led to acute kidney injury with high vancomycin trough level. Given that his LFTs have continued to worsen despite stopping ancef, id felt the Ancef is less likely to be the cause of Abnormal LFTs, hence; he was placed back on Ancef and Vanco was discontinued. Unfortunately patient continued to decline and have further elevation in bilirubin levels. Ultimately after consultation with various consultants it was felt that the liver failure was more attributable to sepsis. Renal function also continued to decline with subsequent noted hyperkalemia. Given patient's overall decline and lack of options for possible medical intervention to reverse liver failure (patient deemed not to be a transplant candidate per Gastroenterology in setting of bacteremia) patient and family ultimately decided to pursue comfort care and patient was transitioned to inpatient comfort care on 09/16. Palliative Care was consulted and assisted with medication. Patient was placed on a fentanyl drip. Physician was called that patient passed away at 3:30 p.m. 09/17/2021. Patient officially pronounced on 15:50 on 09/17/2021. Family present in room.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 8.19.21: Acute Hepatic Encephalopathy (Office Visit) 8.25.21: ED visit - COVID-19 positive; fatigue 8.26.21: ED visit - shortness of breath; antibody infusion 8.30.21: Office visit 8.31.21: ED - knee injury; COVID; weakness
- Vorgeschichte
- Acute on chronic diastolic heart failure Elevated LFTs Colonic polyp OSA (obstructive sleep apnea) Diabetes mellitus type 2, uncontrolled, without complications Squamous cell skin cancer, upper arm Tubular adenoma of colon Other cirrhosis of liver Thrombocytopenia, unspecified Type 2 diabetes mellitus with hyperglycemia Morbid (severe) obesity due to excess calories Body mass index (BMI) 45.0-49.9, adult Mixed hyperlipidemia Gastro-esophageal reflux disease without esophagitis Essential (primary) hypertension Long term (current) use of insulin Primary open-angle glaucoma, bilateral, mild stage Mild intermittent asthma without complication Pancytopenia Delta beta thalassemia Unspecified severe protein-calorie malnutrition Multiple comorbid conditions Counseling regarding advanced directives and goals of care End of life care
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet Blood Glucose Monitoring Suppl MISC ceFAZolin (ANCEF) 2 g/20mL SOSY syringe Insulin Pen Needle (BD ULTRA-FINE SHORT PEN NEEDLE 8 MM X 31G) lactulose (CHRONULAC) 10 GM/15ML solution Lancets (ONETOUCH DEL
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 10.09.2021
- Impfdatum
- 11.01.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 210,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Intensive care
Malaise
Symptomtext
developed symptoms on 08/04/2021 and was admitted to the ICU on 08/09/2021 Patient expired on 8/24/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Patient is a 75yo man with PMH of dementia, seizure d/o, CKD III, ETOH use disorder
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 10.09.2021
- Impfdatum
- 06.02.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 195,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Atrial fibrillation
COVID-19
Cardiogenic shock
Catheterisation cardiac abnormal
Cough
Death
Dyspnoea
Echocardiogram abnormal
Ejection fraction decreased
Electrocardiogram ST segment elevation
Endotracheal intubation
Feeding disorder
Intensive care
Intra-aortic balloon placement
Myocarditis
Positive airway pressure therapy
Right ventricular dysfunction
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer BioNTech Vaccine on 1/18/2021 and 2/06/2021. Presented to ED on 8/20/21 with worsening shortness of breath. Patient was diagnosed with COVID-19 on 8/18/2021. Patient was tachypneic upon arrival and did not improve with BiPAP and was subsequently intubated and transferred to ICU. Before admission patient developed poor appetite and mild cough and PCP ordered monoclonal antibody for patient. Bedside echo showed an underfilled, hyperdynamic RV. Patient developed ST elevations in inf leads. She underwent LHC on 8/22 which showed myocarditis and lvef of 10%. She had an IABP placed and started on multiple pressors for cardiogenic shock. Patient also developed AKI, afib (started on amiodarone). Received vancomycin, cefepime, and azithromycin. Patient was transitioned to inpatient hospice on 8/28/21. Patient expired on 8/29/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- COVID19 Positive 8/21/21 The sample was analyzed using one or a combination of Real-Time PCR based methods and multiplex reagents
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD on continuous 2 L of oxygen at home, HTN, remote hx of CVA caused by meningitis causing right hemiparesis, pulmonary embolism not on AC
- Andere Medikamente
- Probiotic & Acidophilus 300-250 million cell-mg daily, Tylenol 325mg 2 tab q4h prn, temazepam 15mg 2 cap at bedtime, Symbicort 160-4.5mcg 2 puff BID, cetirizine 10mg daily. Flonase 50mcg 2 sprays in both nostrils daily, metoprolol 50mg BID
- Allergien
- Codeine Phosphate, Colistimethate Sodium, Diltiazem, Metoprolol Tartrate, Penicillin V Potassium, Pentazocine
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 24.02.2021
- Beginn
- 05.08.2021
- Tage bis Beginn
- 162,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Aspiration
Atelectasis
COVID-19
Cardiac arrest
Chest X-ray abnormal
Death
Dyspnoea
Ileus
Pleural effusion
SARS-CoV-2 test positive
Symptomtext
Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/3/2021 and 2/24/2021. Presented to ED on 8/5/2021 with shortness of breath. Medications administered: acetylcysteine, baricitinib, dexamethasone, methylprednisolone, prednisone, ceftriaxone, azithromycin, remdesivir, piperacillin/tazobactan, zinc, and vancomycin. During hospitalization, patient aspirated and had small bowel ileus subsequently requiring vasopressor support. Patient eventually went to cardiac arrest and expired on 9/01/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 28,0
- Labordaten
- COVID Positive on 8/5/2021; CXR showed Probable left pleural effusion with atelectasis or possible pneumonia at the left lung base on 8/5/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, congestive heart failure, chronic obstructive pulmonary disease, atrial fibrillation, hyperlipidemia, chronic kidney disease, sleep apnea
- Andere Medikamente
- Torsemide 20 mg daily, pantoprazole 40 mg daily, flonase, 1 spray each nostril daily, acetazolamide 250 mg every other day, albuterol 90 mcg/actuation 1 puff four times daily as needed, cholecalciferol 5000 units daily, dorzolamide 2% 1 dro
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 27.08.2021
- Impfdatum
- 02.02.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Death
Fatigue
Headache
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Upper respiratory tract infection
Vomiting
Symptomtext
Became symptomatic on 8/8/21 feverish, chills, runny nose, headache, fatigue, cough, vomiting, and tested positive for COVID-19 on 8/10/21. Died on 8/17/21 due to upper respiratory infection d/t COVID-19, HTN, hyperlipidemia, T2D, obesity, per death certificate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- SARS coronavirus 2 RNA: Detected, Collected 8/10/21.
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- TYPE 2 DIABETES, OBESTIY, HTN, HYPERLIPIDEMIA
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 24.08.2021
- Impfdatum
- 10.02.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 167,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Atrial fibrillation
COVID-19
Chest X-ray abnormal
Death
Fatigue
Hypoxia
Lung opacity
SARS-CoV-2 test positive
Troponin increased
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/20/2021 and 2/10/2021. On 7/27/2021, patient presents to the ED with weakness and fatigue after being diagnosed with COVID-19 1 day prior. On arrival to the ED, patient O2 saturation 88%, 2LNC initiated. Patient admitted to the hospital for COVID-19, hypoxemia, and elevated troponin. Patient received remdesivir x 5 days, convalescent plasma 1 unit, tocilizumab 800 mg x 1 dose, dexamethasone, azithromycin, ceftriaxone. Patient developed new onset atrial fibrillation on 8/7/2021. Throughout hospitalization patient continued to decompensate and eventually expired on 8/8/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 11,0
- Labordaten
- 07/27/2021: troponin 0.035; 07/27/2021: CRX scattered bilateral interstitial opacities; 07/27/2021: COVID positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, parkinson disease, diabetes mellitus type 2 w/ peripheral neuropathy, stage III chronic kidney disease, hyperlipidemia, osteoarthritis, Gastroesophageal reflux disease without esophagitis, vitamin D deficiency
- Andere Medikamente
- Ascorbic acid 500 mg daily, acetaminophen 325-650 mg q6h PRN, Azelastine 0.15 % (205.5 mcg) spry Apply or instill 2 Sprays into both nostrils two times daily, carbidopa-levodopa 25-100 mg tablet Take 1 Tab by mouth three times daily, Choles
- Allergien
- Escitalopram, potassium, sulfonamide antibiotics
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 24.08.2021
- Impfdatum
- 03.03.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Pt was hospitalized on 8/13/2021 and passed away on 8/21/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 8,0
- Labordaten
- Pt tested positive for COVID-19 by RNA on 08/13/2021.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, Diabetes mellitus, AKI
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 24.08.2021
- Impfdatum
- 08.02.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 183,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
PT succumbed to COVID-19 after diagnosis on 8/10/21 during nursing home outbreak. Pt was hospitalized on 8/13/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- Rapid nasal swab 8/10/21
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Patient diagnosed with symptomatic COVID during LTCF outbreak
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 24.08.2021
- Impfdatum
- 25.02.2021
- Beginn
- 07.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Chills
Cough
Death
Decreased appetite
Fatigue
Headache
Lung opacity
Pneumonia
Pyrexia
Respiratory distress
Respiratory failure
SARS-CoV-2 test positive
Thirst decreased
Symptomtext
Pfizer-BioNTech COVID-19 Vaccine EUA Patient received Pfizer-BioNTech COVID Vaccines on 2/4/2021 and 2/25/2021. Patient diagnosed with COVID-19 on 8/6/21 presented to ED complaining of worsening repsiratory status over a couple of days. 1 day prior to ED visit pt was given Decadron and discharged from unknown location per provider note. Associated symptoms include headache, cough, fever (T-max 104?), chills, decreased appetite/thirst, abdominal cramping with cough, and fatigue. X-ray shows moderate bilateral airspace opacities left greater than right, most consistent with multilevel low-grade pneumonia in this clinical setting. Pt treated with ceftriaxone, azithromycin x 3days 8/10, solumedrol #4 cont.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hx of malignant skin melanoma, COPD, paroxysmal AFIB, CAD, DM II cont.
- Andere Medikamente
- asprin 81mg chewable daily, carvedilol 12.5mg BID cont.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 16.08.2021
- Impfdatum
- 29.01.2021
- Beginn
- 25.07.2021
- Tage bis Beginn
- 177,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Covid vaccine received 1/29/21 and 3/4/21, Pfizer mRNA Covid-19 vaccine. Client died of Covid related death on 7/25/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 16.08.2021
- Impfdatum
- 17.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 165,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Computerised tomogram thorax
Death
Hyponatraemia
Legionella test
Procalcitonin increased
Staphylococcus test negative
Streptococcus test negative
Symptomtext
-pt was found to have acute hypoxic respiratory failure secondary to COVID19 and severe hyponatremia - 8/6/21 pt received monoclonal antibodies but not a candidate for remdesivir d/t duration of symptoms -d/t minimal improvement symptoms, Palliative care was consulted. per family wishes pt was transitioned to inpatient hospice on 8/12/21 pt pronounced deceased at 1148 on 8/13/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- CPTA neg for PE pro-cal was 0.79 MRSA DNA probe, Legionella and strep pneumo urine Ag were neg
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypothyroidism, COPD, HTN, CKD, GERD
- Andere Medikamente
- albuterol, alfornoterol, azithromycin, benzonatate, budesonide, calcium/vit d3, clonazepam, famotidine, furosemide, ferrous sulfate, guaifenesin, levothyroxine sodium, losartan potassium, morphine, omeprazole, PEG, prednisone, tiotropium br
- Allergien
- latex, natural rubber
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 16.08.2021
- Impfdatum
- 01.03.2021
- Beginn
- 08.08.2021
- Tage bis Beginn
- 160,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC). PFIZER Lots # EL 9269, EN6200.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 15.08.2021
- Impfdatum
- 03.03.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 160,0
- Dosis
- 1
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Agitation
Asthenia
Atrial fibrillation
Back pain
Blood magnesium decreased
Blood phosphorus decreased
Blood potassium decreased
COVID-19
COVID-19 pneumonia
Cardiac arrest
Condition aggravated
Culture urine positive
Death
Dyspnoea
Echocardiogram abnormal
Ejection fraction decreased
Fall
Symptomtext
Patient required hospitalization due to breakthrough infection. He received the Pfizer vaccine (2nd dose in series) on 03/03/21. Hospitalized from 08/10/21 - 08/14/21 (death). Below is copied from patients discharge (death) summary: Hospital Course: Patient is an 84 year old man with a past medical history of Afib (on eliquis, metoprolol), HTN, HLD, MI admitted to the ICU for acute hypoxemic respiratory failure secondary to Covid-19 pneumonia. He presented to the ED after EMS was called for fall out of bed with generalized weakness, he denies hitting his head or LOC. He was satting 78% on EMS arrival and tachypneic, he had minimal improvement with NRB. In the ED he was found to be in Afib RVR to the 160s with hypotension, levophed was begun, he was cardioverted, and was begun on amiodarone infusion. The patient reports a 1 week history of generalized fatigue and shortness of breath without leg swelling or orthopnea. He was vaccinated in March with the Pfizer vaccine. He reports his cardiologist is at another facility and doesn't remember his medications offhand but knows he takes Eliquis BID. 8/11: TTE ordered, not yet performed. K+, Mg, phos low and repleted. On HFNC + NRB 60L/92% satting high 80s/low 90s. Currently on amio drip. No other acute events. 8/12 Patient elected to be DNR/DNI yesterday. Urine culture growing >100K Staph, started on Vanc/Cefepime while waiting sensitivity. Amio gtt changed to metoprolol. Patient endorsing soreness/back pain and states he uses Percocet and fentanyl patch outpatient. On HFNC + NRB 60L/95%, satting high 80s/low 90s past 24 hours. Echo performed shows EF 50-55%, impaired relaxation, moderately enlarged RV, moderately dilated LA, PASP 45 mm Hg. 8/13: Patient elected to rescind DNR/DNI 1 day ago. Became acutely agitated throughout the night and was removing HFNC stating that he "did not want to do this anymore". Started on precedex gtt and haldol prn for agitation. Pt w/ improved compliance w/ HFNC and able to maintain O2 saturation between 87-89%. 8/14: Patient now DNR/DNI, daughter at bedside while patient's wife was again admitted to the hospital. Decision made to pursue compassionate wean. Started on Morphine infusion for comfort and to prevent air hunger. O2 saturation continually downtrending. Asystole at 1803, confirmed in 2 leads. No signs of life. Pronounced expired at 1803. Dr notified at 1806.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- SARS-COV-2, NAA, Detected on 08/10/21.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Abdominal hernia Chronic constipation Colon polyp GERD (gastroesophageal reflux disease) Heart attack Hyperlipidemia Hypertension
- Andere Medikamente
- apixaban (ELIQUIS) 5 MG aspirin 81 MG Tablet l atorvastatin (LIPITOR) 80 MG Tablet fentaNYL (DURAGESIC) 100 MCG/HR fluticasone (FLONASE) 50 MCG/ACT Suspension losartan-hydroCHLOROthiazide (HYZAAR) 100-12.5 MG Ta
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 06.02.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 187,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acquired oesophageal web
Anticoagulant therapy
Bilevel positive airway pressure
Colonoscopy abnormal
Death
Dyspnoea
Endotracheal intubation
Fatigue
Gait disturbance
Gastritis
Haematochezia
Haemorrhoids
Intensive care
Mental status changes
Oesophagogastroduodenoscopy abnormal
Oxygen saturation decreased
Respiratory symptom
Supportive care
Symptomtext
Patient received dose 1 and 2 of COVID vaccine on 2/6/21 and 2/27/21, respectively. On 8/4/21 the patient presented from home after progressive upper respiratory symptoms that began on 7/28/21. She states that about a week prior to admission she started having some generalized fatigue with progressively worsening shortness of breath to the point where it is difficult for her to ambulate. She checked her oxygen levels at home and they were low hence she presented to the ED today for further evaluation. On arrival she was found to be 82% on room air oxygen saturation. She had no recent nausea, vomiting or diarrhea. She stated that she has been occasionally seeing blood in her stools. She had an EGD April 2021 which showed some gastritis and Schatzki's ring. She also stated that she had a colonoscopy 2 weeks prior to admission which according to the patient showed some hemorrhoids. Patient was started on remdesivir, Lovenox for prophylaxis of DVT, continued home blood pressure medications, as well as vitamins. Her inflammatory markers were trended. Since oxygen saturation deteriorated rapidly, patient was upgraded and was placed on Vapotherm 40 L 100% with as needed BiPAP. Patient was continued on IV steroids and remdesivir. Patient continued to decompensate while on Vapotherm, patient was requiring continuous BiPAP for several days and was unable to be weaned off of it. Patient's mental status deteriorated as well. All attempts were made to reach family but had difficulty, supportive care medicine was involved as well. Her mentation began to further deteriorate and patient began to desaturate on BiPAP, necessitating intubation as per family's wishes. Further goals of care discussion guarded family patient was made DNR. Patient's family members came to hospital to see her, noted her again deconditioning discussed poor prognosis. Patient is then made comfort care as per family. Patient expired on 8/13/2021 at 4:18 AM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None that are known
- Vorgeschichte
- HTN, HLD, DM2, Rheumatoid arthritis, chronic back pain, carotid disease status post left CEA, hypothyroidism
- Andere Medikamente
- Divalproex sodium, amlodipine, topiramate, thyroid desiccated, pantoprazole, hydrochlorothiazide-triamterene, gabapentin, tofacinitib, cevimeline, irbesartan, methocarbamol, metformin, gemfibrozil, rosuvastatin, celecoxib, trazodone
- Allergien
- Ciprofloxacin, doxycycline, penicillins
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 08.08.2021
- Impfdatum
- 06.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 176,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
COVID-19 pneumonia
Death
SARS-CoV-2 test positive
Symptomtext
Patient was vaccinated with 2 doses Pfizer Covid-19 vaccine in January and February of 2021, and was hospitalized for Covid (8/1/21) and subsequently died of Covid pneumonia on 8/4/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 3,0
- Labordaten
- Ordered Test: SARS-CoV-2 (COVID-19) in Specimen with probe detection (SARS Coronavirus 2) Ordered Test Codes: 94309-2 /2019nCoV Status: Final Accession Number: 1574473 Specimen Source: Other Specimen Site: Specimen Collection Date/Time: 2021-07-30 00:00:00.0
- Aktuelle Erkrankungen
- ? Aortic insufficiency ? Aortic stenosis ? Ascending aorta dilation ? Asthma ? Benign prostatic hyperplasia ? Bilateral carotid artery disease ? Cerebrovascular accident ? Chest pain ? Chronic interstitial cystitis ? COPD (chronic obstructive pulmonary disease) ? COPD with acute exacerbation 1/6/2021 ? Coronary artery disease ? ED (erectile dysfunction) ? History of emphysema ? Hypertension ? Hypoxemia dependant to supplimental oxygen ? Left bundle branch block ? Obesity ? OSA (obstructive sleep apnea) ? Pacemaker ? Pneumothorax 1996 ? Pulmonary fibrosis mild ? S/P CABG x 5 ? Stroke 4/2014 left sided deficits, ambulates without a cane or walker ? Urinary urgency 08/2010 Cystoscopy/Bladder
- Vorgeschichte
- See #11
- Andere Medikamente
- acetaminophen (TYLENOL) 500 mg tabletTake 500 mg by mouth every 6 hours as needed for Pain. --albuterol 90 mcg/puff inhalerInhale 2 puffs into the lungs every 6 hours as needed for Wheezing. --Ascorbic Acid (VITAMIN C) 1000 MG tabletT
- Allergien
- Lidocaine, Sulfa, Pennicillins, Latex
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 05.08.2021
- Impfdatum
- 27.02.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 153,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
Pneumonia
Symptomtext
death - Multifocal pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 13.02.2021
- Beginn
- 04.07.2021
- Tage bis Beginn
- 141,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Patient was diagnosed with Covid-19 on 6/30/2021, and subsequently died on 7/8/2021. Covid-19 was listed as a contributing factor on his death certificate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- SARS-CoV-2 (COVID-19) RNA (Presence) in Respiratory specimen by NAA with probe detection on 6/30/2021
- Aktuelle Erkrankungen
- Anxiety BPH (benign prostatic hypertrophy) Dementia Depression Diverticulosis Former Smoker Herpes Zoster History of tobacco use Hyperlipidemia, unspecified Hypertension, Unspecified Insomnia, Other Lumbar spondylosis Post herpetic neuralgia S/P gastrectomy Sacroiliac dysfunction SPINAL STENOSIS-LUMBAR Valvular heart disease Vitamin B12 deficiency.
- Vorgeschichte
- Anxiety BPH (benign prostatic hypertrophy) Dementia Depression Diverticulosis Former Smoker Herpes Zoster History of tobacco use Hyperlipidemia, unspecified Hypertension, Unspecified Insomnia, Other Lumbar spondylosis Post herpetic neuralgia S/P gastrectomy Sacroiliac dysfunction SPINAL STENOSIS-LUMBAR Valvular heart disease Vitamin B12 deficiency.
- Andere Medikamente
- acetaminophen 325 mg oral tablet 650 mg = 2 tab(s), PRN, PO, Amitizia Aspercreme Heat Pain Relieving aspirin Debrox Earwax Removal Kit 6.5% otic solution Discontinue Medication Order 1 EA, No Route, As Directed-see order comment Ensure Plus
- Allergien
- Gabapentin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 29.07.2021
- Impfdatum
- 03.03.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 147,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Death
Symptomtext
death I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 01.02.2021
- Beginn
- 21.04.2021
- Tage bis Beginn
- 79,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute myocardial infarction
Catheterisation cardiac
Chest pain
Coronary arterial stent insertion
Electrocardiogram
Troponin
Symptomtext
sudden onset of chest pain found to have STEMI requiring urgent cardiac cath and stenting x 2
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 3,0
- Labordaten
- 4/2021 EKG, troponin c/w STEMI
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- allergies, migraine, Gerd, glaucoma, anxiety, lymphocytic colitis
- Andere Medikamente
- Celebrex, aspirin, progesterone, magnesium, Tumeric, Super B Complex, zoloft
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 27.02.2021
- Beginn
- 17.07.2021
- Tage bis Beginn
- 140,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cardiac arrest
Death
Seizure like phenomena
Symptomtext
death R56.9 - Seizure-like activity (CMS/HCC) Cardiac arrest
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 13.07.2021
- Impfdatum
- 04.05.2021
- Beginn
- 07.05.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Blood test
Cardiovascular disorder
Cerebrovascular accident
Dizziness
Dyspnoea
Heart rate
Heart rate decreased
Oedema
Pallor
Peripheral swelling
Peripheral vascular disorder
Pharyngeal disorder
Thyroid disorder
Symptomtext
Thyroid or throat area was pounding; Thyroid or throat area is pounding; legs swelled up so bad; Heart rate very low; circulation issues; Felt like having a stroke; Dizzy; Pitting in left leg, which was pale and had veins showing; Pitting in left leg, which was pale and had veins showing; Pitting in left leg, which was pale and had veins showing; Struggling to breathe/can't breathe; Weak; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm, on 04May2021 12:00 (Batch/Lot Number: EL9269), as dose 1, single, at age 22 years old, for COVID-19 immunization, at a pharmacy/drug store. The patient was not pregnant at the time of vaccination. Medical history included Hashimoto's disease, Ehlers-Danlos syndrome, and Raynaud's disease, all from unknown dates, not reported if ongoing or not. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient received unspecified medications within 2 weeks of vaccination (unspecified concomitant medications). On 07May2021 (also reported as "around day 3 or day 4"), the patient started to get dizzy. On the same day, 07May2021, the patient felt like have a stroke because she could not make thoughts. She had pitting in left leg (also reported as "pitting in left left", pending clarification), which was pale and had veins showing, and she was struggling to breathe and was weak. On 09May2021 (also reported as "about day 5"), her heart rate was very low and she noticed circulation issues. On 11May2021 (also reported as "day 7"), her legs swelled up so bad. On 14May2021 (also reported as "day 10"), the patient's thyroid or throat area was pounding. The events resulted to emergency room and physician's office visits. Treatment for the events included turmeric and aspirin which the patient took every day, multiple times a day. Blood work on an unspecified date mostly came back normal. The patient reported the events were better in two weeks. Her physician advised her to skip the second dose. However, the patient received the second dose out of "fear of missing out" on 25May2021 12:00 (Batch/Lot Number: EW0178) in the left arm. The patient was recovering from the events. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- Test Name: Bloodwork; Result Unstructured Data: Test Result:mostly came back normal; Test Date: 20210509; Test Name: heart rate; Result Unstructured Data: Test Result:very low
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Ehlers-Danlos syndrome; Hashimoto's disease; Raynaud's disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 96,0
- Geschlecht
- F
- Eingang
- 08.07.2021
- Impfdatum
- 14.01.2021
- Beginn
- 21.06.2021
- Tage bis Beginn
- 158,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Patient was fully vaccinated. Doses on 1/14/21 and 2/4/21. Diagnosed with COVID-19 on 6/21/2021 and passed away on 7/3/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID-19 PCR test on 6/21/21 and 6/28/21.
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- dementia, coronary artery disease, GERD, hypertension, hyperlipidemia, osteoarthritis
- Andere Medikamente
- unknown
- Allergien
- Adhesive bandage, amoxicillin, cortisone
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 08.07.2021
- Impfdatum
- 27.02.2021
- Beginn
- 21.06.2021
- Tage bis Beginn
- 114,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Haemorrhagic stroke
Symptomtext
Hemorrhagic stroke NSTEMI (non-ST elevated myocardial infarction)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 117,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Pulmonary embolism
Systemic inflammatory response syndrome
Symptomtext
Pulmonary embolus, right SIRS (systemic inflammatory response syndrome)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 21.06.2021
- Tage bis Beginn
- 114,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Pulmonary embolism
Symptomtext
I26.99 - Other pulmonary embolism without acute cor pulmonale N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 11.02.2021
- Beginn
- 23.05.2021
- Tage bis Beginn
- 101,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
I21.4 - Non-ST elevation (NSTEMI) myocardial infarction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 28.06.2021
- Impfdatum
- 03.03.2021
- Beginn
- 10.05.2021
- Tage bis Beginn
- 68,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Pneumonia
Symptomtext
Death J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.06.2021
- Impfdatum
- 02.02.2021
- Beginn
- 16.02.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Died 3/6/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID-19 antigen test collected 2/16, and another positive antigen test collected 3/4/21
- Aktuelle Erkrankungen
- ASTHMA, HEART DISEASE, HYPOTHYROIDISM
- Vorgeschichte
- ASTHMA, HEART DISEASE, HYPOTHYROIDISM, DIVERTICULITIS
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 14.06.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Arrhythmia
Cardioversion
Catheterisation cardiac abnormal
Dizziness
Dyspnoea
Electrocardiogram abnormal
Electroencephalogram abnormal
Implantable defibrillator insertion
Intensive care
Near death experience
Ventricular tachycardia
Symptomtext
Near death heart arrhythmia (ventricular tachycardia) heart rate about 250 could not breath dizzy faint got to ER where they had to shock my heart to prevent a cardiac arrest admitted to ICU pacemaker/defibrillator implanted cardiac device (ICD) surgically placed in my chest
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Near death experience
- Hospital-Tage
- 3,0
- Labordaten
- EKG Cardiac Catherization EEG
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Melanoma Skin Cancer
- Andere Medikamente
- Paxil 10mg, Miralax, Flonase, Vit D
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 21.05.2021
- Tage bis Beginn
- 83,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Facial paresis
Symptomtext
I63.9 - CVA (cerebral vascular accident) (CMS/HCC) R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 31.05.2021
- Impfdatum
- 09.02.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 29,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Anticoagulant therapy
Arthralgia
Back pain
Chest pain
Dyspnoea
Echocardiogram
Fibrin D dimer increased
Pain in extremity
Pulmonary embolism
Thrombosis
Ultrasound Doppler abnormal
Symptomtext
Within 1 week of receiving COVID vaccine,I started having left leg pain that lasted until hospitalization. I?ve had sciatica before and thought it was this. After second COVID vaccine(03/02/2021),started getting shortness of breath that continued to get worse. Finally, in mid-April, along with the shortness of breath and left leg pain, I started getting right,mid back pain that radiated to right chest and shoulder. On April 21,2021, I could no longer tolerate the chest and back pain and drove myself to ER and Urgent Care. The Dr. ordered a CT Angio of chest and determined I had bilateral pulmonary embolism and sent me by ambulance to Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- Cardiac Echo, venous Doppler left leg, given oxygen and blood thinners. On 4/22/2021- clot in left leg. Labs showed elevated D dimer.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omeprazole, Bupropion, Pravastatin, Trazadone(for sleep), Vit.D3.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 24.05.2021
- Impfdatum
- 24.02.2021
- Beginn
- 10.05.2021
- Tage bis Beginn
- 75,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death within 90 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, Non-Hodgkin's Lymphoma; Pancreatitis; Prostate Cancer
- Andere Medikamente
- Unknown
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 24.05.2021
- Impfdatum
- 24.02.2021
- Beginn
- 07.05.2021
- Tage bis Beginn
- 72,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death within 90 Days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, Head and Neck radiation for Merkell Cell Cancer, G-tube, Renal Cell CA with mets to spine
- Andere Medikamente
- Unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 12.05.2021
- Impfdatum
- 09.02.2021
- Beginn
- 14.04.2021
- Tage bis Beginn
- 64,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Condition aggravated
Death
Endotracheal intubation
Extubation
Facial pain
Fall
Hypoxia
Intensive care
Jaw fracture
Oxygen therapy
Respiratory failure
SARS-CoV-2 test positive
Skin laceration
Symptomtext
Pneumonia due to COVID-19 virus ED to Hosp-Admission Discharged 4/14/2021 - 4/22/2021 (8 days) Last attending ? Treatment team Maxillary fracture Principal problem Final Summary for Deceased Patient Admission Date: 4/14/2021 Discharge Date: 4/22/2021 Final Diagnosis Principal Problem: Maxillary fracture (CMS/HCC) Active Problems: Pneumonia due to COVID-19 virus Demand ischemia (CMS/HCC) Dyslipidemia Essential hypertension Acute kidney injury (CMS/HCC) Glomerulonephritis, IgA Lactic acidosis Septic shock (CMS/HCC) Cytomegalovirus (CMV) viremia (CMS/HCC) Acute respiratory failure with hypoxia (CMS/HCC) Left femoral vein DVT (CMS/HCC) Malnutrition (CMS/HCC) Hypothermia DETAILS OF HOSPITAL STAY Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Fall, initial encounter [W19.XXXA] COVID-19 [U07.1] COVID-19 virus infection [U07.1] Hospital Course Patient is a 72-year-old female with past medical history of hypertension, hyperlipidemia, recent hospitalization due to CMV viremia and an AKI and myelosuppression. Who presented to the emergency room after a fall in her house on 4/14. She had significant face pain and was hypoxic with an O2 saturation of 68% on room air on presentation. She was then found to be Covid positive. Initially admitted to the medical floor however required increasing amounts of oxygen and was ultimately transferred to the ICU on 4/16. She was maintained on nonrebreather oxygen until the evening of 4/21 when she was intubated and increasing vasopressor requirements. Given her worsening condition, her husband elected to palliatively extubate and pursue comfort care. Time of death was 10:02 AM on 4/22/2021. Disposition of the body: morgue
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- Ordered Respiratory Therapy communication Initiate Epoprostenol Continuous Inhalation Daily 0800, Status: Canceled 04/22/21 0548 RT FLOLAN Assessment Q2H SCH Every 2 hours scheduled (odd hours), Status: Canceled 04/22/21 0548 Respiratory Therapy communication Initiate Epoprostenol Continuous Inhalation Once, Status: Canceled 04/22/21 0548 Transthoracic echo (TTE) complete Once, Status: Canceled 04/22/21 0023 RT FLOLAN Assessment Q2H SCH Every 2 hours scheduled (odd hours), Status: Canceled 04/21/21 2013 ETCO2 Mechanical Vent Daily 0800 Daily 0800, Status: Canceled 04/21/21 2058 Vent Settings (Trauma/Non-Trauma) Continuous (tasks Q4H), Status: Canceled 04/21/21 2058 Respiratory Therapy communication RT to discontinue ventilator bundle when patient extubated. Bronchodilators to continue as needed. Once, Status: Canceled 04/21/21 2058 Extubate patient - RT Once RT may extubate per protocol. Once, Status: Canceled Comments: RT may extubate per protocol. 04/21/21 2058 SBT Screen (Trauma/Non-Trauma) Per unit protocol Per unit protocol 04/21/21 2058 SBT (Trauma/Non-Trauma) Once If SBT (wean) screening criteria are met, perform a RR/VT. If RR/VT is less then 105, place patient on breathing trial using PSV of +5 to +7 cm H2O for 1 to 2 hours. At the end of the 1 to 2 hours perform another RR/VT... Once Comments: If SBT (wean) screening criter... 04/21/21 2058 Central Line Insertion Once Comments: This order was created via pro... 04/21/21 2039 Cardioversion - Electrical Once, Status: Canceled Comments: This order was created via pro... 04/21/21 2038 Respiratory Therapy communication During Proning, RT to adjust ventilator settings aggressively to goal Until discontinued, Status: Canceled Comments: During Proning, RT to adjust v... 04/21/21 2005 Respiratory Therapy communication Wean PEEP and FIO2 as tolerated when patient is supine if patient tolerates lighter sedation (RASS -2 to -3) and oxygenation goals are met. Until discontinued, Status: Canceled 04/21/21 2005 Moderate Sedation Once, Status: Canceled 04/21/21 1447 Oxygen therapy - High Flow Nasal Cannula (HFNC); Titrate Continuous (tasks Q4H), Status: Canceled 04/21/21 1010 CPAP - Acute respiratory failure Continuous (tasks Q4H) Continuous (tasks Q4H), Status: Canceled 04/20/21 1352 Wound care - Xeroform dressing, Exudry and rolled gauze to skin tears arms and legs daily. Daily 0900, Status: Canceled Comments: Xeroform dressing, Exudry and ... 04/15/21 1216 Wound care - Skin prep to heels daily and leave open to air Daily 0900, Status: Canceled Comments: Skin prep to heels daily and l... 04/15/21 1216 Airway Expansion & Secretion Clearance Protocol QID (daytime) Oscillatory PEP (OPEP) 4 times daily (daytime), Status: Canceled 04/14/21 1620 Oxygen therapy - High Flow Nasal Cannula (HFNC); 90% Continuous Comments: With surgical mask on patient 04/14/21 1620 Oxygen therapy - 90% As needed, Status: Canceled 04/14/21 1620 Change dressing Once on the morning after the procedure Once, Status: Canceled Comments: Once on the morning after the ...
- Aktuelle Erkrankungen
- Cytomegalovirus (CMV) viremia
- Vorgeschichte
- Respiratory Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (CMS/HCC) Circulatory Demand ischemia (CMS/HCC) Essential hypertension Left femoral vein DVT (CMS/HCC) Digestive Esophageal reflux Malnutrition (CMS/HCC) Genitourinary Acute kidney injury (CMS/HCC) Glomerulonephritis, IgA Musculoskeletal Osteopenia Basal cell carcinoma of skin Intrinsic eczema Maxillary fracture (CMS/HCC) Endocrine/Metabolic Dyslipidemia Impaired fasting glucose Lactic acidosis Hypoalbuminemia Hyponatremia Infectious/Inflammatory Septic shock (CMS/HCC) Cytomegalovirus (CMV) viremia (CMS/HCC) Immune Severe sepsis (CMS/HCC) Immunosuppression due to drug therapy Other Squamous cell carcinoma Decreased GFR Aphthous ulceration Elevated LFTs Hypothermia
- Andere Medikamente
- al mag hydroxide-simethicone-diphenhydramine-lidocaine (STOMATITIS) amLODIPine (NORVASC) 10 mg tablet chlorhexidine (PERIDEX) 0.12 % solution famotidine (PEPCID) 20 mg tablet(Expired) furosemide (LASIX) 40 mg tablet(Expired) omega-3 acid et
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 11.05.2021
- Impfdatum
- 06.02.2021
- Beginn
- 18.03.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebral haemorrhage
Symptomtext
I61.9 - ICH (intracerebral hemorrhage)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 11.05.2021
- Impfdatum
- 06.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Cerebral haemorrhage
Cerebrovascular accident
Facial paresis
Lacunar stroke
Symptomtext
I61.9 - ICH (intracerebral hemorrhage) (CMS/HCC) I63.9 - CVA (cerebrovascular accident) (CMS/HCC) I63.81 - Right-sided lacunar stroke (CMS/HCC N17.9 - Acute kidney failure, unspecified R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 10.05.2021
- Impfdatum
- 27.02.2021
- Beginn
- 23.04.2021
- Tage bis Beginn
- 55,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Chest pain
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction) CHEST PAIN
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 10.05.2021
- Impfdatum
- 03.02.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Abnormal behaviour
Aggression
Bedridden
Blood glucose increased
Condition aggravated
Confusional state
Crepitations
Death
Dementia
Diabetes mellitus
Fatigue
General physical condition abnormal
Head injury
Hypotension
Patient restraint
Posture abnormal
Repetitive speech
Salivary hypersecretion
Symptomtext
The morning after Mom's first dose of the Pfizer shot, Dad woke up and found Mom lying on the floor next to the bed. Mom said, "I can't move my arm." Dad called paramedics who checked her. They said her vital signs were normal and left. On 2/9/21 in the morning my da awoke to see that Mom had large amounts of bubbly saliva pouring from her mouth onto her pillow. Dad called paramedics, who said this was a diabetic reaction. Mom had NEVER had anything happen like this before. Mom was very sleepy, could not be aroused, and made only gurgling noises. She was admitted to the hospital for care and therapy. She pulled her own IV out. Mom had to be restrained in the hospital and sedated, due to confusion and worsening dementia. By 2/18 when we spoke by phone mom's speech was abnormally slow and very repetitive. "I'm very tired today" was spoken many times. In morning time mom was able to follow basic conversation. Not so later in the day. Mom came home from rehab on 2/26/21. She was able to walk steadily and independently at home after her therapy. After a week or so, Mom began hitting the in-home caregiver. Dad's presence would calm her. In a short time Mom seemed not to know dad anymore, and would hit him and the caregiver when they helped her. She also pulled all covers off the bed and pulled clothes out of the closet, throwing them all over the room during the night. Mom was usually walking around the house during each night. On 4/16/21 Mom and dad were napping sitting up on the couch in the morning. Mom fell forward and hit her head on the hearth. Dad and caregiver gave first aid and called paramedics, who took her to the ER. Mom came home on 4/17/21. On 4/18/21 Mom pulled her catheter out in the early morning. In the afternoon Mom's appearance was concerning, so Dad called paramedics. They said that Mom's BP had dropped very low and took her to the ER. Mom was combative the next day in the hospital. Dr. adjusted her medications periodically to ensure that mom's care would be manageable when she would eventually be sent home. Minimal therapy was done due to dementia. By 5/3/21 doctor said that Mom is bed bound and needing total care. Her blood sugar spiked high despite special diet. Staff waiting for insulin order from doctor. 5/4/21 Doctor called Dad to say that Mom had died during the night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 34,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Some memory loss; diabetes type 2; bipolar disorder.
- Vorgeschichte
- Same as in item 11.
- Andere Medikamente
- See medical file.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 08.05.2021
- Impfdatum
- 04.02.2021
- Beginn
- 19.04.2021
- Tage bis Beginn
- 74,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure measurement
Dyspnoea
Heart rate
Heart rate increased
Hypertension
Pulmonary embolism
SARS-CoV-2 test
Symptomtext
high heart rate; high blood pressure; shortness of breath; bilateral pulmonary emboli; This is a spontaneous report from the patient. This 49-year-old non-pregnant female patient reported that she received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9269) via an unspecified route of administration in the right arm on 04Feb2021 at 08:30 (at the age of 48-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient's known allergies included morphine, hydromorphone (DILAUDID), sulfas, and coconut. The patient did not have COVID prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9269) via unspecified route in the right arm on 14Jan2021 as a single dose for COVID-19 immunization. Concomitant medications were not reported. On 19Apr2021, the patient was having high heart rate, high blood pressure and shortness of breath. She was hospitalized and diagnosed with bilateral pulmonary emboli. The events resulted in emergency room/department or urgent care and hospitalization for 3 days. The patient stated that she doubts this was vaccine related but wanted to report it. The patient was treated with intravenous heparin, then oral rivaroxaban (XARELTO). The clinical outcome of the events high heart rate, high blood pressure and shortness of breath, and bilateral pulmonary emboli was recovering. The patient was tested for COVID post vaccination via nasal swab on 19Apr2021 with result of negative. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the current available information, a possible contributory role of the suspect product BNT162B2 to the development of reported events cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 20210419; Test Name: blood pressure; Result Unstructured Data: Test Result:high; Test Date: 20210419; Test Name: Heart rate; Result Unstructured Data: Test Result:increased; Test Date: 20210419; Test Name: COVID test Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Food allergy (known allergies: Morphine, Dilaudid, Sulfas, Coconut); Sulfonamide allergy (known allergies: Morphine, Dilaudid, Sulfas, Coconut)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 07.05.2021
- Impfdatum
- 13.01.2021
- Beginn
- 21.01.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Ageusia
Anosmia
Chest X-ray
Computerised tomogram thorax
Cough
Dyspnoea
Fatigue
Headache
Pulmonary embolism
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Scan with contrast abnormal
Symptomtext
Headache Congestion or running nose New loss of taste or smell Dx Cough ? Shortness of Breath FATIGUE FEVER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- 01/22/21 1624 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 01/22/21 0815 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result DetectedCritical CT angiogram chest pulmonary embolism with and without contrast 3/28/2021 Imaging Services - CT X-ray chest 2 views 3/28/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Digestive Obesity BMI 40.0-44.9, adult (CMS/HCC) Fatty infiltration of liver Other Anxiety Reactive depression Fatigue, unspecified type History of 2019 novel coronavirus disease (COVID-19)
- Andere Medikamente
- buPROPion XL (WELLBUTRIN XL) 150 mg 24 hr tablet cholecalciferol, vitamin D3, (VITAMIN D3 ORAL) CYANOCOBALAMIN, VITAMIN B-12, ORAL DULoxetine (CYMBALTA) 30 mg capsule
- Allergien
- Keflex [cephalexin]
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 06.05.2021
- Impfdatum
- 27.02.2021
- Beginn
- 08.04.2021
- Tage bis Beginn
- 40,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Sepsis
Shock
Symptomtext
J96.01 - Acute respiratory failure with hypoxia R57.9 - Shock A41.9 - Sepsis, unspecified organism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 04.05.2021
- Impfdatum
- 12.02.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Blood test
Brain stem thrombosis
Cerebrovascular accident
Computerised tomogram abnormal
Cerebral thrombosis
Hypoaesthesia
Joint range of motion decreased
Magnetic resonance imaging abnormal
Symptomtext
I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face.; I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face.; This is a spontaneous report from a contactable consumer. A non-pregnant 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 12Feb2021 15:00 (Batch/Lot Number: EL9269) as single dose (at the age of 53 years old) for COVID-19 immunisation. Medical history included depression, pre-diabetes and hysterectomy from 2003 hormones due to hysterectomy in 2003. Concomitant medications included metformin, semaglutide (OZEMPIC), estradiol, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), lisdexamfetamine mesilate (VYVANSE) and ascorbic acid (C [ASCORBIC ACID]), all taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 (lot number=EL9262) at 20Jan2021 03:00 AM, on the right arm for COVID-19 immunisation. The patient stated on 24Mar2021, "I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face." Patient received blood thinners as treatment. The patient had emergency and physician visit. The patient was hospitalized for 2 days. The outcome of the event was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Depression; Hysterectomy (hormones due to hysterectomy in 2003); Pre-diabetes
- Andere Medikamente
- METFORMIN; OZEMPIC; ESTRADIOL; ADDERALL; VYVANSE; C [ASCORBIC ACID]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 04.05.2021
- Impfdatum
- 12.02.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Blood test
Brain stem thrombosis
Cerebrovascular accident
Computerised tomogram abnormal
Cerebral thrombosis
Hypoaesthesia
Joint range of motion decreased
Magnetic resonance imaging abnormal
Symptomtext
I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face.; I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face.; This is a spontaneous report from a contactable consumer. A non-pregnant 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 12Feb2021 15:00 (Batch/Lot Number: EL9269) as single dose (at the age of 53 years old) for COVID-19 immunisation. Medical history included depression, pre-diabetes and hysterectomy from 2003 hormones due to hysterectomy in 2003. Concomitant medications included metformin, semaglutide (OZEMPIC), estradiol, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), lisdexamfetamine mesilate (VYVANSE) and ascorbic acid (C [ASCORBIC ACID]), all taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 (lot number=EL9262) at 20Jan2021 03:00 AM, on the right arm for COVID-19 immunisation. The patient stated on 24Mar2021, "I had a stroke. The blood clot is on the left side of the brain which has affected the right side of my body: right leg, right foot, right arm, right hand, and the right side of my face." Patient received blood thinners as treatment. The patient had emergency and physician visit. The patient was hospitalized for 2 days. The outcome of the event was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Depression; Hysterectomy (hormones due to hysterectomy in 2003); Pre-diabetes
- Andere Medikamente
- METFORMIN; OZEMPIC; ESTRADIOL; ADDERALL; VYVANSE; C [ASCORBIC ACID]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- M
- Eingang
- 29.04.2021
- Impfdatum
- 26.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Symptomtext
This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is the first of two reports. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 26Mar2021 (Lot Number: EL9269; Expiration Date: 01May2021) as single dose for COVID-19 immunization. The patient's medical history and patient's concomitant medications were not reported. The patient experienced acute stroke on an unspecified date. The patient was still hospitalized in ICU. The outcome of the event was unknown.; Sender's Comments: Limited information can not support a complete medical assessment. A causal association between administration of BNT162B2 and the onset of acute stroke cannot be excluded, considering the temporal association. Case will be re-assessed upon the additional information provided. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021415134 same reporter and drug, similar events, different patients
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 28.04.2021
- Impfdatum
- 26.03.2021
- Beginn
- 03.04.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram cerebral normal
Arteriogram carotid normal
Body temperature increased
Cerebrovascular accident
Chills
Computerised tomogram abnormal
Cough
Culture urine positive
Dysarthria
Facial paralysis
Muscular weakness
Nausea
Oxygen saturation decreased
Symptomtext
4/3/2021- c/o nausea and chills, dry cough and decrease in O2 sat (86% RA), increase pulse (107), T-101.4. Rocephin 1 gram x1 given. Urine culture obtained- > 100,000 pseudomas aeruginosa. Midline placed IV Zosyn started. On 4/11/2121 he had acute onset L upper extremity weakness with facial droop and slurring of speech. Sent to facility and TPN administered. Returned to facility on 4/14/2021 with L upper ext weakness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- Initial CT scan on 4/11/2021- showed no acute intracranial process and CT agiography of head and neck showed no significant aortic abnormality and indeterminate mediastinal lymphadenopathy which may be reactive or neoplastic. Repeat CT scan on 4/12/2021 (24 hours post TPA) showed small, acute right parietal cortical infarct suspected.
- Aktuelle Erkrankungen
- Resident completed IV Zosyn and Gentamycin on 03/13/2021 for pseudomonas for bloodstream infection and Pseudomonas AV endocartitis. Echo done on 3/3/21 showed no evidence of endocarditis, port-a-cath was removed during hosppitalization in February. s/p suprapubic catheter placement 3/11/2021. ASA and Plavix was held for 5 days prior. ASA and plavix was also held 3/14-3/17 d/t hematuria. Blood culture on 3/29/2021- No growth.
- Vorgeschichte
- Re-current UTI's, CKD stage 3, Hx of Covid-19, Type 2 DM, Dementia without behaviors, Chronic anemia, Hypothyroidism, Anxiety, Vitamin D deficiency, MS, GERD, MDD, Barrett's esophagus,
- Andere Medikamente
- Aspirin, Atorvastatin, Calcium Carbonate, Cholecalciferol, Plavix, Fosamax, Latanoprost, Levemir, Synthroid, Lisinopril, Miralax, MVI, Omeprazole, Oxybutynin, Rebif Solution, Venalfaxine, Alphagan, Hyprex, Lyrica, Micro-K, Senna-S, Novol
- Allergien
- Meperidine, Demerol
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 28.04.2021
- Impfdatum
- 06.02.2021
- Beginn
- 17.02.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Escherichia sepsis
Mental status changes
Urinary tract infection
Symptomtext
This 97 year old female received the Covid shot on 2/06/21 and went to the ED and was admitted on 2/17/21 with AMS, UTI, Sepsis from e.coli, and subsequently on 3/10/21 and again on 3/24 and recevied the 2nd Covid shot on 4/9/21 and died on 4/19/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 28.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 52,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Death
Symptomtext
Acute respiratory failure with hypoxia Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 13.02.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 53,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Magnetic resonance imaging
Symptomtext
8 weeks later had a stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- MRI April 7,2021
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Amlodapine We sosorbide Metoprolol Fluoxetine Bupropion
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 11.02.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Pulmonary embolism
Symptomtext
Patient presented to the ED and was subsequently hospitalized with a pulmonary embolism within 6 weeks of receiving COVID vaccination. Patient also hospitalized on 3/12/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 27.04.2021
- Impfdatum
- 06.02.2021
- Beginn
- 07.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Abdominal pain upper
Back pain
Death
Dyspnoea
Enzyme level test
Headache
Nausea
Oxygen saturation decreased
Renal failure
Respiratory failure
Retching
Spinal X-ray
Urinary incontinence
Symptomtext
After 1st dose of Pfizer: Nausea, and trouble breathing (Oxygen went up and down from 90 to 95) - Took to Dr and advise to watch oxygen levels After 2nd dose of Pfizer: Nausea, Dry heaves, Stomach Pain, Head Aches, Back Pain, Loosing Control of Bladder (Kidney Failure), Trouble Breathing (Oxygen went under 90) - Took to her Dr and she said to take her to the Emergency Room due to her Oxygen going below 90. I took her to Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 3,0
- Labordaten
- Hospital gave her Antibiotics for Kidney failure for couple of days, gave pain medicine for back pain, nausea medicine for nausea, strapped oxygen mask around her face. Tests: X-Rays for Back Pain, Enzyme Checks for Oxygen Levels She Passed away on April 4, 2021, Easter Sunday for Respiratory Failure.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- Amlodipine Besylate - 5mg Januvia - 25 mg Levothyroxine - 112 mcg Xarelto - 15 mg Furosemide - 40 mg Potassium CL ER 10 MEQ Atorvastatin - 20 mg Losartan Potassium - 25 mg Lyrica - 50 mg Omeprazole Dr - 40 mg Zurtec 10 mg
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 05.04.2021
- Tage bis Beginn
- 37,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Lumbar radiculopathy
Lumbar spinal stenosis
Spinal claudication
Spondylolisthesis
Symptomtext
This 71 year old male received the Covid shot on 2/27/21 and went to the ED and was admitted on 4/5/2021 and died on 4/25/2021. Lumbar radiculopathy, spondylolisthesis of lumbar region, lumbar stenosis with neurogenic claudication, lumbar spinal stenosis. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- M
- Eingang
- 25.04.2021
- Impfdatum
- 26.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ammonia normal
Blood chloride increased
Blood creatinine normal
Blood glucose increased
Blood sodium increased
Blood urea increased
Carotid artery stenosis
Cerebrovascular accident
Haematocrit decreased
Haemoglobin increased
Cerebral artery occlusion
Pulmonary mass
Red blood cell count decreased
Vertebral artery occlusion
Symptomtext
I have another male (patient) who had an acute CVA we send him to the hospital he had acute CVA, he had a right artery occlusion, he passed away; I have another male (patient) who had an acute CVA we send him to the hospital he had acute CVA, he had a right artery occlusion, he passed away; This is a spontaneous report from a contactable Nurse (Registered nurse with title of Infection Preventionist). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Mar2021 (Lot Number: EL9269; Expiration Date: 01May2021) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had an acute CVA and was sent him to the hospital he had acute Cerebrovascular accident (CVA), he had a right artery occlusion, he passed away. The patient died on an unspecified date in 2021. It was not reported if an autopsy was performed.; Sender's Comments: The information currently available is very limited. There is no sufficient evidence that the reported events may be related to administration of BNT162B2. Of note, medical history and concomitant medications were not provided to determine pre-existing risk factors or conditions that may have led to the events. Case will be re-assess once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: patient had an acute CVA and was sent him to the hospital he had acute CVA, he had a right artery occlusion; patient had an acute CVA and was sent him to the hospital he had acute CVA, he had a right artery occlusion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- M
- Eingang
- 25.04.2021
- Impfdatum
- 26.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ammonia normal
Blood chloride increased
Blood creatinine normal
Blood glucose increased
Blood sodium increased
Blood urea increased
Carotid artery stenosis
Cerebrovascular accident
Haematocrit decreased
Haemoglobin increased
Cerebral artery occlusion
Pulmonary mass
Red blood cell count decreased
Vertebral artery occlusion
Symptomtext
I have another male (patient) who had an acute CVA we send him to the hospital he had acute CVA, he had a right artery occlusion, he passed away; I have another male (patient) who had an acute CVA we send him to the hospital he had acute CVA, he had a right artery occlusion, he passed away; This is a spontaneous report from a contactable Nurse (Registered nurse with title of Infection Preventionist). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Mar2021 (Lot Number: EL9269; Expiration Date: 01May2021) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had an acute CVA and was sent him to the hospital he had acute Cerebrovascular accident (CVA), he had a right artery occlusion, he passed away. The patient died on an unspecified date in 2021. It was not reported if an autopsy was performed.; Sender's Comments: The information currently available is very limited. There is no sufficient evidence that the reported events may be related to administration of BNT162B2. Of note, medical history and concomitant medications were not provided to determine pre-existing risk factors or conditions that may have led to the events. Case will be re-assess once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: patient had an acute CVA and was sent him to the hospital he had acute CVA, he had a right artery occlusion; patient had an acute CVA and was sent him to the hospital he had acute CVA, he had a right artery occlusion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 24.04.2021
- Impfdatum
- 30.01.2021
- Beginn
- 31.01.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Myocardial infarction
Pulmonary thrombosis
Symptomtext
Chest pain/stabbing pain on her chest wall at the right side; This is a spontaneous report from a contactable consumer. A 76-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: EL9269; Expiration Date: unknown), via an unspecified route of administration, administered in arm Left on 30Jan2021 at 11:00 (at the age of 76-year-old) as SINGLE DOSE for covid-19 immunization. Medical history included Lupus from 1976 to an unknown date. There were no concomitant medications. Prior Vaccinations (within 4 weeks) reported as none. History of all previous immunization and additional vaccines administered on same date with the Pfizer vaccine reported as none. Consumer reported that she had a side effect that she had never seen listed. She had no pain or redness at the vaccine site; but about 18:00 on Sunday night she had stabbing pain on her chest wall at the right side with no other symptoms. She took an aspirin and laid down because she couldn't move with the pain. The next morning she took another aspirin and laid in bed that day. It was bad for three days. The last time she noticed that the pain was on Monday. She was thinking that she had dodged a bullet because she was not having any pain at the site. Patient stated that she had friends, (name provided) and (name provided), in their 80s, who had pain from the elbow to shoulder, she spoke with them the day after they received their shots and they got there shot at the same time and place as the patient. Patient was scheduled to receive the second dose of the vaccine on 20Feb2021. She wanted to know that the chest pain a side effect and mentioned that she was concerned about getting the next dose. On 31Jan2021, the patient experienced Chest pain/stabbing pain on her chest wall at the right side. Therapeutic measures were taken as a result of chest pain and included treatment with aspirin. Patient did not required a visit to physician or Emergency room. Relevant test reported as none. The outcome of the event was recovered on 08Feb2021. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Lupus syndrome (Verbatim: Lupus)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 21.04.2021
- Impfdatum
- 26.03.2021
- Beginn
- 14.04.2021
- Tage bis Beginn
- 19,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood calcium normal
Blood chloride decreased
Blood creatinine increased
Blood glucose increased
Blood potassium increased
Blood sodium decreased
Blood urea increased
Death
Fatigue
Haematocrit decreased
Haemoglobin decreased
Headache
Malaise
Platelet count decreased
Red blood cell count decreased
Symptomtext
4/14-Resident c/o not feeling well and declined scheduled dialysis. c/o bilateral shoulder pain and fatigue. AP- 44, BP- 80/45, c/o headache, no chest pain and no SOB. Sent to ER- patient deceased on 4/14/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 4/14- BUN- 64, CREA- 9.30. Calcium- 9.9, Sodium- 131, Potassium- 6.3, Chloride- 96, Glucose- 237, RBC- 3.76, H/H- 10.3/33.8, Platelet- 122
- Aktuelle Erkrankungen
- Positive for C-diff, resident refused dialysis at times,. Resident has been reporting GI discomfort. L BKA wound and Sacral wound.
- Vorgeschichte
- Hx of Sepsis, stump complication, weakness, Aorvalve stenosis, Bacteremia, Malignant Neoplasm of endometrium, Vitamin D Defficiency, Hx of Covid-19 received monoclonal anitbodies on 11/2020, Anemia, Hypothyroidism, Type 2 DM, Hyperlipidemia, MDD, Insomnia, HTN, Glaucoma, A-fib, CHF, AV Fistula, Lhyphedema, Chrcot's joint, Ends stage renal disease-dialysis dependent, Hx of venous thrombosis and embolism.
- Andere Medikamente
- Amlodipine, Aspercreme with Lidocaine Creame 4%, Aspirin 81, Buspirone HCl, Doxazosin, Escitalopram, Letrozole, Levothyroxine Sodium, Protonix, Oxycodone, Vitamin D, Eliquis, Metoprolol tartrate, Preparation H, Brimonidine Tartrate Solution
- Allergien
- Megestrol, Actos, Glucophage, Medrol Sudafed
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 19.04.2021
- Impfdatum
- 06.02.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 41,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 19.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 15.04.2021
- Tage bis Beginn
- 47,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 19.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 33,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 19.04.2021
- Impfdatum
- 06.02.2021
- Beginn
- 18.04.2021
- Tage bis Beginn
- 71,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 16.04.2021
- Impfdatum
- 10.02.2021
- Beginn
- 05.03.2021
- Tage bis Beginn
- 23,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Amniocentesis normal
Foetal death
Foetal gastrointestinal tract imaging abnormal
Foetal hypokinesia
Inappropriate schedule of product administration
Single umbilical artery
Stillbirth
Ultrasound antenatal screen abnormal
Viral test negative
Symptomtext
is 38 yo healthy G5P 2012 at time of event. -LMP 10/14/2020, EDC 7/21/2021 -Prenatal Ultrasound on 1/15/2021, size consistent with GA, 13 2/7 days, 3 vessel cord, rest WNL -received first Pfizer Covid-19 vaccine 2/10/2021 at 16 0/7 GA -received second Pfizer Covid-19 vaccine 3/1/2021 (19 days from first, NOT recommended 21 DAYS) -3/12/2021 had MFM level II ultrasound for advanced maternal age. -3/12/21 US revealed early IUGR est. fetal weight 296gm, GA consistent with 19/37 GA, now SINGLE uterine artery and echogenic bowel -Amnio, NITP, TORCH all normal/neg -4/3//21 mother noted no movements, fetal demise confirmed, delivered stillborn 4/4/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Foetal death
- Hospital-Tage
- 1,0
- Labordaten
- can be provided Utrasounds, labwork
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- ADHD. All meds discontinued before pregnancy.
- Andere Medikamente
- Prenatal vitamins
- Allergien
- Nkda, no food allergies or other allergies.
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 95,0
- Geschlecht
- M
- Eingang
- 16.04.2021
- Impfdatum
- 15.01.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arterial disorder
Contusion
Death
Dysphagia
Haematoma
Injection site bruising
Peripheral swelling
Thrombosis
Haemorrhage
Limb mass
Oedema peripheral
Skin discolouration
Suture insertion
Vein disorder
Symptomtext
PATIENT HAD BRUISING AROUND INJECTION SITE OF 2ND VACCINE (LEFT DELTOID), BRUSING AND SWELLING PROGRESSED DOWN ARM AND HAND, PATIENT WAS SENT TO ER AND THEN HOSPITALIZED. PATIENT THEN PASSED AWAY SHORTLY THEREAFTER IN THE HOSPITAL FROM MASSIVE BLOOD CLOTS AROUND EVERY LYMPH NODE IN THE BODY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 3,0
- Labordaten
- UNKNOWN - CONTACT HOSPITAL
- Aktuelle Erkrankungen
- UNKNOWN, BUT ON HOSPICE AT TIME OF VACCINATION
- Vorgeschichte
- UNKNOWN, BUT ON HOSPICE AT TIME OF VACCINATION
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 15.04.2021
- Impfdatum
- 08.02.2021
- Beginn
- 18.03.2021
- Tage bis Beginn
- 38,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Adenocarcinoma metastatic
Death
Femur fracture
Symptomtext
Death Metastatic adenocarcinoma Intertrochanteric fracture of left femur
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 04.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Brain oedema
Cerebral venous sinus thrombosis
Cerebral venous thrombosis
Cerebrovascular accident
Coagulation factor
Computerised tomogram
Full blood count
Lipids
Loss of consciousness
Magnetic resonance imaging
Metabolic function test
Muscular weakness
Partial seizures
Thyroid function test
Symptomtext
I was admitted to ER with stroke and right arm weakness. While I was in the ER, I also developed unconsciously seizure. The diagnosis are Cerebral Venous Thrombosis (CVT, multiple clots) and Cerebral Venous Sinus Thrombosis (CVST), Focal motor seizure and Cerebral Edema.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 5,0
- Labordaten
- Between 2/24/21 to 2/28/21: Several blood test for thrombosis factors, metabolic panels, thyroid factors, CBC, lipid panels, etc. several CT and MRI
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Estrogen and Progestin (Oral Contraceptives) Advil Multi vitamin Apple Cider Vinegar
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 13.04.2021
- Impfdatum
- 06.02.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 32,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Chest pain
Death
Sepsis
Symptomtext
Acute hypoxemic respiratory failure (CMS/HCC) Chest pain sepsis Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 13.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 09.04.2021
- Tage bis Beginn
- 41,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 10.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
C-reactive protein
C-reactive protein increased
Cardiac arrest
Inflammation
Mechanical ventilation
Symptomtext
had sudden cardiac arrest; inflammatory reaction; CRP blood values were extremely high; This is a spontaneous report from a contactable consumer (wife of patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 71-year-old, via an unspecified route of administration, administered in the left arm on 19Feb2021 15:30 (Lot Number: EL9269) as single dose for COVID-19 immunization. Medical history included sulfa allergy and penicillin allergy. Concomitant medications included fosinopril sodium (MONOPRIL) and tamsulosin hydrochloride (FLOMAX RELIEF); both taken for an unspecified indication, start and stop date were not reported. It was reported that roughly 12 hours later at 4:30am on 20Feb2021, the patient had sudden cardiac arrest. The wife was concerned that on 20Feb2021, the patient had an inflammatory reaction. His CRP blood values were extremely high on 20Feb2021. The events resulted in emergency room visit and physician office visit. The patient was also hospitalized due to the events. The patient died a few days later on an unspecified date due to the events. It was unknown if an autopsy was performed. The events were also reported as life-threatening and disability. It was unknown if the patient received treatment for the events. The outcome of the events was fatal.; Reported Cause(s) of Death: he had sudden cardiac arrest; inflammatory reaction; CRP blood values were extremely high
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210220; Test Name: CRP blood values; Result Unstructured Data: Test Result:extremely high
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Penicillin allergy; Sulfonamide allergy
- Andere Medikamente
- MONOPRIL; FLOMAX RELIEF
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 10.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
C-reactive protein
C-reactive protein increased
Cardiac arrest
Inflammation
Mechanical ventilation
Symptomtext
had sudden cardiac arrest; inflammatory reaction; CRP blood values were extremely high; This is a spontaneous report from a contactable consumer (wife of patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 71-year-old, via an unspecified route of administration, administered in the left arm on 19Feb2021 15:30 (Lot Number: EL9269) as single dose for COVID-19 immunization. Medical history included sulfa allergy and penicillin allergy. Concomitant medications included fosinopril sodium (MONOPRIL) and tamsulosin hydrochloride (FLOMAX RELIEF); both taken for an unspecified indication, start and stop date were not reported. It was reported that roughly 12 hours later at 4:30am on 20Feb2021, the patient had sudden cardiac arrest. The wife was concerned that on 20Feb2021, the patient had an inflammatory reaction. His CRP blood values were extremely high on 20Feb2021. The events resulted in emergency room visit and physician office visit. The patient was also hospitalized due to the events. The patient died a few days later on an unspecified date due to the events. It was unknown if an autopsy was performed. The events were also reported as life-threatening and disability. It was unknown if the patient received treatment for the events. The outcome of the events was fatal.; Reported Cause(s) of Death: he had sudden cardiac arrest; inflammatory reaction; CRP blood values were extremely high
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210220; Test Name: CRP blood values; Result Unstructured Data: Test Result:extremely high
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Penicillin allergy; Sulfonamide allergy
- Andere Medikamente
- MONOPRIL; FLOMAX RELIEF
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 05.04.2021
- Impfdatum
- 21.01.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 25,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose
Confusional state
Death
Symptomtext
After 2nd vaccine my husband started getting confused. Worse and worse. Had him get a fasting blood draw and was supposed to see his dr the following Monday. His 2nd shot was 2/11/2021. He Died 2/27/2021. Took away my life and husband of 35 years! Would?ve been 70 years old today!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Leukemia (not active) copd
- Andere Medikamente
- Lisinopril atorvastatin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 01.04.2021
- Impfdatum
- 26.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Death
Fatigue
Seizure
Symptomtext
Per the decedent's wife- the decedent reported feeling a little weak and tired after receiving the second shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- kidney transplant 2012, HTN, 2nd Covid vaccination 2/26/2021, kidney failure
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 25.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Fatigue
Pulmonary embolism
SARS-CoV-2 test
Symptomtext
Right lower extremity DVT; Bilateral PE; Severe fatigue; This is a spontaneous report from a contactable physician. A 71-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL9269) via an unspecified route of administration on 25Feb2021 at a single dose for COVID-19 immunization. Medical history included Allergies: adhesive, CT scan dye & flu shot. Concomitant medication included rosuvastatin. The patient previously received first dose of BNT162B2 on an unknown date for COVID-19 immunization. The patient also previously took Demerol, guaifenesin;phenylephrine hydrochloride (ENTEX), epinephrine, amoxicillin;clavulanic acid (AUGMENTIN) and experienced allergies. On 03Mar2021 17:15 the patient experienced severe fatigue, right lower extremity DVT, Bilateral PE. Events were considered serious, due to hospitalization for 1 day and life threatening. Treatment was received for the adverse event which included apixaban (ELIQUIS). The events resulted to a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19 with unknown result on an unknown date. Patient was not pregnant. The facility where the vaccine was administered was in a hospital. Outcome of the events was recovering. Follow up attempts needed. Further information is expected.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- Test Name: COVID-19 test; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to vaccine; Contrast media allergy; Dermatitis contact
- Andere Medikamente
- ROSUVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 31.03.2021
- Impfdatum
- 11.03.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Decreased appetite
Fatigue
Food refusal
Lethargy
Pyrexia
Symptomtext
Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: CAREGIVER REPORTED PATIENT STOPPED EATING AND HAD FEVER OF 101, FEVER WENT DOWN AFTER A DAY OR SO BUT CONTINUED NOT TO EAT-Severe, Additional Details: CAREGIVER REPORTED PT HAD FEVER AND LOSS OF APPETITE AFTER FIRST DOSE, QUESTIONED IF SECOND DOSE IS APPRORPIATE. PER THE CDC GUIDELINES THE PATIENT DID NOT HAVE A SEVERE ALLRGIC REACTON TO THE VACCINE AND THEREFOR SHOULD PROCEED WITH SECOND DOSE. CAREGIVERS STATES TOOK A WHILE FOR PT TO REGAIN APPETITE AFTER THE FIRST DOSE. SECOND DOSE HE HAD FEVER OF 101 FOR ABOUT 1 DAY BUT LOST APPETITE AND NEVER REGAINED. PASSED AWAY ON THE 24TH OF MARCH. CAREGIVER STATES PT WAS \"STRIVING\"" PRIOR TO 2ND DOSE"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 07.03.2021
- Beginn
- 07.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood lactic acid
Blood pH decreased
Chest X-ray abnormal
Chills
Death
Dyspnoea
Hypoxia
Leukopenia
Lung opacity
Procalcitonin increased
Pulmonary oedema
Pyrexia
White blood cell count decreased
Symptomtext
Extreme rigors, fever, shortness of breath/hypoxemia within hours of receiving vaccine according to staff at the care home. leukopenia, pulmonary edema, death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- Lactic Acid 5.9 Ph 7.21 procalcitonin 8.40 WBC 0.84 CXR - patchy opacities b/l lungs concerning for pulmonary edema
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- down syndrome, hypothyroid, dementia, seizure disorder, urinary retention, hypotension
- Andere Medikamente
- Aricept, ASA, atorvastatin, keppra, levothyroxine, loratadine, midodrine, lovenox
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 03.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 19,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Pfizer COVID -19 Vaccine EUA Patient's wife reported to facility, upon contacting for 2nd dose appointment, that the patient passed away from COVID-19. This patient did not pass away at facility, as there are no records of this patient in our EHR. Per patient?s wife, patient was vaccinated on 2/3/21 at the clinic with the initial Pfizer COVID-19 vaccine. The patient passed away on 2/22/21 from COVID-19 (3 weeks after the initial dose, but prior to the booster dose). Pfizer/BioNtech NDC# 59267-1000-2 Pfizer/BioNtech Lot # EL9269 Lot Exp: 05/30/2021 Site: left Deltoid Time of vaccination: 2/3/2021 6:15:53 PM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 27.02.2021
- Beginn
- 26.03.2021
- Tage bis Beginn
- 27,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 28.03.2021
- Impfdatum
- 04.02.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 32,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram normal
Blood pressure increased
Chest discomfort
Chills
Computerised tomogram normal
Echocardiogram normal
Lymph node pain
Myalgia
Myocardial infarction
Pericarditis
Pyrexia
Troponin increased
Symptomtext
3 phases- within 24 hrs of shot - low grade fever and chills lasting 24 hours; during the following 2 weeks, strong pain in arm muscle that travelling under arm into lymph nodes. Approximately 30 days after injection experienced a mild heart attack and unexplained pericarditis. Symptoms at onset were major pressure in chest and elevated blood pressure 210/99. Prescribed blood pressure medication, blood thinners and 4 does of indomethacin for pericarditis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- -
- Labordaten
- 3/8/21Troponin series - elevated. 3/9/21 Echocardiogram - normal; 3/8/21 Angiogram - normal - no blockages. 3/16/21 CT scan of heart and lungs normal.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Migraine
- Andere Medikamente
- Probiotic, Vitamin C, Vitamin D, Multivitamin, Omega 3- Collagen powder, magnesium and calcium
- Allergien
- Penicillin, Rhubarb
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 23.03.2021
- Impfdatum
- 18.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac disorder
Death
Dyspnoea
Ear pain
Feeling abnormal
Malaise
Myalgia
Oropharyngeal pain
Symptomtext
I am writing this on behalf of my mother. She received the first round of the vaccine (Pfizer/EL9269) on 2/18/21. That evening she reported not feeling "right". Over the next two days after receiving the vaccine on Thursday she reported to family that she didnt feel well. She had no fever but muscle aches, an earache and sore throat (this was on Friday and Saturday). On Sunday her breathing became a bit labored. She still had previous symptoms reported and labored breathing -- she stated she thought she would have to go to the Dr the next day (Monday, Feb 22, 201) if she did not feel better. Sometime in the night of Feb 21st and Feb 22nd my mom passed away. My mom had many health problems. Heart disease, diabetic, she was on dialysis and had sleep apnea. However, she definitely seemed to be having some difficulty with the affects of the first vaccine. Please let her life be counted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Sadly, we didn't get a chance to record them.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Heart disease, diabetic, kidney failure (dialysis)
- Andere Medikamente
- Insulin, Wellbutrin,
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 23.03.2021
- Impfdatum
- 06.02.2021
- Beginn
- 14.02.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Chest pain
Dyspnoea
Hypoxia
Respiratory distress
Suspected COVID-19
Symptomtext
CHEST PAIN SHORTNESS OF BREATH Respiratory distress Hypoxia Suspected COVID-19 virus infection Non-ST elevation (NSTEMI) myocardial infarction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 22.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
SARS-CoV-2 test
Symptomtext
Had stroke; This is a spontaneous report from a contactable consumer (patient). A 70-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9269) via an unspecified route of administration, administered in Arm Right on 15Feb2021 (12:00) as SINGLE DOSE for covid-19 immunisation, at 70 years old. Medical history included Cad atrial fibrillation (atrial fibrillation), Cad atrial fibrillation (Coronary Artery Disease), CHF kidney disease (congestive heart failure), CHF kidney disease (kidney disorder) from unspecified dates. No other vaccines in four weeks. No COVID prior vaccination. Concomitant medications included verapamil; alprazolam (XANAX); allopurinol (ZYLOPRIM); furosemide (LASIX); potassium; and mirtazapine (REMERON), all taken for an unspecified indication, start and stop date were not reported. The patient previously took antihistamines and experienced allergies (Known allergies: Antihistamine). The patient experienced had stroke on 19Feb2021. The patient required emergency room visit and was hospitalized for had stroke for 4 days from 2021 to 2021. Treatment reported as unknown. The patient underwent lab tests and procedures which included investigation: SARS-CoV-2 test (Nasal Swab): negative on 19Feb2021. Event outcome was recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 4,0
- Labordaten
- Test Date: 20210219; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Atrial fibrillation; Congestive heart failure; Coronary artery disease; Kidney disorder
- Andere Medikamente
- VERAPAMIL; XANAX; ZYLOPRIM; LASIX [FUROSEMIDE]; POTASSIUM; REMERON
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 22.03.2021
- Impfdatum
- 18.02.2021
- Beginn
- 21.03.2021
- Tage bis Beginn
- 31,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Resident Expired at facility on Hospice services on 3/21/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Covid + 12/14
- Aktuelle Erkrankungen
- Overall general decline in condiition. Parkinson's disease and atrial fibrillation anticoagulated on Coumadin. He has a history of sigmoid thickening suspicious for malignancy. He has been followed by palliative care. He has congestive heart failure with chronic lower extremity edema. He has been followed by palliative care. Symptomatic and tested positive for Covid + 12/16. Did not qualify for monoclonal antibodies. 1/8 Resident with order to admit to Hospice services due to overall decline, poor appetite, weight loss. Admitted to Hospice Services 1/13. First Covid vaccine received on 1/29/2021. Ongoing restlessness, increased hallucinations and behaviors. Ativan scheduled and increased. 2/2 Desatting into 70's-80's. O2 started with rapid improvement noted and able to wean off within 48 hrs. Started on Seroquel for increased agitation and psychosis. 2/18 received 2nd vaccine. Seroquel increased 2/18. Ongoing decline over the next month with deterioration in condition, weight loss, wounds etc.
- Vorgeschichte
- PARKINSON'S DISEASE HEART FAILURE, UNSPECIFIED DYSPHAGIA, OROPHARYNGEAL PHASE COGNITIVE COMMUNICATION DEFICIT ANXIETY DISORDER, UNSPECIFIED CHRONIC VENOUS HYPERTENSION W ULCER OF L LOW EXTREM TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS UNSPECIFIED ATRIAL FIBRILLATION MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED PRESSURE ULCER OF SACRAL REGION, STAGE 2 PERSONAL HISTORY OF COVID-19 PERSONAL HISTORY OF (HEALED) TRAUMATIC FRACTURE OTH DISRD OF BONE DENSITY AND STRUCTURE, UNSPECIFIED SITE OTHER INTERVERTEBRAL DISC DEGENERATION, LUMBAR REGION CHRONIC VENOUS HYPERTENSION W ULCER OF R LOW EXTREM HYPOTHYROIDISM, UNSPECIFIED PERIPHERAL VASCULAR DISEASE, UNSPECIFIED LIPOMATOSIS, NOT ELSEWHERE CLASSIFIED MALIGNANT NEOPLASM OF SIGMOID COLON GASTROINTESTINAL HEMORRHAGE, UNSPECIFIED OTHER SPECIFIED DISEASES OF INTESTINE ANEMIA, UNSPECIFIED ELEVATED PROSTATE SPECIFIC ANTIGEN [PSA] HYPERLIPIDEMIA, UNSPECIFIED ALCOHOL ABUSE, UNCOMPLICATED ATHSCL NATIVE ARTERIES OF RIGHT LEG W ULCER OF UNSP SITE UNSPECIFIED GLAUCOMA VITAMIN D DEFICIENCY, UNSPECIFIED BASAL CELL CARCINOMA OF SKIN OF OTHER PART OF TRUNK HEMANGIOMA OF SKIN AND SUBCUTANEOUS TISSUE OTHER SEBORRHEIC KERATOSIS ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE IDIOPATHIC CHRONIC GOUT, MULTIPLE SITES, WITH TOPHUS (TOPHI AGE-RELATED NUCLEAR CATARACT, BILATERAL OBESITY, UNSPECIFIED ESSENTIAL (PRIMARY) HYPERTENSION
- Andere Medikamente
- 2/18/21 Aspirin Tablet Chewable 81 MG; MiraLax Powder (Polyethylene Glycol 3350) Give 17 gram by mouth in the morning; Probenecid Tablet 500 MG Give 1 tablet by mouth in the morning; Senna-S Tablet 8.6-50 MG-Give 2 tablet by mouth in the mo
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 16.03.2021
- Impfdatum
- 08.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Amnesia
Aneurysm
Angiogram
Balance disorder
Cerebrovascular accident
Computerised tomogram
Confusional state
Fall
Head injury
Headache
Hypertension
Magnetic resonance imaging head
Transient ischaemic attack
Tremor
Vomiting
Symptomtext
fell, hit head, confusion, memory loss, balance disorder, tremors and shaking, vomiting, headache, high blood pressure, TIA, CVA, aneurysm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- hospitalization, MRI head, neck and MRA, CTs 2/23, 2/24, 2/25
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Cardovasular issues, no thyroid, high cholesterol and hypostatic blood pressure
- Andere Medikamente
- Fish oil, aspirin, levothroxin, doxazosin, losartan, Lipitor, escitalopram, ezetimibe, imiquimod, hydralazine hydrochloride, nifedipine, zinc, D3, Vitamin C
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.03.2021
- Impfdatum
- 06.02.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 34,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 15.03.2021
- Impfdatum
- 10.02.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Dizziness
Dysstasia
Malaise
Myocardial infarction
Nausea
Paraesthesia
Retching
Vomiting
Symptomtext
heart attack; became ill; I became nauseous; vomiting; dry heaves; dizzy; tingling in my face and right hand; right hand didn't feel like I could get up on my own; This is a spontaneous report from a contactable consumer. A 95-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 10Feb2021 10:15 at SINGLE DOSE in left arm for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) with lot number: EL3249 on 20Jan2021 in right arm. After receiving the 2nd dose on 10Feb2021, the patient became ill on 11Feb2021, while sitting on the toilet, she became nauseous and vomiting repeatedly even dry heaves also then became dizzy and felt a tingling in my face and right hand didn't feel like the patient could get up on her own so the patient's son and daughter assisted her to her bed. She didn't know what was wrong and her daughter thought it was a side effect of the vaccine and called the nurse on call. After arriving at the emergency and was examined the patient was told she was being kept for observation since she had just had the vaccine. The patient was later told she also had a mild heart attack and to her knowledge I never had any heart issues. She could then no longer use her walker to walk because she couldn't bear weight on her right hand. She was hospitalized for 8 days and transferred to rehab and I'm still in rehab. The events were assessed as serious (hospitalized and disability). The outcome of the events was not recovered. The patient received treatment for the events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 12.03.2021
- Impfdatum
- 06.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 08.03.2021
- Impfdatum
- 13.02.2021
- Beginn
- 13.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebral haemorrhage
Disorientation
Essential hypertension
Generalised anxiety disorder
Headache
Hypertension
Memory impairment
Subarachnoid haemorrhage
Vomiting
Symptomtext
High Blood Preaseure 183/79, headache, disorientation, temporary forgetfulness, vomit. All these happened around 9:00 p.m. As soon as those signs appeared we rushed her to the ER. The results showed Brain bleed. She was transfered to Hospital where she was valorated again and other series of test were performed. On Tuesday, 02/16/2021 she was discharged from the hospital with Discharge Diagnoses: //Bilateral subarachnoid hemorrhage //Intractable headache //Essential hypertension, uncontrolled//Generalized anxiety disorder. Thursday 03/04/2021 we follow up with the neurologist. Saturday 03/06/2021 she went to the ER with blood preasure of 189/83.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Famotidine 40mg, escitalopram 10mg, Hydrochlorothiazide 12.5mg
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 04.03.2021
- Impfdatum
- 11.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 18,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death within 30 days of vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- 2/2/21 New diagnosis of breast cancer and sarcoma left thigh and CT positive for 9mm Right middle lobe nodule, no treatments started prior to vaccine.
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 04.03.2021
- Impfdatum
- 17.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 12,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death within 30 days of vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 5/18/2020 Diagnosed with invasive ductal carcinoma of the breast, elected not to treat
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 03.03.2021
- Impfdatum
- 12.02.2021
- Beginn
- 13.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Cerebrovascular accident
Computerised tomogram
Musculoskeletal pain
Pain in extremity
Symptomtext
stroke; Joint pain; In the palm of my hand I might jump out of my skin; ; arm was hardly sore at all; right arm at the shoulder, elbow, and fingers is hurting at the joints; This is a spontaneous report from a contactable consumer. This 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9269) single dose, dose 1 via unknown route of administration in the left arm for COVID-19 vaccination on 12Feb2021 at 14:30. There were no additional vaccines administered on the same date as the COVID-19 vaccine. Medical history included pneumonia five times on an unknown date, septicemia one time, melanoma cancer in 2015, Factor V Leiden, high blood pressure and blood thinner. Prior Vaccinations (within 4 weeks): Concomitant medications included lisinopril from 2008 and ongoing for high blood pressure and warfarin 9.5 mg daily from 2008 and ongoing for blood thinner. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On an unknown date, the patient's arm was hardly sore at all and he had a stroke. On 13Feb2021, the patient experienced joint pain, in the palm of his hand if he presses right in the dead center he thinks he is going to jump out of the skin and right arm at the shoulder, elbow and fingers is hurting at the joints. When he first felt it in his right arm it wasn't horrible and it seemed like it got worse the next day. Then it seemed like it tapered off a little bit. On 16Feb2021, the pain woke him up in the middle of the night. The events did not require an emergency room or physician's office visit. He gets the flu shot every year and he has no symptoms whatsoever. The clinical outcome of stroke, joint pain, in the palm of my hand I might jump out of my skin, arm was hardly sore at all and right arm at the shoulder, elbow, and fingers is hurting at the joints were unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- Test Name: CT scan; Result Unstructured Data: Test Result:Birth defect in his heart; Comments: The CT scan at the hospital showed a birth defect in his heart
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Anticoagulant therapy (~~~); Blood pressure high (~~~); Factor V Leiden thrombophilia; Melanoma; Pneumonia (pneumonia five times); Septicemia (septicemia one time)
- Andere Medikamente
- LISINOPRIL; WARFARIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 01.03.2021
- Impfdatum
- 18.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain upper
Acute myocardial infarction
Back pain
C-reactive protein normal
Computerised tomogram abdomen normal
Computerised tomogram head normal
Condition aggravated
Full blood count normal
Hypotension
Leukocytosis
Lipase normal
Metabolic function test normal
Neutrophil percentage increased
Pain
Postictal state
Red blood cell sedimentation rate normal
Seizure
Troponin increased
Symptomtext
Pt presented by EMS for acute epigastric pain radiating to the back. While waiting for lab results, she was found down in her room and in post-ictal state. She was moved from an urgent care room to an ER bed and returned to near baseline when she had witnessed seizure activity and subsequently required multiple medications to break her status that lasted around 30 minutes
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- Initial lab tests prior to seizure unremarkable (CBC/d, CMP, lipase, troponin, ESR, CRP). Repeat labs after seizure activity showed mild leukocytosis and (12.75, 93% neutrophils) and detectable troponin 0.11 that was thought likely to be type 2 MI due to transient hypotension due to medications used to break her seizure. CT head and CT abdomen/pelvis were not significant. Pt was transferred to Hospital where she had no further seizure activity (and troponin was stable).
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- systemic lupus erythematosus, lupus cerebritis, seizure disorder, lupus nephritis
- Andere Medikamente
- hydroxychloroquine, ASA 81 mg, mycophenolate, zonisamide, lacosamide, lisinopril, calcium carbonate-vitamin D
- Allergien
- levetiracetam - thought to have caused renal impairment
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 01.03.2021
- Impfdatum
- 16.02.2021
- Beginn
- 28.02.2021
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Foetal death
Ultrasound antenatal screen abnormal
Symptomtext
Fetal demise sometime between 15-18 weeks based on ultrasound findings. EDC 7/30/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Foetal death
- Hospital-Tage
- 1,0
- Labordaten
- Ultrasound in hospital 2/28/2021 D&E scheduled 3/2/2021
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Lantus Valtrex Phenergan Cyclobenzaprine Prenatal Vitamin Unisom
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 24.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Dyspnoea
Loss of consciousness
Syncope
Symptomtext
Extreme difficulty breathing upon exertion, collapsed shortly after walking started, loss of conciousness, and death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- COPD exascerbation' UTI flare-up
- Vorgeschichte
- Advanced severe COPD, UTI
- Andere Medikamente
- Digoxin, Levothyroxine, Atorvastatin, Pregabalin, Sertraline, Monteleucast, Tylenol, Aspirin 81 mg,, Vitamin D3, Vitamin C, probiotic, Benadryl
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 23.02.2021
- Impfdatum
- 16.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure immeasurable
Body temperature increased
Cardio-respiratory arrest
Chills
Death
Dyspnoea
Pain
Feeling abnormal
Hyperhidrosis
Pallor
Vomiting
Symptomtext
Systemic: Death-Severe, Additional Details: Patient (Resident of facility) received COVID19 2nd dose vaccine at approximately 11am on 2/21. Pharmacy administered the vaccine through the LTC partnership program. Patient had no issues following vaccine. The director of the facility called me on 2.22 to update me on the situation. Per facility, at 8PM patient complained of body aches and chills. At 12AM patient had temperature of 102.2, vomiting, and trouble breathing. Paramedics arrived at 0040. Patient passed away at 0110 at hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 17.02.2021
- Impfdatum
- 11.02.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cerebrovascular accident
Computerised tomogram head normal
Eye pain
Eyelid ptosis
Full blood count normal
Headache
Hemianopia
Hypertension
Metabolic function test
Troponin normal
Symptomtext
Within 15-minutes, the patient reported a "pulsating sharp pain" behind their right eye. EMS evaluated the patient on-site and they were found to be hypertensive (173/88). The patient proceeded to a emergency department. In the ED, the patient remained hypertensive with a mild generalized headache. They reported that their eye pain is constant but comes in waves of higher intensity. Differential diagnosis was possible stroke due to right-sided hemianopsia and right-sided ptosis. Patient was admitted and evaluated. Aspirin was administered and blood pressure was monitored prior to discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- CT Head w/o Contrast (2/11): No acute intracranial pathology CBC/CMP (2/11): Unremarkable Troponin (2/11): Negative
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- Arthritis, DDD, GERD, HLD, Resection of meningioma (2017)
- Andere Medikamente
- Cholecalciferol, Melatonin, Naproxen sodium
- Allergien
- Sulfadiazine
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 13.02.2021
- Impfdatum
- 30.01.2021
- Beginn
- 31.01.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardio-respiratory arrest
Death
Unresponsive to stimuli
Symptomtext
Patient received his first dose of Covid vaccine on Jan. 30, 2021. On Jan 31, 2021 at 6:08 AM, patient noted unresponsive per facility. Code blue was called and 911 dispatched. He expired in the ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Unknown
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 12.02.2021
- Impfdatum
- 16.01.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 27,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
DEATH 2/12/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 11.02.2021
- Impfdatum
- 04.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Cerebrovascular accident
Computerised tomogram
Gait disturbance
Symptomtext
This patient received his 2nd dose of Pfizer vaccine yesterday. Today, he had focal weakness and difficulty walking and was transferred for suspected stroke.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- CT Scan
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- NO Chronic Med
- Allergien
- NOne
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 08.02.2021
- Impfdatum
- 04.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest X-ray normal
Chest pain
Computerised tomogram abnormal
Dyspnoea
Pulmonary embolism
Pulmonary mass
Symptomtext
Starting having Chest Pain and SOB on 2/5/21. Had oxygen saturation of 85%. Went to ICC and then ER on 2/8/21 for these symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- CXR Normal 2/8/21 CT scan Abnormal- Bilateral upper and Lower lobe Pulmonary Emboli and possible infarct. Solid pulmonary nodule 2/8/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ceclor, doxycycline, ofloxacin, sulfa
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 04.02.2021
- Impfdatum
- 02.02.2021
- Beginn
- 03.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death </= 24 hours post-vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- None. Coroner opted against autopsy due to age and significant comorbidities
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Left anterior fascicular block, hyperlipidemia, hypertension, allergic rhinitis, dysphagia, gastroesophageal reflux disease, benign prostatic hyperplasia, equinovarus deformity, toe amputation, stroke, essential tremor, parkinson's disease, hemiplegia due to old stroke, neuropathy, spasticity.
- Andere Medikamente
- ascorbic acid 500 mg, carbidopa-levodopa 25-100 mg, clopidogrel 75 mg, entacapone 200 mg, finasteride 5 mg, multivitamin, pravastatin, Prevident 5000 Plus 1.1%, propranolol 40 mg, rivaroxaban 20 mg, tamsulosin 0.4 mg.
- Allergien
- Hay fever
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 21.04.2023
- Impfdatum
- 11.01.2022
- Beginn
- 07.04.2022
- Tage bis Beginn
- 86,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Ischaemic stroke
Symptomtext
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 06.02.2021
- Beginn
- 05.10.2022
- Tage bis Beginn
- 606,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Atrial fibrillation
COVID-19
Cardioversion
Imaging procedure abnormal
Intensive care
Peripheral artery stenosis
SARS-CoV-2 test positive
Surgery
Symptomtext
This is a 75y.o. female with history of PAD with difficulty ambulating who presented on 10/5/2022 for surgery. Findings on imaging consistent with left popliteal artery stenosis. Pt underwent procedure listed above which they tolerated well without complication, see operative report for full details. She went into afib with RVR in the PACU requiring ICU admission. She was started on a cardizem gtt and converted to NSR. She was then started on a heparin gtt and transitioned to Eliquis. Patient recovered well. Hospital course significant for afib with RVR.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- 10/5 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 05.01.2020
- Beginn
- 05.04.2022
- Tage bis Beginn
- 821,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Autoimmune disorder
Bartonellosis
Dysbiosis
Electric shock sensation
Haematological infection
Laboratory test
Lyme disease
Malignant melanoma
Muscle twitching
Post viral fatigue syndrome
Tongue disorder
Symptomtext
1) Myalgic Encephamyolitis, 2) Reactivated Lyme Disease, 3) Furry Tongue Disease, 4) Bartonella Blood Infection 5) Melanoma skin cancer 6) Muscle Twitching and Electric Shocks 7) Auto Immune Disease 8) Gut Dysbiosis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- Lab 6/22
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Statins
- Vorherige Impfungen
- Flu Shot 2018 Quad
- Staat
- -
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 05.04.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 422,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
Increased upper airway secretion
Respiratory distress
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID breakthrough first dose 3/15/2021 EL9266, second 4/5/2021 EL 9269. COVID pos respiratory PCR 6/1/2022. 73-year-old female who presented to the emergency room today with complaints of shortness of breath which she developed over the last the 48 hours. Patient states that has been tested at the assisted level of care facility where she resides for COVID yesterday and it was reported as negative. Unfortunately, her respiratory distress has persisted, and worsened over the night and she decided to present to the emergency room. She was diagnosed by PCR method with COVID-19 infection. She had difficulty breathing, with increased secretions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- -
- Labordaten
- COVID pos respiratory PCR 6/1/2022.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, DM, hyperlipidemia, GERD, osteoarthritis
- Andere Medikamente
- -
- Allergien
- no known
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 27.05.2022
- Impfdatum
- 16.10.2017
- Beginn
- 04.05.2022
- Tage bis Beginn
- 1.661,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Dementia
Interchange of vaccine products
Parkinson's disease
Pyrexia
Seizure
Symptomtext
Parkinson's disease; Dementia due to Parkinson's disease; Interchange of vaccine products; Seizures; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PARKINSON'S DISEASE (Parkinson's disease), DEMENTIA (Dementia due to Parkinson's disease) and SEIZURE (Seizures) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065K21A and 030H21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect products included non-company products CARBIDOPA, LEVODOPA (DUOPA) for Parkinson's disease and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination. The patient's past medical history included Alcohol use in 2012 and Arterial stent insertion NOS. Concurrent medical conditions included Penicillin allergy, Non-smoker and Parkinson's disease. Concomitant products included LORAZEPAM for Anxiety, QUETIAPINE FUMARATE (SEROQUEL) for Anxiety and Prophylaxis, PARACETAMOL (TYLENOL) for Pain, TRAZODONE for Prophylaxis, VENLAFAXINE, MIDODRINE, MACROGOL 3350 (MIRALAX), VITAMIN D2 and LANSOPRAZOLE (PREVACID) for an unknown indication. On 16-Oct-2017, the patient started CARBIDOPA, LEVODOPA (DUOPA) (Percutaneous) at an unspecified dose. On 06-Feb-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form. On 12-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2022, the patient experienced SEIZURE (Seizures) (seriousness criteria death and medically significant) and PYREXIA (Fever). On an unknown date, the patient experienced PARKINSON'S DISEASE (Parkinson's disease) (seriousness criteria death and medically significant), DEMENTIA (Dementia due to Parkinson's disease) (seriousness criteria death and medically significant) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with Hospice care for Parkinson's disease; Hospice care for Dementia; Hospice care for Seizure and Hospice care for Pyrexia. The patient died on 12-May-2022. The reported cause of death was parkinson's disease and dementia due to parkinson's disease. It is unknown if an autopsy was performed. At the time of death, PYREXIA (Fever) had not resolved and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.3 f 104.3 F. Company Comment: This spontaneous case concerns a 75-year-old old male patient with concurrent condition of Parkinson's Disease and relevant medical history of Arterial stent insertion who experienced the fatal unexpected, serious (medically significant) adverse event of special interest of Seizure and fatal, unexpected (medically significant) events of Parkinson's disease and Dementia which occurred after receiving a dose of mRNA-1273 vaccine taken as fourth dose of COVID-19 immunization. He previously received mRNA-1273 approximately five months prior to the current dose but with no information on adverse event. Interchange of vaccine products is noted in this case as he received Pfizer BIONTECH COVID-19 vaccine as primary series of COVID-19 immunization. Patient has been taking several central nervous system medications and was admitted to hospice care 10 months prior to the events. Two days after the last dose of mRNA-1273 administration, he developed high grade fever (104.7 degrees Fahrenheit) and seizure. The clinical course was not provided but reported that patient died at home 8 days after the onset of seizure. Death occurred 9 days after second dose of mRNA-1273 vaccine. The cause of death was reported as Parkinson's disease and Dementia due to Parkinson's disease. It is unknown if an autopsy was performed. Dementia is a common manifestation of Parkinson's disease. Concomitant use of Venflaxine and Trazodone and occurrence of high grade fever are confounders for the event Seizure. Advanced age, medical history and low body mass index are also considered confounders for the fatal outcome. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 75-year-old old male patient with concurrent condition of Parkinson's Disease and relevant medical history of Arterial stent insertion who experienced the fatal unexpected, serious (medically significant) adverse event of special interest of Seizure and fatal, unexpected (medically significant) events of Parkinson's disease and Dementia which occurred after receiving a dose of mRNA-1273 vaccine taken as fourth dose of COVID-19 immunization. He previously received mRNA-1273 approximately five months prior to the current dose but with no information on adverse event. Interchange of vaccine products is noted in this case as he received Pfizer BIONTECH COVID-19 vaccine as primary series of COVID-19 immunization. Patient has been taking several central nervous system medications and was admitted to hospice care 10 months prior to the events. Two days after the last dose of mRNA-1273 administration, he developed high grade fever (104.7 degrees Fahrenheit) and seizure. The clinical course was not provided but reported that patient died at home 8 days after the onset of seizure. Death occurred 9 days after second dose of mRNA-1273 vaccine. The cause of death was reported as Parkinson's disease and Dementia due to Parkinson's disease. It is unknown if an autopsy was performed. Dementia is a common manifestation of Parkinson's disease. Concomitant use of Venflaxine and Trazodone and occurrence of high grade fever are confounders for the event Seizure. Advanced age, medical history and low body mass index are also considered confounders for the fatal outcome. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Parkinson's disease; Dementia due to Parkinson's disease
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Test Name: BODY TEMPERATURE; Result Unstructured Data: 104.3 F
- Aktuelle Erkrankungen
- Non-smoker; Parkinson's disease; Penicillin allergy
- Vorgeschichte
- Medical History/Concurrent Conditions: Alcohol use; Arterial stent insertion NOS
- Andere Medikamente
- VENLAFAXINE; LORAZEPAM; MIDODRINE; TRAZODONE; MIRALAX; TYLENOL; VITAMIN D2; PREVACID; SEROQUEL; DUOPA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 04.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthma
Condition aggravated
Headache
Immunisation reaction
Impaired work ability
Laboratory test
Thrombosis
Symptomtext
First vaccination, I had a headache. Then for the 2nd vaccination, I had ended up in the hospital, the shot triggered my asthma, I had to miss a couple of days of work. The third vaccination, booster, I had a headache. The last booster, I ended up in the emergency room from 2:30pm -3am, they thought I had blood clots, and my asthma was acting up, I had an asthma attack as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 1,0
- Labordaten
- Yes, while I was at the hospital (they all said it is the shot)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 29.04.2022
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Loss of consciousness
Symptomtext
First Dose: felt like she was going to pass out, but no problems breathing; First Dose: Headache; First Dose: Chills; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 05Feb2021 as dose 1, single (Lot number: EL9269) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history included: "High Blood Pressure" (ongoing), notes: High Blood Pressure. Concomitant medication(s) included: HYDROCHLORZIDE taken for hypertension (ongoing). Vaccination history included: Measles vaccine (she was 19, she had a rash and fever for 3 weeks, starting the day after the vaccine, Date: Unknown it was 40 Years Ago, Almost 50 Years, NDC, Lot, Expiration: Unknown), when the patient was 19 years old, reaction(s): "Fever", "Rash"; Small pox (she was in the health clinic for 6 days with a reaction to the Small Pox doses, Dates: Unknown, NDC, Lot, Expiration: Unknown), reaction(s): "reaction"; Herpes (horrible cold sores), reaction(s): "horrible cold sores"; Herpes (did blood work for her physical and her hematocrit was low so she had to take Iron 3 times a day because she did not have enough RBC.), reaction(s): "hematocrit was too low". The following information was reported: CHILLS (non-serious) with onset 05Feb2021, outcome "recovered", described as "First Dose: Chills"; HEADACHE (non-serious) with onset 05Feb2021, outcome "recovered" (07Feb2021), described as "First Dose: Headache"; LOSS OF CONSCIOUSNESS (medically significant) with onset 05Feb2021, outcome "recovered", described as "First Dose: felt like she was going to pass out, but no problems breathing". Clinical course: Vaccine administered at private facility was not reported. Additional vaccines administered on same date of the Pfizer suspect was reported as none. Caller stated they asked her if she wanted the pneumonia vaccine but she said she wanted to wait and she was glad she did. The AE's did not require a visit to emergency room and physician office. The patient did not receive any other vaccines within four weeks prior to the vaccination. Caller stated with the First Pfizer COVID Shot, within a few hours, she felt like she was going to pass out, but she had no problems breathing. Caller stated she also had a headache for two days and chills. Caller stated it started the afternoon of 05Feb2021. AE(s) following prior vaccinations reported as she did had an even worse case of herpes in college when she was in nursing school her sorority gave blood all of the time, and they used to drop the thing in and it would tell if you could give blood, well her haematocrit was too low but she gave blood anyway. Caller stated they did blood work for her physical and her haematocrit was low so she had to take Iron 3 times a day because she did not have enough RBC. She broke out with horrible cold sores. She was in a project where they gave pricks of the Small Pox Vaccine starting with 5 then 10 for a 12 week series at withheld and they continued to work up to 60 pricks of the Small Pox vaccine. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Blood pressure high (High Blood Pressure)
- Vorgeschichte
- -
- Andere Medikamente
- HYDROCHLORZIDE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 86,0
- Geschlecht
- U
- Eingang
- 12.03.2022
- Impfdatum
- 05.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Antibody test normal
Dry eye
Dry mouth
Fatigue
Pain
Thrombosis
Full blood count
Full blood count abnormal
Pain in extremity
Symptomtext
CBC abnormal; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). An 86-year-old patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 05Feb2021 13:00 (Lot number: EL9269) at the age of 86 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Irregular beats", start date: 2000 (ongoing); "pacemaker installed", start date: 10Mar2021, stop date: 10Mar2021; "macular degeneration", start date: 2006 (ongoing); "High blood pressure", start date: 1970 (ongoing); "High cholesterol" (ongoing), notes: Onset date: before 2017. Concomitant medication(s) included: PRESERVISION taken for macular degeneration, start date: 2001 (ongoing); VIT D [COLECALCIFEROL], start date: 2010 (ongoing); OMEPRAZOLE taken for gastrooesophageal reflux disease, start date: 2021 (ongoing). The following information was reported: FULL BLOOD COUNT ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "CBC abnormal". Relevant laboratory tests and procedures are available in the appropriate section. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Date: 2021; Test Name: CBC; Result Unstructured Data: Test Result:Abnormal
- Aktuelle Erkrankungen
- Blood pressure high; Heartbeats irregular; High cholesterol (Onset date: before 2017); Macular degeneration; Pacemaker insertion (cardiac)
- Vorgeschichte
- -
- Andere Medikamente
- PRESERVISION; VIT D [COLECALCIFEROL]; OMEPRAZOLE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 27.02.2021
- Beginn
- 09.10.2021
- Tage bis Beginn
- 224,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Computerised tomogram
Echocardiogram
Electrocardiogram
Full blood count
Ischaemic stroke
Magnetic resonance imaging
Ultrasound Doppler
Symptomtext
2 ischemic strokes (simultaneous) one of left pons , ; second in corona radiata right side
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- 1,0
- Labordaten
- Ekg EKG ECG MRI CT scan TEE test CBC Carotid artery scan ( all of these tests were done either in the ER or in the 12 days following the stroke diagnosis)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes Hypertension
- Andere Medikamente
- Metformin Glipizide Venlafaxine Cozaar lipitor
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 17.02.2021
- Beginn
- 08.02.2022
- Tage bis Beginn
- 356,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Gait disturbance
Lethargy
Presyncope
Symptomtext
CHIEF COMPLAINT: Patient presents to ER with history of TIA. Pt was dizzy and lethargix lasting a approx. 3 min. EMS states all symptoms resolved before their arrival. denies SOB or SP. pt is A/O x 4. pt has full strength, no facial droop, arm drift. last known well: 0900 HISTORY OF PRESENT ILLNESS: 88-year-old female with a history of CKD stage III, atrial fibrillation, prior TIAs presenting for the evaluation of dizziness and near syncope. Patient reports several episodes of dizziness and instability on her feet over the past day. She states that she almost fainted while walking to the couch earlier this morning. She denies chest pain, palpitations, shortness of breath. She denies symptoms at rest. Denies cough, fever, headache, neck stiffness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Chronic kidney disease (CKD), Diabetes,
- Andere Medikamente
- Unknown
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 17.02.2022
- Impfdatum
- 28.03.2021
- Beginn
- 08.02.2022
- Tage bis Beginn
- 317,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase normal
Albumin globulin ratio
Angiogram cerebral normal
Angiogram pulmonary abnormal
Anion gap
Aspartate aminotransferase normal
Asthenia
Bacterial test
Basophil count abnormal
Basophil percentage decreased
Bilirubin urine
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin increased
Blood calcium decreased
Blood chloride normal
Blood creatinine increased
Blood glucose normal
Symptomtext
2/8/22 90-year-old male brought in by EMS after his wife found him on the ground next to his bed. She states for the past several weeks he has been having cough productive of mucus. She states that initially discussed with his physician and he was given Mucinex which helped briefly however the cough then returned. He is not typically on supplemental oxygen. Was seen again yesterday and apparently had a negative Covid swab and was given an oral penicillin which she has been taking. He went to bed this evening and then his wife states around midnight he heard him "moaning and groaning in the bedroom" and she found him on the ground next to the bed. The patient is notably an extremely poor historian due to severe The patient is notably an extremely poor historian due to severe hearing loss but denies pain anywhere. It is unclear whether he struck his head. They state he has not had any nausea/vomiting or diarrhea. No report of abdominal pain. The did not know he had a fever. They do report some worsening fatigue, decreased p.o. intake with approximate 8 pound weight loss. REVIEW OF SYSTEMS Review of Systems Constitutional: Positive for fatigue and unexpected weight change. Respiratory: Positive for cough. Gastrointestinal: Negative for diarrhea and vomiting. Musculoskeletal: Negative for neck pain. Psychiatric/Behavioral: Positive for confusion. All other systems reviewed and are negative. CT Chest, Abdomen, & Pelvis Wo IV Con Without Oral Contrast: IMPRESSION: Findings compatible with pneumonia, IMPRESSION: No acute process detected in abdomen or pelvis Hospital Course: Patient is a 90 yr/o male with history of hypertension, dyslipidemia, other medical problems who presented to the emergency room because of altered mental status, fall and fever. Was uncertain whether the patient hit his head. He apparently had been sick with respiratory symptoms few weeks prior to this event and was seen by primary medical doctor the day prior to presentation and was prescribed oral penicillin. Patient will try to emergency room because of worsening symptoms. Evaluation in the emergency room showed BUN of 27 creatinine 1.95, COVID-19 was positive and CT angiogram of the chest showed new consolidative pulmonary infiltrate with predominant involvement of the right lower lobe and a small additional region of consolidation in the right upper lobe consistent with pneumonia. Other findings as reported below. CT of the head was unremarkable. Patient was admitted to intensive care unit on aggressive pulmonary toilet, bronchodilators, systemic corticosteroids, remdesivir, antibiotics. Patient also required IV hydration. Patient also remarkable improvement and is currently saturating at 98% on room air. Renal function has improved with a BUN of 22 and creatinine of 1.14. COVID-19 inflammatory markers, specifically fighting and procalcitonin remain elevated. Discharge plan: Patient will follow up with primary medical doctor 2/17/22 F/u with PCP: Here with wife for hospital follow-up Admitted to hospital from February 8?February 12, 2022 for pneumonia, hypotension and sepsis due to COVID-19. Presented to ER with altered mental status, fever and a fall at home. Admitted to the ICU. EMR review showed BUN 27, creatinine 1.95 CT angiogram chest showed new consolidative pulmonary infiltrate with predominant involvement of the right lower lobe and right upper lobe consistent with pneumonia. CTA head was negative. CT abdomen pelvis showed 2 prominent cysts on mid and lower pole of right kidney. Of note, there is mention of a 6 mm poorly defined soft tissue nodule in the right lower lobe that was measured at 4 mm on a CT chest 20 months prior. Nodule appeared larger on most recent scan. Repeat CT Chest recommended- Patient reports feeling better but still fatigued/weak at times. No shortness of breath, chest pain, fever, chills. Wife reports patient has gotten his appetite back. He was not eating in the hospital, but now she reports he has been eating double portions of meals over the past couple days. Patient has been able to walk around the house, even walking up and down the stairs. Patient denies syncope, dizziness or any falls. Reports he does not feel like he is going to fall but has some orthostatic hypotension when he gets up after sitting for a while. Discussed with wife to hold 1 dose of his carvedilol until his hypotension and fatigue are better. Will see them back in the office in 1 week. Has upcoming follow-up appt with nephrology
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 4,0
- Labordaten
- 2/8/22 COVID-19 Result Detected Abnormal CBC w/Diff Collection Time: 02/08/22 2:20 AM Result Value Ref Range White Blood Count 10.60 4.5 - 11.0 10*3/uL CBC w/Diff Collection Time: 02/08/22 2:20 AM Result Value Ref Range White Blood Count 10.60 4.5 - 11.0 10*3/uL Red Blood Count 4.06 (L) 4.5 - 5.9 10*6/uL Hemoglobin 12.7 (L) 13.5 - 17.5 g/dL Hematocrit 38.8 (L) 41.0 - 53.0 % Mean Corpuscular Volume 95.6 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 31.3 26.0 - 34.0 pg Mean Corpuscular HGB Conc 32.7 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 11.7 (L) 12.0 - 16.8 % Platelet Count 206 140 - 440 10*3/uL Mean Platelet Volume 10.4 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 91.6 (H) 45 - 80 % Lymphocyte % 2.5 (L) 15 - 50 % Monocyte % 4.7 0 - 15 % Eosinophil% 0.1 0 - 7 % BASO% 0.1 0 - 2 % Immature Granulocyte% 1.0 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 9.70 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.27 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.50 0.0 - 1.7 10*3/uL EOS-Absolute 0.01 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.11 (H) 0.00 - 0.10 10*3/uL Comprehensive Metabolic Panel (CMP) Collection Time: 02/08/22 2:20 AM Result Value Ref Range Sodium 136 136 - 145 mmol/L Potassium 4.3 3.5 - 5.1 mmol/L Chloride 100 98 - 107 mmol/L Carbon Dioxide 24 22 - 29 mmol/L Anion Gap 12 5 - 13 (arb'U) Glucose 139 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 27 (H) 8 - 26 mg/dL Creatinine-Blood 1.95 (H) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 13.8 RATIO Estimated GFR 32 (L) >60 /1.73 m2 Estimated GFR if African-American 39 (L) >60 /1.73 m2 Total Protein 6.5 6.2 - 8.0 g/dL Albumin 3.5 2.9 - 4.5 g/dL Globulin 3.0 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.2 1.1 - 2.5 RATIO Calcium 8.9 8.4 - 10.2 mg/dL Total Bilirubin 1.4 (H) 0.2 - 1.2 mg/dL AST/SGOT 23 5 - 34 U/L ALT/SGPT 11 0 - 55 U/L Alkaline Phosphatase 47 40 - 150 U/L Troponin I Collection Time: 02/08/22 2:20 AM Result Value Ref Range Troponin 0.257 (HH) 0.000 - 0.034 ng/mL B-Type Natriuretic Peptide Collection Time: 02/08/22 2:20 AM Result Value Ref Range B-Type Natriuretic Peptide 115.4 4 - 254 pg/mL Magnesium Collection Time: 02/08/22 2:20 AM Result Value Ref Range Magnesium 1.8 1.6 - 2.6 mg/dL Phosphorus Collection Time: 02/08/22 2:20 AM Result Value Ref Range Phosphorus 1.6 (L) 2.3 - 4.7 mg/dL Urinalysis Collection Time: 02/08/22 2:20 AM Result Value Ref Range Color-Urine Yellow Clarity-Urine Clear Specific Gravity Urine 1.022 (H) 1.005 - 1.030 (arb'U) pH-Urine 6.5 5.0 - 9.0 (pH) Protein-Urine >300 (A) Negative mg/dL Glucose-Urine Negative Negative mg/dL Ketone-Urine TRACE (A) Negative mg/dL Bilirubin-Urine SMALL (A) Negative mg/dL Occult Blood-Urine Moderate (A) Negative (arb'U) Nitrite-Urine Negative Negative (arb'U) Urobilinogen-Urine 4.0 (A) Normal (EhrlichU)/dL Leukocyte Esterase-Urine Negative Negative (arb'U) Source-Urine Urine Midstream Reflex Microscopic? Microscopic performed RBC-Urine 6 (H) 0 - 2 (HPF) WBC-Urine 1 0 - 3 (HPF) Squamous Epithelial-Urine None Seen 0 - 4 (HPF) Bacteria-Urine TRACE (A) None Seen (HPF) Mucus-Urine TRACE (A) None Seen (LPF) Amorphous Sediment-Urine TRACE (A) None Seen (HPF) Hyaline Cast-Urine 1 0 - 5 (LPF) Lactic Acid Collection Time: 02/08/22 2:20 AM Result Value Ref Range Lactic Acid 1.5 0.7 - 2.0 mmol/L
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Benign essential HTN o Hyperlipidemia
- Andere Medikamente
- allopurinol (ZYLOPRIM) 100 MG tablet Take 2 tablets by mouth o aspirin 81 MG EC tablet Take 1 tablet by mouth every other day. o carvedilol (COREG) 3.125 MG tablet TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS o clopidogrel (PLAVIX) 75
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 08.01.2022
- Impfdatum
- 19.02.2021
- Beginn
- 09.03.2021
- Tage bis Beginn
- 18,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Fall
Loss of consciousness
SARS-CoV-2 test
Tinnitus
Feeling abnormal
Feeling hot
Impaired work ability
Swelling
Vertigo
Symptomtext
collapsed onto the floor at work; collapsed onto the floor at work; vertigo; dizzy; tinnitus; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient. A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 19Feb2021 09:00 (Lot number: EL9269) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ulcerative Colitis" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Meniere's Disease" (unspecified if ongoing). Concomitant medication included: HUMIRA (ongoing); LISINOPRIL; HYDROCHLOROTHIAZIDE; PRAVASTATIN. Past drug history included: Known allergies=ampicillian, reaction(s): "known allergies=ampicillian", notes: known allergies=ampicillian. The following information was reported: LOSS OF CONSCIOUSNESS (non-serious), FALL (non-serious) all with onset 09Mar2021 10:00, outcome "recovered with sequelae" and all described as "collapsed onto the floor at work"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "vertigo"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "I spun my head it felt like it did not stop but kept going"; DIZZINESS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "dizzy"; TINNITUS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "ears were roaring with tinnitus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jun2021) negative, notes: Nasal Swab; (18Dec2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of loss of consciousness, fall, vertigo, vertigo, dizziness, tinnitus. Clinical course: Beginning 18 days after the first dose on 09Mar2021, patient suddenly encountered vertigo. When he spun his head, it felt like it did not stop but kept going and he collapsed onto the floor at work. He needed to sit down the rest of the day. The next morning, he was very dizzy, and his ears were roaring with tinnitus when the rooms ambient sound was quiet. It slowly went away over a three-week period. He called his gastroenterologist because he had assumed it was the Humira he had started 6 weeks earlier, but he said Humira has no such side effects. He continued to take the Humira with no effects. He later heard about vertigo and tinnitus being reported as side effects from the vaccine. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210604; Test Name: Covid test; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20211218; Test Name: Covid test; Test Result: Negative ; Comments: Nasal Swab
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypertension; Meniere's disease; Psoriasis; Ulcerative colitis
- Andere Medikamente
- HUMIRA; LISINOPRIL; HYDROCHLOROTHIAZIDE; PRAVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 05.01.2022
- Impfdatum
- 05.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Atrial fibrillation
Confusional state
Decreased appetite
Dehydration
Diarrhoea
Dyspnoea
Electrocardiogram abnormal
Fatigue
Headache
Impaired self-care
Intensive care
Laboratory test abnormal
Loss of consciousness
Pericardial drainage
Pericardial effusion
Pleural effusion
Pyrexia
Renal abscess
Symptomtext
2-12 headache,confusion,shortness of breath. 2-16 fatigue , loss of appetite, 100 degree fever. 2-24 continued symptoms. 2-28 fever 103.1. 3-5 Dr appointment sent to ER with fluid around heart, lungs, kidney failure, abnormal EKG, dehydration, abnormal lab work. Sent to CCU for fluid removal from heart . 3-6 spent 12 days in hospital CCU and ICU. Spent next 2 months on walker unable to care for myself. Passed out several times.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 13,0
- Labordaten
- Abscess on kidney, atrial fibrillation, severe diarrhea,
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Atrial fibrillation
- Andere Medikamente
- Eliquis, amiodarone, gabapentin, aspirin, losartan, potassium, clonazepam, vitamin c, fish oil
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 16.12.2021
- Impfdatum
- 15.03.2021
- Beginn
- 26.11.2021
- Tage bis Beginn
- 256,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Brain natriuretic peptide increased
C-reactive protein increased
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Cough
Decreased appetite
Diarrhoea
Dyspnoea
Intensive care
Lung infiltration
SARS-CoV-2 test positive
Troponin
Symptomtext
Patient admitted to hospital on 12/3/2021 weakness, shortness of breath and decreased appetite Patient tested COVID positive on 11/26/2021 she reported being ill for about 9-10 days Initially she had a cough, then later diarrhea with worsening dyspnea. No fever, chest pain. Admitted to ICU need for heated high flow oxygen. Received remdesivir and dexamethasone
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- COVID positive on 11/26/2021 12/3/2021 troponin 3511 12/3/2021 BNP 421 12/3/2021 CXR: patchy infiltrates throughout both lungs consistent with atypical pneumonia. COVID19 pneumonia is suspected. 12/4/2021 troponin 4774 12/4/2021 CRP 13.8
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes mellitus Renal transplant recipient HTN Coronary artery disease s/p 3V CABG Bilateral BKA
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 11.12.2021
- Impfdatum
- 21.02.2021
- Beginn
- 05.12.2021
- Tage bis Beginn
- 287,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: ja
Apnoea
Computerised tomogram head
Electroencephalogram
Endotracheal intubation
Hypotension
Intensive care
Magnetic resonance imaging
Mental status changes
Muscle spasticity
Symptomtext
Admitted to hospital for altered mental status. Two days later patient became apneic and responsive only to pain requiring intubation. At the time bilateral upper extremities were observed to have spastic movements. Patient then was transferred to critical care unit. Patient was finally extubated on 12/10 and transferred out of unit on 12/11/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 6,0
- Labordaten
- 12/5: CT head, MRI and EEG (all negative for explanation) 12/7: Intubation due to apneic breathing 12/8: Levo gtt to manage hypotension 12/10: Extubated
- Aktuelle Erkrankungen
- MDD with psychotic features CKD Stage 3 Hypothydroid Anxiety HLD Dementia Anemia
- Vorgeschichte
- Same as above
- Andere Medikamente
- Tylenol Abilify Vitamin C Lipitor Cogentin Dulcolax Ciprofloxacin HCL Flonase Synthroid Lidocaine patch Claritin Ativan Namenda Percocet Seroquel Trazodone Effexor
- Allergien
- Aricept Bactrim
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 04.11.2021
- Impfdatum
- 15.02.2021
- Beginn
- 30.10.2021
- Tage bis Beginn
- 257,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Adenovirus test
Aortic arteriosclerosis
Asthenia
Bordetella test negative
COVID-19
Cardiomegaly
Chest X-ray normal
Chlamydia test negative
Condition aggravated
Coronavirus test negative
Deep vein thrombosis
Diarrhoea
Dyspnoea
Electrocardiogram abnormal
Enterovirus infection
Enterovirus test positive
Haemorrhoids thrombosed
Human metapneumovirus test
Symptomtext
ED to Hosp-Admission Discharged 10/30/2021 - 11/3/2021 (4 days) Weakness Presenting Problem/History of Present Illness/Reason for Admission Weakness Diarrhea, unspecified type COVID-19 Hospital Course 86 yo female admitted with generalized weakness, shortness of breath, leg discomfort, diarrhea. Was found to have both rhinovirus/enterovirus, and COVID-19 positive on viral PCR. She was started on appropriate medications, and did show improvement in terms of viral infection. She was however found to have a lower extremity DVT in spite of being on Eliquis for stroke prevention and A. fib. Due to this we considered her to be a treatment failure, and she was transitioned to Coumadin. She was bridged with heparin, and became therapeutic today at 2.6. She received 5 mg x 3 days, I will transition her to 1 mg daily with INR check in 3 days. Attempted to obtain stool cultures to rule out infectious etiology for diarrhea however patient having minimal stool output therefore cultures could not be obtained. If she continues to have symptoms this could be addressed as an outpatient. She will discharge to skilled nursing facility for post hospital reconditioning and then return home. The remainder of her stay was otherwise unremarkable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- 4,0
- Labordaten
- 10/30/2021 1402 Respiratory virus detection panel Collected: 10/30/21 1402 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Positive Abnormal Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected 10/30/2021 1402 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 10/30/21 1402 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result Detected Critical Narrative: XR CHEST 1 VW PORT IMPRESSION: No acute radiographic findings. NB: Imaging can be negative in the early stages of COVID 19 pneumonia. END OF IMPRESSION: INDICATION: covid. TECHNIQUE: Portable AP projection of the chest was acquired. COMPARISON: 9/29/2021. FINDINGS: EKG wires project over the thorax. A battery projects over the mid left hemithorax.. The heart size is borderline enlarged. The vascular distribution is normal. The aorta is calcified. The lungs are clear. No acute airspace opacity is identified radiographically (taking into account the overlying battery on the left). No pleural effusion is identified. There is no evidence of pneumothorax. There is a healed fracture of the right humeral head and neck. There is a stable leftward tilt of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ultrasound lower extremity venous bilateral [3312148160] (Abnormal) Resulted: 10/30/21 1631 Order Status: Completed Updated: 10/30/21 1632 Narrative: PROCEDURE INFORMATION: Exam: US Duplex Lower Extremity Veins, Bilateral Exam date and time: 10/30/2021 2:50 PM Age: 86 years old Clinical indication: Pain; Leg, lower; Bilateral; Additional info: R/O dvt TECHNIQUE: Imaging protocol: Real-time duplex ultrasound of the extremities with 2-D gray scale, color Doppler flow and spectral waveform analysis with image documentation. Complete exam focused on the bilateral lower extremity veins. COMPARISON: US LOWER EXTREMITY VENOUS BILATERAL 12/12/2018 11:38 AM FINDINGS: Right deep veins: Occlusive thrombus is noted within the right peroneal and posterior tibial veins. The remaining evaluated venous structures of the right lower extremity are patent. Right superficial veins: Saphenofemoral junction is patent without thrombus. Left deep veins: Unremarkable. The common femoral, femoral, proximal profunda femoral and popliteal veins are patent without thrombus. Normal Doppler waveforms. Normal compressibility and/or augmentation response. Left superficial veins: Nonocclusive superficial venous thrombosis is noted within the left small saphenous vein. Soft tissues: Unremarkable. THIS REPORT CONTAINS FINDINGS THAT MAY BE CRITICAL TO PATIENT CARE. The findings were verbally communicated via telephone conference 10/30/2021. The findings were acknowledged and understood. IMPRESSION: 1. Occlusive thrombus involving the right peroneal and posterior tibial veins. 2. No evidence of DVT in the left lower extremity. 3. Nonocclusive superficial venous thrombosis involving the left SSV.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Nervous Peripheral neuropathy Numbness in feet Spinal stenosis of lumbar region with neurogenic claudication Greater trochanteric bursitis, right Lumbar radiculitis Dementia without behavioral disturbance, unspecified dementia type (CMS/HCC) Circulatory Atrial fibrillation (CMS/HCC) [I48.91] DVT (deep venous thrombosis) (CMS/HCC) Essential hypertension First degree AV block Pulmonary embolism (CMS/HCC) Diastolic dysfunction Hypertension Digestive Barrett's esophagus Gastroesophageal reflux disease without esophagitis Gastroesophageal reflux disease Acute diverticulitis Genitourinary UTI (urinary tract infection) Musculoskeletal Arthritis Lumbar spondylosis Osteoarthrosis, localized, primary, knee Age-related osteoporosis without current pathological fracture Primary osteoarthritis of right hip Lumbar herniated disc Endocrine/Metabolic Hyperlipidemia Hypothyroidism Hypokalemia Hematologic Coagulation defect (CMS/HCC) Immune Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (CMS/HCC) Other Anxiety Living will in place Long-term (current) use of anticoagulants Controlled substance agreement signed Weakness
- Andere Medikamente
- albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler dilTIAZem CD (CARDIZEM CD) 240 mg 24 hr capsule donepeziL (ARICEPT) 5 mg tablet esomeprazole (NexIUM) 40 mg capsule furosemide (LASIX) 20 mg tablet levothyroxine (SYNTHROID) 5
- Allergien
- TerazosinSyncope Sulfamethoxazole-trimethoprimHives / Urticaria TheophyllinePalpitations VerapamilSwelling AmoxicillinNausea Only Vistaril [Hydroxyzine Hcl] Amoxicillin-pot ClavulanateNausea and Vomiting CefuroximeNausea Only, Nausea Only ClarithromycinNausea Only, Nausea Only CodeineNausea Only, Other (document details in comments) Erythromycin BaseNausea Only GatifloxacinOther (document details in comments) Hydrocodone-acetaminophenOther (document details in comments) MeperidineOther (document details in comments) MinocyclineNausea and Vomiting PenicillinsRash Sulfa (Sulfonamide Antibiotics)Welts TetracyclinesNausea and Vomiting VancomycinItching ZafirlukastOther (document details in comments)
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 06.02.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 264,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Dehydration
Diarrhoea
Malaise
SARS-CoV-2 test positive
Syncope
Symptomtext
10/27/21 in ED with Covid symptoms: diarrhea, cough, syncope, dehydration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 1,0
- Labordaten
- 10/27/21 Covid +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 04.02.2021
- Beginn
- 04.10.2021
- Tage bis Beginn
- 242,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Contusion
Induration
Limb injury
Skin texture abnormal
Superficial vein thrombosis
Ultrasound scan abnormal
Symptomtext
Client injured her left leg, bruising it as she hit it against a hard surface on 10/1/2021. Injury caused a large bruise. On 10/4/21 client noticed a hard area in her left leg, "felt like a straw under my skin". Was seen on 10/6/2021 by her medical provider and diagnosed as having a superficial blood clot in her left leg.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Superficial vein thrombosis
- Hospital-Tage
- -
- Labordaten
- ultrasound of left leg
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- none
- Andere Medikamente
- Yaz birth control Methotrexate weekly for psoriasis Folic acid daily
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- M
- Eingang
- 16.10.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alanine aminotransferase normal
Albumin globulin ratio
Anion gap
Aspartate aminotransferase normal
Basophil count decreased
Autoimmune disorder
Guillain-Barre syndrome
Basophil percentage decreased
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin
Blood calcium normal
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Blood potassium normal
Blood sodium normal
Blood thyroid stimulating hormone decreased
Symptomtext
GBS; an autoimmune condition that looks like GBS or some form thereof; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient seemed to have precipitated an autoimmune condition that looked like GBS (Guillain Barre syndrome) or some form thereof. He lived in a remote spot but needed to find a great neurologist or neuroimmunologist to get on track. Outcome of the events was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 01.02.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 59,0
- Dosis
- 1
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Heavy menstrual bleeding
Thrombosis
Symptomtext
Blood clots at time of periods that have been abnormally large. Much heavier bleeding than last 20 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 21.09.2021
- Impfdatum
- 04.02.2021
- Beginn
- 13.09.2021
- Tage bis Beginn
- 221,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Full blood count
Hypoaesthesia
Magnetic resonance imaging
Metabolic function test
Symptomtext
Bells palsy, left arm and left leg numbness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- MRI, CBC, BMP
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 10.09.2021
- Impfdatum
- 21.01.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Dyspnoea
Dyspnoea exertional
Fatigue
Loss of consciousness
Oxygen saturation decreased
Symptomtext
87-year-old female with history of hypertension, hyperlipidemia, diabetes presents to emergency department complaining of worsening fatigue, shortness of breath, cough as well as 2 episodes when she passed out at home. Patient mentions that she was recently diagnosed with COVID-19 infection on 8/25/2021 at which time she was evaluated in this emergency department but was feeling well and was discharged home as she was not hypoxic. Her oxygen saturations ranging high 80s to low 90s on room air. When she exerts her oxygen saturation drops down further.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 06.03.2021
- Beginn
- 06.09.2021
- Tage bis Beginn
- 184,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Chills
Decreased appetite
Musculoskeletal discomfort
Pyrexia
SARS-CoV-2 test positive
Syncope
Symptomtext
Patient presented to facility with syncope, neck pressure, decreased appetite, chills, fevers. Pt was admitted to facility.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- COVID PCR test was performed no 9/6/21 and was positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 07.09.2021
- Impfdatum
- 04.02.2021
- Beginn
- 16.03.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asymptomatic COVID-19
Deep vein thrombosis
Erythema
Mental status changes
Peripheral swelling
SARS-CoV-2 test positive
Ultrasound Doppler abnormal
Symptomtext
Bilateral lower extremity swelling with the distal leg redness as well as hand swelling as well as change in mental status. Tested positive for COVID19 prior to admission. MD stated the patient was completely asymptomatic and most likely the test was false positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- 4,0
- Labordaten
- US: Chronic left lower extremity DVT
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- vascular dementia, CKD stage IIIA, hypothyroidism, history of alcohol abuse, CVA, history of DVT, history of falls
- Andere Medikamente
- Tylenol, clonazepam, divalproex, escitalopram, folic acid, gabapentin, levothyroxine, milk of magnesia, melatonin, quetiapine, triamcinolone cream, vitamin B1
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.09.2021
- Impfdatum
- 08.03.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 158,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram pulmonary normal
Asthenia
Brain natriuretic peptide increased
Bronchitis
COVID-19
Chills
Cholecystitis
Computerised tomogram thorax
Cough
Diastolic dysfunction
COVID-19 pneumonia
Cardiac failure
Cardiac failure acute
Cardiac failure congestive
Chest X-ray abnormal
Dizziness
Dyspnoea
Dyspnoea exertional
Symptomtext
Hospitalized; COVID-19 positive (8.21.21) - hospitalized on 8.28.21 due to COVID (fully vaccinated) Discharge Information: Admission Date: 8/27/2021 Discharge Date: 09/02/2021 Admitting Diagnoses: Pneumonia due to COVID-19 virus PRESENTING PROBLEM: Hypoxia Acute on chronic congestive heart failure, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: Patient is a 71 y.o. male who presented to the emergency department with complaints of shortness of breath. He has a past medical history of chronic obstructive pulmonary disease, hypertension, GERD, gout, non-Hodgkin's lymphoma, CKD stage 3, type 2 diabetes, and lymphedema. Patient states that on 08/18/2021, he started having symptoms of COVID-19 including shortness of breath, fatigue, chills, fever, congestion, rhinorrhea, nausea, dizziness and weakness. On 08/21/2021, he presented to the emergency department and COVID-19 was confirmed. He states that since then he has had increasing shortness of breath. Yesterday afternoon, a home health nurse checked his oxygen saturation and found it to be 87% on room air. He presented to the emergency department after realizing he was hypoxic on room air. In the emergency department, patient was febrile, tachypneic, and required 2 liters/minute supplemental oxygen via nasal cannula to maintain a saturation greater than 90%. Complete blood count was unremarkable. BMP was remarkable for chronic kidney disease. BNP was 2261 in the emergency department, and increase from 1296 last week. EKG showed V paced rhythm. Chest x-ray showed few patchy opacities in the right perihilar region and left lower lung along with small bilateral pleural effusions. Echocardiogram from 08/16/2020 shows LVEF of 45% with mild septal hypokinesis. Additionally, it shows diastolic dysfunction stage I. Suspect hypoxia related to COVID-19 pneumonia. Patient has been admitted for further evaluation management of COVID-19 pneumonia and acute on chronic combined systolic and diastolic congestive heart failure. Patient was admitted and diuresed with Lasix. Had echocardiogram done recently on 08/16 was obtained from outpatient and found to have a stable ejection fraction of 40-45%. He diuresed well with improvement of his renal function to his baseline. He was treated with steroids and remdesivir. He was able to be weaned off of oxygen but continued to have persistent dyspnea and exertional shortness of breath with cough. With continued treatment the symptoms eventually improved and was felt he was stable to be discharged home for continued care. He will follow salt and fluid restrictions, and his Lasix was increased to twice daily. He will have a BMP drawn within 1 week and will follow up with tip in the latter more within the next week. He is greater than 10 days from onset of symptoms so he no longer needs to self isolate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Found to be COVID-19 positive 8.21.21 - ED visit (8.21.21) - SYNCOPE Acute bronchitis - seen in office 7.28.21 (chronic shortness of breath) from ED visit 8.21.21: ED Provider Notes (Physician) ? ? Addiction Medicine Patient was signed out to me by the prior emergency department provider. For original emergency department report details, please see prior note. At the time of sign-out, patient was awaiting a CT angiogram of the thorax to rule out PE in the setting of new COVID infection diagnosis and syncopal episode. Patient was never noted to be hypoxic, but did arrive mildly hypotensive. He was given 2 L of IV fluids prior to sign-out and had responded to fluids nicely with normalization of his blood pressures. Patient does report feeling severe generalized fatigue and cough and assumed he had bronchitis. He does appear mildly fatigued here, but is still satting 97% on room air and has otherwise normal vital signs. His CT scan came back negative for PE but did show signs of congestive heart failure verses airspace disease. Given that patient does have a positive COVID test and also has an elevated BNP, he could certainly have a combination of both heart failure and COVID infection causing these findings on CT scan. I did tell him he should follow up with his PCP about possibly having an echocardiogram at some point. He does have lower extremity edema which he states is not new for him. The CT also commented on a an inflamed appearing gallbladder without gallstones, and I asked the patient if he has had any right upper quadrant abdominal pain, and he denies this. I examined him he had a completely nontender abdomen, in particular nontender in the right upper quadrant. Overall, the patient felt comfortable going home. He states he has a pulse oximeter at home. He ambulated with no difficulty and did not have any desaturation episodes. Ultimately this confirmed that he was appropriate for discharge home and patient was in agreement. He understood follow up instructions and return precautions. All questions are answered and patient is discharged in stable condition
- Vorgeschichte
- History of non-Hodgkin's lymphoma Mild persistent asthma without complication Gastroesophageal reflux disease Gout, unspecified cause, unspecified chronicity, unspecified site Chronic obstructive pulmonary disease, unspecified COPD type Essential hypertension Hyperlipidemia, unspecified hyperlipidemia type Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Sarcoidosis of lung with sarcoidosis of lymph nodes Stage 3a chronic kidney disease Lymphedema Acute bronchitis, unspecified organism Pneumonia due to COVID-19 virus Gout GERD (gastroesophageal reflux disease) COPD (chronic obstructive pulmonary disease) Acute on chronic combined systolic and diastolic congestive heart failure
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 100 MG tablet atorvastatin (LIPITOR) 20 MG ta
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 30.08.2021
- Impfdatum
- 28.01.2021
- Beginn
- 29.08.2021
- Tage bis Beginn
- 213,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Intensive care
Symptomtext
COVID Vaccine 2/81/21 and 1/28/21 PFIZER Admitted wo ICU with COVID infection 8/29/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 22.08.2021
- Impfdatum
- 08.03.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Asthma
Back pain
Blood test
Cardiac stress test
Computerised tomogram
Condition aggravated
Dyspnoea
Echocardiogram
Electrocardiogram
Loss of personal independence in daily activities
Magnetic resonance imaging
Pericarditis
Peripheral swelling
Symptomtext
1) Massive asthma attack. Felt close to dying. Breathing is still not controlled. 2) Excruciating lower left back pain. Could not be alleviated with hydrocodone or even morphine. Lasted 4 months. Tolerable now after 6 months. 3) Pericarditis 4) Extreme weakness. Could barely do daily routine chores. 5) Both legs and feet swollen tremendously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- 3,0
- Labordaten
- I was admitted at first at an Urgent Care facility as there were no beds anywhere in town. Regular nor ER. After trying for 2 days, I was examined at a Hospital's ER. A day later, was admitted to hospital. Have been treated (until now) by numerous specialists- cardiologist, pulmonologist, allergy/immunology expert, pain/spine specialist Numerous blood tests were conducted on multiple occasions. covering the entire routine and non-routine spectrum. CT Scans MRI Echocardiograms Stress Test with EKG. All results are available from hospital as well as another Hospital where I was seen as well.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Stent in one artery. High Blood Pressure, BPH, Asthma
- Andere Medikamente
- Metformin, Ramipril, Amlodipine, Rosuvastatin, Clopidogrel, Travatan eye drops, Vitamin D, Vitamin B complex, Zinc, Glucosamine
- Allergien
- Aspirin, Sea food (only with shell)
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 21.08.2021
- Impfdatum
- 09.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Biopsy bone abnormal
Biopsy thyroid gland abnormal
Bone cancer metastatic
Bone scan
Chest X-ray
Chest pain
Computerised tomogram
Computerised tomogram head
Computerised tomogram thorax
Electrocardiogram
Fall
Fatigue
Gait disturbance
Hepatic cancer metastatic
Hospice care
Magnetic resonance imaging head
Medullary thyroid cancer
Symptomtext
2/22/21 Fatigue has been started till now. The week of 2/22-2/25/21 he fainted a few second then found himself sitting on the floor. 2/26/21 evening he fainted and fell from the chair. He had lower back pain then couldn't walk well. He was taken to ER and disharged 3/4/21. 5/31/31 He had chest pain and lower back pain. He was taken to ER and disharged 6/2/21. Onchologyst thought he has cancer. After that He went to Hospital. Based on his thyroid biopsy and bone biopsy, he has been diagnosed with a stage IV medullary thyroid cancer metastatic to bone, liver and lymph nodes. Currently he is under home Hospice Care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- 2/26-3/4/21 CT CHEST, HEAD, LUMBAR SPINE, ECG 12 LEAD, IR needle Biopsy, MRI Sacrum NM Bone Scan whole Body. 6/1-6/2/21 CT CHEST, HEAD, LUMBAR SPINE, ECG 12, ED, MRI BRAIN, XR CHEST
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 18.08.2021
- Impfdatum
- 15.02.2021
- Beginn
- 27.02.2021
- Tage bis Beginn
- 12,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Burning sensation
Confusional state
Coordination abnormal
Dysarthria
Feeling hot
Headache
Hypoaesthesia
Impaired work ability
Laboratory test normal
Pain in extremity
Seizure
Speech disorder
Therapeutic response delayed
Thrombosis
Symptomtext
I experienced at time of vaccine couple of hours later, my neck and my head was burning. I never experienced this. I felt I was no functioning properly. I could not feel my touch and hold a pencil. I also really hot but did not have any fever. I had a severe headache and I did not have a fever. My son was called to pick me up at work. I had trouble speaking and slurred speech and my coordination was slow. I also had a seizure episode and was taken by ambulance to the ER . I also felt very confused and delayed in response. I had exams done and everything came back to normal. I also had a blood clot on the back of my left leg. I also had hand pain and saw my physician. After 48 hours I was fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- lab work
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- Living donor; kidney donor had donation 6 years ago
- Andere Medikamente
- None reported
- Allergien
- Morphine
- Vorherige Impfungen
- 30years ago, the tetanus shot. but don't remember any adverse reaction
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 02.03.2021
- Beginn
- 07.08.2021
- Tage bis Beginn
- 158,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Amnesia
COVID-19
Chills
Condition aggravated
Epistaxis
Head injury
Hypotension
Nasal cavity packing
Nasal cavity packing removal
Nausea
SARS-CoV-2 test positive
Syncope
Symptomtext
This is a 78-year-old female with past medical history of hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction status post 3 stents, permanent atrial fibrillation on chronic anticoagulation with Eliquis, history of multiple episodes of epistaxis, COPD/emphysema, history of CVA with residual deficit in the vision, hypothyroidism, peripheral neuropathy, history of skin cancer status post excision, chronic sinusitis. She came to the hospital with a chief complaint of an episode of syncope this morning. Patient was here in the emergency room last night for epistaxis. Patient underwent nasal 8/7/2021 tested positive This is a 78-year-old female with past medical history of hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction status post 3 stents, permanent atrial fibrillation on chronic anticoagulation with Eliquis, history of multiple episodes of epistaxis, COPD/emphysema, history of CVA with residual deficit in the vision, hypothyroidism, peripheral neuropathy, history of skin cancer status post excision, chronic sinusitis. She came to the hospital with a chief complaint of an episode of syncope this morning. Patient was here in the emergency room last night for epistaxis. Patient underwent nasal packing in the emergency room. She has previous similar episodes of epistaxis. Eliquis was advised to be held. Patient was supposed to see her cardiologist Dr. for decision regarding resuming Eliquis. This morning the patient woke up but she could not really sleep all night due to discomfort in the nasal cavity from the packing. She felt that the packing was too tight. She had some difficulty breathing due to tight packing in the nasal cavity. The patient denied any fevers but did have some chills. Denies any cough. Currently the epistaxis is resolved. Nasal packing is removed. The patient denies any chest pain, shortness of breath, palpitations, abdominal pain, burning or painful urination, diarrhea. She did have some nausea but denies any episodes of vomiting. After the patient got up from the bed this morning she went to the bathroom but she collapsed on the floor, she hit her head, then she suddenly found herself in the bathroom but does not remember how she went there, the episode was unwitnessed. She came to the hospital and had low blood pressure. Nasal packing was removed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease, hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction
- Andere Medikamente
- codeine, benadryl
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 12.08.2021
- Impfdatum
- 22.01.2021
- Beginn
- 19.07.2021
- Tage bis Beginn
- 178,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Seizure
Symptomtext
Seizures have worsened in the last 3 weeks. I was having about 7-10/day. Now I?m having up to 22/day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- None so far.
- Aktuelle Erkrankungen
- Brain tumor, seizures
- Vorgeschichte
- Brain tumor. Seizures
- Andere Medikamente
- Lexapro, triliptal, Ativan, briviact
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 10.08.2021
- Impfdatum
- 03.03.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 159,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
COVID-19
Chills
Decreased appetite
Diarrhoea
Illness
Nasal congestion
Productive cough
Pyrexia
SARS-CoV-2 test positive
Sputum discoloured
Syncope
Symptomtext
PATIENT PRESENTED TO MEDICAL CENTER ER ON 8/9/2021 WITH APPROXIMATELY 5-6 DAYS OF GENERAL ILLNESS TO INCLUDE NASAL CONGETSTION, COUGH PRODUCTIVE WITH WHITISH SPUTUM. SUBJECTIVE FEVERS AND CHILLS, GENERALIZED WEAKNESS AND DECREASE APPETITE, MULTIPLE SYNCOPAL EPISODES, SOME DIARRHEA. DENIES ANY KNOWN SICK CONTACTS OR RECENT TRAVEL. TOOK HOME COVID TEST REPORTED IT WAS POSITIVE. RETESTED AT HOSPITAL. COVID19 SARSCoV2 = DETECTED ON8/9/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- 8/9/21 SARSCoV2 = DETECTED
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 09.08.2021
- Impfdatum
- 27.01.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 186,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19 pneumonia
Hypoxia
Respiratory distress
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Breakthrough Covid pneumonia, respiratory failure, hypoxemia, respiratory distress syndrome,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- -
- Labordaten
- COVID positive test 8/1/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD
- Andere Medikamente
- prednisone albuterol brovana pulmicort calcium + D ferrous sulfate synthroid losartan omeprazole zofran miralax
- Allergien
- latex
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 08.04.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 117,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Intensive care
SARS-CoV-2 test positive
Symptomtext
Patient tested positive for COVID 19 on 8/3/21 despite completing two part vaccine series. Patient is admitted to the ICU with increased oxygen requirments and COVID pneumonia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- Respiratory PCR detected COVID on 8/3/21
- Aktuelle Erkrankungen
- Unable to assess
- Vorgeschichte
- Diabetes, hypertension, hyperlipidemia, BPH, and degenerative spinal stenosis.
- Andere Medikamente
- Diclofenac, APAP, glipizide, metformin, atorvastatin, lisinopril, carvedilol, tadalafil, oscal, tamsulosin, tizanadine, and oxybutynin.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 02.08.2021
- Impfdatum
- 16.03.2021
- Beginn
- 06.04.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Chest discomfort
Chest pain
Computerised tomogram thorax
Echocardiogram
Ejection fraction normal
Electrocardiogram normal
Magnetic resonance imaging heart
Myocarditis
Painful respiration
Pericardial fibrosis
Pulmonary artery dilatation
Scan with contrast
Troponin increased
Symptomtext
Myopericarditis - 22 yo man with no significant PMH presented to the ED on 7/26/21 with 4 days of constant, progressively worsening chest pain. Pain is sharp and pressure over mid-chest, 8-9/10 at worst, worse when laying flat on back and deep inspiration, improved with Tylenol at home but then pain returned. Pain controlled with Tylenol, colchicine, high-dose ASA, later switched to colchicine and Ibuprofen given improved creatinine. Pain improved and w/u including EKGs, CXR, Echo, CT chest, Cardiac MRI completed over following days. Discharged on 7/29/21 with plan to continue 3 months of colchicine and taper ibuprofen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 3,0
- Labordaten
- See below Serial High Sensitivity Troponins: 5,157* (7/27/21) 10,590* (7/27/21) 8,750* (7/27/21) 7,192* (7/27/21) 6,945* (7/28/21) ECG 7/27/2021 00:16: NSR, <0.5mm J-pt elevation V2-V6, no convincing PR depression and no PR elevation in aVR ECG 7/27/2021 08:27: SR, small TWI lead III, otherwise unchanged TTE 7/27/2021: Normal LV size, no LVH, EF 65%, no WMA. Normal RV sise and systolic function, RVSP 25, RAP 3. No significant valve disease. No pericardial effusion. No intracardiac shunt on bubble study. No basal inferior mass noted, but not high resolution in that region. CMR 7/28/2021: Normal LV size and function. +subepicardial delayed enhancement in the basal inferolateral segments with enhancement in pericardium too, in the basal inferior wall the delayed enhancement thickness is ~50%. Per prelim report, "Of note, the LGE of the basal inferior segment appears to be masslike. There is thickening and enhancement of the surrounding pericardium. Findings are consistent with acute myopericarditis. Recommend follow-up with cardiac MRI in 4-6 weeks when patient's symptoms resolve to exclude underlying pericardial/cardia mass." CT chest with contrast 7/29/2021: A 20 mm left supraclavicular soft tissue density may represent a lymph node versus a normal anatomic structure. Its evaluation is limited due to streak artifact. Further evaluation with a CT of the neck with contrast is recommended. No thoracic lymph node enlargement. Mildly dilated main pulmonary artery.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- ibuprofen, multivitamin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 02.08.2021
- Impfdatum
- 01.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Amnesia
Antinuclear antibody negative
Bell's palsy
Borrelia test
C-reactive protein increased
Cerebral infarction
Computerised tomogram head normal
Facial paralysis
Headache
Immediate post-injection reaction
Impaired work ability
Magnetic resonance imaging head abnormal
Neurological examination abnormal
Red blood cell sedimentation rate increased
Thalamic infarction
Symptomtext
Patient reports headaches begain right after the second dose of pfizer vaccine and 2 weeks or less after thist time the headached have increased and he has missed work - at this time headaches are constant; relates a short term memory loss since receiving the second dose also; has been following up with primary care physician since the symptoms started. Hospitalization at from 7/26 to 7/28. He had an outpatient MRI of the brain for persistent headaches that showed acute/subacute infarct involving genu and posterior limb of right internal capsule as well as adjacent anterior aspect of the thalamus. Patient was started on ASA and atorvastatin for stroke prevention. He was evaluated by neurology and was recommended for outpatient follow up for management of his chronic headaches. He was instructed to discontinue sumatriptan and start taking topiramate 50 mg qAM and 100 mg qhs for 7 days, then start taking topiramate 50 mg BID. He was also instructed to start taking benadryl 25 mg qd, gabapentin 100 mg TID, and compazine 10 mg qd. He has follow up scheduled with neurology on August 10 and August 28 with neurology. He feels that his new medications help to take the edge off his headache pain but do not completely resolve the pain. He also adds that he has only been taking topamax 50 mg in the morning and has not been taking an evening dose. ESR and CRP were only minimally elevated. ANA was negative. Lyme panel was ordered and is pending. Of note, patient was diagnosed with Bell's palsy resulting in left facial droop on June 12, 2021. He had a negative head CT at that time. He was treated with prednisone and his symptoms resolved after a week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- 3,0
- Labordaten
- As stated in # 18
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- No known drug allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 02.08.2021
- Impfdatum
- 05.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood test normal
Computerised tomogram normal
Epistaxis
Haemoptysis
Thrombosis
COVID-19
Vascular cauterisation
Symptomtext
At about midnight after receiving the vaccine, I started coughing up clotted blood. That continued for about a half hour. I then went to the emergency room. They took CAT scans and other tests and couldn't find anything. After 3 days, they sent me home. 2 weeks later, I started coughing them up again. I went back to the ER but was sent home again. I was taken off Xarelto and everything was fine. They put me back on Xarelto and then I started having nosebleeds with blood clots. I have never had nose bleeds in my life. I was put on Xarelto again and then once again taken off. Currently I am off the Xarelto, and I am having no issues. I went to a nose doctor who cauterized something. The most recent nosebleed I experienced was on May 9.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- CAT Blood tests Nothing unusual
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Rheumatoid Arthritis; TIA; thyroid nodule; A-fib; loop recorder implant
- Andere Medikamente
- Xarelto; Methotrexate; Folic Acid; Vitamin D; Zinc
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 02.08.2021
- Impfdatum
- 05.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood test normal
Computerised tomogram normal
Epistaxis
Haemoptysis
Thrombosis
COVID-19
Vascular cauterisation
Symptomtext
At about midnight after receiving the vaccine, I started coughing up clotted blood. That continued for about a half hour. I then went to the emergency room. They took CAT scans and other tests and couldn't find anything. After 3 days, they sent me home. 2 weeks later, I started coughing them up again. I went back to the ER but was sent home again. I was taken off Xarelto and everything was fine. They put me back on Xarelto and then I started having nosebleeds with blood clots. I have never had nose bleeds in my life. I was put on Xarelto again and then once again taken off. Currently I am off the Xarelto, and I am having no issues. I went to a nose doctor who cauterized something. The most recent nosebleed I experienced was on May 9.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- CAT Blood tests Nothing unusual
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Rheumatoid Arthritis; TIA; thyroid nodule; A-fib; loop recorder implant
- Andere Medikamente
- Xarelto; Methotrexate; Folic Acid; Vitamin D; Zinc
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.07.2021
- Impfdatum
- 04.03.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Bell's palsy
Hypoaesthesia
Symptomtext
Numbness at base of skull; Bell's Palsy; Numbness on left side of tongue, went to jaw and cheek, travelled up left side of face, to back of head at the base of the skull; This is a spontaneous report from a contactable pharmacist via medical information team. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL9269), via an unspecified route of administration, administered in Arm Right on 04Mar2021 at 15:30 as a single dose for COVID-19 immunization. Medical history included osteoporosis. There were no concomitant medications. Reported that pharmacist was involved in administering the Pfizer COVID-19 vaccines at her work and due to the increase in concerns about Guillain-Barre syndrome developing with the Johnson and Johnson COVID-19 vaccine it prompted her to call Pfizer because she remembered 1 patient who was diagnosed with Guillain-Barre syndrome after receiving the second dose and she remembers 2 patients who developed Bell's Palsy after receiving their first doses of the Pfizer COVID-19 vaccines and they were not given the second doses due to these adverse events. She stated that she did report these events through the VAERS reporting system per their hospital protocol. These doses were given as outpatient. No history of previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect. No prior Vaccinations within 4 weeks of vaccinations. No AE(s) following prior vaccinations. On 04Mar2021, the patient experienced bell's palsy, numbness on left side of tongue, went to jaw and cheek, travelled up left side of face, to back of head at the base of the skull, on an unspecified date in Jun2021, the patient experienced numbness at base of skull. Term highlighted by the reporter for Bell's palsy, Numbness on left side of tongue, went to jaw and cheek, travelled up left side of face, to back of head at the base of the skull, Numbness at base of skull. Relatedness of drug to reaction(s)/event(s) assessed for Bell's palsy, Numbness on left side of tongue, went to jaw and cheek, travelled up left side of face, to back of head at the base of the skull, Numbness at base of skull by method of assessment as related. All reported events were medically significant. It was reported that the patient's symptoms started around 1600-1615 on the day of their vaccine, 04Mar2021. The patient did not seek medical attention so was never formally diagnosed. Experienced numbness starting on the left side of the tongue that went up to the jaw and cheek. The numbness travelled up the left side of their face to the back of their head at the base of their skull. These symptoms lasted for about 48 hours and they were recovered completely. About a month ago, in June, the patient experienced the same kind of numbness at the base of their skull. It lasted for a couple of hours and then was gone. No AE(s) require a visit to emergency Room and physician Office. The outcome of event (Bell's Palsy, Numbness on left side of tongue, went to jaw and cheek, travelled up left side of face, to back of head at the base of the skull) was recovered on an unspecified date in Mar2021 and the outcome of event (Numbness at base of skull) was recovered on an unspecified date in Jun2021.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events Bell's palsy and Hypoaesthesia due to close temporal relationship. The case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021895191 same reporter/drug/event, different patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Osteoporosis (Verbatim: Osteoporosis)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 09.02.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 119,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Atrial fibrillation
Biopsy
Pericarditis
Symptomtext
Pericarditis; a-fib; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9269) via an unspecified route of administration in the left arm on 09Feb2021 as single dose for Covid-19 immunization. Medical history included chronic lymphocytic leukemia, thyroid cancer, right lobe was removed. Concomitant medications included ibrutinib (IMBRUVICA) for chronic lymphocytic leukaemia, levothyroxine sodium (LEVOXYL) for thyroid cancer, vitamins. The patient previously received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283) in the left arm on 19Jan2021 for Covid-19 immunization, with 0.3mg on the card. On 08Jun2021, the patient developed atrial fibrillation and pericarditis. 4 months after the second COVID 19 vaccine, she developed pericarditis. Like the male guys get from the vaccine. She was just curious. The patient had heard that these can be side effects for young boys. She wanted to know if there's a report on atrial fibrillation and pericarditis for people belonging to her age group. At first they thought she had A-fib from one of her other pills, but they also had to pull 16oz bloody fluid off of her heart. They put her on pills for the A-fib. They think the A-Fib could be related to her other pill, but they couldn't figure out the fluid. The biopsy didn't answer the question. She was not on the medication that caused the A-fib anymore. That medication was Imbruvica for her CLL, Chronic lymphocytic leukemia. On that medication 5% of people can get A-fib. She was on it 2.5 years. Her Imbruvica was 140mg. She was no longer on it. She wanted to donate the ones she didn't use, but they wouldn't let her. Outcome of the event pericarditis was recovered in 2021, of the event a-fib was unknown. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- -
- Labordaten
- Test Name: biopsy; Result Unstructured Data: Test Result:unknown results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Chronic lymphocytic leukemia; Lobectomy (thyroid); Thyroid cancer
- Andere Medikamente
- IMBRUVICA; LEVOXYL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 18.07.2021
- Impfdatum
- 08.02.2021
- Beginn
- 16.02.2021
- Tage bis Beginn
- 8,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Stent placement
Thrombosis
Symptomtext
Blood Clot in Right Leg
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 1,0
- Labordaten
- Emergency room and emergency stint filter in artery.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Warfarin Atorvastatin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 18.07.2021
- Impfdatum
- 05.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Eyelid ptosis
Foreign body sensation in eyes
Headache
IIIrd nerve paralysis
Vision blurred
Symptomtext
Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- IIIrd nerve paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Heart attack; Stent placement (preventative for plaque build up in veins)
- Andere Medikamente
- SIMVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 18.07.2021
- Impfdatum
- 05.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Eyelid ptosis
Foreign body sensation in eyes
Headache
IIIrd nerve paralysis
Vision blurred
Symptomtext
Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- IIIrd nerve paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Heart attack; Stent placement (preventative for plaque build up in veins)
- Andere Medikamente
- SIMVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- XB
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 17.07.2021
- Impfdatum
- 05.02.2021
- Beginn
- 09.05.2021
- Tage bis Beginn
- 93,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Eye discharge
Eye pain
Eyelid ptosis
Facial paralysis
Lip disorder
Speech disorder
Symptomtext
02/05/2021 10:30 AM RECEIVED FIRST COVID19 PFIZER-BioNTech SHOT EL9269 AT HOSPITAL. 02/26/2021 10:30 AM RECEIVED SECOND COVID19 PFIZER SHOT EN6202 AT SAME FACILITY. 05/09/2021 07:00 AM WOKE UP IWTH RIGHTSIDE OF MY FACE PARALYZED; INCLUDING A DROOPY RIGHT EYE THAT WAS PAINFUL AND DROPPING FLUID, MY SPEECH WAS HEAVILY IMPAIRED AND MY LIPS LEANED TO THE LEFT... 05/09/2021 11:00 AM WENT TO ER AT THE HOSP., I WAS DIAG. WITH BELL'S PALSEY.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- I DO NOT RECALL WHAT TESTS, ETC. I WAS GIVEN AT THE HOSPITAL, OR AT MY DOCTORS OFFICE, IWHERE I WENT ON 05/11/2021. DOCTOR ORDERED ANTIBOTICS AND 100 MG ACYCLOVIR 2X DAY
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE, MILD, OCD.
- Andere Medikamente
- BISOPROLOL-HCTZ, LOSARTEN, VENLAFLAXIN
- Allergien
- PENICILLIN
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 16.07.2021
- Impfdatum
- 08.02.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 120,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Guillain-Barre syndrome
Laboratory test abnormal
Symptomtext
Guillain-Barre syndrome
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- 35,0
- Labordaten
- Multiple
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High Blood pressure, pre diabetic
- Andere Medikamente
- Glipiside 10mg, Synthroid 50mcg, Amlodipin 5mg, Bisopropol 2.5mg
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 09.07.2021
- Impfdatum
- 09.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Magnetic resonance imaging
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- MRI to rule out stroke
- Aktuelle Erkrankungen
- Gout Arthritis
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 09.07.2021
- Impfdatum
- 09.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 7,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Magnetic resonance imaging
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- MRI to rule out stroke
- Aktuelle Erkrankungen
- Gout Arthritis
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 05.07.2021
- Impfdatum
- 02.02.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 53,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anovulatory cycle
Blood follicle stimulating hormone
Decidual cast
Heavy menstrual bleeding
Hormone level abnormal
Menstruation irregular
Progesterone
Thrombosis
Symptomtext
Within one month I began missing my period. I was regular to the exact day each month prior to the vaccination. I also stopped ovulating and my hormone levels were off. The following month I had a period that wouldn't stop. I starting taking birth control again to reset my cycle. This was my first period on the pill and I shed an entire uterine cast along with seven plus days of heavy bleeding with clotting. Its would not stop so I had to double my doses of birth control for over three days to make it slow down.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- 4/8/21- progesterone- <0.2 meaning irregular ovulation 4/8/21- fsh serum- 3.4
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma that is controlled Previous pregnancy induced high blood pressure that is controlled
- Andere Medikamente
- Zoloft Claritin Singulair Pulmicort flexhaler Vitamins BCD and iron Omeperazol Labetalol
- Allergien
- Ibuprofen Pennecillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 11.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Dysphagia
Intensive care
Swelling face
Swollen tongue
Symptomtext
I had difficulty swallowing my saliva, and notes asymmetric left sided tongue swelling, swelling of the left cheek. I have never had similar symptoms in the past. I have no dyspnea, fever, chills. I was admitted to ER then transferred to ICU, doctors gave me some steroids and anti-histamine treatment. After around 5 hours my swellings were all gone. But doctors kept me in hospital for several days for safety and discharged me after 5 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Lupus; nasal septal deviation; kidney stone
- Vorgeschichte
- lupus
- Andere Medikamente
- Plaquenil, folic acid
- Allergien
- Pollen, mites
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 23.06.2021
- Impfdatum
- 03.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Angiogram cerebral
Blood test
Computerised tomogram head abnormal
Gait inability
Headache
Intensive care
Magnetic resonance imaging head
Subarachnoid haemorrhage
Symptomtext
Subarachnoid hemorrhage - bleed day 5/24 - rushed to ER and was seen immediately on first CAT scan. Admitted to Neuro ICU for 14 days. Then transferred to rehabilitation hospital and is now going to outpatient PT. Symptoms were extreme headache and then inability to walk. Rushed to ER via ambulance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 24,0
- Labordaten
- CAT scans, MRIs, angiograms (2 of 3 completed so far), daily bloodwork in ICU.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Suffered spinal cord injury in 2000 - no health issues resulted
- Andere Medikamente
- Baclofen
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 16.06.2021
- Impfdatum
- 05.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Bronchoscopy
Cardiac failure
Catheterisation cardiac
Computerised tomogram
Echocardiogram
Fall
Loss of consciousness
Magnetic resonance imaging
Pneumonia
X-ray
Symptomtext
January 26, given clean bill of health by cardiologist heart was functioning well; February 5, COVID-19 Shot; Feb 9 -- fell and broke left humerus neck, no real treatment except for sling; Various dates during February and March, passed out when standing up, no treatment; March 22nd, admitted to a Medical Center with Heart failure and Pneumonia, treatment antibiotics, diuretics, released on March 31 with prescriptions for beta blockers, diuretics and potassium; April 4, passed out again, EMT read my BP as 41 systolic, readmitted to hospital, fluids added. Discharged April 6th. Advised to use caution when moving around, limit fluids, take beta blocker and potassium.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 10,0
- Labordaten
- March 22 - March 31 -- Since I was hospitalized for more than 10 days, there were numerous tests done including an echocardiogram and cardiac catheterization, bronchoscopy, Xrays, MRIs CT Scans, Blood tests several times a day.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- COPD, Diabetes Type 2
- Andere Medikamente
- Ceterizine 10mg; Fluoxetine 40mg; Fosamax 40mg;metformin 500mg; Mucinex DM 30mg-300mg;omeprazole 20mg; simvastatin 20 mg; symbicort 160 mg; trospium 20 mg
- Allergien
- Augmentin; Lamictal; Wellbutrin; Tussionex; Procaine; Benzocaine; Sulfa
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 14.06.2021
- Impfdatum
- 07.02.2021
- Beginn
- 04.06.2021
- Tage bis Beginn
- 117,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arteriogram coronary normal
Back pain
Chest pain
Electrocardiogram ST segment elevation
Electrocardiogram abnormal
Myocarditis
Pain in extremity
Palpitations
Troponin increased
Symptomtext
Left arm, back, chest pain, heart palpitations starting on Friday, June 4th. ED visit and testing showed normal EKG, labs. Discharged home. Returned to ER on Sunday, June 6th. EKG showed ST elevation. Transferred to ED. Positive troponin, admitted to hospital with suspected perimyocardits with intent to rule out heart attack.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 1,0
- Labordaten
- 6/4 - negative EKG, Troponins 6/6 - EKG positive for ST elevation, positive troponin 6/6 Repeat EKG, troponins - still irregular 6/7 Angio gram - ruled out heart attack/blockages 6/7 discharged home with Colchicine.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Multivitamins, Omega 3s, Turmeric, probiotics, collagen
- Allergien
- B12 injections
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 11.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 05.06.2021
- Tage bis Beginn
- 98,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Guillain-Barre syndrome
Symptomtext
G61.0 - Guillain-Barre syndrome
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 09.06.2021
- Impfdatum
- 04.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 25,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Mesenteric vein thrombosis
SARS-CoV-2 test
Symptomtext
SMV thrombosis; This is a spontaneous report from a contactable healthcare professional (patient). This 48-years-old non-pregnant female patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, in right arm, on 04Feb2021 at 09:45 (lot EL9269), at 48 years of age, for COVID-19 immunization. The first dose of BNT162B2 vaccine was administered on 14Jan2021 at 09:45 (at 48 years of age), lot: EL3248 intramuscular, in right arm. Medical history included GERD, hiatal hernia and Hasimotos dx. Prior to vaccination, the patient was not diagnosed with COVID-19. Past drug history included clarithromycin (BIAXIN). Concomitant medication included esompeprazole (NEXIUM). On 01Mar2021 the patient experienced GI/epigastric pain, back pain, abdominal pain. She was diagnosed SMV thrombosis. The events required Emergency room/department or urgent care, Doctor or other healthcare professional office/clinic visit, hospitalization for 3 days and treatment with heparin. The events were reported as serious also as life-threatening and per disability. The events were resolving at the time of report. On 07Apr2021 the patient underwent COVID-19 test with negative result.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event mesenteric vein thrombosis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mesenteric vein thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 20210407; Test Name: COVID-19 test; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: GERD; Hashimoto's disease; Hiatal hernia
- Andere Medikamente
- NEXIUM [ESOMEPRAZOLE MAGNESIUM]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 27.05.2021
- Impfdatum
- 02.02.2021
- Beginn
- 02.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Computerised tomogram thorax
Dry eye
Dyspnoea
Ear pain
Hepatic steatosis
Hilar lymphadenopathy
Hypoaesthesia
Nodule
Oropharyngeal discomfort
Pruritus
Symptomtext
Patient presented to her primary care provider on 2/11/2021 with right ear pain, numbness on right side of face and head, full feeling on right side of throat and right eye dryness. Patient had received 2nd dose of Pfizer COVID19 vaccine on 2/2/2021 and started feeling itchy from head to tow that lasted 24 hours. Was diagnosed with Bell's Palsy at this visit. She then presented to the Emergency Department on 2/13/2021 with shortness of breath.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- CT scan of chest with IV contrast on 2/13/2021: 1. No evidence of pulmonary embolus or acute infiltrate. 2. Pathologic mediastinal and right hilar lymph nodes with multiple noncalcified nodules within the right upper lobe measuring up to 1.1 cm. PET/CT follow-up recommended. Metastatic disease or primary malignancy considered in the differential. Micronodule also present right lower lobe 0.3 cm as well as pleural-based density 0.7 cm as stated above. 3. Fatty infiltration of the liver as well as at least borderline splenomegaly.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Anxiety, depression, obsessive-compulsive disorder, GERD
- Andere Medikamente
- Alprazolam, bupropion, omeprazole, sertraline.
- Allergien
- Clonazepam (rash)
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 19.05.2021
- Impfdatum
- 10.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Consciousness fluctuating
Headache
Metabolic encephalopathy
Psychogenic seizure
Seizure
Seizure like phenomena
Vitamin B1 deficiency
Symptomtext
Following her covid vaccine patient presented to the observation area where she reported a headache. Within minutes she was in and out of consciousness with seizure like activity. Vital signs were stable, however her O2 sat was at 86%. Patient was transferred to the ED & admitted to the hospital. Admitted to the hospital. Patient with history of migraines and seizures. Evaluated inpatient for possible vaccine reaction vs. seizure vs. psychogenic seizures vs. AMS related to metabolic encephalopathy vs. B1 deficiency.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Psychogenic seizure
- Hospital-Tage
- 20,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- M
- Eingang
- 15.05.2021
- Impfdatum
- 14.02.2021
- Beginn
- 18.03.2021
- Tage bis Beginn
- 32,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Peripheral swelling
Subclavian vein thrombosis
Ultrasound Doppler
Symptomtext
Acute Deep Vein Thrombosis of the Right Subclavian Vein; Swelling of his right arm; This is a spontaneous report received from a contactable Physician. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via intramuscular, administered in right arm on 14Feb2021 (Lot Number: el9269) at single dose for COVID-19 immunization in workplace clinic. Medical history included hypertension, hyperlipidemia, lyme, osteoarthritis. There was no known allergies. Concomitant medications included lisinopril; pravastatin; pantoprazole sodium sesquihydrate (PROTONIX). It was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 via intramuscular, administered in left arm on 24Jan2021 (Lot Number: en5318) at single dose for COVID-19 immunization. The patient evaluated in the emergency room on 18Mar2021 for swelling of his right arm. Patient had a venous doppler right ext, which showed acute deep vein thrombosis of the right subclavian vein. The events result in doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care, and serious for life threatening illness. Treatment for the events included rivaroxaban (XARELTO) and referral to hematologist. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not resolved.; Sender's Comments: Based on the information currently available, causality between reported events Subclavian vein thrombosis and Peripheral swelling and BNT162B2 vaccine cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Subclavian vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210318; Test Name: venous Doppler right ext.; Result Unstructured Data: Test Result:Acute Deep Vein Thrombosis; Comments: Acute Deep Vein Thrombosis of the Right Subclavian Vein
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hyperlipidemia (other medical history: htn, hyperlipidemia, lyme, osteoarthritis); Hypertension (other medical history: htn, hyperlipidemia, lyme, osteoarthritis); Lyme disease (other medical history: htn, hyperlipidemia, lyme, osteoarthritis); Osteoarthritis (other medical history: htn, hyperlipidemia, lyme, osteoarthritis)
- Andere Medikamente
- LISINOPRIL; PRAVASTATIN; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 14.05.2021
- Impfdatum
- 02.03.2021
- Beginn
- 24.04.2021
- Tage bis Beginn
- 53,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Blood test normal
Computerised tomogram normal
Electrocardiogram normal
Laboratory test abnormal
Body height
Ear pain
Oral herpes
Stress
Weight
Symptomtext
fever blisters; ear ache; stress; 2nd dose of the Pfizer Covid vaccine on 02Mar2021 and on 24Apr2021 she went to the emergency room with Bell's Palsy; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A currently 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 02Mar2021 16:00 (also reported as 16:30) (Batch/Lot Number: Unknown) as 2nd dose, single dose (at the age of 66-years-old) for COVID-19 immunisation. Medical history included bell's palsy from 07Jan2015; and an unspecified risk factor. The patient had no concomitant medications. The patient did not have any prior vaccinations within 4 weeks. The patient did not have family medical history that was relevant to adverse events and no relevant tests were done. The patient previously took shingles vaccine (Merck) that started with the letter 'Z' and had Bell's Palsy in Jan2015 which was exactly 6 weeks after she got a shingles vaccine; tetanus vaccines 10 years ago as a booster and experienced severe swelling on her arm, swelling in her body; Quadravalent flu vaccine and never had a reaction to the flu vaccines; and the first dose of BNT162B2 (reported as 'Pfizer COVID') for COVID-19 immunisation on 02Feb2021 in the left arm. On 24Apr2021, the patient experienced bell's palsy. On unspecified dates, the patient experienced fever blisters, ear ache and stress. The events were reported as follows: Her HCP should have the information on the shingles vaccine she got in 2015. When she had bell's palsy the 1st time in 2015, she had to go to the hospital for a day and a half to rule out everything and the best they found was that she had herpes simplex based on the blood work done at that time and it was what her HCP believed it was at that because it showed she had some kind of virus but neither time she had bell's palsy did she have seizure or other symptoms other than the ear ache she had this time. The patient got the second dose of the vaccine on 02Mar2021 and on 24Apr2021 she went to the emergency room with Bell's palsy. She can talk better when she holds her mouth. She was out of town when she noticed the symptoms of bell's palsy the night before on 24Apr2021 and when she got home she then went to the emergency room on 25Apr2021; she could tell something was happening again and it was noticeable and she had an ear ache the day before and her face was drooping. The HCPs swear there was no correlation between the vaccine and bell's palsy but she found this very coincidental. The patient stated that she would rather get bell's palsy again than get covid. For treatment, the only thing she has done was to call the HCP to schedule the follow-up visit as directed by the emergency room (ER) HCP; she went to the ER to rule out stroke and they did rule out stroke; states the only other thing she can think of is that she had quite a bit of stress because they put down her dog on Sunday and other than that she had an ear ache at her granddaughter's track meet on the day before on 24Apr2021 and the emergency room visit was on 25Apr2021. She has had recurrent fever blisters and her HCP has given her a prescription for Valcyclovir and she takes that at the onset of fever blisters and where she gets the fever blisters is constantly on the previous side where she had bell's palsy and was in the same spot on her left side of her lip. States the Valcyclovir she has was one gram tablets and she takes one when she has a fever blister and one 12 hours later; states she has two prescriptions for the Valcyclovir and they are in orange pharmacy bottles with no lot numbers, expiry dates and NDC numbers and the other prescription for Valcyclovir is also 1 gram and she takes it three times per day now after this outbreak. The patient required a visit to the ER or medical doctor office. The outcome of the events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Test Name: HEIGHT; Result Unstructured Data: Test Result:157; Test Name: WEIGHT; Result Unstructured Data: Test Result:113.4
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Bell's palsy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 13.05.2021
- Impfdatum
- 28.02.2021
- Beginn
- 26.04.2021
- Tage bis Beginn
- 57,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anticoagulant therapy
Blood test
Chest X-ray
Chest pain
Computerised tomogram
Echocardiogram
Pulmonary thrombosis
Thrombosis
Symptomtext
Patient stated she developed clots during hospital admission with the complaint of chest pain. Patient stated at hospital admission, they discovered blood clot in her right leg and right lung. Patient was treated with oxygen and medication. Patient was inpatient for two nights and sent home lovenox injections for one week and continuing with Eliquis. Patient is currently on Eliquis for unknown duration. Patient will see cardiologist in three weeks and reevaluate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary thrombosis
- Hospital-Tage
- 2,0
- Labordaten
- Patient got CT, ECHO cardiogram, blood work, Chest X-ray, and CAT scan on on 4/26/2021 and 4/27/2021.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension Anemia
- Andere Medikamente
- Lisinopril 10mg, hydrochlorothiazide 25mg, Restasis for eye, Vitamin B12 2000mcg, Iron 29mg
- Allergien
- No known drug allergies
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 12.05.2021
- Impfdatum
- 10.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acquired diaphragmatic eventration
Angiogram pulmonary abnormal
Aortic arteriosclerosis
Arthropathy
Blood calcium decreased
Blood chloride normal
Blood creatinine normal
Blood potassium normal
Blood sodium decreased
Blood urea normal
Condition aggravated
Convalescent plasma transfusion
Cough
Dyspnoea
Echocardiogram
COVID-19
COVID-19 pneumonia
Carbon dioxide normal
Symptomtext
COUGH AND GENERALLY NOT FEELING WELL, FATIGUE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary oedema
- Hospital-Tage
- 5,0
- Labordaten
- ED to Hosp-Admission, Discharged 2/23/2021 - 2/28/2021 (5 days), Hospital, MD, Last attending; Treatment team Discharge Summary, MD (Physician), Inpatient Discharge Summary; Brief Overview, Admitting Provider: MD, Discharge Provider: MD, Primary Care Physician at Discharge: Admission Date: 2/23/2021, Discharge Date: 2/28/2021; Active Problems: Hypoxia, COVID-19, Pneumonia due to COVID-19 virus, Active Issues Requiring Follow-up, COVID-19 pneumonia Details of Hospital Stay; Presenting Problem/History of Present Illness/Reason for Admission, COVID-19 [U07.1] Hospital Course; This is a 89-year-old lady with a history of pancreatic cancer, diabetes mellitus, hypertension, chronic atrial fibrillation on anticoagulation with Eliquis who came to Hospital emergency department with worsening shortness of breath. She was admitted for work-up and found to have COVID-19 pneumonia. She was treated with 2 units of convalescent plasma, 5-day course of IV Remdesivir and Dexamethasone which she needs to continue for 4 more days to finish 10-day course. She was hypoxic and requiring oxygen. Did a home oxygen evaluation she need 2 L at rest and 5 L with exertion. On day of discharge she denies any shortness of breath at rest. Has occasional cough. Denies any chest pain/palpitation. Denies any nausea vomiting or abdominal pain. Afebrile. No other new symptoms or acute event as per nursing staff Operative Procedures Performed; Consults: Pertinent Test Results: Results from last 7 days, Lab Units 02/26/21, 0526 SODIUM, mmol/L, 135, POTASSIUM, mmol/L 4.1, CHLORIDE mmol/L, 99, CO2, mmol/L, 27, BUN, mg/dL, 19, CREATININE, mg/dL, 0.58*, CALCIUM, mg/dL, 8.2*, Results from last 7 days, Lab, Units 02/26/21, 0526, WBC AUTO,K/mcL, 6.3, HEMOGLOBIN, g/dL, 9.5*, HEMATOCRIT, %, 28.2*, PLATELETS, K/mcL, 254, X-ray Chest 1 View, Result Date: 2/23/2021, XR CHEST 1 VW PORT IMPRESSION: Worsening mild bilateral interstitial opacities compared with 2/19/2021. Constellation of findings consistent with developing bilateral pneumonia versus pulmonary edema. Recommend clinical correlation. END OF IMPRESSION: INDICATION: shortness of breath, Covid. TECHNIQUE: AP portable projection of the chest is acquired. COMPARISON: 2/19/2021, 10/30/2020 FINDINGS: Mild diffuse interstitial opacities throughout both lungs, increased compared with 2/19/2021 and new compared with October 30, 2020. Heart, mediastinal, pleural space and normal limits. Stable moderate scoliosis in the spine. Degenerative changes also noted about the right shoulder. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View - Portable, Result Date: 2/19/2021, XR CHEST 1 VW PORT IMPRESSION: Right infrahilar opacity, likely representing prominent vessels and crowding of lung markings due to right hemidiaphragm elevation, however less likely could represent atelectasis or airspace consolidation. Consider follow-up imaging as clinically directed. END OF IMPRESSION: INDICATION: COVID, hypoxia, fatigue. TECHNIQUE: AP upright portable projection of the chest is acquired. COMPARISON: Chest radiograph performed on October 30, 2020. FINDINGS: Elevation of right hemidiaphragm is noted. There is prominence of bilateral interstitial markings. There is a right infrahilar opacity, similar in location to prominent vessels noted on the October 9, 2020 radiographs, however more prominent. No pleural effusion or pneumothorax identified. Cardiomegaly is noted. There is calcification of the aortic arch. Severe narrowing of the right Acromiohumeral interval, suggestive of right rotator cuff pathology. Bilateral shoulder degenerative arthropathic is noted. Multilevel thoracic spondylosis and Dextroconvex curvature is noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ed Ultrasound Cardiac Limited, Result Date: 2/19/2021 This focused, bedside examination was performed in the Emergency Department during the patient's emergency visit. Please see the Medical Record for the interpretation of this procedure by the Physician. Ed Ultrasound Pulmonary, Result Date: 2/19/2021,This focused, bedside examination was performed in the Emergency Department during the patient's emergency visit. Please see the Medical Record for the interpretation of this procedure by the Physician. Ct Angiogram Chest Pulmonary Embolism With And Without Contrast; Result Date: 2/23/2021, CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: 1. Examination is negative for pulmonary carol embolism. 2. Diffuse bilateral Covid 19 pneumonia. This involves approximately 50% of the underlying lung parenchyma. Pulmonary Artery Embolism: None. Cardiomegaly: None. END OF IMPRESSION: INDICATION: Covid 19 positive, shortness of breath, concern for pulmonary arterial embolism. Assess for pulmonary artery embolism. TECHNIQUE: Multidetector CT scan chest is performed per pulmonary embolism protocol, after IV contrast administration, using 2.0 mm intervals reconstructed in axial plane. Coronal and sagittal reformatted images are also obtained. Post processing 3-dimensional volume rendered views are created at an independent workstation, under concurrent supervision, and subsequently sent to the PACS system. CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. COMPARISON: Chest x-ray from earlier today. Chest CT from December 8, 2020 FINDINGS: On soft tissue windows, there is adequate contrast opacification of the pulmonary arterial system. Mean Hounsfield units over the main pulmonary artery measure 368. This is best seen on axial series 402, image 56. There is no convincing evidence of an intraluminal filling defect. There is no pulmonary arterial embolism demonstrated. There is no thoracic aortic aneurysm. There is no thoracic aortic dissection. There is no mediastinal hemorrhage. Moderate ASCVD. Calcified plaque involving the thoracic aorta and coronary arteries. Post processing 3-dimensional volume rendered views best demonstrates the degree of calcified plaque. There is no axillary, internal mammary, mediastinal, hilar adenopathy. There is no pericardial effusion. There is no pleural effusion. Limited images to the upper abdomen demonstrates no suspicious abnormalities. On lung windows, there are groundglass parenchymal opacities most pronounced peripherally. This involves approximately 50% of the underlying lung parenchyma. This is consistent with diffuse bilateral Covid 19 pneumonia. Central airways are patent. There are no endobronchial lesions. On bone windows, scoliosis and degenerative change. No suspicious lytic or blastic lesion. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Physical Exam at Discharge, Heart Rate: 81, Resp: 17, BP: 127/74, Temperature: 36.3 ?C (97.4 ?F),= Weight: 59.2 kg (130 lb. 8.2 oz.) Physical Exam; GENERAL: The patient is awake, alert and not in any acute distress. Sitting comfortably in recliner, HEENT: Mucous membranes moist. Eyes: Extraocular movements are intact, NECK: Supple. CHEST: Clear to auscultation bilaterally. Equal expansion, equal air entry. CARDIAC: Normal S1, S2, no audible murmur. ABDOMEN: Soft, non-tender, non-distended and active bowel sounds. EXTREMITIES: No pedal edema, no calf swelling/tenderness. Skin: Warm to touch. Psychiatry: Mood is stable
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Nervous Carpal tunnel syndrome, bilateral Cervical radiculopathy Diabetic peripheral neuropathy (CMS/HCC) Lumbar radiculopathy Basal cell carcinoma (BCC) of helix Respiratory Asthma, intermittent Hypoxia Pneumonia due to COVID-19 virus Circulatory Angiodysplasia of colon Atrial fibrillation (CMS/HCC) Cardiomyopathy (CMS/HCC) Congenital arteriovenous fistula Hypertension Venous insufficiency of both lower extremities Digestive Adenomatous polyp of stomach Diverticulosis Malignant neoplasm of body of pancreas (CMS/HCC) Musculoskeletal Primary osteoarthritis involving multiple joints Squamous cell carcinoma in situ of skin Basal cell carcinoma of anterior chest Basal cell carcinoma of upper extremity Superficial basal cell carcinoma Rosacea Endocrine/Metabolic Hypothyroidism Type 2 diabetes mellitus (CMS/HCC) Mixed hyperlipidemia Hyponatremia Infectious/Inflammatory COVID-19
- Andere Medikamente
- amLODIPine (NORVASC) 5 mg tablet apixaban (ELIQUIS) 5 mg tablet betamethasone valerate (VALISONE) 0.1 % cream blood sugar diagnostic (glucose blood) strip diclofenac sodium (VOLTAREN GEL) 1 % gel(Expired) digoxin (LANOXIN) 250 mcg (0.25 mg)
- Allergien
- Allergies MetoprololShortness of breath / Dyspnea Diltiazem HclRash DiltiazemRash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 12.05.2021
- Impfdatum
- 02.03.2021
- Beginn
- 05.05.2021
- Tage bis Beginn
- 64,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Seizure
Symptomtext
R56.9 - New onset seizure (CMS/HCC) R56.9 - Unspecified convulsions N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 29.04.2021
- Impfdatum
- 11.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Hospitalisation
Hypoxia
Pyrexia
Symptomtext
Patient presented to the ED and subsequently hospitalized on 2/18/2021 with fever. Again she presented to the ED and subsequently hospitalized on 2/24/2021 with hypoxia. These visits were within 6 weeks of receiving COVID vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hospitalisation
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 29.04.2021
- Impfdatum
- 12.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
SARS-CoV-2 test
Thrombosis
Symptomtext
left leg deepvein thrombosis; blood clot; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9269), via an unspecified route of administration, administered in Arm Right on 12Feb2021 19:30 (7:30 pm) as single dose for COVID-19 immunization in a hospital. Medical history included high blood pressure and high cholesterol both from an unknown date. No known allergies. The patient took an unspecified medication. No other vaccines in four weeks. No COVID-19 prior to vaccination. The patient received the first dose of bnt162b2 (lot number: EL9261) on 22Jan2021 07:15 am on the right arm for COVID-19 immunization. On 25Feb2021 21:00 (9:00 pm), the patient experienced left leg deep vein thrombosis and blood clot which required a visit to the emergency room and subsequent hospital admission. The patient was given Eliquis as treatment. The patient was tested for COVID-19 post vaccination via nasal swab on 08Apr2021 with a negative result. The outcome of the events was reported as recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210408; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high; High cholesterol
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 15.04.2021
- Beginn
- 15.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Off label use
Product use issue
Thrombosis
Symptomtext
Blood Clots both legs; had other vaccine same date at 2nd dose in the left arm; had other vaccine same date at 2nd dose in the left arm; This is a spontaneous report from a contactable Consumer (patient). A 69-year-old male patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9269) via an unspecified route of administration in the left arm on 15Apr2021 12:00 PM at single dose for COVID-19 immunization. Medical history was unknown. The patient had no known allergies. The patient had no covid prior vaccination, no covid tested post vaccination. The patient had no other vaccine in four weeks or other medications in two weeks. Concomitant medications were none. The patient had other vaccine same date at 2nd dose in the left arm. The patient experienced blood clots both legs on 15Apr2021 12:15 PM. The patient had extensive dvt IVC and both legs as treatment for event. Outcome of the event blood clots both legs was not recovered. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (duration: 5 days), Life threatening illness (immediate risk of death from the event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.04.2021
- Impfdatum
- 06.03.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Angiogram
Anion gap increased
Atelectasis
Bacteraemia
Blood bilirubin increased
Blood creatinine increased
Blood lactic acid normal
Blood sodium decreased
Cardiomegaly
Chest X-ray abnormal
Computerised tomogram abnormal
Diarrhoea
Dyspnoea
Effusion
Electrocardiogram normal
Essential hypertension
Gastroenteritis Escherichia coli
Symptomtext
3/8/21 ED: c/c of SOB x 2 days. Pt c/o diarrhea. Pt states that she received the 2nd pfizer vaccine 2 days ago. O2 at triage was 96% on RA. She was seen in this facility Saturday 3/6/21 for HA. CTA and labs unremarkable. She reports persistent HA, though improved when compared to Saturday. Reports multiple episodes of NB diarrhea. No other medications or treatments tried. In the ER she was seen to have a significant leukocytosis with wbc in 26, AKi with SCr in 2.7, thombocytopenia. Ordered CT scan which showed congestion and LLL pna and trace effusion. ID, Cardiology and Nephrology consulted. Treated for acute kidney injury with hyposmolar hyponatremia, on tolvactam, Sodium 133, trending up. Treated for sepsis with gram negative bacteremia d/t e.coli, completed ceftriaxone course. Treated for essential hypertension, elevated troponin, BP now controlled. Discharged home on 3/17/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary oedema
- Hospital-Tage
- 9,0
- Labordaten
- ED 3/8/21 Physical Exam: BP 117/60 | Pulse 103 | Temp 97.9 ?F (36.6 ?C) (Oral) | Resp 18 | Ht 5' 7" (1.702 m) | Wt 134 lb (60.8 kg) | LMP (LMP Unknown) | SpO2 96% | BMI 20.99 kg/m?. Diagnostic evaluation- laboratory and radiologic studies- was significant for: negative SARS-CoV-2 RN, labs reviewed, wbc 26, lactic 3.2, Na 128, Cr 2.71, total Bili 1.77, anion 17.2, platelets 98, trop .458, ekg no ischemic changes, CXR - BORDERLINE ENLARGED CARDIAC SILHOUETTE. MILD INTERSTITIAL EDEMA AND ATELECTASIS/CONSOLIDATION AT THE LUNG BASES. NO SIGNIFICANT PLEURAL EFFUSIONS.
- Aktuelle Erkrankungen
- 3/6/21 ED visit complaining of severe headache, similar to previous shingles episodes.
- Vorgeschichte
- Aneurysm, anxiety, malignant neoplasm of upper-outer quadrant of right breast, estrogen receptor positive, hypertension
- Andere Medikamente
- Unknown
- Allergien
- No known drug allergies
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 08.02.2021
- Beginn
- 29.03.2021
- Tage bis Beginn
- 49,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Condition aggravated
Facial paralysis
Symptomtext
Bell's palsy. Developed L facial droop on 3/29/2021; COVID vaccines on 1/16/2021 and 2/8/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- 2,0
- Labordaten
- Was kept overnight in the hospital to evaluate for stroke. Stroke was ultimately ruled out and she was diagnosed with Bell's palsy.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- sleep apnea, depression, hypertension, chronic pain, history of Bell's palsy
- Andere Medikamente
- Effexor, trazodone, Maxzide, gabapentin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 13.04.2021
- Beginn
- 13.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Confusional state
Dizziness
Hyperhidrosis
Loss of consciousness
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: pt was dizzy and light headed after vaccine and lost conciousness for a couple of seconds. she was sweaty and a little confused for a couple of seconds. she ate and drank something after and was feeling better and we phoned 911 to check her out. she was released and doing much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 06.04.2021
- Impfdatum
- 09.03.2021
- Beginn
- 20.03.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Angiogram cerebral abnormal
Arteriogram carotid abnormal
Bell's palsy
Computerised tomogram head normal
Dysarthria
Eyelid ptosis
Facial paralysis
Glycosylated haemoglobin
Laboratory test normal
Lipids
Magnetic resonance imaging head normal
Neurological symptom
Vertebral artery arteriosclerosis
Vertebral artery stenosis
Symptomtext
DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Stroke-like symptoms [R29.90] HOSPITAL COURSE: A 63 y.o. male who presented with chief complaint of left facial droop, left forehead droop and slurred speech. Patient reports his symptoms started on Saturday and failed to improve. He contacted his PCP and he was recommended to go to the ER for evaluation. Patient had his COVID-19 vaccine-1st dose 2 weeks prior and was concerned that he might be having 1 of the rare side effects from the vaccine. On admission patient had normal vitals. His labs were within normal limits. Patient's presentation was discussed with Neurology who recommended admission for stroke workup given his comorbidities-hypertension, hyperlipidemia, diabetes and obesity. Patient received 1 dose of prednisone 80 mg in the emergency department for treatment of Bell's palsy (patient's symptoms more consistent with Bell's palsy presentation). Patient was admitted to medicine service for workup of stroke with MRI brain without contrast and monitoring for any worsening of neurological symptoms. Patient's CT head on admission was negative for any acute abnormality. CTA head and neck showed near occlusion of intracranial left vertebral artery. MRI brain without contrast was negative for acute infarct. Patient's facial paralysis slightly improved with 1 dose of 80 mg prednisone. Patient's presentation was consistent with Bell's palsy. Patient worked with PT OT and speech therapy and was recommended outpatient physical therapy and speech therapy. He was discharged home in stable condition on oral prednisone 80 mg daily for 7 days and valacyclovir 1000 mg 3 times a day for 7 days. Patient was recommended to follow-up with Ophthalmology as outpatient for possible left eye patch if his symptoms fail to improve. Patient's Lipitor dose was increased to 40 mg daily from 10 mg daily due to finding of atherosclerotic changes on CT head and neck. Active Issues Requiring Follow-up Issue: Bell's palsy and abnormal finding on CT head and neck. Recommended follow-up provider/specialty: PCP What is needed: 1. Referral to Ophthalmology for an eye patch if symptoms fail to improve. 2. Referral to neurovascular surgery for CT head and neck findings. 63-year-old male with history of hypertension, hyperlipidemia and diabetes mellitus admitted for workup of stroke-like symptoms. * Stroke-like symptoms Assessment & Plan Patient presented with left-sided facial droop, left forehead droop and slurred speech. - CT head on admission showed no acute intracranial process. - CTA head and Neck shows near occlusion of intracranial left vertebral artery. Patient reports his symptoms started 3 days ago. Patient's presentation appears similar to Bell's palsy. He received 80 mg of prednisone in the emergency department. Patient's symptoms were discussed with stroke Neurology who recommended MRI brain without contrast to rule out possible stroke given his underlying comorbidities-hypertension, hyperlipidemia and obesity. Plan: - will obtain MRI brain w/o contrast. - Check A1c and Lipid profile - continue Aspirin and statin. - monitor on tele - Neurochecks q4h Bell's palsy Assessment & Plan Patient has loss of left forehead wrinkles, left eyelid droop, droop of his left corner of the mouth. Patient's presentation more consistent with Bell's palsy. Patient reports that he had COVID 19 vaccine 2 weeks prior to developing symptoms and read it as one of the rare side effects online. Patient received one dose of Prednisone 80 mg in the ED. Will continue with Prednisone taper until MRI results are back. SLP ordered. Patient advised on following with ophthalmology for eye patch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- 2,0
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- TIIDM, hypertension, osteoarthritis, proteinuria, hyperlipidemia, s/p right hip replacement, venous insufficiency,
- Andere Medikamente
- amLODIPine, amoxicillin PRN, ascorbic acid, atorvastatin, hydroCHLOROthiazide, insulin glargine, lisinopril, metFORMIN, naproxen, vitamin D, vitamin E, zine acetate
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 02.04.2021
- Impfdatum
- 09.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anaphylactic reaction
Chest discomfort
Dyspnoea
Pruritus
Rash
Hypersensitivity
Symptomtext
Shortness of breath; allergic reaction; Rash on arms, neck, chest, hands.; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received first dose of bnt162b2 (Lot number: EL3249; solution for injection), via an unspecified route of administration in left arm on 21Jan2021 at 11:30 AM at a single dose and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9269), via an unspecified route of administration in left arm on 09Feb2021 at 01:45 PM at a single dose, for COVID-19 immunisation. The patient's medical history included asthma and hypertension. Concomitant medication included montelukast sodium (SINGULAIR), ammonium chloride, diphenhydramine hydrochloride, menthol, sodium citrate, sulfogaiacol (BENACOL EXPECTORANT), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA). The patient was not diagnosed with COVID-19 prior to vaccination. On 12Feb2021 at 06:30 PM (52 hours after second dose of bnt162b2), the patient experienced allergic reaction, rash on arms, neck, chest, hands and shortness of breath. The patient received diphenhydramine (BENADRYL) and albuterol as treatment for the events. The outcome of the events was recovered on an unspecified date. It was also reported that post vaccination, the patient had not been tested for COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma; Hypertension; Penicillin allergy
- Andere Medikamente
- SINGULAIR; BENACOL EXPECTORANT; BREO ELLIPTA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 02.04.2021
- Impfdatum
- 09.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anaphylactic reaction
Chest discomfort
Dyspnoea
Pruritus
Rash
Hypersensitivity
Symptomtext
Shortness of breath; allergic reaction; Rash on arms, neck, chest, hands.; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received first dose of bnt162b2 (Lot number: EL3249; solution for injection), via an unspecified route of administration in left arm on 21Jan2021 at 11:30 AM at a single dose and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9269), via an unspecified route of administration in left arm on 09Feb2021 at 01:45 PM at a single dose, for COVID-19 immunisation. The patient's medical history included asthma and hypertension. Concomitant medication included montelukast sodium (SINGULAIR), ammonium chloride, diphenhydramine hydrochloride, menthol, sodium citrate, sulfogaiacol (BENACOL EXPECTORANT), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA). The patient was not diagnosed with COVID-19 prior to vaccination. On 12Feb2021 at 06:30 PM (52 hours after second dose of bnt162b2), the patient experienced allergic reaction, rash on arms, neck, chest, hands and shortness of breath. The patient received diphenhydramine (BENADRYL) and albuterol as treatment for the events. The outcome of the events was recovered on an unspecified date. It was also reported that post vaccination, the patient had not been tested for COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma; Hypertension; Penicillin allergy
- Andere Medikamente
- SINGULAIR; BENACOL EXPECTORANT; BREO ELLIPTA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 09.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Phlebitis
Thrombosis
Ultrasound scan
Symptomtext
phlebitis in my Right leg; small blood clot; This is a spontaneous report from a contactable nurse (patient). A 66-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 09Feb2021 (Batch/Lot Number: EL9269) as single dose for covid-19 immunisation. Medical history included many allergies. The patient has no COVID prior to vaccination. The patient had other medications in two weeks but no other vaccine in four weeks. The patient previously had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL9263) on 20Jan2021 at 10:00 administered in the right arm for Covid-19 immunization. On 20Feb2021 at 12:00 (also reported as "in February"), the patient had a phlebitis in her right leg, a week later (Feb2021) a vascular surgeon office did an ultrasound and found a small blood clot. The events resulted in doctor or other healthcare professional office/clinic visit. The events were treated with Eliquis BID (twice a day) for 45 days. The patient was not tested for COVID post vaccination. The outcome of the events was not recovered.; Sender's Comments: A causal relationship between BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) and the event thrombosis cannot be excluded based on temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Date: 202102; Test Name: Ultrasound; Result Unstructured Data: Test Result:small blood clot; Comments: a week later a Vascular surgeon office did an Ultrasound and found a small blood clot.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy (known allergies: Yes many)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 28.03.2021
- Impfdatum
- 27.03.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Head injury
Injection site pain
Seizure
Symptomtext
Site: Pain at Injection Site-Mild, Systemic: Seizure-Medium, Additional Details: Patient sitting on chair post vaccine (waiting area) she reported (after seizure and fall) that she was feeling dizzy. She doesn't remember after that and was awake on the floor. Customer reported witnessing a seizure for 4-7 seconds BEFORE the fall. She has an abrasion on her left temple post fall. EMS called and patient refused to go to the ED. She said she would go with her friend.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 25.03.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cardiac disorder
Loss of consciousness
Symptomtext
Passed out; cardiac event; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program COVAX Support. A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 05Feb2021 15:30 (Batch/Lot Number: EL9269) as a single dose for COVID-19 immunisation. Medical history included defibrillator insertion from 2014 to an unknown date (has never had it go off), blood pressure abnormal, heart disorder, blood cholesterol increased (Lipitor indication: to lower cholesterol), and eye disorder. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL3246), on 15Jan2021, at 15:30 PM in the left arm, for COVID-19 immunization. Concomitant medications included acetylsalicylic acid (ASPIRIN) taken for heart from 2010 and ongoing; carvedilol taken for heart from 2014 and ongoing; ubidecarenone (CO Q 10) helps with the statin for his heart from 2014 and ongoing; atorvastatin (LIPITOR) taken to lower cholesterol from 2014 and ongoing; lisinopril taken for blood pressure from 2014 and ongoing; xantofyl (LUTEIN) taken for eye from an unspecified start date and ongoing; and warfarin taken as blood thinner from 2010 and ongoing. The patient reported that 2 hours and 15 minutes after the second dose on 05Feb2021, he passed out and his defibrillator kicked in and he had a cardiac event but was not sure what kind of cardiac event. He stated it was probably unrelated, but the doctor said to call Pfizer to notify. He said he has had the defibrillator since 2014 and has never had it go off. He is having a stress test to check it all out. He added he felt great by about two hours after the defibrillator kicked in and went golfing. The outcome of the events was recovered on 05Feb2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure abnormal; Cholesterol blood increased (Lipitor indication: to lower cholesterol); Defibrillator/pacemaker insertion (has never had it go off); Eye disorder; Heart disorder
- Andere Medikamente
- ASPIRIN [ACETYLSALICYLIC ACID]; CARVEDILOL; CO Q 10 [UBIDECARENONE]; LIPITOR [ATORVASTATIN]; LISINOPRIL; LUTEIN [XANTOFYL]; WARFARIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 10.02.2021
- Beginn
- 21.03.2021
- Tage bis Beginn
- 39,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Bell's palsy
Symptomtext
Symptoms of Bell's Palsy on right side of face as diagnosed by Dr.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- 3/23/21 11:30 AM examination by Dr. at office visit.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Lininopril 10 MG/day Rosuvastatin 20 MG/day Daily over 50 Multi Vitamin Policosanol 40 MG Day Fish Oil 360 MG 2X/day Equate Daily Fiber Pill Psyllium Husk 2x/day
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 02.02.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 37,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Bell's palsy
Symptomtext
Developed Bell's palsy, was treated with prednisone and valtrex, almost completely resolved by 3/24/2021, he had previously when he was 15 or 16 years of age with complete resolution, was told at that time that it may recur, given over one month doubt if from the vaccine but wanted to report since may be important in data collection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- asthma
- Andere Medikamente
- vitamin d
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 22.03.2021
- Impfdatum
- 13.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure increased
Blood pressure measurement
Blood test
Computerised tomogram
Investigation
Magnetic resonance imaging
Paralysis
Peripheral sensory neuropathy
Trigeminal nerve disorder
Symptomtext
mild peripheral neuropathy/sensory peripheral neuropathy around her gums and lips on her left side, as well as tingling on 4 of the 5 fingers of her left hand; paralysis in her lips and gums all the way down to her finger tips on the side of the injection which was the left side; portion of the trigeminal nerve on the left side seemed to have been impacted; blood pressure had sky rocketed; This is a spontaneous report from a contactable physician and a contactable consumer (patient). A 71-year-old female patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine), lot no. EL9269, via an unspecified route of administration on 13Feb2021 at a single dose for COVID-19 immunisation. Medical history was not reported. There were no concomitant medications. The physician asked if there were any reports of paresthesia around the gums and/or tingling in the hands and fingers. The patient received the first dose of the Pfizer COVID-19 vaccine. About 1 week after receiving the vaccine (20Feb2021), she experienced symptom complex, consistent with a mild peripheral neuropathy/sensory peripheral neuropathy around her gums and lips on her left side, as well as tingling on 4 of the 5 fingers of her left hand, She was admitted and a full workup for central disorders and vascular disorders was negative (Feb2021). But her symptoms were continuing intermittently. She had numbness of the gums. A portion of the trigeminal nerve on the left side seemed to have been impacted. Also, peri-orally on the left side. The physician asked if this symptom complex has been reported and if there were reports of these mild sensory peripheral neuropathies coming from the vaccine. The physician stated that any info on dental paresthesia or any reports of other incidents of sensory paresthesia would be very helpful. The patient also called about the COVID 19 vaccine. On 13Feb, she got the vaccine in and then one week later on the following Saturday, the date would have been 20Feb, she started having a sensation of tingling and paralysis in her lips and gums all the way down to her finger tips on the side of the injection which was the left side and that has continued. She went to see the doctor the following Monday 22Feb and not knowing what it was, she sent her to the ER she was kept overnight, she was discharged 23Feb but her symptoms persisted even through today. These sensations were happening on average 3 times per day, sometimes many more anywhere from 3 minutes to 1 hour 45 minutes then it goes away. She did not go to her primary care. She confirmed her first dose was given 13Feb and the tingling and paralysis started the 20Feb it was still ongoing at this time. It has persisted but she can't tell whether it was getting better or not because sometimes it will last 3 minutes sometimes it will last 1 hour and 45 minutes. It started to effect other parts of her so she thinks it might be getting a little bit worse. It was starting to effect other parts of her body the progression goes, it started at the tip of her tongue and gums and then shortly within 30 seconds or less than a minute it spread to her upper and lower lip only on the left side and that was how it was on her gums as well it was only on the left side then she had the tingling in her finger tips on the left hand. She specified that she experienced these sensations on the tip of her tongue, left gums, lower left lip, and into the fingers on the left hand. She would like to know if these symptoms have been reported in association with the vaccine and if so, how long she can expect them to last. She stated that yesterday, a physician called in on her behalf for more information and said he received literature from 29Jan regarding reports that included information about dental paresthesia after the vaccine. She was planning not to get the second vaccine. She was not taking medications, she was in good health she did go and was admitted in the ER, they did a work up. Her blood pressure had sky rocketed on Feb2021 and since she mentioned sensation they ruled out a stroke. On Feb2021, they did blood work, MRI and CT scan and everything was they did not find anything linking to a stroke. She spent the night in observation. She was in the ER, they did put her in the main hospital but it was for observation from the emergency room. She went in on the 22Feb and was discharged home on 23Feb. She asked where this goes from here, these symptoms were concerning to her. She did not find any incidences at least in general of reporting this, asked if there were these kinds of things being reported, she didn't know how long it was going to last or if it will get worse. The outcome of blood pressure had sky rocketed was unknown while outcome of other events was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- 1,0
- Labordaten
- Test Date: 202102; Test Name: blood pressure; Result Unstructured Data: Test Result:sky rocketed; Test Date: 202102; Test Name: blood work; Result Unstructured Data: Test Result:did not find anything linking to a stroke; Test Date: 202102; Test Name: CT scan; Result Unstructured Data: Test Result:did not find anything linking to a stroke; Test Date: 202102; Test Name: full workup for central disorders and vascular disorders; Test Result: Negative ; Comments: full workup for central disorders and vascular disorders was negative; Test Date: 202102; Test Name: MRI; Result Unstructured Data: Test Result:did not find anything linking to a stroke
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 19.03.2021
- Impfdatum
- 06.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Chest pain
Dyspnoea
Pulmonary thrombosis
SARS-CoV-2 test
Thrombosis
Symptomtext
multiple blood clots in lungs; multiple blood clots in legs; feeling chest pain; short of breath; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient (pregnant: No) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9269), via an unspecified route of administration in left arm on 06Feb2021 at 18:00 at single dose for covid-19 immunisation. The relevant medical history included DCIS Breast cancer from 2016, Known allergies: pencillin from an unspecified date. Concomitant medications included levothyroxine sodium (SYNTHROID). The patient previously received first dose of BNT162B2 on 16Jan2021 at the age of 68 years old (lot number: EL3249, at 06:15 PM, in Left arm) for covid-19 immunisation. The patient received 2nd Pfizer vaccine dose on Sat, 06Feb2021. On Wednesday 10Feb2021 she became short of breath. On 11Feb2021, she began feeling chest pain. On 12Feb2021, she was advised by primary care Dr to go to the emergency room. She was admitted on 12Feb2021 to ICU with multiple blood clots in her lungs and legs. She was told by the emergency Dr this was a sign of Covid, they did a Covid test, came back negative. She remained in the hospital till 18Feb2021. She was at the time of the report on Eliquis (10 mg/d). A hereditary blood clot test was done that came back negative. She had never had an issue before the vaccination with blood clots nor anyone in her family and she was in good health before the vaccination. Dr didn't think the vaccine caused the blood clots but her primary care Dr thought it did-which was why she was reporting it. The patient also stated that event multiple blood clots in her lungs and legs resulted in Emergency room/department or urgent care, Hospitalization and Life threatening illness. The patient had hospitalization for 7 days. Treatment Heparin 25,000unit in .45% NaCl Premix, Narcan received. No covid prior vaccination. The patient underwent lab test included Nasal Swab which showed negative on 12Feb2021; Hereditary blood clot test which showed negative on an unspecified date in 2021. Therapeutic measures were taken as a result of all the events. The outcome of the events was recovered with sequel.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary thrombosis
- Hospital-Tage
- 7,0
- Labordaten
- Test Date: 20210212; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 2021; Test Name: Hereditary blood clot test; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Breast cancer female; Penicillin allergy
- Andere Medikamente
- SYNTHROID
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 18.03.2021
- Impfdatum
- 02.02.2021
- Beginn
- 03.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chills
Decreased appetite
Disturbance in attention
Dizziness
Fatigue
Hot flush
Nausea
SARS-CoV-2 test
Sleep disorder
Syncope
Symptomtext
fainting; Fatigue; dizziness/sleep disturbance (wake up with hot, dizzy, nauseous every few hours); nausea/sleep disturbance (wake up with hot, dizzy, nauseous every few hours); hot flashes/sleep disturbance (wake up with hot, dizzy, nauseous every few hours); chills; loss of appetite; unable to focus; sleep disturbance (wake up with hot, dizzy, nauseous every few hours); This is a spontaneous report from a contactable consumer (patient). A 22-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, LOT#EL9269), via an unspecified route of administration in left arm from 02Feb2021 14:00 at first single dose for Covid vaccine. Medical history included known allergies: Oak trees, kiwi. Concomitant medication in two weeks included hydroxyzine hydrochloride (ATARAX), sertraline hydrochloride (ZOLOFT). No other vaccine was received in four weeks. The patient experienced fatigue, dizziness, nausea, hot flashes, chills, fainting, loss of appetite, unable to focus, sleep disturbance (wake up with hot, dizzy, nauseous every few hours). Adverse event start date: 03Feb2021 02:00 AM. AEs resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the events. No covid prior vaccination. Covid was tested post vaccination: nasal swab on 05Feb2021: negative. Symptoms lasting 6 days and counting. Outcome of the events was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210205; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to plants (Known allergies: Oak trees, kiwi); Fruit allergy (Known allergies: Oak trees, kiwi)
- Andere Medikamente
- ATARAX [HYDROXYZINE HYDROCHLORIDE]; ZOLOFT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 16.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Headache
Ischaemic stroke
Magnetic resonance imaging head
Pain
Pyrexia
White blood cell count
White blood cell count increased
Symptomtext
small ischemic stroke; elevated white blood count; fever; body aches; chills; headache; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL9269, expiration date May2021), via an unknown route of administration on 15Feb2021 (at the age of 68-years-old) as a single dose in the left arm for COVID-19 Prevention/ immunization. The patient's medical history included a dental procedure on 18Feb2021 for a cracked tooth from an unknown date. The patient received procaine hydrochloride (NOVOCAIN) on 18Feb2021 for the dental procedure. On 18Feb2021 the patient experienced fever, body aches, chills, and a headache; and on an unknown date in Feb2021 the patient experienced a small ischemic stroke. The patient was hospitalized for the ischemic stroke on 19Feb2021. The patient underwent lab tests and procedures which included a Magnetic resonance imaging (MRI) of the brain on 20Feb2021 which showed a small ischemic stroke and white blood cell count which was elevated (in the low 20s) on 19Feb2021 and on 20Feb2021, white blood cell count was normal. Therapeutic measures were taken as a result of the ischemic stroke which included Plavix. The clinical outcome of the ischemic stroke was unknown; fever, body aches and chills were recovered on 19Feb2021; white blood cell count increased recovered on 20Feb2021; headache was not recovered. The patient was hospitalized for three days. The patient mentioned that he was not associating the stroke with the vaccine but rather associates it with the added stress on his body.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 20210220; Test Name: MRI brain; Result Unstructured Data: Test Result:Small Ischemic Stroke; Test Date: 20210219; Test Name: WBC; Result Unstructured Data: Test Result:in the low 20s; Test Date: 20210220; Test Name: WBC; Result Unstructured Data: Test Result:normal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Dental treatment (Dental Procedure); Tooth fracture (cracked tooth)
- Andere Medikamente
- NOVOCAIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 16.03.2021
- Impfdatum
- 13.03.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute pulmonary oedema
Hypoxia
Symptomtext
FLASH PULMUNARY EDEMA, HYPOXIA (O2 SAT IN 60S)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute pulmonary oedema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CORONARY ARTERY DISEASE, HEART FAILURE, CHRONIC KIDNEY
- Andere Medikamente
- ALLOPURINOL, ASPRIN, CARTIA, DOCUSATE, CARDURA, NEURONTIN, HYDRALIZINE, HYDROCODONE, POTSSIUM
- Allergien
- MORPHINE, NORVASC, STATINS
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 16.03.2021
- Impfdatum
- 21.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Blood glucose normal
Dysarthria
Facial paralysis
Hypoaesthesia
Hypoaesthesia oral
Mastication disorder
Symptomtext
partial paralysis on the right side of my face as Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Feb2021 at 14:45 at single dose in left arm for COVID-19 immunisation at the age of 61-year-old. Medical history included Hypertension and Chronic Leukemia in remission. Patient was not pregnant. Concomitant medications included Metoprolol, Hydrochlorothiazide, ponatinib hydrochloride (ICLUSIG), potassium. On 25Feb2021 at 06:45, the patient experienced paralysis on the right side of face as Bell's Palsy. The patient went to the emergency room on 26Feb2021, and the doctors at hospital diagnosed partial paralysis on the right side of face as Bell's Palsy. The patient received Prednisone and VALTREX for 7 days. The patient did not recover from the event. Patient had not tested positive for COVID-19 since having the vaccine. Information on batch/lot number was requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Chronic leukemia of unspecified cell type in remission; Hypertension
- Andere Medikamente
- HYDROCHLOROTHIAZIDE; ICLUSIG; METOPROLOL; POTASSIUM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 15.03.2021
- Impfdatum
- 11.02.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Head injury
Seizure
Symptomtext
Patient stated he had a seizure four hours after receiving the first dose and fell and hit his head. He was life flighted and was hospitalized for several days. He does not know if this was a reaction to the vaccine and said the hospital was not sure either, but he has never had a seizure before.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- No on vaccine sheet
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 51,0
- Geschlecht
- U
- Eingang
- 15.03.2021
- Impfdatum
- 10.03.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Bed rest
Dizziness
Palpitations
Presyncope
Symptomtext
Vasovagal episode within 10 minutes of vaccination. Reported lightheadedness, palpitations BP= 74/40; HR=39. Pt Managed by healthcare workers with IV fluids and bedrest for 20 minutes. Symptoms resolved. Refused transport to ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- Has appointment with PCP @ 3PM this afternoon.
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 15.03.2021
- Impfdatum
- 05.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Fibrin D dimer increased
Ultrasound Doppler
Symptomtext
Left femoral DVT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Elevated D-Dimer, doppler
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Celebrex 200mg
- Allergien
- Iodine, iodinated contrast
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.03.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Symptomtext
Bell's palsy; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9269), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that the patient had an attack of bell's palsy on an unspecified date. Outcome of the event was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 11.03.2021
- Impfdatum
- 17.02.2021
- Beginn
- 17.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure abnormal
Chills
Dizziness
Feeling hot
Investigation
Oxygen saturation
Syncope
Throat irritation
Vaccination site pain
Symptomtext
syncope; feeling of heat rising into throat; feeling of heat rising into throat; lightheaded; chills; mild pain at injection site; This is a spontaneous report from a contactable pharmacist reported for self. This 67-year-old female patient (no pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 17Feb2021 13:45 PM on Arm left via Intramuscular at single dose (Lot # EL9269) for covid-19 immunisation. Medical history included Osteoporosis, known allergies: Sulfa, flu vaccine for immunisation. No COVID prior vaccination. Concomitant medications included alendronate sodium (FOSAMAX), ergocalciferol (VITAMIN D), calcium, magnesium, biotin, bifidobacterium lactis (PROBIOTIC). No other vaccine in four weeks. Past similar reaction from Flu vaccine 8 years ago (2013) for immunisation and treated in ED, had no problems with any other vaccine such as HepB (Hepatitis B), DTAP, pneumococcal 23, Shingrix all for immunization. On 17Feb2021 14:15 PM, feeling of heat rising into throat, then lightheaded- EMT on-site monitored BP, heart, oxygen then administered IV Benadryl and zofran - signed out in 2hr, developed chills and syncope for next 4 days and mild pain at injection site. Self treated with Tylenol/ advised by MD to not get 2nd dose. Events resulted in emergency room/department or urgent care. Treatments were received for the events. Treatment included IV Benadryl and IV Zofran. Outcome of the events was recovering.; Sender's Comments: Based on a temporal association, a causal relationship between the events of feeling of heat rising into throat, lightheaded and syncope, and BNT162B2 cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Test Name: BP; Result Unstructured Data: Test Result:Unknown result; Test Name: heart; Result Unstructured Data: Test Result:Unknown result; Test Name: Oxygen; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Osteoporosis; Sulfonamide allergy (known allergies: Sulfa, flu vaccine)
- Andere Medikamente
- FOSAMAX; VITAMIN D [ERGOCALCIFEROL]; CALCIUM; MAGNESIUM; BIOTIN; PROBIOTIC [BIFIDOBACTERIUM LACTIS]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 09.03.2021
- Impfdatum
- 09.02.2021
- Beginn
- 16.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Aortic dilatation
Arteriogram carotid normal
Blood thyroid stimulating hormone normal
Computerised tomogram head normal
Computerised tomogram neck
Computerised tomogram thorax normal
Echocardiogram abnormal
Electrocardiogram normal
Pericardial effusion
Skin laceration
Skin swelling
Suture insertion
Syncope
Troponin normal
Symptomtext
Pt experienced syncope and collapse, was admitted for pericardial effusion without cardiac tamponade. Treated for suspected inflammatory pericardial effusion with colchicine 0.6 mg daily for 3 months, ibuprofen 600 mg 3 times daily for two weeks. Patient was discharged home from hospital in good condition 2 days after admission, scheduled for follow-up with cardiology. Additionally pt was treated for a scalp laceration from collapse with staples to posterior scalp.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 2,0
- Labordaten
- 2/17/21 Carotid ultrasound - without hemodynamically significant stenosis bilaterally. 2/16/21 Serial troponins and EKGs - unremarkable. 2/17/21 Echocardiogram - moderate pericardial effusion without tamponade. EF >70%. Mildly dilated ascending aorta. 2/16/21 Chest CT - unremarkable. 2/16/21 TSH - within normal limits. 2/16/21 - 2/18/21 Continuous telemetry monitoring - no cardiac events or arrhythmias. 2/16/21 Head CT - right parietal scalp soft tissue swelling, otherwise no noted abnormalities. 2/16/21 Neck CT - no abnormalities.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- arrhythmia/palpitations, asthma, essential hypertension, osteoarthritis of the lumbar spine, hyperlipidemia, hypothyroidism
- Andere Medikamente
- albuterol, amlodipine, calcium carb/vitamin D3/minerals, duloxetine, ferrous sulfate, gabapentin, hydrocodone-acetaminophen, levothyroxine, loratadine-pseudoephedrine, naproxen sodium, omeprazole, simvastatin, valsartan, vitamin D3, zolpide
- Allergien
- procainamide, procaine, lisinopril, promethazine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 08.03.2021
- Impfdatum
- 10.02.2021
- Beginn
- 13.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Ageusia
Dry eye
Facial paralysis
Fatigue
Headache
Symptomtext
facial drooped right side of face; headache; dry eye, right side; cannot taste anything; tired; This is a spontaneous report from a contactable consumer reported for self. This 73-year-old male received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el9269), via an unspecified route of administration, left arm on 10Feb2021 12:45 at single dose for COVID-19 immunisation. Medical history was none. No covid prior vaccination. No known allergies. Concomitant medications included Pantoprazole and Lisinopril. No other vaccine in four weeks. He experienced facial drooped right side of face; dry eye, right side; cannot taste anything; tired; headache on 13Feb2021 10:00 AM. Ae resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid tested post vaccination. No treatments were received. Outcome of the events were not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
- Andere Medikamente
- PANTOPRAZOLE; LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 07.03.2021
- Impfdatum
- 05.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Condition aggravated
Electric shock sensation
Neuropathy peripheral
Pruritus
Symptomtext
I have a history of neuropathy that has been dormant most of the last year. I went in with no nueropathy occuring to get my vaccines. After the 1st Pfizer shot I had neuropathy starting the day after that went away in about a week. After the 2nd about 3 days later it started with itching all over my body (neuropathic itch), and burning mostly in my feet, but random electrical shocks throughout my body 24/7 (while awake). It has not subsided and has actually gotten worse. There are at least a dozen people on the clinic message board saying the same thing happened to them, that the vaccine awakened or made worse their neuropathy exponentially. Here is the link to similar complaints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- awaiting medical emg next week.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Colitis, Asthma, Nueropathy, Hashimotos
- Andere Medikamente
- vitamin d; b12
- Allergien
- no
- Vorherige Impfungen
- flu vaccine
- Staat
- AZ
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 03.03.2021
- Impfdatum
- 05.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Facial paralysis
Neurological examination
Symptomtext
BELL'S PALSY, FACIAL PARALYSIS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- 3/1: URGENT CARE, ER VISIT, NEUROLOGICAL TESTS
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- HYPERTENSION
- Andere Medikamente
- AMLODIPINE 5MG
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 02.03.2021
- Impfdatum
- 04.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 11,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Heavy menstrual bleeding
Polymenorrhoea
Thrombosis
Ultrasound abdomen normal
Ultrasound scan vagina
Symptomtext
I ended my normally scheduled menstrual cycle on 02/06/2021, and exactly 6 days later (02/15/2021) I had severe menstrual bleeding with blood clots that has continued to this day (03/02/2021). I went to urgent care and was prescribed Provera to stop the bleeding to no avail. I then proceeded to go to urgent care again because the bleeding had not stopped. At my second Doctors visit, I had an abdominal and a transvaginal ultrasound done, and both of them came back completely normal. I have now scheduled an upcoming obgyn appointment, but cannot be seen until 03/09/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Abdominal and transvaginal ultrasound.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- promethazine
- Vorherige Impfungen
- anxiety attack,33,01/14/2021,covid 19 pfizer
- Staat
- MO
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 02.03.2021
- Impfdatum
- 19.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Dizziness
Dysarthria
Facial paralysis
Somnolence
Swelling face
Swollen tongue
Vision blurred
Symptomtext
Per patient's report: She received her first dose of Pfizer COVID-19 vaccine and developed soreness at localized injection site and felt sleepy, otherwise no adverse reaction signs or symptoms patient reported. On 2-19-21 at 2:30 PM she received her second dose of the Pfizer COVID-19 vaccine at a mall. She reports the lot number of the vaccine was EL9269. She was monitored for 15 minutes after receiving the second dose. She and her husband left and took the car to a car wash where she fell asleep on her way home and her husband woke her up when they got home. At about 320 or 3:25 PM, she noticed that her face felt puffy and she had a sensation that her face was sliding down, she developed tongue swelling, blurry vision, dizziness, and she reports that she was talking funny/slurring her words. Her husband got a flashlight and looked in her throat and said that her throat was swelling. She felt like falling asleep. Her husband used her EpiPen on her. The EpiPen worked right away to improve the symptoms. She took no other treatments at home. Her husband drove her to the hospital where she slept the entire way. She never developed rash, flushing, skin itching, wheezing, coughing, chest tightness, shortness of breath, nausea, vomiting, diarrhea, fevers, chills, or joint pains. She does not know if she passed out, she states it was hard to stay awake. She reports having some abdominal cramping and churning for the following 2 to 3 days afterwards. She was discharged from the hospital ED where she was never admitted. They gave her an albuterol inhaler to use every 4 hours for 6 days after she left the ED. She went home at about 10:00 PM and went to bed about 10:30 PM. She woke up at 3:00 AM crying and then fell back asleep and woke up again around 7:30 AM. She did not develop any local injection site reactions on her arm this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- Baseline tryptase ordered, patient has not yet completed this test.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- GERD, hypertension, allergic rhinitis
- Andere Medikamente
- medication list: ? amlodipine-benazepril (LOTREL) 5-20 mg capsule Take 1 capsule by mouth daily. ? amoxicillin-potassium clavulanate (AUGMENTIN) 875/125 mg tablet Take one tablet by mouth every 12 hours. Take with food. ? azelastine (ASTELI
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 01.03.2021
- Impfdatum
- 26.02.2021
- Beginn
- 27.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pyrexia
SARS-CoV-2 test negative
Seizure
Symptomtext
Fever of 102.5 and seizures
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Taken to ER, COVID test came back negative. Given fluids. Parents had already given him Clonazapam
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Tuberous Sclerosis
- Andere Medikamente
- 10 mg Rapamune, 200 mg Zonegran, 900 mg Trileptal, Allegra - morning 300 mg Zonegran, 900 mg Trileptal
- Allergien
- Adhesive
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 01.03.2021
- Impfdatum
- 04.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Computerised tomogram
Electrocardiogram
Facial paralysis
Symptomtext
Bell's palsy; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9269/expiration date: not provided), via an unspecified route of administration, on 04Feb2021 08:30 (at the age of 41 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history included attention deficit hyperactivity disorder (ADHD). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EK9231/expiration date: not provided), via an unspecified route of administration, on 14Jan2021 at 08:45 (at the age of 41 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Feb2021, the patient experienced Bell's~ palsy. The event resulted in an emergency room/department or urgent care visit and received treatment which included CT scan, EKG, blood tests, and steroid prescribed. The outcome of the event Bell's palsy was not recovered. Since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of Bell's palsy due to temporal relationship. However, the reported event may possibly represent intercurrent medical condition in this patient. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including Head CT/MRI and viral serology, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- Test Date: 202102; Test Name: blood tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 202102; Test Name: CT scan; Result Unstructured Data: Test Result:Unknown results; Test Date: 202102; Test Name: EKG; Result Unstructured Data: Test Result:Unknown results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: ADHD
- Andere Medikamente
- ADDERALL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 26.02.2021
- Impfdatum
- 08.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test normal
Computerised tomogram head
Computerised tomogram head normal
Eye movement disorder
Eyelid ptosis
Facial paralysis
Hypoaesthesia oral
Paraesthesia oral
Symptomtext
left side of face drooping, could not smile, could not close left eye; feeling numbness/tingling lower lip; feeling numbness/tingling lower lip; This is a spontaneous report from a contactable consumer reporting for herself. A 84-years-old female patient received the second dose of bnt162b2 (BNT162B2;Lot # EL9269) vaccine , via an unspecified route of administration in the left arm on 08Feb2021 19:30 at single dose for covid-19 immunisation . Medical history included atrial fibrillation, allergy to sulpha. The patient's concomitant medications were not reported. The patient received the first dose of BNT162B2 on 15Jan2021. The patient experienced left side of face drooping, could not smile, could not close left eye on 09Feb2021 12:00 with outcome of recovering , feeling numbness/tingling lower lip on 09Feb2021 12:00 with outcome of recovering. Therapeutic measures included: Prednisone, Valacyclovir Follow up information has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: AFib; Sulfonamide allergy (known allergies: sulpha)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 25.02.2021
- Impfdatum
- 24.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Hypertension
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Hypertension-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 24.02.2021
- Impfdatum
- 18.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Headache
Intensive care
Respiratory distress
Wheezing
Symptomtext
20 year old with cerebral palsy, chronic bronchitis, G-tube dependent received COVID 19 vaccine approximately 1030 on 2/18. Within 5 minutes c/o headache and had audible wheezing. He was treated with Benadryl in the vaccine clinic. He was taken to ER noted to be in resp distress. He received IM epinephrine and symptoms quickly improved. Less than an hour later was again noted to be wheezing and in respiratory distress. He was treated with second IM epinephrine, albuterol, steroids, and antihistamines. Admitted into PICU overnight and remained asymptomatic. Patient received the pneumococcal and influenza vaccines 3 days prior. Has never had any similar reactions in the past. Patient was discharged on 2/19.21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Cerebral Palsy, GDD, Gtube dependent and chronic bronchitis
- Andere Medikamente
- montelukast; lactulose
- Allergien
- Chocolate, Dust, Peanuts
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 24.02.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Chest discomfort
Discomfort
Pain
Asthenia
Dysphagia
Dyspnoea
Cytokine test
Full blood count
Laboratory test
Lip swelling
Eye swelling
Fatigue
Lethargy
Mouth swelling
Metabolic function test
Palpitations
SARS-CoV-2 antibody test
Symptomtext
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: epipen was administered at 1:02 PM by, benadryl 50 mg po, and O2 inhalation, and patient was transported to ED at 1:08 PM. patient was given a second dose of epipen in the ambulance and at 2:48 PM, patient is stable and improving-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Severe, Systemic: Weakness-Severe, Additional Details: at 12:20 PM, recieved the pfizer bointech covid vaccine- 1st dose. lot:el9269 exp:05/21 which was mixed by employee and injected by employee. prior to getting the vaccine, patient told employee that she recueves cortisone injections in her elbow, unknown frequency, and due for her next injection on the following day 02-24-2021 and employee told her that she can double check with her doctor and consented to recieving the vaccine. at 12:30 PM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 24.02.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Chest discomfort
Discomfort
Pain
Asthenia
Dysphagia
Dyspnoea
Cytokine test
Full blood count
Laboratory test
Lip swelling
Eye swelling
Fatigue
Lethargy
Mouth swelling
Metabolic function test
Palpitations
SARS-CoV-2 antibody test
Symptomtext
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: epipen was administered at 1:02 PM by, benadryl 50 mg po, and O2 inhalation, and patient was transported to ED at 1:08 PM. patient was given a second dose of epipen in the ambulance and at 2:48 PM, patient is stable and improving-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Severe, Systemic: Weakness-Severe, Additional Details: at 12:20 PM, recieved the pfizer bointech covid vaccine- 1st dose. lot:el9269 exp:05/21 which was mixed by employee and injected by employee. prior to getting the vaccine, patient told employee that she recueves cortisone injections in her elbow, unknown frequency, and due for her next injection on the following day 02-24-2021 and employee told her that she can double check with her doctor and consented to recieving the vaccine. at 12:30 PM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 22.02.2021
- Impfdatum
- 15.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cold sweat
Dizziness
Gaze palsy
Hypertension
Nausea
Seizure
Swollen tongue
Symptomtext
Lightheaded. Skin was clammy, convulsions started, Epi pen administered, she had tongue swelling, came around then eyes rolled back in head, nausea, blood pressure high.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 22.02.2021
- Impfdatum
- 04.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Seizure
Symptomtext
Had seizure 2/5/21 . Does have dx of seizures disorder
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Sent to ER at Medical Center
- Aktuelle Erkrankungen
- HEMIPLEGIA AND HEMIPARESIS FOLLOWING CEREBRAL INFARCTION AFFECTING LEFT NON-DOMINANT SIDE SLP Acute Neurologic 2/3/2021 Principle Admitting Dx 2/3/2021 update G40.309 T GENERALIZED IDIOPATHIC EPILEPSY AND EPILEPTIC SYNDROMES, NOT INTRACTABLE, WITHOUT STATUS EPILEPTICUS Medical Management 2/1/2021 Secondary 1 Admission 2/1/2021 update I25.10 ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS Cardiovascular and Coagulations 2/1/2021 Secondary 2 Admission 2/1/2021 update I48.0 PAROXYSMAL ATRIAL FIBRILLATION Cardiovascular and Coagulations 2/1/2021 Secondary 3 Admission 2/1/2021 update I10 ESSENTIAL (PRIMARY) HYPERTENSION N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary 4 Admission 2/1/2021 update E78.5 HYPERLIPIDEMIA, UNSPECIFIED Medical Management 2/1/2021 Secondary 5 Admission 2/1/2021 update G45.9 TRANSIENT CEREBRAL ISCHEMIC ATTACK, UNSPECIFIED SLP Medical Management 2/1/2021 Secondary 6 Admission 2/1/2021 update E02 SUBCLINICAL IODINE-DEFICIENCY HYPOTHYROIDISM Medical Management 2/1/2021 Secondary 7 Admission 2/1/2021 update I27.20 PULMONARY HYPERTENSION, UNSPECIFIED Cardiovascular and Coagulations 2/1/2021 Secondary 8 Admission 2/1/2021 update M62.81 T MUSCLE WEAKNESS (GENERALIZED) N/A, not an acceptable Primary Diagnosis 2/12/2021 Secondary Other During Stay 2/12/2021 update R26.2 T DIFFICULTY IN WALKING, NOT ELSEWHERE CLASSIFIED N/A, not an acceptable Primary Diagnosis 2/12/2021 Secondary Other During Stay 2/12/2021 update R13.12 T DYSPHAGIA, OROPHARYNGEAL PHASE N/A, not an acceptable Primary Diagnosis 2/12/2021 Secondary Other During Stay 2/12/2021 update R48.8 T OTHER SYMBOLIC DYSFUNCTIONS N/A, not an acceptable Primary Diagnosis 2/12/2021 Secondary Other During Stay 2/12/2021 update F33.1 MAJOR DEPRESSIVE DISORDER, RECURRENT, MODERATE Medical Management 2/5/2021 Secondary Other Admission 2/5/2021 update G20 T PARKINSON'S DISEASE Acute Neurologic 2/1/2021 Secondary Other Admission 2/1/2021 update F03.90 T UNSPECIFIED DEMENTIA WITHOUT BEHAVIORAL DISTURBANCE Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update R55 SYNCOPE AND COLLAPSE Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update Z85.42 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF OTHER PARTS OF UTERUS N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update L80 VITILIGO N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update Z86.16 PERSONAL HISTORY OF COVID-19 N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update Z95.0 PRESENCE OF CARDIAC PACEMAKER N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update N17.9 ACUTE KIDNEY FAILURE, UNSPECIFIED Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update R06.09 OTHER FORMS OF DYSPNEA N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update Z87.440 PERSONAL HISTORY OF URINARY (TRACT) INFECTIONS N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update E87.6 HYPOKALEMIA Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update F41.1 GENERALIZED ANXIETY DISORDER Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update K21.9 GASTRO-ESOPHAGEAL REFLUX DISEASE WITHOUT ESOPHAGITIS N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update I50.9 HEART FAILURE, UNSPECIFIED Cardiovascular and Coagulations 2/1/2021 Secondary Other Admission 2/1/2021 update D64.9 ANEMIA, UNSPECIFIED Medical Management 2/1/2021 Secondary Other Admission 2/1/2021 update K59.01 SLOW TRANSIT CONSTIPATION N/A, not an acceptable Primary Diagnosis 2/1/2021 Secondary Other Admission 2/1/2021 update Z90.710 ACQUIRED ABSENCE OF BOTH CERVIX AND UTERUS
- Vorgeschichte
- -
- Andere Medikamente
- INVanz Solution Reconstituted 1 GM (Ertapenem Sodium) Inject 1 gram intramuscularly one time a day for ESBL/EColi in urine OXcarbazepine Suspension 300 MG/5ML Give 400 mg by mouth one time a day related to GENERALIZED IDIOPATHIC EPILEPSY
- Allergien
- oranges, strawberries
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 19.02.2021
- Impfdatum
- 07.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dehydration
Headache
Loss of consciousness
Symptomtext
2 days after vaccine, she fainted and later contacted her PCP. Patient may have been dehydrated with headaches after vaccine. Advised to seek medical assistnace for ongoing issues.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 18.02.2021
- Impfdatum
- 15.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Seizure like phenomena
Symptomtext
Within 15-minutes of vaccination, EMS evaluated the patient for "focal seizure like activity". No other information was given and no EMS report was submitted for the incident. There have been no hospital visits identified for the patient's condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure like phenomena
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 16.02.2021
- Impfdatum
- 11.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Anion gap increased
Blood creatinine increased
Blood glucose increased
Blood lactic acid increased
Blood urea increased
Carbon dioxide decreased
Condition aggravated
Diabetic ketoacidosis
Glomerular filtration rate decreased
Hyperglycaemia
Hyponatraemia
Intensive care
Lactic acidosis
Type 2 diabetes mellitus
White blood cell count increased
Symptomtext
Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus (CMS/HCC) (2/15/2021) POA: Yes Active Problems: Uncontrolled type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin (CMS/HCC) (5/6/2016) POA: Not Applicable Lactic acidosis (2/15/2021) POA: Yes Vaccination reaction - suspected (2/15/2021) POA: Yes Hyponatremia (2/15/2021) POA: Yes Was admitted to the ICU for further treatment
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 2,0
- Labordaten
- Pertinent ED labs: elevated lactic 3.3, glucose 461, BUN 30, Cr 1.8, WBC 12, decreased CO2 19, GFR 31, elevated anion gap 16
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety/depression, DM, Hypertension, Neuropathy, obstructive sleep apnea, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis,
- Andere Medikamente
- -
- Allergien
- Sulfa and Tramadol
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 16.02.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Impaired work ability
Loss of consciousness
Syncope
Symptomtext
She passed out a couple hours after the second dose of the vaccine was received. The employee was contributing it to the vaccine, but she has been to 3 emergent/urgent visits since then for continued episodes of syncope. She has not returned to work since the vaccine she works in a Dr.'s office.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 15.02.2021
- Impfdatum
- 09.02.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Computerised tomogram normal
Extraocular muscle paresis
Facial paralysis
Facial paresis
Lacrimation increased
Metabolic function test
Symptomtext
Pt reports that he had the first round of the COVID vaccine on Tuesday (2/9/21), and he began having L sided eye weakness/watering and L sided facial droop/weakness on Thursday (2/11/21) that has been worsening since. This resulted in a visit to the ER and workup for Bell's Palsy vs stroke - presented to ER on 2/15/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- CMP, BMP negative for abnormal values and CT head negative (2/15/21). Patient discharged from ER for tx of Bell's Palsy with Valtrex and prednisone prescriptions with first doses given in ER prior to discharge.
- Aktuelle Erkrankungen
- none per patient
- Vorgeschichte
- DM2, HTN, CAD (h/o MI), h/o Bell's Pallsy
- Andere Medikamente
- metformin, metoprolol tartrate, lisinopril, isosorbide mononitrate, aspirin, atorvastatin, Soliqua PRN
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 15.02.2021
- Impfdatum
- 09.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Thrombosis
Ultrasound scan
Symptomtext
Blood clot right thigh
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Vaso vagal episodes- on BP med
- Andere Medikamente
- Acetaminophen per dr
- Allergien
- Codeine,penicillin,sulfa
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 15.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Loss of consciousness
Symptomtext
1533 Lightheaded post shot pt passed out. BP 182/120, 1540 148/108 pt lying on the floor, responding to nurse. Son was called to meet her at Hospital. 1542 911 called and squad arrived. 1545 Sitting in chair with EMS present. Oriented x3. 1548 Pt ambulated to squad with EMTS. Pt agreed to go to ER. Pt states she passes out after shots. She was advised to inform her PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN new meds 2 weeks ago
- Andere Medikamente
- Amlodipine
- Allergien
- PCN, Azithromicyn, Clindamicyn, Bactrim, Levaquin
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 15.02.2021
- Impfdatum
- 14.02.2021
- Beginn
- 14.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fall
Head injury
Presyncope
Syncope
Vomiting
Symptomtext
Appears to have had a vasovagal response, vomiting and syncope approx. 7pm same day of 2 vaccine. Hit head causing head injury.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Spinal stenosis back pain day of with use of Tylenol to allow activities of daily living.
- Vorgeschichte
- Spinal stenosis and hypertension and eschemic colitis.
- Andere Medikamente
- Hypertensive medications.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 15.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Blood pressure increased
Blood pressure measurement
Chills
Rash
Hypertension
Symptomtext
Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL9269), via an unspecified route of administration into left arm on 06Feb2021, at 15:15 as first single dose for covid-19 immunization. Medical history included high blood pressure from an unknown date, known allergies to peanuts, tree nuts from an unknown date (elaborated as allergies to peanuts, non-steroidal-anti-inflammatory drugs (NSAIDs), tree nuts, penicillin), from unknown dates. Concomitant medication included lisinopril (MANUFACTURER UNKNOWN) and unspecified multivitamins. No other-vaccines were given with four weeks. On 06Feb2021, at 15:45, the patient experienced adverse event: anaphylaxis reaction. high blood pressure. body shivering. rash on neck and chest. The events were serious as they were life-threatening. The events were noted as resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and was life threatening illness (immediate risk of death from the event). The patient underwent lab tests and procedures which included blood pressure measurement: high on 06Feb2021. Therapeutic measures were taken as a result of the adverse events; dexamethasone sodium phos- diphenhydramine (BENADRYL), famotidine. No covid infection was noted prior to vaccination. No covid test has been administered post vaccination. The outcome of events was recovered in Feb2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210206; Test Name: blood pressure; Result Unstructured Data: Test Result:High
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to nuts (Known- allergies: Peanuts, NSAIDs, Tree nuts, penicillin); Drug allergy; Hypertension (Other-medical-history: High blood pressure); Penicillin allergy
- Andere Medikamente
- LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 15.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Blood pressure increased
Blood pressure measurement
Chills
Rash
Hypertension
Symptomtext
Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; Adverse event: Anaphylaxis reaction. High blood pressure. Body shivering. Rash on neck and chest.; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL9269), via an unspecified route of administration into left arm on 06Feb2021, at 15:15 as first single dose for covid-19 immunization. Medical history included high blood pressure from an unknown date, known allergies to peanuts, tree nuts from an unknown date (elaborated as allergies to peanuts, non-steroidal-anti-inflammatory drugs (NSAIDs), tree nuts, penicillin), from unknown dates. Concomitant medication included lisinopril (MANUFACTURER UNKNOWN) and unspecified multivitamins. No other-vaccines were given with four weeks. On 06Feb2021, at 15:45, the patient experienced adverse event: anaphylaxis reaction. high blood pressure. body shivering. rash on neck and chest. The events were serious as they were life-threatening. The events were noted as resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and was life threatening illness (immediate risk of death from the event). The patient underwent lab tests and procedures which included blood pressure measurement: high on 06Feb2021. Therapeutic measures were taken as a result of the adverse events; dexamethasone sodium phos- diphenhydramine (BENADRYL), famotidine. No covid infection was noted prior to vaccination. No covid test has been administered post vaccination. The outcome of events was recovered in Feb2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210206; Test Name: blood pressure; Result Unstructured Data: Test Result:High
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to nuts (Known- allergies: Peanuts, NSAIDs, Tree nuts, penicillin); Drug allergy; Hypertension (Other-medical-history: High blood pressure); Penicillin allergy
- Andere Medikamente
- LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 14.02.2021
- Impfdatum
- 13.02.2021
- Beginn
- 14.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Cold sweat
Fall
Loss of consciousness
Pain in extremity
Symptomtext
Extremely sore arm intensified 14 hours later when I decided to take Advil. Within a minute I began to weaken, ultimately collapsing on bathroom floor. My husband heard me fall and tended to me. He stated that I was unresponsive for 5-10 seconds. My husband provided me water and allowed me to lie on the floor until I was strong enough for him to assist back to bed. He reported my skin was clammy and moist to the touch. After resting for 15 mins he assisted me to the bathroom to urinate. I returned to bed and slept until 5:30 am when I awoke and went downstairs. I was feeling well enough to go on my weekly 90 minute bike ride at 8:30 am.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- cymbalta, lisinopril, simvastatin, aller-tec, aspirin, biotine,
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 12.02.2021
- Impfdatum
- 11.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram abnormal
Facial bones fracture
Loss of consciousness
Malaise
Symptomtext
Woke up very sick, lost consciousness twice in the middle of the night in the bathroom and broke my nose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- CT- broken nose
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- Iron, vitamin d, magnesium
- Allergien
- Bee venom
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 12.02.2021
- Impfdatum
- 08.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase increased
Albumin globulin ratio normal
Anion gap normal
Aspartate aminotransferase increased
Basophil percentage
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium normal
Blood chloride normal
Blood creatinine increased
Blood glucose normal
Blood potassium normal
Blood sodium normal
Blood urea increased
Blood urea nitrogen/creatinine ratio
Carbon dioxide normal
Computerised tomogram head
Symptomtext
Shortly after receiving vaccine; whole right side of her face went numb. Pt took Benadryl after injection afraid it was an allergic reaction. Pt seen by MD in office; noted with right facial dropping .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- MRI of Brain w/ wo contrast on 2/11/21 FINDINGS: PROCEDURE: MRI BRAIN W WO CONTRAST. COMPARISON: CT brain on the same date CLINICAL INDICATION: facial numbness TECHNIQUES: The MR scan was performed using departmental protocol for MRI BRAIN W WO CONTRAST. 15 cc MultiHance was infused. FINDINGS: The ventricles and cortical sulci are compatible with patient's age. The brain parenchyma demonstrates normal MR signal characteristics without evidence acute intracranial hemorrhage, acute stroke, mass, midline shift, abnormal fluid collections, or abnormal enhancement. The craniocervical junction is unremarkable. Empty sella is seen. Normal signal flow voids are identified image of branches of intracranial vessels. IMPRESSION: Unremarkable MRI brain with without contrast. Electronically Signed by: MD Signed on: 2/11/2021 9:24 PM CT head completed : 2/11/21 Results EXAM: Head CT without contrast. COMPARISON: None. CLINICAL INDICATION: facial numbness TECHNIQUE: Multiple axial scans were obtained from the base of the skull to the vertex. Adjustment of KV/mA was done based on patient size. FINDINGS: Bone windows are unremarkable, visualized paranasal sinuses and mastoid air cells on both sides are unremarkable. There is no evidence of intracranial hemorrhage, focal abnormality within the brain, mass effect or extra-axial collections. IMPRESSION: Unremarkable head CT without contrast. Electronically Signed by: MD Signed on: 2/11/2021 7:15 PM CBC 2/11/21 performable only) Order: 15155146777 - Part of Panel Order 15155146762 Status: Final result Visible to patient: Yes (Patient Portal) Ref Range & Units 1d ago WBC 4.2 - 11.0 K/mcL 7.6 RBC 4.00 - 5.20 mil/mcL 4.63 HGB 12.0 - 15.5 g/dL 13.5 HCT 36.0 - 46.5 % 41.6 MCV 78.0 - 100.0 fl 89.8 MCH 26.0 - 34.0 pg 29.2 MCHC 32.0 - 36.5 g/dL 32.5 RDW-CV 11.0 - 15.0 % 13.7 RDW-SD 39.0 - 50.0 fL 45.6 PLT 140 - 450 K/mcL 296 NRBC <=0 /100 WBC 0 Neutrophil, Percent % 53 Lymphocytes, Percent % 37 Mono, Percent % 7 Eosinophils, Percent % 2 Basophils, Percent % 1 Immature Granulocytes % 0 Absolute Neutrophils 1.8 - 7.7 K/mcL 4.0 Absolute Lymphocytes 1.0 - 4.0 K/mcL 2.8 Absolute Monocytes 0.3 - 0.9 K/mcL 0.6 Absolute Eosinophils 0.0 - 0.5 K/mcL 0.2 Absolute Basophils 0.0 - 0.3 K/mcL 0.0 Absolute Immmature Granulocytes 0.0 - 0.2 K/mcL 0.0 Resulting Agency Hosp Narrative Performed by: Hosp This is an appended report. These results have been appended to a previously verified report. Specimen Collected: 02/11/21 18:34 CMP 2/11/21 Contains abnormal data Comprehensive Metabolic Panel Order: 15155146764 Status: Final result Visible to patient: Yes (Patient Portal) Ref Range & Units 1d ago Fasting Status Sodium 135 - 145 mmol/L 139 Potassium 3.4 - 5.1 mmol/L 4.2 Chloride 98 - 107 mmol/L 103 Carbon Dioxide 21 - 32 mmol/L 29 Anion Gap 10 - 20 mmol/L 11 Glucose 65 - 99 mg/dL 96 BUN 6 - 20 mg/dL 24High Creatinine 0.51 - 0.95 mg/dL 0.97High Glomerular Filtration Rate >90 mL/min/1.73m2 68Low Comment: eGFR 60 - 89 mL/min/1.73m2 = Mild decrease in kidney function. BUN/ Creatinine Ratio 7 - 25 25 Calcium 8.4 - 10.2 mg/dL 8.7 Bilirubin, Total 0.2 - 1.0 mg/dL 0.3 GOT/AST <=37 Units/L 41High GPT/ALT <64 Units/L 50 Alkaline Phosphatase 45 - 117 Units/L 68 Albumin 3.6 - 5.1 g/dL 4.0 Protein, Total 6.4 - 8.2 g/dL 7.6 Globulin 2.0 - 4.0 g/dL 3.6 A/G Ratio 1.0 - 2.4 1.1 Resulting Agency Hosp Specimen Collected: 02/11/21 18:34 Last Resulted: 02/11/21 19:00
- Aktuelle Erkrankungen
- Anxiety Hypothyroidism
- Vorgeschichte
- Hypothyroidism
- Andere Medikamente
- buPROPion HCl ER (XL) 300 MG Oral Tablet Extended Daily levothyroxine (Tirosint) 100 MCG capsule Daily acyclovir (ZOVIRAX) 400 MG tablet 5 times per day for 7 days (Started on 2/9/21)
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 10.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Body temperature decreased
Loss of consciousness
Nasopharyngitis
Pain in extremity
Peripheral swelling
Vomiting
Symptomtext
About 4 hours later, started getting an intense pain in stomach. At night had cold sweats, vomited once, severe diarrhea, low temp, blacked out, but did not go to the ER. Arm soreness and swollen. Stopped around 1:00 the next day. Monday felt a little froggy. Feeling better now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- Claritin D
- Allergien
- Sulfur Drugs, Neomycin, Lanolin, Nickel
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 10.02.2021
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Hypertension
Syncope
Symptomtext
Systemic: Fainting-Medium, Systemic: Other- High BP
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- no known allergy
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 09.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Seizure
Symptomtext
Patient had multiple seizures that were treated with 5 mg Versed intranasally and 5 mg IVP. Seizures broke and weas transferred to Hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Seizure disorder
- Andere Medikamente
- Keppra
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 08.02.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Fall
Syncope
Symptomtext
Patient fainted and fell to the floor. EMS administered first Aid and ref pt to hospital. Refused to be transported by Ambulance car. Brother tranport pt to Hosp.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Adverse effect to covid vaccination
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 08.02.2021
- Impfdatum
- 08.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Electrocardiogram
Syncope
Symptomtext
Patient had a syncope episode.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- ECG Vital Signs
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None reported
- Allergien
- None reported
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 07.02.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Chills
Hot flush
Loss of consciousness
Syncope
Symptomtext
9pm had chills then a hot flash, slight stomach ache. Went to go use the restroom and passed out and fell. Woke up and was stood up by friends and passed out again. I do have a history of vasovagel syncopy but it hasn?t happened in over 10years
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Prilosec, Busbar
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 05.02.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Electrocardiogram
Loss of consciousness
Vomiting
Symptomtext
5 minutes after shot, patient passed out for 10-15 seconds. Nurse woke up patient. Patient reports vomiting about 1 minutes later. Patient states they had a migraine before getting the vaccine today. Patient reports a history of getting anxious and passing out with shots or blood draws.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- EKG since patient passed out
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Probiotic; multivitamin, citalopram 10mg daily.
- Allergien
- alupent syrup (seizure as baby)
- Vorherige Impfungen
- Any vaccine/shot; anxious with history of fainting
- Staat
- IL
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 05.02.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Immediate post-injection reaction
Syncope
Symptomtext
Pt had immediate syncopal episode lasting about 30 seconds as witnessed per staff.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 05.02.2021
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Electrocardiogram
Syncope
Tremor
Symptomtext
Pt had the vaccine at 7:15 a.m. today, sat at the facility where he received the vaccine for 15 minutes, pt was with his mother who was driving. Pt then went to his mom's car, they were driving when pt had a syncope episode, per his mother his hands were shaking, pt's mother then drove him to our ER facility.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- 2-5-2021, pt came to the ER, where he saw an ER MD and had an EKG.
- Aktuelle Erkrankungen
- seasonal allergies ("nose stuffy")
- Vorgeschichte
- -
- Andere Medikamente
- Sudafed, fish oil, B complex
- Allergien
- omnicef, chlorine
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 04.02.2021
- Impfdatum
- 04.02.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling abnormal
Immediate post-injection reaction
Loss of consciousness
Tremor
Symptomtext
Patient lost consciousness immediately after receiving first COVID-19 vaccination, reported to writer by MD on site. MD reports that patient did not hit head. Received patient conscious and in wheelchair at 1625 in nurse response tent. Patient reported dizziness/lightheadedness, shakiness, and "felt weird". Patient received rest, juice, water, reassurance. Patient recovered and was discharged at 1700 per recommendation of Dr., patient denies need for further care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 01.12.2023
- Impfdatum
- 06.02.2021
- Beginn
- 22.01.2022
- Tage bis Beginn
- 350,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Chest X-ray abnormal
Decreased appetite
Dyspnoea
Pleuritic pain
Pneumonia
Productive cough
SARS-CoV-2 test positive
Sputum discoloured
Symptomtext
Patient had covid 19 earlier this year (tested positive on January 5). She did not have increased oxygen requirements and was recovering well, tested negative on 1/12. However 7 days prior to admission she began to have decreased appetite, generalized weakness. The day prior to admission she developed SOB, cough productive of yellow phlegm, increasing oxygen requirements, pleuritic pain. In the ER she required 5 LPM NC, covid test is still positive, CXR with bilateral PNA. She was started on antibiotics, steroids and Lovenox. Patient was discharged home with home health.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 26.09.2023
- Impfdatum
- 06.02.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 297,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Anticoagulant therapy
Blood creatinine increased
COVID-19
Chemotherapy
Hyperuricaemia
Non-Hodgkin's lymphoma recurrent
Peripheral swelling
Pneumonia
T-cell lymphoma
Waist circumference increased
Symptomtext
Presented to ED with LE swelling and increase abd girthInitially diagnosed with pneumonia started on broad-spectrum antibiotics/also noted to be in AKI with a creatinine of 2.1/ hyperuricemia, diagnosed with recurrent T-cell non-Hodgkin's lymphoma; subsequently developed COVID-19)Tx: Decadron, Vit C, lovenox, zinc; also receiving chemotherapy for lymphoma; covid symptoms remained minimal; required 2-5 LPM NC O2 during stay but back to room air by d/c;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 22.09.2023
- Impfdatum
- 17.11.2022
- Beginn
- 02.09.2023
- Tage bis Beginn
- 289,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chemotherapy
Dyspnoea
Fatigue
Palpitations
Symptomtext
8/28/2023 - 9/11/2023 (14 days) Discharge Disposition: Home with Home Health Services PMH: -right breast cancer-ductal carcinoma; most recent chemotherapy on 08/24/2023 -immunocompromised -anxiety; depression -hyperlipidemia -macular degeneration -atrial fibrillation -HFrEF; echocardiogram showing LVEF: 30-35%; Presents emergency department with shortness of breath, palpitations and fatigue. 11/17/2022 Pfizer, Inc GJ6738 9/28/2021 Pfizer, Inc FC3184 3/4/2021 Pfizer, Inc EN6198 2/10/2021 Pfizer, Inc EL9269
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 22.08.2023
- Impfdatum
- 22.02.2021
- Beginn
- 22.01.2022
- Tage bis Beginn
- 334,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Dyspnoea
Hypoxia
SARS-CoV-2 test positive
Tachypnoea
Symptomtext
She presented to the emergency department, by ambulance, from the a Care Center, for shortness of breath and hypoxia. According to the nursing staff she os positive for Covid-19 (unsure of when she tested positive). When the paramedics arrived, she was hypoxic and tachypneic, she was placed on supplemental oxygen at six liters per minute by nasal cannula, her oxygen saturation was then in the "80's" and she then was placed on twenty-five liters per minute by a non-rebreather and her oxygen saturation improved to 90%. Disposition: She will be transferred today to nursing home on Hospice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 22.08.2023
- Impfdatum
- 10.02.2021
- Beginn
- 19.01.2022
- Tage bis Beginn
- 343,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Anaemia
COVID-19
Dyspnoea
Laboratory test abnormal
Peripheral swelling
Weight decreased
Symptomtext
swelling in legs, SOB, loss of 20 lbs; seen in ER received 1 L of fluids. labs showed AKI and anemia.referred for inpt for further management. DX with COVID 19 w/out hypoxia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 17.08.2023
- Impfdatum
- 04.02.2021
- Beginn
- 09.10.2022
- Tage bis Beginn
- 612,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Arrives to the ED c/o SOB and weakness since yesterday. Pt tested positive for COVID-19 last night begin Remdesivir, decadron, singulair, zinc, add oxygen protocol and RTTE protocol.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 17.08.2023
- Impfdatum
- 04.02.2021
- Beginn
- 02.01.2022
- Tage bis Beginn
- 332,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Lethargy
Magnetic resonance imaging
Mental status changes
SARS-CoV-2 test negative
Symptomtext
C/o lethargy, AMS. MRI to r/o CVA. Covid lab (negative) but Tx for covid pneumonia per medical record
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 22,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 16.08.2023
- Impfdatum
- 06.02.2021
- Beginn
- 14.08.2023
- Tage bis Beginn
- 919,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
SARS-CoV-2 test positive
Symptomtext
Patient admitted with COVID pneumonia on 8/13/23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NSAIDS, Amlodipine, Statins
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 15.08.2023
- Impfdatum
- 08.02.2021
- Beginn
- 09.01.2022
- Tage bis Beginn
- 335,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19 pneumonia
Symptomtext
Admitted for pneumonia due to COVID-19; tx w/steroids, singulair, zinc, abx, O2. Weaned to RA for dc home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 10.08.2023
- Impfdatum
- 04.02.2021
- Beginn
- 14.01.2022
- Tage bis Beginn
- 344,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Dyspnoea
Pyrexia
Symptomtext
Presents to the ED c/o increased shortness of breath x2 days. Patient was diagnosed with COVID on January 4, 2022 and was doing well until 2 days ago we started with increased cough and fever. He did receive the COVID vaccine in February of 2021, but did not receive a COVID booster. Tx. IV steroid, vitamin-C, zinc, 2 L by nasal cannula.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 17,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 03.08.2023
- Impfdatum
- 10.02.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 335,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19 pneumonia
Dyspnoea
Symptomtext
Presented w c/o shortness of breath and weakness. Patient has a history of interstitial lung disease and normally requires 2-4 L of oxygen via nc; diagnosed with pneumonia secondary to COVID-19 virus. Tx w/ steorids, zinc, advair, singular, remdesivir, abx, O2; weaned down to 2 L of oxygen via nasal cannula; dc'd to SNF.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 31,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 12.06.2023
- Impfdatum
- 12.06.2023
- Beginn
- 12.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Blood test abnormal
Hypoaesthesia
Laboratory test normal
Pain
Paraesthesia
Rheumatoid arthritis
Sleep disorder
Symptomtext
Started to be awakened at night with numbness is different parts of my body. Sometimes sharp pains and sometime tingling. I have never experienced anything like that before and just waited for several months thinking it would go away. I went to my doctor and he suggested it was carpel tunnel and then saw my pain management doctor and he suggested the same thing. I had the test and it was determined that it was not carpel tunnel. My Primary doctor then did blood work and the work came back with a marker. I was then sent to see Dr. She started me on Methotrexate and folic acid. After about 6 months, at the third visit Dr. told me I have Rheumatoid Arthritis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Osteo arthritis knee replacement
- Andere Medikamente
- Fish Oil Citrizine Simvastatin Lisinopril Metoprolol Centrum Silver Tizanidine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 02.05.2023
- Impfdatum
- 05.03.2021
- Beginn
- 15.05.2021
- Tage bis Beginn
- 71,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Biopsy skin abnormal
Burning sensation
Neuritis
Neuroma
Neuropathy peripheral
Pain
Pain in extremity
Paraesthesia
Therapeutic nerve ablation
Symptomtext
After the second vaccine in May 2021 I developed very acute pain in my feet. I had horrible burning and pain, The pain and burning was progressing and in November 2021 stared a series of steroid injections in my feet for pain. They didn?t help. I was diagnosed with nerve inflammation : bilateral neuromas. I started a series of alcohol injection ( ablation of the neuromas). They brought me a relief. January 2022 I got more pain and tingling in feet that spread out to ankles and hands and arms. January 2023- diagnosed with short fiber neuropathy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- January 2023 I had a skin biopsy that showed short fiber neuropathy.
- Aktuelle Erkrankungen
- Stress fracture of the 2 nd metatarsal in the left foot
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 10.03.2023
- Impfdatum
- 04.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Bundle branch block left
Catheterisation cardiac
Chest X-ray
Chest pain
Dyspnoea
Echocardiogram
Ejection fraction
Electrocardiogram
Fluid retention
Laboratory test
Oedema
Pulmonary hypertension
Symptomtext
Shortness of breath, chest pain, dyspnea, Pulmonary HTN, Left Bundle Branch Block, Edema, Fluid Retention.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 2,0
- Labordaten
- EKGx5: 2021, 2022, 2023 Chest xraysx3: 2021, 2022 EF Fraction: 2021, 2022, 2023 Echo: 2022, 2023 Left heart cath: 2021 Labs: 2021, 2022, 2023 Right heart cath: 2022
- Aktuelle Erkrankungen
- HTN, Hypothyroidism, Depression, GERD
- Vorgeschichte
- HTN
- Andere Medikamente
- Armour Thyroid, Losartan, Sertraline, Prevacid, Amytriptiline.
- Allergien
- KNDA
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 10.03.2023
- Impfdatum
- 04.02.2021
- Beginn
- 22.12.2022
- Tage bis Beginn
- 686,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chest discomfort
Flushing
Hypopnoea
COVID-19
Diarrhoea
Dyspnoea
Nausea
Vomiting
Symptomtext
Patient presents to the ED with nausea, vomiting, diarrhea, and shortness of breath. Patient was hospitalized for further evaluation with covid and treated with remdesivir.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 05.03.2023
- Impfdatum
- 08.02.2021
- Beginn
- 07.02.2023
- Tage bis Beginn
- 729,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Computerised tomogram abdomen abnormal
Computerised tomogram head normal
Computerised tomogram spine
Condition aggravated
Culture urine positive
Cystitis
Dysuria
Escherichia test positive
Fall
Nausea
Pollakiuria
Pyrexia
SARS-CoV-2 test positive
Scan with contrast abnormal
Sepsis
Urinary tract infection
Symptomtext
Patient is 73 years old with past medical history of multiple sclerosis, neurogenic bladder, hyperlipidemia, recurrent UTI, hyperlipidemia presented to the hospital s/p a fall. Patient fell from the wheelchair and was laying face down when she was found by her husband. Subsequently after patient had 2 episode of nausea and vomiting. Patient denies any syncope. Otherwise patient has no fever, chills, chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, constipation. Admits to frequent urination and dysuria. In the ED, patient was found to have urinary tract infection and was initiated on Rocephin. She was found to have a positive COVID. She did receive COVID-vaccine previously. Prior urine cultures grew E. coli. Patient had CT of the head and CT of the cervical spine and were both negative. Patient had a CT of the abdomen and pelvis with IV contrast and was consistent with cystitis. Clinical Summary Patient presented to the emergency department due to nausea vomiting and fall at home. She was admitted to the medical surgical unit for the treatment of urinary tract infection. Neurology was consulted given her history of MS. She was found to be at her discharge and neurology recommended baseline and neurology recommended discharge. She was found to be COVID-positive which could be etiology of her nausea vomiting and weakness. She did not meet criteria for remdesivir. She had 1 episode of fever at 100.7 which quickly resolved and did not recur. This is likely secondary to COVID rather than UTI. After antibiotic treatment her dysuria was resolved. She is feeling well and requesting discharge. I discussed case with husband who was in agreement. She will be discharged to complete course of Keflex x5 days and Paxlovid. I did confirm no interacting drugs with the pharmacist. Extensive education with both the patient and husband. Patient was previously set up for IR placement in 2 days of suprapubic catheter to aid in her frequent UTIs, but this has to be rescheduled due to her present COVID infection. Discharge diagnosis Urinary tract infection with sepsis COVID infection Multiple sclerosis Generalized weakness s/p fall Neurogenic bladder with incontinence Hyperlipidemia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 09.02.2023
- Impfdatum
- 26.09.2022
- Beginn
- 14.01.2023
- Tage bis Beginn
- 110,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest pain
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
01/14/23 presents to ED for "chest pain, shortness of breath". PMHx of "hypertension, CAD, cardiomyopathy, CKD stage III, heart block status post pacemaker placement, and hyperlipidemia"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 01/14/23 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 30.12.2022
- Impfdatum
- 15.01.2021
- Beginn
- 13.11.2022
- Tage bis Beginn
- 667,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
11/13/22 presents to ED for "breathing problem". PMHx of "Parkinson's disease, atrial fibrillation"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 1/13/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 28.12.2022
- Impfdatum
- 22.01.2021
- Beginn
- 11.11.2022
- Tage bis Beginn
- 658,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
11/11/22 presents to ED for "dyspnea". PMHx of "paroxysmal AF and DM"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 11/11/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 19.01.2021
- Beginn
- 06.10.2022
- Tage bis Beginn
- 625,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Brain natriuretic peptide increased
COVID-19
Dyspnoea
Fatigue
Hypoxia
Renal impairment
SARS-CoV-2 test positive
Symptomtext
87 yo female with history of Parkinson's disease, HFmrEF 45%, autoimmune hepatitis, anxiety/depression, TIA, and CAD who presented to Hospital on 10/6/2022 with a chief complaint of generalized weakness and fatigue. She was found to be COVID-19 positive and elevated BNP concerning for acute on chronic HF. Diuresed in the ED with 1 dose of lasix and her kidney function improved. She required oxygen supplementation initially and was started on steroids and Remdisnivir. Hypoxia and SOB resolved. She was deemed stable for transfer to PRIVATE with continued COVID isolation until 10/15, however, COVID PRIVATE was unable to take patient. Family initially accepted home with home care, then started the appeal process. After a few days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 10/6 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 18.01.2021
- Beginn
- 03.10.2022
- Tage bis Beginn
- 623,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Bladder catheterisation
Blood sodium abnormal
COVID-19
Dehydration
Fall
Fluid intake restriction
Fractured sacrum
Hyponatraemia
Imaging procedure abnormal
SARS-CoV-2 test positive
Urinary retention
Symptomtext
This is a 84y.o. female with a PMH significant for hypertension, CKD stage II, neurogenic bladder and osteoperosis presented to hospital on 10/3/2022 after a mechanical fall. Was found to be hyponatremic. Imaging showed nondisplaced fracture of right sacrum and comminuted right fracture. Patient was seen and evaluated by ortho and no intervention was indicated beside PT/OT. Fall was attributed to hyponatremia, excess fluid intake escitalopram and dehydration from recent illness . Pt was put on fluid restriction with improvement in Sodium. She was also given one dose of tolvaptan to bring sodium to higher normal level. Sodium was normal Upon discharge and she will f/u with nephrology. She also had covid and completed 5 days of paxlovid op that was started 9/30. Urology saw pt due to urinary retention. Pt had 3 days of urinary cath for decompression of the bladder after which TOV was attempted with success. She will follow up with urology for further eval of possible neurogenic bladder Pt was discharged to sar. She was encouraged to f/u with colorectal surgery for evaluation of fecal incontinence although not observed during admission. Her gabapentin frequency was increased to 4 times daily for pelvic pain. She will follow up with neurosurgery for further eval. She has an mri that she will get outpatient. Patient was discharged in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- -
- Labordaten
- 10/3 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 16.12.2022
- Impfdatum
- 12.02.2021
- Beginn
- 04.11.2022
- Tage bis Beginn
- 630,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
11/04/22 presents to ED for "shortness of breath". PMHx of "COPD, hypertension, pernicious anemia"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 11/04/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 26.11.2022
- Impfdatum
- 19.01.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 305,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Balance disorder
Cerebellar ataxia
Computerised tomogram normal
Condition aggravated
Dysarthria
Dysstasia
Electromyogram normal
Feeling abnormal
Gait disturbance
Muscle atrophy
Scan with contrast normal
Symptomtext
Equilibrium became worse (already has an existing condition due to Meniere's) , affected gait, slurred speech, lower body muscle degradation (cannot get up from a sitting position without help), significant brain fog all occurred post- vaccine. Some PT, no marked response.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- diagnosed as cerebellum ataxia. CT, Electromyography, contrast scans all proved negative.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Meniere's Disease, pre-diabetic, high cholesterol (managed with medication)
- Andere Medikamente
- Medicines ? Daily 11/15/22 ? Bayer Aspirin 81mg ? 1 ? Metformin 1000mg ? 2 xs per day ? Amlodipine Besylate 10mg ? Jardiance 25mg ? Ezetimibe 10mg ? Olmesartan Medoxomil 40mg ? Citalopram 20mg Vitamin B, D, C 1000, Zinc, Prilosec
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 02.02.2021
- Beginn
- 19.10.2022
- Tage bis Beginn
- 624,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Bed rest
COVID-19
Endotracheal intubation
Hypoaesthesia
Hypotension
Lethargy
Paraesthesia
SARS-CoV-2 test positive
Symptomtext
Pt to ED 10/18 for numbness and tingling in R leg. Pt COVID+ 10/19. 10/20 pt to complete 3 d course of remdesivir. 10/21 pt is intubated, hypotensive. 10/23 Pt lethargic, oriented x4. 10/27 Pt is alert and oriented x4; able to follow commands, on RA with no respiratory difficulties noted. 10/29 pt on bedrest, aox4, room air. 10/30 Pt A&Ox4 and VSS on room air. Pt discharged 11/1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- 15,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hepatic steatosis ...
- Andere Medikamente
- amLODIPine (NORVASC) 10 MG PO Tab apixaban ...
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 10.12.2021
- Beginn
- 15.05.2022
- Tage bis Beginn
- 156,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Blood creatinine increased
COVID-19
Dehydration
Dyspnoea
Oropharyngeal pain
SARS-CoV-2 test positive
White blood cell count increased
Symptomtext
5/15/2022- Presents to ED, c/o of SOB and sore throat, tested Covid + at home. Had fever of 100 at home. VSS in ED afebrile. WBC-15.7 , creatnine 1.91 and covid + test. Ordered Decadron , azithromycin and Bebtelovimab. Admit Covid 19. 5/16/2022- AKI s/t to dehydration d/t sore throat. Follow up with Nephro outpatient. Creatnine stable 1.6. WBC-12.6 Complete Zithromax and d/c home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, hyperlipidemia, Type 2 DM and CKD.
- Andere Medikamente
- -
- Allergien
- Procardia,Ampicillin, Latex, PCN and Tetracyclins.
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 02.11.2022
- Impfdatum
- 19.01.2021
- Beginn
- 06.09.2022
- Tage bis Beginn
- 595,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Atrial fibrillation
COVID-19
Condition aggravated
SARS-CoV-2 test positive
Symptomtext
09/06/22 presents to ED for "A. fib". PMHx of "A. fib."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 09/06/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test
Gait disturbance
Magnetic resonance imaging abnormal
Meniscus injury
Mobility decreased
Peripheral swelling
Symptomtext
Day after I received my vaccination my legs began swell to the point I could barely walk and was unable to bend my legs. The swelling was very bad initially and got better over the next 90 days. Went to heart doctor, liver doctor, and ortho with none of these finding anything wrong. Swelling was in both legs and came and went.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Blood work - results unknown. MRI - to confirm torn meniscus.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- A-Fib; Asthma
- Andere Medikamente
- Diltiazem; losartan; PRADAXA; testosterone
- Allergien
- Codeine; doxycycline; triple antibiotic ointment
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 15.01.2021
- Beginn
- 28.08.2022
- Tage bis Beginn
- 590,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest pain
SARS-CoV-2 test positive
Symptomtext
08/28/22 presents to EC ED for "right chest pain". PMHx of "right lung transplant on chronic immunosuppression, GERD, hypothyroidism, prior bladder cancer, osteoporosis, CKD, MDD/GAD"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 08/28/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 03.02.2021
- Beginn
- 03.08.2022
- Tage bis Beginn
- 546,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Atrial fibrillation
Blood thyroid stimulating hormone decreased
COVID-19
Cardioversion
Chest X-ray normal
Cold sweat
Dizziness
Electrocardiogram abnormal
Feeling hot
Gastrointestinal disorder
Heart rate increased
Hyperhidrosis
Hypotension
Nausea
SARS-CoV-2 test positive
Thyroxine free normal
Vomiting
Symptomtext
65-year-old woman with history of provoked right lower extremity DVT status post right total knee arthroplasty, HTN, anemia, hypocalcemia who comes to the emergency department due to dizziness, nausea and vomiting. Started 5 hours before presentation to the ER, she was at store, having episodes of diaphoresis, feeling hot, clammy and top of GI symptoms. Upon presentation to the ER, she was found to have new onset atrial fibrillation with RVR, heart rate as high as 134, blood pressure as low as 84/53 on the night of presentation. Received fluid bolus. She was found to be COVID-positive, vaccinated and posted with 1 booster. Chest x-ray without acute abnormalities, EKG was reviewed A. fib with RVR, without acute ischemic changes. Initially started on amiodarone drip which was later discontinued. TSH was 0.3 with normal free T4. Patient converted to normal sinus rhythm, started initially on heparin which was transitioned to Eliquis, hydrochlorothiazide and losartan were discontinued, started on Toprol 12.5 mg twice daily with good heart rate control. Unable to obtain echocardiogram inpatient due to COVID-positive status, okay per cardiology to do an echocardiogram as an outpatient. Instructed to follow-up with PCP to repeat thyroid function test in 4-6 weeks to rule out hyperthyroidism as an inciting etiology for her atrial fibrillation. Endocrinology follow-up added in AVS. Evaluated by ID did not require treatment for COVID during this admission.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- 2,0
- Labordaten
- 8/3 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 08.02.2021
- Beginn
- 26.09.2021
- Tage bis Beginn
- 230,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Symptomtext
Admit for COVID pna. Fully vaccinated 3/2021. Out of range for remdesivir and plasma. Steroids, O2, vit-c, vit-d, zinc, singulair, ivermectin, zithromax, doxy. Weaned to 3 L and discharged home with O2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 13.07.2022
- Impfdatum
- 17.01.2021
- Beginn
- 11.07.2022
- Tage bis Beginn
- 540,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Respiratory failure
Symptomtext
admitted to hospital with COVID pneumonia and respiratory failure. started on remdesivir and steroids
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 08.07.2022
- Impfdatum
- 20.04.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 78,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Cough
Decreased appetite
Dyspnoea
Dyspnoea exertional
Exposure to SARS-CoV-2
Symptomtext
Patient is a 75-year-old male with history of obesity hypoventilation syndrome, memory impairment, venous insufficiency, hyperglycemia, hyperlipidemia, hypertension who presents to the emergency room with shortness of breath. Patient was actually at the immediate care center earlier today for shortness of breath and was diagnosed with COVID-19, he had sats 88-89 on room air and was dyspneic with exertion so they recommended him come to the emergency room for further evaluation. Patient is fully vaccinated against COVID-19, however he did tell the emergency room provider that he was not vaccinated, his vaccinations are seen in epic. He does have history of memory impairment, and seems to be a somewhat poor historian and changes his story about onset of symptoms. In review of the note from immediate care center he did then that his wife had COVID and his symptoms have been ongoing for a few days. He tell me that he was not aware of any exposure but he has had symptoms for 2 days with shortness of breath and cough. She denies any fever, no nausea or vomiting although he has had a poor appetite the last few days. He states he feels much better since being put on oxygen, at this time he has no complaints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 05.02.2021
- Beginn
- 10.05.2022
- Tage bis Beginn
- 459,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Abdominal pain
Asthenia
Chest X-ray normal
Chest discomfort
Chills
Dyspnoea
Fatigue
Full blood count normal
Lipase normal
Liver function test normal
Productive cough
Pyrexia
Sputum discoloured
Troponin
Urine analysis normal
Symptomtext
Patient is fully vaccinated. 28-year-old female presents to the ED complaining of fatigue, generalized weakness, dyspnea. States that she was diagnosed with COVID 3 days ago. Has been having symptoms for the last 4 to 5 days. Also has a cough productive of yellow sputum. Having mild generalized chest tightness. On and off subjective fever and chills. Also having on and off mild generalized abdominal pain. No dysuria hematuria or polyuria. Symptoms are moderate in severity. She says that she was getting better and then worsened yesterday. No leg pain or swelling. No history of DVT/PE.BP 106/77 | Pulse 80 | Temp 98.4 ?F (36.9 ?C) (Oral) | Resp 18 | Ht 177.8 cm (5' 10") | Wt 77.1 kg (170 lb) | SpO2 100% Troponin less than 0.01. UA negative for UTI. Hepatic function and lipase normal. CBC and chest x-ray unremarkable.She was given IV fluids, Toradol Zofran and Robaxin. Discharged home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 05.02.2021
- Beginn
- 14.03.2021
- Tage bis Beginn
- 37,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Biopsy thyroid gland abnormal
Cardiac stress test
Dyspnoea
Echocardiogram
Electrocardiogram
Electrocardiogram ambulatory
Extrasystoles
Fatigue
Headache
Palpitations
Papillary thyroid cancer
Thyroid mass
Symptomtext
Racing and skipped heart beats, palpitations, some breathiness, fatigue, Mild headaches as reported in V-Safe application which continues On/off Fatigue Also, diagnosed in October 2021 with thyroid nodule which was biopsied and positive for papillary cancer. Partial thyroidectomy surgery on January 18, 2022. Surgery was delayed due to cardiac evaluation/workup for palpitations
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Cardiology evaluation, EKG's (3). Cardiac ECHO. Holter monitor, Stress test
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- Skelaxin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 19.01.2021
- Beginn
- 21.05.2022
- Tage bis Beginn
- 487,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Dyspnoea
Pyrexia
SARS-CoV-2 test positive
Symptomtext
5/21 79-year-old female with past medical history of CAD, hypertension, sleep apnea to ER for 4-day history of cough, shortness of breath, fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 5/21 Covid-19 by NAA, Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 21.10.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 42,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood pressure increased
Blood test normal
COVID-19
Chest X-ray abnormal
Cough
Dyspnoea
Fatigue
Feeling abnormal
Headache
Pneumonia viral
Pyrexia
Respiratory disorder
Respiratory tract congestion
SARS-CoV-2 test positive
Scan normal
Symptomtext
December 2 I started getting very tired, next morning felt bad, headache, fever of 100.3 temp. Got tested on Friday 12/3 tested positive for COVID-19. Sunday night & Monday, nasal swab burned. Respiratory problems started. Trouble breathing and extremely congested. Contacted MD Mon AM. Went to Urgent Care, got evaluated car-side. For about a week trouble breathing and coughing, BP was up. Monoclonal antibodies administered on 12/9. Started feeling a lot better by Saturday. Also got Z-Pak. Codeine cough syrup was also prescribed. Didn't feel recovered until Sat 12/14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- COVID-19 test bloodwork looked good chest X-ray showed mild viral pneumonia Follow-up X-ray in April was normal Sinus scan came back as normal
- Aktuelle Erkrankungen
- Sinus infections in Sept 2021
- Vorgeschichte
- Osteoporosis Mild asthma
- Andere Medikamente
- Flovent inhaler Flonase Astelin Prolia (2x year)
- Allergien
- Sulfa
- Vorherige Impfungen
- Flu vaccine and allergy shot.
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 27.04.2022
- Impfdatum
- 09.02.2021
- Beginn
- 06.04.2022
- Tage bis Beginn
- 421,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest X-ray abnormal
Chest discomfort
Chest pain
Cough
Dyspnoea
Hypoxia
Leukocytosis
Lung opacity
Platelet count decreased
Pneumonia
SARS-CoV-2 test positive
Symptomtext
Patient is fully vaccinated and boosted 10/27/2021. COVID + 4/6/2022.72y.o. male with a PMHx of R sided partial Lung resection, carcinoid tumor present to the hospital with complaint of Chest Pain and SOB. Symptoms began today and describes chest pain as pressure that is worse with deep breaths. Admits to nonproductive cough. Denies fever, chills, nausea, vomiting. No acute PE. Mild leukocytosis. Patient hypoxic requiring initiation of O2 via NC. PLTS 131; CXR: Bilateral lung opacities as described above may represent pneumonia. Treatment: O2 via NC, IV rocephin and azithromycin added, decadron. Patient discharged to home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 15.01.2021
- Beginn
- 13.04.2022
- Tage bis Beginn
- 453,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chills
Respiratory syncytial virus test positive
SARS-CoV-2 test positive
Tremor
Pain
Symptomtext
4/13/22 PMH significant for rheumatoid arthritis admitted due to rigors and body shaking.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- 4/14/22 COVID-19, RSV by NAA-- Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 15.01.2021
- Beginn
- 13.04.2022
- Tage bis Beginn
- 453,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chills
Respiratory syncytial virus test positive
SARS-CoV-2 test positive
Tremor
Pain
Symptomtext
4/13/22 PMH significant for rheumatoid arthritis admitted due to rigors and body shaking.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- 4/14/22 COVID-19, RSV by NAA-- Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 26.04.2022
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Injection site pain
Magnetic resonance imaging
Pain
X-ray normal
Symptomtext
I have had issues with my left shoulder for nearly 2 years. Arm hurt really bad from the first day I had the vaccine. It feels like a shoulder injury or rotator cuff injury. It continued to hurt 3 weeks afterwards when I went to get the next vaccine. The pain in my arm is so bad, that I can hardly take my wallet out of my pocket. I had the other vaccine in my right arm. I believe that the needle was too long and the shot was given up to high. I told my regular family doctor who thought it was something else. We were not able to get any results after being prescribed medications such as muscle relaxers. I had an x-ray which did not show anything so I decided to go to an orthopedic doctor. I have an appointment today with the orthopedic doctor. I get the results from the MRI that was performed on me last Friday 04-22-2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- X-ray, MRI.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type 2 Diabetes
- Andere Medikamente
- Metformin; Glipizide; B Complex; D Complex; Januvia
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 25.01.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 190,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Dyspnoea
Hypoxia
SARS-CoV-2 test positive
Symptomtext
8/3/21 h/o CAD s/p CABG and PCI, HLD, bipolar disorder who presented from urgent care for cough, SOB, found to be hypoxic
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 8/3/21 SARS-CoV-2 (COVID-19) by NAA Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 06.02.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 208,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
9/1/21 hx of HTN,DM, and GERD; presented w/ SOB
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 9/1/21 SARS-CoV-2 (COVID-19) by NAA, Micro Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 18.04.2022
- Impfdatum
- 06.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 23,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ankle brachial index
Blood test
Fatigue
Mobility decreased
Pain in extremity
Paraesthesia
Rash erythematous
Symptomtext
The week of Feb 20th, I began to experiencing pain in the right heel that slowly began to go up my right leg. The next day the same symptoms started on my left leg/calf. Went to the doctor on March 18th where they ran some tests and prescribed 5days of anti-biotic which did not help. On March 25th 2021 both legs felt very fatigued. I began to develop red spots on my lower legs which lasted for a couple of days. By the time I saw my doctor it had cleared up. Went to doctor again on April 20th which was more bloodwork and a lower extremity test on 4/22. I was then referred to a neurologist whom I saw on June 3rd. The doctor stated at this visit that it was most likely not due to the vaccine. I started physical therapy on July 1st and ended Oct which helped. In Dec, the leg tingling began again and in Jan, it was getting harder to get out of bed and the sensation had spread to my hips. By the end of Jan, the sensation had gone back down.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- ABI test; blood work
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Pravastatin, Omeprazole
- Allergien
- Sulfa; Penicillin
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 05.04.2022
- Impfdatum
- 11.02.2021
- Beginn
- 04.04.2022
- Tage bis Beginn
- 417,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
Chest pain
Diarrhoea
Dyspnoea
Exposure to SARS-CoV-2
Headache
Nausea
Pyrexia
SARS-CoV-2 test positive
Vomiting
Symptomtext
Hospitalized for weakness, covid positive on 4/2 after being exposed to daughter. Headache, fever, dyspnea, chest pain, nausea, vomiting, diarrhea.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Kidney disease stage 4, CVA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 05.04.2022
- Impfdatum
- 03.02.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 148,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Balance disorder
Blood test
Fall
Magnetic resonance imaging
Tremor
Symptomtext
Approximately 3 months after vaccine, I began experiencing tremors in hands, unsteady balance, began running into walls and furniture, and frequent falls. Doctor prescribed B12 and symptoms have improved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- Blood work MRI
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Pantoprazole, Crestor, Aspirin, Amitriptyline, Liothyronine, Perphenazine, Bethanechol, Restasis, Multiple vitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 04.04.2022
- Impfdatum
- 15.01.2021
- Beginn
- 18.01.2022
- Tage bis Beginn
- 368,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea exertional
SARS-CoV-2 test positive
Symptomtext
01/18/22 presents to ED for "Dyspnea on exertion". PMHx of "CAD, CABG x 1 and stents, AVR replacement and DM A1C 6.1 x 1mo, GERD with Barret's"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- -
- Labordaten
- 01/19/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 24.03.2022
- Impfdatum
- 05.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Cough
Dyspnoea
Feeling abnormal
Injection site pain
Myalgia
Palpitations
Pneumonia
SARS-CoV-2 test positive
Streptococcal infection
Streptococcus test positive
Symptomtext
I was having difficulty breathing. I noticed my heart was racing and I had a lingering cough. I also had pain at the injection site. So I went to the urgent care center. They triaged me and advised me to take OTC medicine for muscle pain and tested for COVID which was negative. 2 weeks later I went back and they prescribed cough syrup for the lingering cough. The remaining symptoms did not get better and I tested positive for COVID 3 months later. The coughing and shortness of breath continued I was given an infusion. After the infusion I caught pneumonia. I went back to urgent care and had a breathing treatment. I was prescribed cough syrup and nasal spray. I was also diagnosed with strep as well. I was given albuterol. The cough resolved in November or December. I still have a brain fog at times.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- COVID Swab, X-ray, throat swab.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Shortness of breath
- Andere Medikamente
- Vitamin D; Zinc; Goji Berry; Tylenol
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 23.03.2022
- Impfdatum
- 04.02.2021
- Beginn
- 21.09.2021
- Tage bis Beginn
- 229,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Nausea
SARS-CoV-2 test positive
Vomiting
Symptomtext
Presented with N/V x 4 days; Covid + in ED; admit to facility with Covid 19 infection; CXR consistent with Covid PNA; tx with Vit C, singulair, zinc; no supplemental needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 22.03.2022
- Impfdatum
- 22.02.2020
- Beginn
- 01.05.2020
- Tage bis Beginn
- 69,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Costochondritis
Dyspnoea
Fatigue
Feeling abnormal
Gastrooesophageal reflux disease
Palpitations
Symptomtext
Very healthy person. I developed several odd issues in the following order costochondroitis shortness of breath heart palpitations acid reflux extreme fatigue extreme brain fog
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- emergency room Hospital diagnosed and treated costochondroitis. primary doctor could not explain the rest of the symptoms
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- basic vitamins, bio identical hormones
- Allergien
- sulfa
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 18.03.2022
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram normal
Discomfort
Facial pain
Hypoaesthesia
Hypoaesthesia oral
Injection site pain
Injection site paraesthesia
Nasal congestion
Neck pain
Pain in extremity
Paraesthesia
Respiratory tract congestion
Tooth extraction
Toothache
Symptomtext
12 hours later after receiving the vaccine I could feel pain and a tingling feeling moving from the injection site up my arm to my neck and then to my right cheek. It was uncomfortable and it lasted for about 3 days. I had to take medicine once and then it went away. I got the next dose on February 26, 2021 (Lot #: EN6202). I got it in my left arm, and I didn't have any problems with it. In mid June 2021, I started having bad episodes of cheek pain, congestion, and teeth pain. I went to about 3 different doctors. They all thought it was a sinus infection. I took some antibiotics, but that didn't help. I went back to my dentist in June 2021, and I told them there was something wrong with the right side of my face and teeth area. They decided to do a root canal. On October 14, 2021, I went to have the root canal. When the dentist went half way through it, they saw a cracked tooth. They said they wouldn't be able to do the root canal because my tooth would need to removed. On October 22, 2021, I had to get my tooth pulled. Then on October 29, 2021, I had to go back to the doctor because of the pain I was in. They gave me steroids that did help. My cheek and gums are still numb. I saw an ENT doctor on February 21, 2022 because the numbness on my face had spread from the center of my right cheek to the bottom of my eye and upper gum area. I have nasal congestion. My doctor told me that if I notice paralysis in my face then I need to come back in. The numbness is only on the right side.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site paraesthesia
- Hospital-Tage
- -
- Labordaten
- CT Scan- no issues with sinuses (12/29/2021)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Thyroid Disease
- Andere Medikamente
- Levothyroxine 75mcg
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 05.02.2021
- Beginn
- 17.02.2022
- Tage bis Beginn
- 377,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abdominal discomfort
Anticoagulant therapy
Ascites
Aspiration pleural cavity
COVID-19
Decreased appetite
Dyspnoea
Echocardiogram abnormal
Fibrin D dimer increased
Paracentesis
Pneumonia
Pulmonary arteriovenous fistula
SARS-CoV-2 test positive
Symptomtext
Patient is fully vaccinated and boosted. COVID positive 2/17/2022 on admission to hospital. 79-year-old male with a history of follicular lymphoma, umbilical and inguinal hernia, hypertension, diabetes who presented with worsening shortness of breath and abdominal discomfort. Patient stated that shortness of breath started a month ago. Patient reports being diagnosed with Covid last month. Patient states that he lost appetite and he experiences abdominal discomfort after eating. Per EMS, oxygen was 88% upon arrival. Patient is status post thoracentesis and paracentesis for acites and patient condition improved. Treatment: oxygen, IV decadron, Breo inhaler, alberterol for pneumonia. Recent 2-D echo with bubble study revealed pulmonary AV malformation. D-dimer, elevated given IV heparin. Patient discharged with home O2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 02.02.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 204,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Atrial fibrillation
Cardiac ablation
Cardioversion
Condition aggravated
Electrocardiogram abnormal
Exercise tolerance decreased
Ventricular extrasystoles
Symptomtext
Entered atrial fibrillation during light exercise August 25, 2021. Self-diagnosed using Kardia DTC EKG monitor. Began anticoagulant therapy as per doctor's orders: rivaroxaban 20mg daily. Outpatient DC cardioversion Sept. 1 was successful, and I remained in sinus rhythm. Then I had a repeat episode of atrial fibrillation beginning the morning of December 4. Successful cardioversion Dec. 8. Both cardioversions performed by Dr. Previous catheter ablation procedure was August 9, 2021 at hospital, requiring an overnight hospital stay. Procedure successfully resolved premature ventricular contractions arising from two sites.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Three previous atrial fibrillation events in 2016-17, s/p catheter ablation for premature ventric. contract. July 2021
- Andere Medikamente
- Atenolol 12.5 mg b.i.d, cetirizine 10 mg daily
- Allergien
- No known drug or food allergies, allergic to polle dust, mold.
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 16.01.2021
- Beginn
- 27.12.2021
- Tage bis Beginn
- 345,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
Pyrexia
SARS-CoV-2 test positive
Symptomtext
12/27/21 presents to EC ED for "fever and dyspnea". PMHx of "CAD, HTN, HLD."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 12/27/21 SARS-CoV-2 (COVID-19) detected.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 05.02.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 318,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Hypoxia
Symptomtext
12/20/21 presents to ED for "Acute hypoxia due to COVID 19 pneumonia". PMHx of "HTN, HLD, CAD and asthma".
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 24.02.2022
- Impfdatum
- 18.01.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 346,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
12/30/21 presents to ED for "shortness of breath". PMHx of "A-Fib on Coumadin, CAD, LE DVT, CHF, GERD, HLD, and Lymphoma"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 12/30/21 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 17.09.2021
- Beginn
- 20.02.2022
- Tage bis Beginn
- 156,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 04.02.2021
- Beginn
- 26.08.2021
- Tage bis Beginn
- 203,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood test
C-reactive protein increased
Inflammation
Insomnia
Mobility decreased
Pain in extremity
Symptomtext
I started having pain in both shoulders and upper arms to the point wasn't able to move them. The pain was causing me to have trouble sleeping. I went to the doctor, C-reactive level in the blood was 68 and normal is 8. I was prescribed Prednisone, still currently on this medication to monitor my levels. I'm still trying to get this under control and has been a change in my life. I don't know if this is a result of the vaccine and wanted to report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Blood work (monthly for inflammation level).
- Aktuelle Erkrankungen
- Bad Cold
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- Telmisartan, Nexium 20 mg, Hydrochlorothiazide, Low dose Aspirin, Topamax
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 11.02.2022
- Impfdatum
- 07.10.2021
- Beginn
- 10.02.2022
- Tage bis Beginn
- 126,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 05.02.2021
- Beginn
- 05.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthma
Chest X-ray
Chest discomfort
Condition aggravated
Full blood count normal
Pruritus
SARS-CoV-2 test negative
Urticaria
Wheezing
Symptomtext
I started itching almost immediately after the vaccine but it was bearable. On the drive home the itching got worse and later into the night I began itching severely all over my body and noticed hives developing so I took an Allegra to help. The next morning the hives were now on my legs, chest, arms and neck/face area so I then took 2 Benadryl and the symptoms got better and by later that day the hives got better as well. In Oct I had an asthma flare up and because my inhaler was not helping I went to the local Urgent Care. There a COVID test and Chest X-ray was performed but everything was normal and the test was negative. 3 breathing treatments were given at the Urgent care, 1 every 15-20 minutes, prednisone was administered and I was released after being monitored for a while and advised if the symptoms returned take an additional breathing treatment and if the symptoms got worse to go the ER. At home another breathing treatment was performed after about 4hrs. Waited another 20 minutes and took another and continued to take meds and got better. But in Dec I began wheezing again and had to use my inhaler and take breathing treatments more frequently. Reached out to my PCP because I had taken 3 breathing treatments at home which did not work and was advised to got to the Urgent Care, but when the doctor listened to me he said I was too tight and advised I go to the ER. I then went to an alternate ER and there 1 more breathing treatment was given, prednisone administered again and another Chest X-ray and COVID test were performed and still all were normal and the COVID test was negative again at this time. The chest tightness had lessened and the wheezing had lessened and I was released with more prednisone and advised to follow up with my PCP and Pulmonologist. Because I still had the chest tightness my PCP gave more prednisone and advised I see my pulmonologist. At that Pulmonology appointment I felt better but I had been on prednisone for about 16 days at that time. My pulmonologist advised to continue with current meds, albuterol breathing treatments and the use of Cingular at night and Brio Alito in the mornings. I have since noticed the chest tightness has returned, wheezing and coughing has returned also so I now have a appointment again tomorrow 2/9 with my PCP and 2/17 with my Pulmonologist to see what else can be done to help. My asthma has been well controlled for year but it seems since I got the vaccine I am having more flare ups that are totally unusual for me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- COVID-19-neg, Chest X-ray-normal, CBC-normal.
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- Asthma, Migraines
- Andere Medikamente
- no
- Allergien
- Penicillin, Percocet
- Vorherige Impfungen
- Pfizer COVID-19.
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 19.08.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 166,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Symptomtext
admit covid pna
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 03.02.2022
- Impfdatum
- 10.03.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Amnesia
Arthralgia
Autoimmune thyroiditis
Chest pain
Dyspnoea
Fatigue
Headache
Hypothyroidism
Symptomtext
Fatigue, chest pains, inability to inhale completely, memory loss, continual joint aches, development of Hashimotos's disease, decrease in thyroid function, sever headaches
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Covid -19 6 months prior
- Vorgeschichte
- High Cholesterol
- Andere Medikamente
- Rosuvastatin, Montelukast, 80mg baby aspirin, Men's multi-vitamin
- Allergien
- Ampicillan, Gluten, Various plants and animals
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 27.09.2021
- Beginn
- 27.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Cough
Fatigue
Musculoskeletal chest pain
Pain
Productive cough
Symptomtext
Later on after being vaccinated I felt chills, body aches and fatigued and then two days later I produced a dry cough and then on oct 7th the cough got worse on friday on oct 8th the cough got productive and hurt my ribs and then on 10-13 I had a visit with my dr and she gave me and albuterol inhaler for my cough and breathing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Musculoskeletal chest pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Valsartin 324\25 1 tab daily Metoprolol 50mg 2x daily Atorvastatin 10mg 1 tab daily Biotin 25mg every other day as needed Vitamin d 3 50mcg every other day as needed
- Allergien
- Penicillin, Latex and Codeine
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 20.03.2021
- Beginn
- 24.01.2022
- Tage bis Beginn
- 310,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Activated partial thromboplastin time shortened
Alanine aminotransferase normal
Albumin globulin ratio
Angiogram pulmonary normal
Anion gap
Appetite disorder
Aspartate aminotransferase normal
Asthenia
Basophil count decreased
Basophil percentage decreased
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium normal
Blood chloride increased
Blood creatinine normal
Blood glucose normal
Blood magnesium normal
Symptomtext
1/24/22 Patient states that she was diagnosed with Covid on 1/10/2022 and at that time was experiencing headache, sore throat and cough. Patient states that her symptoms have continued to get progressively worse since that time. She continues to experience headache, and cough but has also developed worsening shortness of breath, difficulty breathing and severe dizziness. Patient states that she has also been experiencing significant fatigue and weakness stating that it takes a significant amount of energy for her to be able to get up to use the restroom and takes her several minutes of resting between moving. 1/24/22 Patient states that she easily becomes short of breath when walking and feels as though her heart is racing. Patient feels that her dizziness is as if the room is spinning making it very difficult for her to walk. She also feels lightheaded feeling as if she may pass out. Patient has recently developed diarrhea and has had difficulty tolerating foods due to nausea. She has had a temperature to 100.0 yesterday. Review of Systems Constitutional: Positive for activity change, appetite change, chills, diaphoresis, fatigue and fever. HENT: Positive for congestion, rhinorrhea and sore throat. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Cardiovascular: Positive for chest pain and palpitations. Gastrointestinal: Positive for diarrhea and nausea. Negative for abdominal pain and vomiting. Neurological: Positive for dizziness, tremors, light-headedness and headaches.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 1/24/22 No COVID test result listed for 2022 1/24/22 Sodium 142 136 - 145 mmol/L Potassium 3.7 3.5 - 5.1 mmol/L Chloride 108 (*) 98 - 107 mmol/L Carbon Dioxide 20 (*) 22 - 29 mmol/L Anion Gap 14 (*) 5 - 13 (arb'U) Glucose 88 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 8 7 - 19 mg/dL Creatinine-Blood 0.75 0.55 - 1.02 mg/dL BUN/Creatinine Ratio 10.7 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR >60 >60 /1.73 m2 Total Protein 7.3 6.4 - 8.2 g/dL Albumin 4.4 3.5 - 5.2 g/dL Globulin 2.9 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.5 1.1 - 2.5 RATIO Calcium 10.3 (*) 8.4 - 10.2 mg/dL Total Bilirubin 0.5 0.2 - 1.2 mg/dL AST/SGOT 17 5 - 34 U/L ALT/SGPT 16 0 - 55 U/L Alkaline Phosphatase 74 40 - 150 U/L PROTIME-INR Prothrombin Time 12.1 10.3 - 13.3 s INR 1.0 INR PARTIAL THROMBOPLASTIN TIME Partial Thromboplastin Time 32.1 25.1 - 36.5 s CBC W/DIFF White Blood Count 7.04 4.5 - 11.0 10*3/uL Red Blood Count 4.92 4.0 - 5.2 10*6/uL Hemoglobin 14.0 12.0 - 16.0 g/dL Hematocrit 42.1 36.0 - 46.0 % Mean Corpuscular Volume 85.6 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 28.5 26.0 - 34.0 pg Mean Corpuscular HGB Conc 33.3 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 12.2 12.0 - 16.8 % Platelet Count 280 140 - 440 10*3/uL Mean Platelet Volume 9.2 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 68.0 45 - 80 % Lymphocyte % 25.6 15 - 50 % Monocyte % 4.8 0 - 15 % Eosinophil% 0.9 0 - 7 % BASO% 0.3 0 - 2 % Immature Granulocyte% 0.4 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 4.79 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.80 0.7 - 5.5 10*3/uL Monocyte Absolute 0.34 0.0 - 1.7 10*3/uL EOS-Absolute 0.06 0.0 - 0.8 10*3/uL Basophil Abs 0.02 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.03 0.00 - 0.10 10*3/uL B-TYPE NATRIURETIC PEPTIDE B-Type Natriuretic Peptide <10.0 0 - 85 pg/mL MAGNESIUM Magnesium 2.0 1.6 - 2.6 mg/dL TROPONIN Troponin <0.010 0.000 - 0.034 ng/mL HCG,QUALITATIVE HCG Qualitative Serum Negative Negative TROPONIN 1/24/22 Chest xray: IMPRESSION: No active cardiopulmonary disease. 1/24/22 CT Angiogram Chest for PE: IMPRESSION: 1. No pulmonary embolism or aortic dissection. 2. No acute cardiopulmonary abnormality. No CT signs of Covid 19 pneumonitis.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety o Arnold-Chiari malformation (CMS/HCC) o Depression o Family history of blood clots FATHER o Gastroparesis o GERD (gastroesophageal reflux disease) o Migraines o Personal history of sepsis S/P GALLBLADDER SX o Ulcerative colitis (CMS/HCC o Gastroparesis o GERD (gastroesophageal reflux disease) o Migraines o Personal history of sepsis S/P GALLBLADDER SX o Ulcerative colitis
- Andere Medikamente
- albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulizer solution Take 1 ampule by nebulization every 4 (four) hours as needed for Wheezing for up to 30 days. 75 mL 11 o albuterol HFA 108 (90 Base) MCG/ACT inhaler Inhale 2 puffs into the lungs
- Allergien
- COVID19 (mrna) vaccine, Piperacillin-tazobactam in dex, Dilaudid, Duloxetine HCL, Solu-medrol
- Vorherige Impfungen
- Moderna 3/20/21-anaphylaxis, no other symptoms or treatment listed, also listed Moderna again on 10/14/21
- Staat
- -
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 03.03.2021
- Beginn
- 10.01.2022
- Tage bis Beginn
- 313,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Hypoxia
SARS-CoV-2 test positive
Symptomtext
LOCAL TITLE: EMERGENCY STANDARD TITLE: EMERGENCY MEDICINE NOTE DATE OF NOTE: JAN 10, 2022@16:30 ENTRY DATE: JAN 10, 2022@16:30:28 AUTHOR: EXP COSIGNER: URGENCY: STATUS: COMPLETED *** EMERGENCY Has ADDENDA *** ER Triage Note Patient, a 69 year old FEMALE presents to Emergency Department on 01/10/22 16:15. Tetanus status: Last Tdap: Jul 25, 2017 LMP: NA - menopausal Chief Complaint: Visit CC: Pt tested positive at Summit, needs meds filled. LOCAL TITLE: H&P_ STANDARD TITLE: H & P NOTE DATE OF NOTE: JAN 10, 2022@18:24 ENTRY DATE: JAN 10, 2022@18:24:36 AUTHOR: EXP COSIGNER: URGENCY: STATUS: COMPLETED *** H&P_ Has ADDENDA *** Patient is a 69 year old FEMALE who is being admitted to the Hospital. This patient meets inpatient level of care because COVID pneumonia w/ hypoxia LOCAL TITLE: H&P_ STANDARD TITLE: H & P NOTE DATE OF NOTE: JAN 10, 2022@18:24 ENTRY DATE: JAN 10, 2022@18:24:36 AUTHOR: EXP COSIGNER: URGENCY: STATUS: COMPLETED *** H&P_ Has ADDENDA *** Patient is a 69 year old FEMALE who is being admitted to the Hospital. This patient meets inpatient level of care because COVID pneumonia w/ hypoxia Patient, a 69 year old FEMALE currently on FCU was admitted on JAN 10,2022 17:16.The patient is being discharged 14-Jan-2022by.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 09.02.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 51,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
Arthritis
Calcification of muscle
Hypertension
Mobility decreased
Nerve compression
X-ray
Symptomtext
It was left shoulder pain, extreme. Not heart related. It was so severe she couldn't move. My sister took her to her PCP Dr. and they did an x-ray and everything was fine. Her BP was high just because of the pain. 2 days later my sister took her to the ER because of high blood pressure. Hospital. Mon April 26th x-ray showed calcification, arthritis and a pinched nerve.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- Dr. did an x-ray on left shoulder - chowed calcification, arthritis and a pinched nerve.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Diagnosed with bladder cancer 2017
- Andere Medikamente
- Baby aspirin; Lorazepam; Diclofenac; Printol; RESTASIS
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 18.01.2022
- Impfdatum
- 12.02.2021
- Beginn
- 07.01.2022
- Tage bis Beginn
- 329,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Condition aggravated
Dyspnoea exertional
Fatigue
Feeling abnormal
Headache
Myalgia
Oxygen therapy
Productive cough
Pyrexia
SARS-CoV-2 test positive
Sinus congestion
Symptomtext
Per MD note, video visit 1-12-22 patient wanted to be seen for COVID 19 , tested positive on Friday 1-8-2022. Started with headaches last Tuesday with fever, headaches , myalgia , no sore throat , has sinus congestion , has DOE , has coughs brings up green mucus. no changes taste or smell , no diarrhea , has brain fog , has fatigue more then before . tried Tylenol , Advil cold plus checked oxygen is running in the 80 uses oxygen 5 l gets 93% . patient uses oxygen at night ususaly , never during the daytime .Stated that without oxygen 85%RA and HR 77 . 1) COVID-19 virus infection (ICD-10: U07.1) recommended to go to the hospital for antiviral therapy . patient declines , understands the risk . will continue same oxygen , start decadron 6 mg po daily for 10 -14 days - script was sent to pharmacy continue same neb therapy if not better needs to go to emergency room .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- Bee Venom
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 24.02.2021
- Beginn
- 17.01.2022
- Tage bis Beginn
- 327,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Computerised tomogram abdomen abnormal
Cough
Diarrhoea
Dizziness
Gait inability
Nausea
Pneumonia
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Vaccine breakthrough infection
Vomiting
Symptomtext
Covid19 breakthrough. 1st vaccine received on 01/27/2021. 66 y/o PMH ESRD on peritoneal dialysis, DM, HTN , Breast CA presents to ED for c/o progressive weakness, dizziness and unable to walk. Pt initially had symptoms begin 12/31 with fever, cough, congestion, N/V/D which improved but then returned. CT A/P multifocal PNA, Rm air sat 98%. Pt treated with low dose oral steroids.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia
- Hospital-Tage
- -
- Labordaten
- SARS CoV 2 PCR Covid19- Detected 01/17/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ESRD on peritoneal dialysis, DM, HTN, Breast CA
- Andere Medikamente
- -
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 16.01.2022
- Impfdatum
- 21.01.2021
- Beginn
- 11.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Chills
Inflammation
Inflammatory marker increased
Loss of personal independence in daily activities
Malaise
Mobility decreased
Musculoskeletal stiffness
Pain
Pain in extremity
Pyrexia
SARS-CoV-2 test negative
Swelling
Symptomtext
22 hours after the second Pfizer vaccine dose patient developed a fever and malaise. Next day she was so stiff and sore she could not raise herself on the couch to take the Tylenol and Ibubrofen. I had to put the meds in her mouth while she was lying down and give her sips of water with a straw. She had chills, fever and stiffness for two weeks and we were snowed in. Finally got her to her medical doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Tests for active Covid infection were negative. Inflammatory markers were high and the doctor started her on steroids and sent her to a rheumatologist. He felt it was an auto inflammatory process that started when she had the second Covid injection. He has continued the prednisone since Feb 2021. When she tries to taper off this her inflammation (hand pain, stiffness, swelling and daily fevers )come back and she has to go back to the higher dose. This has been going on since Feb 2021
- Aktuelle Erkrankungen
- Hypertension being treated
- Vorgeschichte
- No
- Andere Medikamente
- Lorsatin
- Allergien
- Ragweed
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 01.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 14,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arrhythmia
Cardiac stress test
Dyspnoea
Echocardiogram
Electrocardiogram
Electrocardiogram ambulatory
Palpitations
Symptomtext
"Palpitations" later dx as Arrythmia by cardiologist. Difficulty breathing and heart "racing" just getting out of car and began walking at normal pace. Was initially intermittent. Increased in frequency at end of October, no pattern of event trigger; e.g., walking from one end of house to other could cause symptoms. First week in November became multiple events daily. Scheduled appt with GP. Saw GP on 11/08/2021 said if continued for another 5 days, see a cardiologist. Saw cardiologist on 11/16/2021. Rx for low dose of beta blocker and scheduled multiple tests because of anomaly on ECG and family hx of heart issues on maternal side. All tests completed by 12/15/2021 and heart of "fine". Beta blocker has helped but still have some break through episodes occasionally. No pattern to onset or time of day. Cardiologist suggested might be stress reaction. Lately has seen a relationship b/w possible dehydration and arrhythmia episodes, i.e., if I experience symptoms and drink water, symptoms ease up. I have no history of heart issues. Elevated BP has been managed for over 15 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arrhythmia
- Hospital-Tage
- -
- Labordaten
- ECG 11/16/2021; Eco-cardiogram 11/30/2021; 24-hr heart monitor 12/01/2021; Nuclear Stress Test 12/06/2021
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- thryoid, high blood pressure
- Andere Medikamente
- losartan, amlodipine, synthroid, magnesium, low dose aspirin, osteo-biflex, Biotin complex, focus factor, flax seed oil, cinnamon, tumeric, b-12 sublingual, probiotic.
- Allergien
- sulfa, feldene, lamb, saki
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 11.02.2021
- Beginn
- 27.12.2021
- Tage bis Beginn
- 319,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Dyspnoea
Lung disorder
Mental status changes
Pleural effusion
SARS-CoV-2 test positive
Urinary tract infection
Symptomtext
Patient received pfizer vaccine on 02/11/21 and 03/4/21. COVID positive on 12/27/21 and hospitalized 12/28/21. She had changes in mental status, shortness of breath, and UTI. Noted to have COVID pneumonia in addition to a UTI. She does appear altered, unclear of baseline mental status. CXR reviewed. Remains on RA. Hemodynamically stable. Receiving IVFs and IV abx in the ED which will be continued. To be admitted for further evaluation and management. received doxycycline and ceftriaxone. Discharged on 1/5/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 8,0
- Labordaten
- 12/27/21 COVID19: positive 12/28/21 chest xray: Airspace disease in the left lower lobe as well as a tiny left effusion. These findings are nonspecific, but can be seen in the setting of COVID infection.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ? Asthma ? Depression ? Diabetes mellitus (HCC) ? High cholesterol ? Hypertension
- Andere Medikamente
- lantus, metformin, miconazole, aspirin, atorvastatin, calcium, clopidogrel, humalog, losartan, montelukast, omeprazole, pramipexole
- Allergien
- Levofloxacin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.01.2022
- Impfdatum
- 09.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Dizziness
Malaise
Tremor
Vertigo
Symptomtext
Vertigo; Dizziness; Weakness; Trembling in the leg; I still feel weak; Shakiness in my hand; I am not feeling too well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 09Feb2021 (Lot number: EL9269) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VERTIGO (non-serious) with onset 2021, outcome "not recovered", described as "Vertigo"; DIZZINESS (non-serious) with onset 2021, outcome "not recovered", described as "Dizziness"; ASTHENIA (non-serious) with onset 2021, outcome "not recovered", described as "Weakness"; TREMOR (non-serious) with onset 2021, outcome "not recovered", described as "Trembling in the leg"; ASTHENIA (non-serious) with onset 2021, outcome "not recovered", described as "I still feel weak"; TREMOR (non-serious) with onset 2021, outcome "not recovered", described as "Shakiness in my hand"; MALAISE (non-serious) with onset 2021, outcome "not recovered", described as "I am not feeling too well". Additional Information: It was reported that NDC number and UPC number of Covid 19 vaccine was unknown. Patient did not have any reaction right away but patient think like sometime around the weekend patient started getting vertigo and dizziness, weakness, trembling in the leg and it has been stopped patient meant it comes and go, symptoms are coming and going and patient was looking at the papers and saw there was symptoms of dizziness, patient thought it might be something related, it didn't happened right away, it happened by weekend so now it's really almost a month and patient still feel weak and dizzy every now and then. Patient registered for second dose because patient was still weak and do not feel normal right now. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 06.01.2022
- Impfdatum
- 14.01.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chest discomfort
Chest pain
Dyspnoea
Dyspnoea exertional
Laboratory test
Rash
Symptomtext
I still have chest pain, shortness of breath and intermittent rashes that I cannot get rid of. I thought it was a temporary side effect and would go away. It never went away, sometimes its really bad chest pain and sometimes it's a discomfort, but it is always on my sternum. A pressure lingers most of the day when it efaces. The shortness of breath is worse after exersicing. I never contracted COVID and I'm afraid to excerise in case of the chest pain/SOB. I never had heart problems, painful rashes or lung problems before. No family history of heart issues. I am not a smoker either. I do have GI issuses IBS, but thats it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 02/27/2021 Labwork because of a rash June 2021 visit with a cardiologist
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- IBS
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 30.12.2021
- Impfdatum
- 21.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Atrial fibrillation
Cardiac monitoring
Dehydration
Symptomtext
After receiving the first shot I went home and had an alcoholic beverage and experienced an AFIB event. I had never before experienced AFIB but my Apple Watch diagnosed it. I subsequently saw my cardiologist and wore a monitoring device for two weeks which recorded another AFIB event. When I had the second shot I did not experience an event directly but have experienced about 6 or 7 events in the past 10 months. The most recent was two days after I received a booster shot but seemed to be triggered by my being dehydrated as well after a long bike ride. Triggering of an event also seemed to be related to consumption of alcohol which I have now ceased to consume. After stopping alcohol I had gone 4 months without an event culminating with the booster-related event mentioned above.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- -
- Labordaten
- Heart Monitor for two weeks at the end of June/beginning of July.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Previous stroke at 44 years of age followed by PFO closure procedure
- Andere Medikamente
- Azaelic Acid cream
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- U
- Eingang
- 29.12.2021
- Impfdatum
- 10.02.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 189,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Cough
Dyspnoea
Headache
Myalgia
Nasal congestion
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Presents to the ED for SOB w/ associated cough,myalgias and HA nasal congestion/ sore throat, fever, and difficulty breathing on 8/6.tested positive for COVID on 08/16.1. COVID-19 pneumonia-Oxygen supplementation, IV empiric antibiotics .Discharge Condition:Improved Completed COVID Vacination 2/10/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 29.12.2021
- Impfdatum
- 09.02.2021
- Beginn
- 22.08.2021
- Tage bis Beginn
- 194,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
COVID-19 pneumonia
Cough
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Presented for SOB, nonproductive cough. Reports COVID + on 8/1 PTA. Hx of HTN, Afib, CAD. Admit for COVID PNA. Spportive tx only required, Vit D, zinc. DC'd to home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 28.12.2021
- Impfdatum
- 24.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Grip strength decreased
Insomnia
Mobility decreased
Polymyalgia rheumatica
Prostatic specific antigen increased
Spinal X-ray
Symptomtext
I had pain in my shoulders and hips. I couldn't rest or pick something up off the ground. In bed I had to sit up. This was going on for two months before it was properly diagnosed. I was diagnosed with Polyrheumatica myalgia in May 2021. I was prescribed prednisone. After taking the prednisone I was pain free after 2 hours of receiving it. After the 3rd dose which was 9/25/2021 I had a PSA test and it was high. My doctor said he believes that the results was because of receiving the 3rd dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Back X-ray; PMR Test; PSA Test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Polyrheumatica myalgia (now)
- Andere Medikamente
- Simvastatin 20mg, Baby Aspirin 81mg
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 27.12.2021
- Impfdatum
- 01.04.2021
- Beginn
- 10.06.2021
- Tage bis Beginn
- 70,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Alopecia
Arthralgia
Condition aggravated
Rash
Tremor
Symptomtext
facial body rashes internal tremors nerves joint pain hair falling out
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- facial body rashes tremors nerves not sleeping or eating properly joints hurting
- Andere Medikamente
- blood pressure medicine amlodipine metroprolol levothyroxine
- Allergien
- penicilin amoxocilin sulfates kiwin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 21.12.2021
- Impfdatum
- 06.02.2021
- Beginn
- 05.12.2021
- Tage bis Beginn
- 302,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Cough
Dyspnoea
SARS-CoV-2 test positive
Secretion discharge
Sinus congestion
Symptomtext
short of breath, mucous drainage, cough, sinus congestion +COVID 19 test
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 21.12.2021
- Impfdatum
- 08.02.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 218,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19 pneumonia
Cough
Dyspnoea
Oropharyngeal pain
Oxygen saturation decreased
Pyrexia
SARS-CoV-2 test positive
Troponin increased
Symptomtext
DX COVID-19 84-year-old male with a history of COPD . He states that he decided to take a trip to visit his parents cemetery. He states the day he was coming back he started getting a sore throat of the drive home. The next day he was having some fevers and felt weak. He is coughing he is getting more short of breath as the days went on. He was tested for was found to be positive this past Thursday. He continued to worsen and his oxygen saturations at home were going below 80. He came to the hospital and was subsequently admitted. He is currently on about 8 L of oxygen per minute. Patient was admitted to the hospital. He was treated for COVID 19 pneumonia; (remdesivir and decadron). He is followed by infectious disease and pulmonary as well as cardiology ( for elevated troponins). He improved clinically and was discharged home with outpatient follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 17.12.2021
- Impfdatum
- 01.02.2021
- Beginn
- 03.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Alanine aminotransferase normal
Albumin globulin ratio normal
Arthralgia
Aspartate aminotransferase normal
Bilirubin conjugated normal
Blood albumin normal
Blood alkaline phosphatase increased
Blood bilirubin normal
Blood bilirubin unconjugated normal
Chest pain
Fatigue
Gamma-glutamyltransferase increased
Globulin
Headache
Hepatic cyst
Hepatic enzyme increased
Hepatic steatosis
Hepatomegaly
Symptomtext
Transient joint pain, chest pain, late severe fatigue , headache for 8 weeks. Elevated liver enzymes Concerned about a possible autoimmune disease that had never been diagnosed. Nothing was found on diagnostic tests.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 1/28/2021. Yearly stress test and echo negative. 3/15/21 Rheumatoid factor <10; sedimentation rate 12; hepatic function panel - total protein7.2, albumin 4.2, alkaline pho?s 142, AST 17, ALT 16, total bilirubin 0.4, direct bilirubin 0.2, indirect bili 0.2, globulin 3.0, A/G ratio 1.4; 2/10/2021 RUQ abdominal ultrasound mild hepatomegaly w/ fatty infiltration. Left hepatic cyst. After vaccine #1 ?2/1/2021 hepatic function about the same as above. GGTP 44;all pho?s 144;
- Aktuelle Erkrankungen
- A fib, GERD, sleep apnea
- Vorgeschichte
- A fib x 33 years. Stents due to burned circumflex artery in cardiac ablation. Pacemaker, sleep apnea.
- Andere Medikamente
- Welchol, xarelto, probiotics, omeprazole, zinc, vitamin C, simethicone, Contrave
- Allergien
- Tetracycline, penicillin, sulfa, cardizem, erythromycin, vancomycin, latex, multaq, grass, dust mites
- Vorherige Impfungen
- Bronchitis or pneumonia after flu vaccine for4 years straight
- Staat
- MI
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 12.12.2021
- Impfdatum
- 05.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cardiac stress test abnormal
Decreased appetite
Echocardiogram abnormal
Exercise tolerance decreased
Myalgia
Nausea
Nodal arrhythmia
Pain in extremity
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
First off, I had soreness in my arm and secondary thing that came on in a couple weeks was an inability to exercise at an elevated heart rate. I also had a breakthrough case of COVID on 09/15/2021 between 2nd dose and booster. My symptoms with COVID were mild muscle aches, fever, and a runny nose. The fever lasted 2 days and the runny nose lasted several weeks. I also had slight nausea and loss of appetite.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nodal arrhythmia
- Hospital-Tage
- -
- Labordaten
- Stress Test- showed problems with a junction rhythm; Echocardiogram; PCR COVID Test - Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diagnosed with Chronic Kidney Disease a month prior to 2nd dose, Hypertension
- Andere Medikamente
- Vitamin D2, Amlodipine 2.5mg, Eye drops for Glaucoma Dibromide Tomal, Latanoprost
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 11.12.2021
- Impfdatum
- 21.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chronic myelomonocytic leukaemia
Condition aggravated
Deafness
Symptomtext
complete hearing loss in right ear and diminished hearing in the left; diagnosed with leukemia; very rare form of leukemia, CMML.; had issues with her hearing before, but it was completely gone after the doses of the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71 year-old female patient received bnt162b2 (BNT162B2), administration date 21Feb2021 (Lot number: EL9269) at the age of 71 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "issues with her hearing" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, 31Jan2021, Lot-EN5318 or EM5318- states it is hard to tell), administration date: 31Jan2021, when the patient was 71 years old, for COVID-19 immunization. The following information was reported: CHRONIC MYELOMONOCYTIC LEUKAEMIA (medically significant) with onset Mar2021, outcome "not recovered", described as "diagnosed with leukemia; very rare form of leukemia, CMML."; DEAFNESS (medically significant) with onset Apr2021, outcome "not recovered", described as "complete hearing loss in right ear and diminished hearing in the left"; CONDITION AGGRAVATED (medically significant) with onset Feb2021, outcome "not recovered", described as "had issues with her hearing before, but it was completely gone after the doses of the vaccine". The events "diagnosed with leukemia; very rare form of leukemia, cmml.", "complete hearing loss in right ear and diminished hearing in the left" and "had issues with her hearing before, but it was completely gone after the doses of the vaccine" were evaluated at the physician office visit with ear specialists and the cancer doctor. Clinical course: she has a loss of hearing that occurred after she got the second shot in Feb2021. Complete hearing loss in her right ear occurred toward the end of Apr2021. Hearing was very diminished in her left ear. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Auditory disorder
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 09.12.2021
- Impfdatum
- 13.02.2021
- Beginn
- 27.11.2021
- Tage bis Beginn
- 287,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Dyspnoea
Oxygen saturation decreased
SARS-CoV-2 test positive
Symptomtext
11/27/21 presents to ED for "low pulse ox" "short of breath, weak". PMHx of "HTN, HLD, CAD w/ stent"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 11/27/21 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 17.11.2021
- Impfdatum
- 30.03.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 232,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Condition aggravated
Coronary artery bypass
Coronary artery disease
Dyspnoea exertional
Electrocardiogram abnormal
Positron emission tomogram abnormal
Road traffic accident
Symptomtext
Patient is a 61 yr/o female who presents today for cardiac evaluation for chest pain, abnormal EKG and prior history of coronary artery disease. Conference for discussion of abnormal PET scan imaging and recommendationsShe has chest pain and shortness of breath on exertion cardiac cath on 6/29/2016 showed the left main 30 to 40% stenosis distally LAD 40 to 60% segmental stenosis and normal LV function at that time. 61 yo woman previously evaluated in office for CAD, who was involved in a MVA. She was seen and cleared by NS to have CABG. She has not been in a neck brace since initial visit. Patient denies any issues or changes since last visit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular and Mediastinum Hypertension Coronary artery disease involving native coronary artery of native heart without angina pectoris Coronary artery disease involving native coronary artery of native heart with angina pectoris CAD in native artery PAF (paroxysmal atrial fibrillation) Respiratory Acute respiratory failure Endocrine Type 2 diabetes mellitus with complication, without long-term current use of insulin Secondary diabetes mellitus without complications Musculoskeletal and Integument Patellofemoral arthritis Genitourinary Pyelonephritis Renal insufficiency Other Renal colic Chest pain Abnormal stress test Dyslipidemia Morbid obesity with BMI of 40.0-44.9, adult Hernia of abdominal wall Abnormal nuclear stress test
- Andere Medikamente
- Outpatient Medications albuterol HFA 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 40 MG tablet blood glucometer system carBAMazepine (TEGRETOL XR) 100 MG 12 hr tablet DULoxetine (CYMBALTA) 60 MG capsule gabapentin (NEURONTIN)
- Allergien
- MorphineAnaphylaxis Vitamin CNausea And Vomiting Citric Acid-potassium Citrate [Potassium Citrate]Nausea And Vomiting Orange Juice [Orange Oil] Pcn [Penicillins]
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 96,0
- Geschlecht
- M
- Eingang
- 16.11.2021
- Impfdatum
- 26.02.2021
- Beginn
- 13.11.2021
- Tage bis Beginn
- 260,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chest pain
Confusional state
Dysuria
Epigastric discomfort
Mental status changes
Productive cough
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
CHIEF COMPLAINT: Pt BIBA, pt has had trouble urinating for the last few days. Pts family states he has been a little more confused than usual lately and might possibly have UTI. Pt has hx of BPH. Pt denies any pain. EMS states he urinated on stretcher upon arrival. HISTORY OF PRESENT ILLNESS: 87 years old male with past medical history of BPH, hypertension, hypothyroidism, diabetes mellitus insulin-dependent with long-term insulin use, chronic kidney disease stage IV, history of bradyarrhythmia status post pacemaker placement, coronary artery disease status post PCI, patient presents to the ER brought in by ambulance he was referred by his primary care physician after calling him, family reporting altered mental status slightly from baseline, and having trouble urinating. Patient is alert and awake and oriented x2, is answering my questions appropriately slightly slow, he admits to pain in the lower chest and epigastric area mild discomfort, no radiation, comes and goes, currently present. He denies diarrhea admits to constipation, admits to cough productive unknown color, patient is wheelchair bound, denies shortness of breath at this time, he is states that he has no control of his urine baseline
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- COVID+ breakthrough
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Diabetes, HTN, Hyperlipidemia, Enlarged prostate, recurrent UTIS
- Andere Medikamente
- Unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.11.2021
- Impfdatum
- 11.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Pain in extremity
Pyrexia
Maternal exposure during pregnancy
Tachycardia
Symptomtext
my arm was sore; Fever; Headache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6200) via intramuscular route of administration, administered in arm right on 11Mar2021 08:00 as dose 2, single for COVID-19 immunization (Urgent Care Center). Medical history included obesity, depression, and generalised anxiety disorder from an unknown date and unknown if ongoing. Concomitant medications included paracetamol (TYLENOL), metformin, amoxicillin trihydrate, clavulanic acid (CLAVATIN), bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO) and ascorbic acid, biotin, folic acid, iodine, nicotinic acid, omega-3 fatty acids, pantothenic acid, pyridoxine hydrochloride, riboflavin, thiamine, vitamin b12 nos, vitamin e nos (PRENATAL + DHA) all were taken for an unspecified indication and start and stop date were not reported for them. Prior vaccination the patient received TDAP (Sanofi, Batch/Lot# C5735AA, Left arm) on 25Feb2021 for an unspecified indication. The patient previously received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EL9269) via an intramuscular route of administration, administered in arm left on 17Feb2021 03:30 as dose 1, single for COVID-19 immunization. The patient had not received vaccine administered at military facility. On an unspecified date, the patient experienced my arm was sore, fever and headache. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tachycardia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Depression; Generalized anxiety disorder; Obesity
- Andere Medikamente
- TYLENOL; METFORMIN; CLAVATIN; WELLBUTRIN; LEXAPRO; PRENATAL + DHA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 25.02.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 20,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Chest pain
Feeding disorder
Gastrooesophageal reflux disease
Investigation
Oesophagoscopy
Pain
Symptomtext
Gastrointestinal esophagus flare; pain; chest pain; unable to eat; This is a spontaneous report from a contactable consumer. A 41-year-old female consumer (patient) reported for herself that she received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9269) via an unspecified route of administration in arm left on 25Feb2021 (at the age of 41-year-old) at single dose for COVID-19 immunisation. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL8982) in arm left on 04Feb2021 for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Relevant medical history included allergy to iodine and sulfa medicine. Concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 17Mar2021 the patient experienced gastrointestinal oesophagus flare, pain, chest pain, unable to eat. All started two weeks after last shot and while severed from March through July, still going on. The events were serious due to disability and resulted in Doctor or other healthcare professional office/clinic visit and Emergency Room visit. The patient underwent heart tests, esophagus scope and other tests (unspecified). The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The events were not resolved at the time of report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Test Name: Heart test; Result Unstructured Data: Test Result:No results; Test Name: Esophagus scope; Result Unstructured Data: Test Result:No results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Sulfonamide allergy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 11.11.2021
- Impfdatum
- 12.03.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 98,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blindness
Electrocardiogram
Ventricular tachycardia
Symptomtext
Lost sight while sitting- vision went white screen, 2 - 3 seconds later felt surge of blood in head and vision returned to normal. Sat several minutes to access situation- no SOB, no palpitations, normal pulse, normal respiratory rate. Followed up with Electrophysiologist (submitted pacemaker trace- identified approx 4 hour Afib that transitioned into Ventricular tachycardia with 195bpm rate and heart stopping for 4 seconds unable to maintain rate. Cardiologist, whom I had follow-up appt with said Pacemaker restarted heart and he and new Electrophysiologist- placed me on Flecainide Acetate 50mg bid on 6/25 and all issues resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ventricular tachycardia
- Hospital-Tage
- -
- Labordaten
- Pacemaker trace 6/18; EKG 6/25
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- A-Fib corrected w/MAZE intracardiac ablation 12/2019; Mitral Valve Rpl 12/2019; Pacemaker post MAZE 12/2019
- Andere Medikamente
- Atenolol 25mg bid; Eliquis 5mg bid; Vit B Super Complex; Biotin 10000mg; Omega-3 690mg; Melatonin 12mg; Citracal 12.5mcg x2; Tylenol 500mg x 4; Ester C 500mg x 2
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 10.11.2021
- Impfdatum
- 17.02.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 265,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cough
Dyspnoea
Fatigue
Pneumonia
Pyrexia
Respiratory disorder
Symptomtext
presents to the ED with respiratory issues. Patient reports 4 days of subjective fevers, cough, SOB, and fatigue. States it has been worsening. Patient reports using inhalers with minimal relief. Denies any other alleviating or aggravating factors
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- PNEUMONIA
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, RENAL, HTN, CARDIAC
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 05.11.2021
- Impfdatum
- 20.03.2021
- Beginn
- 02.11.2021
- Tage bis Beginn
- 227,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Chest pain
Cough
Fatigue
Myalgia
Nausea
SARS-CoV-2 test positive
Symptomtext
11/2/21 Cough This is a new problem. Episode onset: 3 days. The problem has been unchanged. The cough is non-productive. Associated symptoms include chest pain and myalgias. Pertinent negatives include no chills, ear congestion, ear pain, fever, headaches, heartburn, nasal congestion, postnasal drip, rhinorrhea, sore throat, shortness of breath or wheezing. Associated symptoms comments: Chest and back hurt, worse with coughing. Nothing aggravates the symptoms. She has tried nothing for the symptoms Review of Systems Constitutional: Positive for fatigue. Negative for activity change, appetite change, chills, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear discharge, ear pain, postnasal drip, rhinorrhea, sinus pressure, sinus pain, sneezing, sore throat, tinnitus, trouble swallowing and voice change. Eyes: Negative for visual disturbance. Respiratory: Positive for cough. Negative for chest tightness, shortness of breath and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations and leg swelling. With coughing Gastrointestinal: Positive for nausea. Negative for abdominal pain, diarrhea, heartburn and vomiting. COVID 19 treatment: - methylPREDNISolone (MEDROL DOSPACK) 4 MG tablet; As directed. - Ascorbic Acid (VITAMIN C) 500 MG CAPS; Take 1 capsule by mouth daily. - zinc sulfate (ZINCATE) 220 (50 Zn) MG capsule; Take 1 capsule by mouth daily. - COVID+ Referral for EUA Covid Antibody Treatment
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 11/2/21 SARS-CoV-2 PCR - IPOC Detected Abnormal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Arthritis o Back pain o Blood transfusion without reported diagnosis o Colon polyp o Diabetes mellitus o Hyperlipidemia o Hypertension o Major depressive disorder with single episode, in full remission 4/16/2019 o Seasonal allergies o Snoring
- Andere Medikamente
- amLODIPine (NORVASC) 10 mg tablet TAKE ONE TABLET BY MOUTH DAILY o atorvastatin (LIPITOR) 10 MG tablet TAKE ONE TABLET BY MOUTH DAILY 9 o diclofenac (VOLTAREN) 1 % gel APPLY 4 GRAMS TOPICALLY FOUR TIMES A DAY TO THE AFFECTED JOINT MAX OF
- Allergien
- Dilaudid, Lisinopril
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 05.11.2021
- Impfdatum
- 24.02.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 250,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Patient presented to facility with shortness of breath for past 11 days. Patient reported being COVID positive at previous facility, Urgent Care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- COVID-PCR test ran on 11/4/21 and was positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 04.11.2021
- Impfdatum
- 12.02.2021
- Beginn
- 31.10.2021
- Tage bis Beginn
- 261,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chills
Cough
Diarrhoea
Hypophagia
Hypotension
Malaise
Pyrexia
SARS-CoV-2 test positive
Inappropriate schedule of product administration
Symptomtext
hospitalization (non-ICU)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 19.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia
Trigeminal nerve disorder
Symptomtext
Began to have paresthesia. Left face in trigeminal 2 distribution, as well as lower extremity paresthesia from soles of feet to below knees bilaterally. Has been present from the evening after inoculation. Not worse but not resolving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hashimotos' thyroiditis, Peripheral polyneuropathy, mild intermittient asthma, chronic insomnia, palpitations, anxiety
- Andere Medikamente
- albuterol inh, Ergocalciferol, Fluoxetine, probiotic
- Allergien
- shellfish, gluten, Neurotin, Terazol 3, Zithromax, Tetracycline
- Vorherige Impfungen
- Influenza-Same SX as above but they went away
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 07.03.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 226,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Condition aggravated
Cough
Decreased appetite
Dehydration
Diarrhoea
Hyponatraemia
Hypophagia
Imaging procedure abnormal
Pain
Physical deconditioning
SARS-CoV-2 test positive
Viral upper respiratory tract infection
Symptomtext
Hospitalized 10/23/2021; COVID-19 positive 10/19/2021; fully vaccinated BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 10/23/2021 Discharge Date: 10/25/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyponatremia [E87.1] Weakness [R53.1] Generalized weakness [R53.1] COVID-19 virus infection [U07.1] HOSPITAL COURSE: Patient was admitted on 10/23/2021 for generalized weakness, unclear etiology at this point likely suspect component of dehydration from poor oral intake, deconditioning in the setting of recent COVID-19 infection. The patient was diagnosed woth COVID-19 on 10/19 status post monoclonal antibody. The patient currently is not in respiratory distress and has remained on room air, he is not a candidate for steroids or remdesivir. The patient's most bothersome symptom is diarrhea he was encouraged to eat yogurt and advanced diet as tolerated. The patient was also given a prescription for imodium but encouraged to use this sparingly with his underlying COVID-19 diagnosis. The patient was noted to have mild hyponatremia upon admission this improved to 129 with PO intake. Recommend checking BMP in 1 week to ensure this improved. The patient will be returning home with family and assistance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 10/19/2021 office visit: Assessment / Plan: 1. Viral URI - Respiratory Pathogens by Film Array; Future - Respiratory Pathogens by Film Array 1. Will check film array. Continue symptomatic treatment in the meantime. Return if symptoms worsen or fail to improve. Patient ID: Patient is a 83 y.o. maleChief Complaint: COUGH (started Saturday, pt also reports body aches and diarrhea that started today, no SOB, fever, chills, no loss of taste or smell, but doesn't have an appetite)
- Vorgeschichte
- HTN (hypertension) PAF (paroxysmal atrial fibrillation) Gout of elbow due to renal impairment COVID PMR (polymyalgia rheumatica) Idiopathic peripheral neuropathy BPH (benign prostatic hyperplasia) Hyperlipidemia Impaired fasting glucose High cholesterol Hyperglycemia due to type 2 diabetes mellitus Hyponatremia H/O colonoscopy Degeneration of cervical intervertebral disc Spinal stenosis in cervical region\
- Andere Medikamente
- acetaminophen (TYLENOL 8 HOUR ARTHRITIS PAIN) 650 MG extended release tablet allopurinol (ZYLOPRIM) 300 MG tablet apixaban (ELIQUIS) 5 MG tablet Calcium-Mag-Vit C-Vit D 185-28-2.5-200 CAPS cetirizine (ZYRTEC ALLERGY) 10 MG tablet fluticason
- Allergien
- Ceclor Finasteride Norco (hydrocodone/acetaminophen)
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 26.10.2021
- Impfdatum
- 31.03.2021
- Beginn
- 02.10.2021
- Tage bis Beginn
- 185,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
HOSPITAL VISIT VIA EMS FOR SOB
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 9,0
- Labordaten
- POSITIVE COVID TEST 10/02/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ARTHRITIS, HTN, THYROID DISEASE
- Andere Medikamente
- amLODIPine 5 mg oral tablet, 5 mg= 1 TAB, PO, Daily aspirin 81 mg oral delayed release tablet, 81 mg= 1 TAB, PO, Daily atorvastatin 20 mg oral tablet, 20 mg= 1 TAB, PO, Daily gabapentin 300 mg oral capsule, 300 mg= 1 CAP, PO, TID (3 times a
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.10.2021
- Impfdatum
- 10.02.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 233,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
COVID-19 pneumonia
Renal function test
Renal impairment
SARS-CoV-2 test
Vaccination failure
Symptomtext
just diagnosed with covid, breakthrough cases; covid pneumonia; kidney function was elevated a little bit; just diagnosed with covid, breakthrough cases; This is a spontaneous report from a contactable consumer or other non-health professional (wife reporting for her husband). A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269), via an unspecified route of administration in arm on 10Feb2021 in the morning as DOSE 2, single for COVID-19 immunisation (age at vaccination: 71-years-old). The patient medical history included: High blood pressure. The patient was also taking other products. The reporter mentioned that the patient was diagnosed with other unspecified conditions most of his life. No additional vaccine was administered on same date of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not report any AE (s) prior vaccination. The concomitant medications include Enalapril for blood pressure from an unspecified date at an unknown dose once a day by mouth. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL8982), via an unspecified route of administration in upper left arm on 20Jan2021 in the morning as DOSE 1, single for COVID-19 immunisation. The symptoms started on 01Oct2021, and he was tested for covid on 06Oct2021, which came back positive and just got diagnosed with covid, breakthrough cases. On 01Oct2021 the patient had covid pneumonia and the patient was in hospital due to that since 12Oct2021 till the date of the report. Patient treatment included: He was on oxygen, steroids and antibiotics. He does not qualify for Remdesivir since his kidney function was elevated a little bit but has now returned to normal. The outcome of the events covid pneumonia and just diagnosed with covid, breakthrough cases (COVID-19)) was not resolved. The oxygen intake was improved but he was still on oxygen. The outcome of the event kidney function was elevated a little bit was resolved on an unspecified date. The outcome of the event just diagnosed with covid, breakthrough cases (Vaccination failure) was unknown. No follow-up attempts are needed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- Test Name: kidney function; Result Unstructured Data: Test Result:elevated a little bit; Comments: his kidney function was elevated a little bit but has now returned to normal.; Test Date: 20211006; Test Name: SARS-CoV-2 test; Test Result: Positive ; Comments: he was tested for covid on 06Oct2021 and it came back positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high
- Andere Medikamente
- ENALAPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 26.10.2021
- Impfdatum
- 06.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 17,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Computerised tomogram
Heart rate increased
Interstitial lung disease
Mobility decreased
Oxygen saturation decreased
Pneumonia
Pulmonary function test
X-ray
SARS-CoV-2 test
Symptomtext
pneumonia; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non-pregnant female patient received first dose of BNT162B2, via an unspecified route of administration at the age of 71-years-old on 06Feb2021 (Lot Number: EL 9269; Expiration Date: 31May2021) as single dose for covid-19 immunisation. Medical history included diabetes II, arthritis, gastroparesis, hypertension, hyperlipidemia, post hero neur, recent ILD and St 3 CKD. Concomitant medications included nabumetone; VIT D; fexofenadine hydrochloride (ALLEGRA); dexlansoprazole (DEXILANT); allopurinol. The patient first diagnosed with pneumonia 23Feb2021 (subsequent multiple times). Adverse event resulted in doctor or other healthcare professional office/clinic visit and treatment with antibiotic. Covid test post vaccination: covid test type post vaccination(Nasal Swab) on 24May2021, on 18Jun2021 and on 16Aug2021: negative. The outcome of the events was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210524; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210618; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210816; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Arthritis; Chronic kidney disease stage 3; Diabetes mellitus non-insulin-dependent; Gastroparesis; Hyperlipidemia; Hypertension; Interstitial lung disease; Post herpetic neuralgia
- Andere Medikamente
- NABUMETONE; VIT D [VITAMIN D NOS]; ALLEGRA; DEXILANT; ALLOPURINOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 26.10.2021
- Impfdatum
- 06.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 17,0
- Dosis
- UNK
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Computerised tomogram
Heart rate increased
Interstitial lung disease
Mobility decreased
Oxygen saturation decreased
Pneumonia
Pulmonary function test
X-ray
SARS-CoV-2 test
Symptomtext
pneumonia; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non-pregnant female patient received first dose of BNT162B2, via an unspecified route of administration at the age of 71-years-old on 06Feb2021 (Lot Number: EL 9269; Expiration Date: 31May2021) as single dose for covid-19 immunisation. Medical history included diabetes II, arthritis, gastroparesis, hypertension, hyperlipidemia, post hero neur, recent ILD and St 3 CKD. Concomitant medications included nabumetone; VIT D; fexofenadine hydrochloride (ALLEGRA); dexlansoprazole (DEXILANT); allopurinol. The patient first diagnosed with pneumonia 23Feb2021 (subsequent multiple times). Adverse event resulted in doctor or other healthcare professional office/clinic visit and treatment with antibiotic. Covid test post vaccination: covid test type post vaccination(Nasal Swab) on 24May2021, on 18Jun2021 and on 16Aug2021: negative. The outcome of the events was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210524; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210618; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210816; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Arthritis; Chronic kidney disease stage 3; Diabetes mellitus non-insulin-dependent; Gastroparesis; Hyperlipidemia; Hypertension; Interstitial lung disease; Post herpetic neuralgia
- Andere Medikamente
- NABUMETONE; VIT D [VITAMIN D NOS]; ALLEGRA; DEXILANT; ALLOPURINOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 17.10.2021
- Impfdatum
- 01.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Blood test
Condition aggravated
Decreased appetite
Fatigue
Headache
Methylenetetrahydrofolate reductase deficiency
Nausea
Troponin
Troponin I increased
Urticaria
Vomiting
Symptomtext
Hives (02/13/2021) Critically high Troponin June 26, 2021 MTHFR Oct 2021 Exhaustion - 2/21 - current Nausea -2/21 - current Vomiting 2/21 - current Severe weakness 2/21 - current. Headaches 2/21 - current. Loss of appetite 2/21 - current
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- Troponin critically high 6/26/2021 Blood test - MTHFR 10/2021
- Aktuelle Erkrankungen
- Constipation.
- Vorgeschichte
- Diabetes MTHFR
- Andere Medikamente
- Metformin Atorvastatin Atenolol Topamax
- Allergien
- Sulfa Contrast dye - anaphylaxis event in past Laytex Also thrombosis at age 12 (blood clot) hospitalized 30 days
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 16.10.2021
- Impfdatum
- 22.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal sensation in eye
Feeling abnormal
Lymph node pain
Lymphadenopathy
Mydriasis
Pharyngeal paraesthesia
Photophobia
Symptomtext
Within the next 24 hours I experienced swollen lymph nodes in my neck and under my arms; Within the next 24 hours I experienced tender lymph nodes in my neck and under my arms; Within 15 minutes of receiving the vaccine my eyes felt not normal.; Throat tingled; My eyes were very sensitive to light, more so than normal even wearing sunglasses; My eyes appeared to be fully dilated; I "felt off " for the next 10 days; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 22Feb2021 at 09:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and known allergy to penicillin and intravenous iodine lab dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide, telmisartan (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN), ezetimibe (MANUFACTURER UNKNOWN) and dapagliflozin propanediol monohydrate (FARXIGA); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021 at 09:45; within 15 minutes of receiving the vaccine, the patient eyes felt not normal and throat tingled, but did not progress to anything approaching serious reaction. The patient waited for another 15 to 20 minutes and returned home. On the same day, her eyes were sensitive to light more so than normal even wearing sunglasses. Shortly after, the patient's granddaughter noticed that the patients' eyes appeared to be fully dilated. They remained fully dilated when the patient went to bed at 22:30. On 24Feb2021 at 06:30, she checked her eyes and they were no longer dilated. On 24Feb2021, the patient experienced swollen and tender lymph nodes in neck and under arms. The patient felt "off" for the next 10 days. The patient saw primary care physician on 10Mar2021 and she advised not to take the second vaccine dose which was scheduled for in 16Mar2021. The physician was most concerned that the dilation of eyes was a neurological reaction and given the other symptoms, a second dose could prove more adverse. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event eyes appeared to be fully dilated was resolved on 23Feb2021, event felt off for the next 10 days was resolved on an unknown date in Mar2021 and the events eyes felt not normal, throat tingled, eyes were very sensitive to light more so than normal even wearing sunglasses and swollen and tender lymph nodes in neck and under arms were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pharyngeal paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypertension; Iodine contrast media allergy (intravenous iodine lab dye allergy); Penicillin allergy
- Andere Medikamente
- TELMISARTAN HCTZ; MONTELUKAST; EZETIMIBE; FARXIGA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 15.10.2021
- Impfdatum
- 13.03.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 11,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Antinuclear antibody negative
Dyspnoea
Haemoglobin decreased
Red blood cell abnormality
Reticulocyte count increased
Transfusion
Symptomtext
pt presented with shortness of breath 11 days later, found to have hbg of 6.0 with abnormal RBC morphology sent for transfusion, + direct Ab to her blood type (A+) hbg rose to 9.9 one week later, then eventually to 12
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- see above. ANA neg, retics 76,000 / 1.9% 3/30/21 , fell to 1.2 % 4/29/21
- Aktuelle Erkrankungen
- COPD, htn, Addison's no acute illness noted
- Vorgeschichte
- Addison's, Diabetes , htn
- Andere Medikamente
- asa 81mg prednisone 25mg bid (for Addison's) metformin
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 12.10.2021
- Impfdatum
- 10.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test normal
Neuralgia
Paraesthesia
Pruritus
Symptomtext
Nerve pain, that felt like pins and needles sensation all over the body. The pin pricking would turn into an itching sensation over time. It started a few days after the second dose of the vaccine. I talked to my doctor, who referred me to a neurologist. They did a full work up and found nothing. After about 2 more months the pin pricking dissipated. I asked my doctor if it could have been from the vaccine and she said: "no one knows." A few days ago, I got the booster shot, and then pins and needles sensations has started up again, so I thought this was more definitive proof that it was as a result of the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- clinic did a full blood panel that was all normal. PROTEIN ELECTROPHORESIS AND TOTAL PROTEIN. Apr 23, 2021 ANTINUCLEAR ANTIBODY Apr 23, 2021 RHEUMATOID FACTOR TITER Apr 23, 2021 BORRELIA BURGDORFERI ANTIBODY Apr 23, 2021 BLOOD HEAVY METAL PANEL Apr 23, 2021 PLASMA VITAMIN B1 (THIAMINE) Apr 23, 2021 ERYTHROCYTE SEDIMENTATION RATE (ESR)
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- high blood pressure hypothyroidism
- Andere Medikamente
- metroprolol succinate ER 25 mg NP Thyroid 15 mg norethindrone acetate 5 mg Dotti .0375 mg patch
- Allergien
- peanuts
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 11.10.2021
- Impfdatum
- 16.01.2021
- Beginn
- 05.10.2021
- Tage bis Beginn
- 262,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Hypoxia
Symptomtext
hospital admission for COVID PNA with hypoxia requiring supplemental O2
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 08.10.2021
- Impfdatum
- 08.02.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 173,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19 pneumonia
Chills
Convalescent plasma transfusion
Dyspnoea
Pain
Symptomtext
Presented w/chills, body ache, SOB. Admit for COVID PNA. Hx of HTN, lung CA in remission. Tx with supplemental O2, steroids, abx, convalescent plasma. At time of DC pt on RA. DC'd home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 08.10.2021
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure abnormal
Chest discomfort
Chest pain
Dizziness
Dyspnoea
Head discomfort
Musculoskeletal discomfort
Neck pain
Tinnitus
Weight
Symptomtext
I could not turn my neck from side to side. It got painful when I turned it.; Dizzy; Felt like I had a pressure on my chest.; Impairment in my breathing; Something has happened in my blood pressure severely, like my head is going to explode; Something has happened in my blood pressure severely, like my head is going to explode; Chest pain is mild; Pulsatile tinnitus; I could not turn my neck from side to side. It got painful when I turned it.; This is a spontaneous report from a Consumer or other non-HCP consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EL9269; Expiration date: not provided) via an unspecified route of administration on 09Feb2021 (age at vaccination 66-year-old) in right arm as dose 1, single for Covid-19 immunization. The patients medical history included enlarged prostate. The patients concomitant medication included tamsulosin hydrochloride (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), 0.4 mg once per day via an oral route of administratiom taken for enlarged prostate from an unspecified start date and ongoing. Patient took second shot of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EN6201; Expiration date: not provided) via an unspecified route of administration on 02Mar2021 as dose 2, single for Covid-19 immunization. On 09Feb2021, the patient experienced could not turn his neck from side to side. It got painful when turned it, dizzy, felt like had a pressure on his chest, pulsatile tinnitus, impairment in my breathing, something has happened in his blood pressure severely, like his head was going to explode, chest pain was mild. Reporter stated that the patient would like to report some reaction that had to the bnt162b2 shot. When the patient got it, the first one, one day later, actually, the patient got the shot and within that 15-minute window, the patient could not turn the neck from side to side. It got painful when the patient turned it. The patient also felt a little dizzy, not to the point of nauseous but just off. Then the patient felt like had a pressure on my chest. The next day on 10Feb2021, 1 day after vaccination, when the patient went to sleep the patient had pulsatile tinnitus all through the night and that lasted one day short of 5 weeks. That thing subside but the patient still have the other symptoms and the patient had made an appointment with doctor to check him up. It was pretty serious stuff and the patient was a healthy guy and the patient was wondering what he had done to himself by taking that shot. The patient just figured that he needed to get it on record. Consumer stated his weight was about 220 -230. It fluctuated between 220-230. Put him down for 225 (pounds). All these things that he told were found after the first shot. Reporter stated that the patient was due for some and the last was done in May2020. It was all bacteria. Everything was normal. Pulsatile tinnitus subsided 1 week ago. What the patient experienced was pressure on his chest and pain in the neck when he turned to the right. Not shortness of breath because of pressure on his chest. On an unspecified date, there was impairment in his breathing, slight and there were the reasons why he was going to the doctor. When probed for chest pain intensity reporter stated chest pain was mild. Not real severe. It had not lessened. Consumer stated that he was not a doctor but had a feeling something radically changed in his blood pressure with the shot. He did not knew really what was going on but he knew something had happened in his blood pressure severely, like his head was going to explode. That was the best he could describe. The patient underwent lab tests and procedures which included weight: 225 lbs on an unspecified date About 220 -230. It fluctuates between 220-230. No therapeutic measures were taken in response to the events. The outcome of the event Pulsatile tinnitus was recovering at the time of reporting and the outcome of all other the events was unknown. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Test Name: Weight; Result Unstructured Data: Test Result:225 lbs; Comments: About 220 -230. It fluctuates between 220-230.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Enlarged prostate (Verbatim: Enlarged prostate)
- Andere Medikamente
- FLOMAX [TAMSULOSIN HYDROCHLORIDE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 08.10.2021
- Impfdatum
- 27.01.2021
- Beginn
- 06.02.2021
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arrhythmia
Cardiac monitoring
Dyspnoea
Heart rate irregular
Palpitations
Ventricular extrasystoles
Symptomtext
still experiencing an irregular HR and PVCs/heart jumps and skips beats; heart pounding and had the feeling like it was skipping beats; still experiencing an irregular HR and PVCs; still experiencing an irregular HR/She has had irregular patterns of feeling like her heart was jumping out of her chest; SOB/short of breath; This is a spontaneous report from a contactable consumer or other non-health care professional (patient, reported for herself). A 60-years-old female patient received BNT162B2((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EL9269), via an unspecified route of administration in left arm on 03Feb2021 14:30 (at the age of 60-year-old) as dose 2, single for covid-19 immunization. The patients medical history included ongoing high blood pressure. Patient previously received BNT162B2((PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3246), via an unspecified route of administration in left arm on 13Jan2021 around 1 PM (at the age of 59-year-old) as dose 1, single for covid-19 immunization. Patient received historical vaccine of flu short on unspecified date in 2020 for immunization and received historical vaccine of shingles shot on unspecified date in 2020 for immunization and experienced minor aches and pains and a sore arm. The concomitant medications were not reported (other products). The patient received hydrochlorothiazide (HYDROCHLOROTHIAZIDE), via an unspecified route of administration from 27Jan2021 at 12.5 mg, 1x/day for hypertension. On unspecified date patient received her 2nd Comirnaty Vaccine dose on 03Feb2021 and had a reaction. She experienced and was still experiencing an irregular HR and PVCs, she also had some shortness of breath (SOB) here and there. The heart issues had not gone away, patient had just gotten used to it. Patient was started on low dose water pill (HCTZ) at the end of January, prior to the 2nd Pfizer dose, patient was exercising to improve her heart health. Patient state that she spoke to cardiology and the NP said they advise her that their patients to take all vaccines. patient works at a withheld 1 day/week and they are requiring the booster. Patient had heart healthy diets. Patient got the second dose in 03Feb2021 and then 3 days later she experienced heart pounding and had the feeling like it was skipping beats. She wasn't expecting this or any side effect as she had none from the previous dose. The patient also explains she was short of breath here and there and then would be fine. She has had irregular patterns of feeling like her heart was jumping out of her chest. The patient reports she had never had problems with her heart, she has always had a strong heart. This has continued and she ended up wearing a heart monitor for a week; she got the results 3 weeks after wearing it. It showed some new things, PVS's but was told she was still in a range of normal. Even now, she still has feelings that her heart jumps and skips beats and she feels out of breath. In retrospect looking at the reports from younger men having arrhythmia, she has the exact same symptoms they are reporting from what she read. Patient doctor was no longer at the practice. She started on 27Jan2021, a new blood pressure medication. The doctor was aware as she asked about it and did not think this was anything relevant. Product was Hydrochlorothiazide, 12.5 mg daily. Patient had not received any other treatments other than wearing a heart monitor. The doctor was not very involved with this event. She also reports she had a sore arm with first dose that lasted maybe 24 hours at most and then resolved. The shortness of breath and heart beating fast was still something she still notices from time to time now. She was currently taking less blood pressure medication and was learning to live with her new situation. Patient had attended Physician Office and had not visited emergency room for the events reported. Patient had not received any vaccines within 4 weeks prior to Vaccination. Patient was reporting because she was concerned about adding more issues occurring after getting the booster; she doesn't feel real strongly about getting a booster and would rather get a little virus than getting the booster. Patient queried for her getting a booster. The patient underwent lab tests and procedures which included cardiac monitoring: pvs's/told she was still in a range of normal and heart monitor worn for a week. Outcome of events was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arrhythmia
- Hospital-Tage
- -
- Labordaten
- Test Date: 2021; Test Name: heart monitor; Result Unstructured Data: Test Result:PVS's/told she was still in a range of normal; Comments: heart monitor worn for a week
- Aktuelle Erkrankungen
- Blood pressure high (high blood pressure)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 06.10.2021
- Impfdatum
- 08.02.2021
- Beginn
- 06.10.2021
- Tage bis Beginn
- 240,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Dyspnoea
Symptomtext
Outpatient MAB infusion and admission to the hospital with worsening SOB
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 05.10.2021
- Impfdatum
- 05.02.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 238,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Dyspnoea
Myalgia
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Positive for COVID-19 infection - fever, myalgias, chills, cough and SOA. Received monoclonal antibody infusion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Covid-19 positive test on 09/30
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- asthma, anemia, OA, hypothyroidism, IBS, HTN
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 02.03.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 36,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adnexa uteri pain
Bacterial infection
Chlamydia test positive
Chlamydial infection
Condition aggravated
Eczema
Fungal infection
Fungal skin infection
Rash
Sexually transmitted disease
Symptomtext
Fungal rash on body occurred exactly 2-3 after vaccination - attempted to clear with diflucin, OTC antifungal (did not help) Within one week, ovaries started to ache and discovered chlamydia with no sexual contact within last 2 years. Never tested before covid vaccine nor had issues with ovaries pain before vaccine. Previous partner tested negative for chlamydia. Also, never had excema flare up or continuous fungal infection before vaccination. Feel that bacteria/ fungus has been overflowing in body since vaccination. Fungus and STI cleared in three months As of today, ovary aches and skin rashes are back with absolutely no change to diet, medication, or sexual contact.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- Positive chlmydia test (with no sexual contact within past two years) Fungal infection for 3 months (never had before in entire lifetime) Multiple antibiotics were prescribed
- Aktuelle Erkrankungen
- Fungal rash on body occurred exactly 2-3 after vaccination - attempted to clear with diflucin, OTC antifungal (did not help) Within one week, ovaries started to ache and discovered chlamydia with no sexual contact within last 2 years. Never tested before covid vaccine nor had issues with ovaries pain before vaccine. Previous partner tested negative for chlamydia. Also, never had excema flare up or continuous fungal infection before vaccination. Feel that bacteria/ fungus has been overflowing in body since vaccination. Fungus and STI cleared in three months As of today, ovary aches and skin rashes are back with absolutely no change to diet, medication, or sexual contact.
- Vorgeschichte
- N/a
- Andere Medikamente
- Birth control
- Allergien
- N/a
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 01.10.2021
- Impfdatum
- 01.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Dyspnoea
Heavy menstrual bleeding
Menstruation irregular
Neurological symptom
Symptomtext
I received my second dose of the Pfizer COVID-19 vaccine. After 15 minutes, I started to experience shortness of breath and tightness in my chest. The nurses brought me into an emergency/rapid response room where I was placed in a recliner and my vital signs were monitored every five minutes. I was monitored for approximately one hour. Since receiving the second dose, I have experienced neurological symptoms that relate to a prior accident I had in 2016. I have also experienced irregularities/clots with my menstrual cycle that are new/abnormal for me. One of my colleagues recommended that I report this to VAERS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- -
- Andere Medikamente
- DULoxetine 60 MG DR capsule, Norgestim-Eth Estrad Triphasic 0.18/0.215/0.25 MG-25 MCG dosepak Norgestim-Eth Estrad Triphasic 0.18/0.215/0.25 MG-25 MCG dosepak spironolactone 50 mg tablet
- Allergien
- Benzoyl Peroxide Sodium Lauryl Sulfate Soy Allergy Latex
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 29.09.2021
- Impfdatum
- 11.03.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Dermatitis
Eyelid rash
Periorbital swelling
Symptomtext
Worsening of eyelids and around the eye areas are very swollen and have a rash around them/ flare up of my dermatitis; flare up of my dermatitis; eyelids and around the eye areas are very swollen and have a rash around them; eyelids and around the eye areas are very swollen and have a rash around them; This is a spontaneous report from a contactable consumer (patient) via CEP 159558. A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9269, Expiration date: unknown), via an unspecified route of administration in arm left (left shoulder) on 11Mar2021 at 12:20 (at the age of 31-year-old) as a dose 1, single for COVID-19 immunization. The family medical history relevant to ae(s) were reported as none. The patient's medical history included ongoing contact dermatitis and skin allergies. The patient's concomitant medications were not reported. The history of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. Additional vaccines administered on same date of the Pfizer suspect was reported as none. Prior vaccinations (within 4 weeks) were reported as none. The AE(s) following prior vaccinations was reported as none. Enquired, any interaction between oral steroids like prednisone and Pfizer-BioNTech COVID-19 Vaccine. Stated that, should the patient not take a steroid at this time. It was reported that, the patient had received the first dose of the Pfizer-BioNTech COVID-19 Vaccine on 11Mar2021, last Thursday at 12:20 in the afternoon, second dose was scheduled for 12Apr2021. Stated that, the patient had a history of contact dermatitis and skin allergies. The caller stated that, she has unrelated skin issues, contact dermatitis and has had it her entire life and was currently having a big flare up right now. Stated that, she don't believe it was related to the vaccine. Stated that, she had a flare up of her dermatitis right now, that started about 3 days ago (morning on 15Mar2021). Stated that, the caller asked whether there was an interaction with prednisone or steroids. Stated that, generally in the past, the patient had taken a prednisone or some sort of steroid for these flare ups. Stated that, it started after her first dose but she had signs of it before. Stated that, she planned to discuss this further with her physician. Stated that, eyelids and around the eye areas are very swollen and have a rash around them on 15Mar2021. Stated that, treatment included was, she used an ointment that she typically uses for her hands. The reporter clarified that, her eyelids and around the eye areas are very swollen and had a rash around them was reported as worsened and her dermatitis was flared up on an unspecified date. Stated that, the patient had skin issues unrelated to the vaccine and may need to take prednisone and would like to know whether prednisone will effect the vaccine. Any unaddressed medical questions referred or forwarded to Medical Information was reported as no. The reporter seriousness for the events eyelids and around the eye areas are very swollen and have a rash around them was reported as unspecified. The AE(s) require a visit to the emergency room and physician office was reported as no, but she did contact her Dermatologist. The investigation assessment was reported as no. The outcome of the events for eyelids and around the eye areas are very swollen and have a rash around them was reported as not recovered while for the other events was unknown. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Contact dermatitis (Verbatim: Contact dermatitis)
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypersensitive skin
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 28.09.2021
- Impfdatum
- 04.01.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 263,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Pneumonia
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
COVID 19 infection with hypoxic respiratory failure and bilateral pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia
- Hospital-Tage
- 3,0
- Labordaten
- COVID 19 pcr 9/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Abnormal CT scan, pancreas or bile duct ? Allergic rhinitis ? BPH (benign prostatic hypertrophy) ? Erectile dysfunction ? High blood pressure ? History of alcohol abuse ? History of alcohol abuse ? Hyperlipidemia ? Hypertension
- Andere Medikamente
- acetaminophen aspirin escitalopram iron gluconate lisinopril simvastatin vitamin B-12
- Allergien
- Streptomycin-syncope sulfa-rash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 28.09.2021
- Impfdatum
- 05.02.2021
- Beginn
- 27.09.2021
- Tage bis Beginn
- 234,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19 pneumonia
Symptomtext
Hospitalization due to COVID-19 pneumonia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 28.09.2021
- Impfdatum
- 26.02.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 195,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ageusia
COVID-19
Chest X-ray
Computerised tomogram thorax
Diarrhoea
Condition aggravated
Hyponatraemia
Pulmonary mass
SARS-CoV-2 test positive
Dyspnoea
Fatigue
Nausea
Pain
Vaccine breakthrough infection
Symptomtext
9/9/21-77 y/o male with hx of PAF, HTN and hyperlipidemia presents body aches, SOB, and fatigue. He recently traveled with his wife. Last Thursday, he started to feel fatigued and lost his taste. He also started developing SOB. He returned and called his ENT who prescribed him Cipro and steroids due to hx of Pseudomonas sinus infection. Despite taken these meds, he hasn't felt any better. He admits to nausea, but no vomiting. He is having loose stools. Review of Systems: Constitutional: Denies fever or chills Eyes: Denies change in visual acuity HENT: Denies nasal congestion or sore throat Respiratory: + dry cough + SOB Cardiovascular: Denies chest pain, palpitations, or edema GI: Denies bloody stools GU: Denies dysuria Musculoskeletal: Denies back pain or joint pain Integument: Denies rash Neurologic: Denies headache, focal weakness or sensory changes Endocrine: Denies polyuria or polydipsia Lymphatic: Denies swollen glands Psychiatric: Denies depression or anxiety
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 9/9/21- COVID-19 Result Detected 9/9/21-CT CHEST W/O CONTRAST DATE: 9/9/2021 4:45 PM CLINICAL HISTORY: lung nodule; COVID-19 +. COMPARISONS: CT chest October 30, 2014, chest x-ray September 9, 2021 Technique: Noncontrast CT images of the chest are provided. Dose reduction technique was utilized per ALARA protocol. FINDINGS: Centered in the superior aspect of the right lower lobe is a 4.2 x 2.1 cm mass. There is focal abutment of the pleura. Surrounding groundglass predominantly extending inferiorly is suspicious for additional areas of neoplasm. A pleural-based pulmonary nodule on series 2 image 62 is stable. Partially calcified nodules in the right lower lobe are not significant change in the prior. There is subtle increased linear bandlike interstitial thickening adjacent to these nodules, however there are several foci of calcification within it which would favor a chronic process. Small pleural nodule in the left series 2 image 79 is stable. Calcified pleural plaques in the apices are unchanged. There are chronic right hilar and mediastinal calcified lymph nodes. No discrete new hilar or mediastinal adenopathy is evident within the limits of noncontrast technique. Multiple midthoracic compression fractures are not significant change from the prior. Lucency of the inferior aspect of the T3 vertebral body appears chronic. Visualized upper abdomen is unremarkable. Coronary artery calcifications are present. 1.IMPRESSION: 2.There is a 4.2 x 2.1 cm mass in the superior aspect of the right lower lobe consistent with carcinoma. Adjacent areas of groundglass attenuation predominantly extending caudally are nonspecific but are suspicious for additional areas of neoplastic involvement. No discrete mediastinal or hilar adenopathy. 3.Numerous scattered nodules including cluster of calcified nodules in the right lower lobe. Adjacent to these calcified nodules there is an area of increased bandlike interstitial thickening which is favored to be chronic. Chronic calcified pleural plaques in the apices. 4.Chronic midthoracic compression fractures. 5.Coronary artery atherosclerosis. 9/9/21-09/09/2021 at 1009 hours HISTORY: Fatigue. COMPARISON: Chest x-ray performed on December 20, 2018 FINDINGS: There is been interval development of a right perihilar nodule. This measures 3.0 x 3.2 cm. The lungs are hyperexpanded. The heart size within normal limits. There is no evidence of pneumothorax or pleural effusion. Mild biapical pleural scarring is demonstrated. IMPRESSION: Interval development of a right perihilar pulmonary nodule. This measures 3.0 x 3.2 cm. CT of the chest would be best able to evaluate.
- Aktuelle Erkrankungen
- No known
- Vorgeschichte
- 9/9/21-hx of PAF on Eliquis and who was vaccinated against COVID-19 earlier this month, was admitted to NBH for + COVID-19 and a lung mass. Hyponatremia Sodium 121 on admission Allergic rhinitis ? Asthma ? BPH (benign prostatic hyperplasia) ? Chronic sinus infection ? Diverticulosis ? Hearing loss LEFT EAR/HAS HEARING AID USES PRN ? History of chicken pox MEASLES, MUMPS AS A CHILD ? History of pneumonia ? Hyperlipidemia ? Insomnia ? Lower back pain ? Neck pain DDD ? OSA on CPAP ? Osteopenia ? Osteoporosis 10/15/2012 ? Paroxysmal atrial fibrillation ? Pseudomonas aeruginosa infection SINUSES/DIAGNOSED X 8-9 YEARS/CURRENTLY HAS ? Swelling of both ankles
- Andere Medikamente
- albuterol HFA 108 (90 Base) MCG/ACT inhaler INHALE 2 INHALATION BY MOUTH EVERY 4 HOURS AS NEEDED alendronate (FOSAMAX) 70 MG tablet Take 1 tablet by mouth every 7 days. Ascorbic Acid (VITAMIN C) 500 MG tablet Take 500 mg by mouth 2 (two) t
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 28.09.2021
- Impfdatum
- 26.02.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 195,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ageusia
COVID-19
Chest X-ray
Computerised tomogram thorax
Diarrhoea
Condition aggravated
Hyponatraemia
Pulmonary mass
SARS-CoV-2 test positive
Dyspnoea
Fatigue
Nausea
Pain
Vaccine breakthrough infection
Symptomtext
9/9/21-77 y/o male with hx of PAF, HTN and hyperlipidemia presents body aches, SOB, and fatigue. He recently traveled with his wife. Last Thursday, he started to feel fatigued and lost his taste. He also started developing SOB. He returned and called his ENT who prescribed him Cipro and steroids due to hx of Pseudomonas sinus infection. Despite taken these meds, he hasn't felt any better. He admits to nausea, but no vomiting. He is having loose stools. Review of Systems: Constitutional: Denies fever or chills Eyes: Denies change in visual acuity HENT: Denies nasal congestion or sore throat Respiratory: + dry cough + SOB Cardiovascular: Denies chest pain, palpitations, or edema GI: Denies bloody stools GU: Denies dysuria Musculoskeletal: Denies back pain or joint pain Integument: Denies rash Neurologic: Denies headache, focal weakness or sensory changes Endocrine: Denies polyuria or polydipsia Lymphatic: Denies swollen glands Psychiatric: Denies depression or anxiety
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 9/9/21- COVID-19 Result Detected 9/9/21-CT CHEST W/O CONTRAST DATE: 9/9/2021 4:45 PM CLINICAL HISTORY: lung nodule; COVID-19 +. COMPARISONS: CT chest October 30, 2014, chest x-ray September 9, 2021 Technique: Noncontrast CT images of the chest are provided. Dose reduction technique was utilized per ALARA protocol. FINDINGS: Centered in the superior aspect of the right lower lobe is a 4.2 x 2.1 cm mass. There is focal abutment of the pleura. Surrounding groundglass predominantly extending inferiorly is suspicious for additional areas of neoplasm. A pleural-based pulmonary nodule on series 2 image 62 is stable. Partially calcified nodules in the right lower lobe are not significant change in the prior. There is subtle increased linear bandlike interstitial thickening adjacent to these nodules, however there are several foci of calcification within it which would favor a chronic process. Small pleural nodule in the left series 2 image 79 is stable. Calcified pleural plaques in the apices are unchanged. There are chronic right hilar and mediastinal calcified lymph nodes. No discrete new hilar or mediastinal adenopathy is evident within the limits of noncontrast technique. Multiple midthoracic compression fractures are not significant change from the prior. Lucency of the inferior aspect of the T3 vertebral body appears chronic. Visualized upper abdomen is unremarkable. Coronary artery calcifications are present. 1.IMPRESSION: 2.There is a 4.2 x 2.1 cm mass in the superior aspect of the right lower lobe consistent with carcinoma. Adjacent areas of groundglass attenuation predominantly extending caudally are nonspecific but are suspicious for additional areas of neoplastic involvement. No discrete mediastinal or hilar adenopathy. 3.Numerous scattered nodules including cluster of calcified nodules in the right lower lobe. Adjacent to these calcified nodules there is an area of increased bandlike interstitial thickening which is favored to be chronic. Chronic calcified pleural plaques in the apices. 4.Chronic midthoracic compression fractures. 5.Coronary artery atherosclerosis. 9/9/21-09/09/2021 at 1009 hours HISTORY: Fatigue. COMPARISON: Chest x-ray performed on December 20, 2018 FINDINGS: There is been interval development of a right perihilar nodule. This measures 3.0 x 3.2 cm. The lungs are hyperexpanded. The heart size within normal limits. There is no evidence of pneumothorax or pleural effusion. Mild biapical pleural scarring is demonstrated. IMPRESSION: Interval development of a right perihilar pulmonary nodule. This measures 3.0 x 3.2 cm. CT of the chest would be best able to evaluate.
- Aktuelle Erkrankungen
- No known
- Vorgeschichte
- 9/9/21-hx of PAF on Eliquis and who was vaccinated against COVID-19 earlier this month, was admitted to NBH for + COVID-19 and a lung mass. Hyponatremia Sodium 121 on admission Allergic rhinitis ? Asthma ? BPH (benign prostatic hyperplasia) ? Chronic sinus infection ? Diverticulosis ? Hearing loss LEFT EAR/HAS HEARING AID USES PRN ? History of chicken pox MEASLES, MUMPS AS A CHILD ? History of pneumonia ? Hyperlipidemia ? Insomnia ? Lower back pain ? Neck pain DDD ? OSA on CPAP ? Osteopenia ? Osteoporosis 10/15/2012 ? Paroxysmal atrial fibrillation ? Pseudomonas aeruginosa infection SINUSES/DIAGNOSED X 8-9 YEARS/CURRENTLY HAS ? Swelling of both ankles
- Andere Medikamente
- albuterol HFA 108 (90 Base) MCG/ACT inhaler INHALE 2 INHALATION BY MOUTH EVERY 4 HOURS AS NEEDED alendronate (FOSAMAX) 70 MG tablet Take 1 tablet by mouth every 7 days. Ascorbic Acid (VITAMIN C) 500 MG tablet Take 500 mg by mouth 2 (two) t
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 27.09.2021
- Impfdatum
- 22.01.2021
- Beginn
- 23.09.2021
- Tage bis Beginn
- 244,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Patient tested positive for COVID-19 at nursing home on 9/23, presented to ED for shortness of breath, admitted and currently undergoing inpatient treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 25.09.2021
- Impfdatum
- 04.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 178,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Chest X-ray abnormal
Diarrhoea
Lung opacity
Nausea
Vomiting
Symptomtext
Presented from home for N/V/D. CXR showed opacities, COVID PNA. Tx w/ supplemental O2, abx, steroids, remdesivir. Hx HTN, Type II DM. At time of DC stable on 2.5L. DCd to SNF.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 24.09.2021
- Impfdatum
- 09.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 16,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Autoimmune disorder
Condition aggravated
Hypersensitivity
Skin test
Symptomtext
Had issue with allergies that was not pronounced before. Was referred to a specialist allergist. (no allergies other than self, out of balance sinus/immune) auto allergic Was given nasal spray: azelastine and Flonase.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- (04/13/2021) Skin test for allergies (no allergies other than self, out of balance sinus/immune) autoimmune disorder.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Acid Reflux; Spinal Stenosis
- Andere Medikamente
- Omeprazole; atorvastatin; Trazodone; mometasone; D3
- Allergien
- Aspirin; sulfur; codeine; shrimp; milk
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 12.02.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 208,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Angiogram pulmonary abnormal
Blood gases abnormal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Cough
Dyspnoea
Headache
Hypoxia
Lung consolidation
Nausea
Pneumonia
SARS-CoV-2 test positive
Sputum discoloured
Symptomtext
Since 9/8/2021, she has been having some problems with cough, shortness of breath, and headache. She thought she had a sinus infection. She went to see her primary care physician and was tested positive for COVID-19. She was sent over to ER for Regeneron transfusion on 9/16/21. However, the patient was found to be quite hypoxemic with ABG showing a pO2 of only 54.8 on room air. The patient was then started on Decadron and since the CTA of the chest showed bilateral consolidation, she was started on Rocephin and Zithromax and then the Hospitalist Service was called for admission. When I saw the patient, she was saturating 93% to 94% on 2 L nasal cannula. Her main complaint is her cough right now. She does not feel short of breath at this point of time. No chest pain. Mild nausea, but no vomiting. No diarrhea. No loss of taste or smell. Says she lives alone. Admitted on 9/16/21 as an inpatient. Continued Decadron on her. Started her on remdesivir as well. Put her on oxygen. Started her on vitamin C and vitamin D as well. For the Bilateral pneumonia, gave her Rocephin and Zithromax. Patient says occasionally she is able to bring up a sputum, mostly it is clear, but sometimes slightly yellow ting as well, but no epistaxis, no hemoptysis. On 9/21/21 patient's symptoms resolved. REquires 1L NC with exertion. Discharged on 9/22/21 with 5 more days of azithromycin and cephalexin.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 5,0
- Labordaten
- 9/8/21 COVID19: Positive 9/16/21 Chest xray: Patchy bilateral airspace disease most consistent with COVID-19 pneumonia. 9/16/21 CTA chest: Multifocal bilateral consolidation most consistent with COVID-19 pneumonia.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- obesity, hypertension, hypothyroidism, history of being at increased risk of breast cancer being followed by oncologist as an outpatient on Aromasin
- Andere Medikamente
- Aspirin, calcium with vitaminD, levothyroxine, lisinopril-hydrochlorothiazide, meclizine, propranolol
- Allergien
- bactrim, doxy, statins
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 21.09.2021
- Impfdatum
- 15.02.2021
- Beginn
- 13.09.2021
- Tage bis Beginn
- 210,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Emphysema
Lung opacity
Lymphadenopathy
Pleural effusion
Pneumonia
Pulmonary mass
SARS-CoV-2 test positive
Spinal cord compression
Symptomtext
Hospitalized 9/13/21; COVID 19 + on 9/13/21; fully vaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 4,0
- Labordaten
- Admitted with COVID-19 pneumonia CXR 9/13/21: Mild opacity in the left lower lung zone may represent atelectasis or infection. CT angio thorax 9/13/21: 1. No pulmonary embolism. 2. Suspected bronchopneumonia involving the bilateral upper and lower lobes. Recommend follow-up CT in 3 months to ensure resolution. 3. Indeterminate 4 mm right upper lobe nodule. 4. Moderate emphysema. 5. Minimal left pleural effusion. 6. Mildly enlarged bilateral hilar lymph nodes, likely reactive. 7. Age-indeterminate thoracic compression deformities. Discharged on 9/17/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Arthritis, hyperlipidemia, wrist fracture, posterior vitreous detachment, low glaucoma risk both eyes, After cataract with vision obscured, dry eyes, presbyopia, epiretinal membrane, nuclear senile cataract, OSA on Cpap, hypertension and dementia
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 40 MG tablet [START ON 9/18/2021] azithromycin (ZITHROMAX) 250 MG tablet Calcium Carbonate (CAL
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 21.09.2021
- Impfdatum
- 27.02.2021
- Beginn
- 20.09.2021
- Tage bis Beginn
- 205,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chills
Cough
Dyspnoea
Exposure to SARS-CoV-2
Fatigue
Nasal congestion
Occupational exposure to SARS-CoV-2
Pyrexia
SARS-CoV-2 test positive
Symptomtext
HPI Had exposure from grand child was feverish but also was at a meeting a week ago with a lady who later turned positive Over weekend fever, chills , fatigue and nasal congestion started Received pfjzer vaccine 6 mo ago Is having shortness of breath Dry cough The following portions of the patient's history were reviewed and updated as appropriate: allergies, current medications, past family history, past medical history, past social history, past surgical history and problem list.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- SARS-CoV-2 PCR - IPOC : Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular and Mediastinum Coronary artery disease Benign essential hypertension Respiratory Mild intermittent asthma without complication Digestive Gastroesophageal reflux disease Genitourinary Benign prostatic hyperplasia Other Bilateral cataracts Nuclear sclerosis Regular astigmatism Presbyopia Hypomagnesemia B12 deficiency Vitamin D deficiency Hyperlipidemia
- Andere Medikamente
- albuterol HFA 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 40 MG tablet carvedilol (COREG) 12.5 MG tablet Cholecalciferol (VITAMIN D) 25 MCG (1000 UNIT) tablet clopidogrel (PLAVIX) 75 MG tablet MAGNESIU
- Allergien
- Wheat Flour: Rash Nuts, All: Hives
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 15.01.2021
- Beginn
- 15.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Disturbance in attention
Dyspnoea
Lethargy
Pyrexia
Symptomtext
Dose 1: extreme arm pain, swelling, bruising, loss of movement. started within hours, swelling lasted 4 days, pain 6 days, bruising almost 14 days. General malaise, low grade fever 38C 2 days Dose 2: Fever, weakness, lethargy, trouble concentrating, 4 days. Shortness of breath after 1 week, persistent (current through today, 21 Sept 21)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- spinal fusion, epilepsy
- Andere Medikamente
- -
- Allergien
- PCN, ASA, APAP, mould (foods/medication/environmental), latex
- Vorherige Impfungen
- Influenza, 1995 unknown brand. Mild flu-like illness, malaise for ~4 weeks.
- Staat
- PA
- Alter
- -
- Geschlecht
- M
- Eingang
- 18.09.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Diarrhoea
Dyspnoea
Suffocation feeling
Symptomtext
Going to suffocate; couldn't breathe very well; Diarrhea; This is a spontaneous report from a contactable consumer (patient). An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL9269, Expiration date: Not reported), via an unspecified route of administration, on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included ongoing stroke. Concomitant medications included warfarin which was taken for stroke; atorvastatin, telmisartan, doxazosin and atenolol were taken for an unspecified indication. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date: Not reported), via an unspecified route of administration, on an unspecified date as dose 1, single for COVID-19 immunization. The patient had two side effects in which the number one was reported as the patient was going to suffocate and couldn't breathe very well which would be the feeling at bedtime and the second one was diarrhea on an unspecified date. No treatment was received by the patient for these events. The patient had a blood test in the last week with unknown results in Feb2021. The outcome of the events was unknown at the time of report. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 202102; Test Name: blood test; Result Unstructured Data: Test Result:Unknown results; Comments: I did have a test last week
- Aktuelle Erkrankungen
- Stroke
- Vorgeschichte
- -
- Andere Medikamente
- WARFARIN; ATORVASTATIN; TELMISARTAN; DOXAZOSIN; ATENOLOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 18.09.2021
- Impfdatum
- 13.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Heart rate increased
Insomnia
Symptomtext
Not sleeping; heart rate up; difficulty in breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 82-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 13Feb2021 (Batch/Lot Number: El9269) as dose 2, single for covid-19 immunization (at the age of 82-years-old). Medical history included chronic CLL slight (lymphocytic leukaemia), A fib long time no effects (atrial fibrillation) and some COPD (chronic obstructive pulmonary disease) no effect till now all were from an unknown date and unknown if ongoing. The concomitant medications included blood pressure and blood thinner all new (other medications in two weeks). The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 20Jan2021 at 01:30 Pm (Batch/Lot Number: El3249) as single dose for covid-19 immunization (at the age of 82-years-old). Patient had not received any other vaccine in four weeks. Patient had no covid prior vaccination. Patient had not been tested for covid post vaccination. Patient had no known allergies. It was reported that after receiving the second dose of vaccine on 15Feb2021 at 12:00 am the patient was not sleeping, heart rate up difficulty in breathing about half his normal breaths have been to doctors they seem to think it is to do with heart. The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient received any treatment for the events. The outcome of the events was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: AFib; CLL; COPD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 10.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Dry throat
Dyspnoea
Fatigue
Nasal congestion
Nasal dryness
Nasopharyngitis
Oropharyngeal pain
Rhinorrhoea
SARS-CoV-2 test
Sinusitis
Symptomtext
out of breath at times; Tiredness, fatigue; Sinus allergy; cold; sore throat; dryness feeling throat and nose; dryness feeling throat and nose; congestion; runny nose; cough; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old non-pregnant female consumer received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9269) via an unspecified route of administration, administered in arm left on 10Feb2021 at 12:30 PM (at the age of 52-year-old) as dose 1, single for covid-19 immunisation . The patients medical history included allergies, known allergies to Aspirin, Penicillin, and Sulfas. The patients past drugs included Tetracycline, Advil, Ibuprofen, and experienced allergies. Concomitant medication in two weeks included cetirizine hydrochloride (ZYRTEC), taken for unspecified indication, start and stop dates were not reported. Patient did not receive other vaccine in four weeks. On 16Feb2021 at 01:30 AM, five days later, she experienced tiredness, fatigue, out of breath at time, cold or sinus allergies. It started with a sore throat, dryness feeling throat and nose, congestion, runny nose and cough. Adverse events resulted in physician office visit. The patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested for COVID post vaccination. The patient underwent lab test and procedure which included SARS-CoV-2 test (Nasal Swab, polymerase chain reaction, and Antigen): result unknown, on 17Feb2021. The clinical outcome of all the events was resolving. Follow-up attempts completed. No further information expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210217; Test Name: covid test; Result Unstructured Data: Test Result:Pending; Comments: Nasal Swab,Pcr,Antigen
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Penicillin allergy; Sulfonamide allergy
- Andere Medikamente
- ZYRTEC
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 18.09.2021
- Impfdatum
- 10.03.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Throat tightness
Tremor
Symptomtext
Odd Tightness in his Throat/same type pressure in his throat; Arms and Legs Shaking, Trembling and Quivering; Face turned a little bit red; Arms and Legs Shaking, Trembling and Quivering; This is a spontaneous report from a contactable consumer (patient, self-reported). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9269 and expiry date was not reported), via an unspecified route of administration, on 10Mar2021 at 14:15 (age at vaccination: 55 years), as a single dose for COVID-19 immunization. The patient's medical history included multiple sclerosis (MS) and bee venom allergy. Concomitant medication included fingolimod hydrochloride (GILENYA) for multiple sclerosis. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN5318 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 13Feb2021 (age at vaccination: 55 years), as a single dose for COVID-19 immunization and had odd tightness in his throat. Vaccine was not administered at Military Facility. The patient stated that on 10Mar2021, he had his second dose. At that point, it was within 2 hours, he had odd Tightness in his Throat/same type pressure in his throat and his arms and legs were shaking and quivering. He stated that he went to the emergency room and the doctor there gave him medication and he ended up getting discharged. He stated that he woke up this morning and had the same thing, trembling in his arms and legs. The patient stated that his question was, how common was that and when did that go away. He stated that steroids took care of that and a corticosteroid. When he woke up and took it, it had been such a long time since the last dose he took of prednisone. He has waited 2 hours and 10 minutes to talk to call handler, so he did have time. He didn't have the pressure in his throat yesterday because he had prednisone late in the day, so Thursday he didn't have it and today as of this morning he has it. He stated that things were getting better, he was not in the ER, stated he guesses once he gets thorough this and arms and legs weren't shaking, so for now unknown. He will find out tomorrow if his arms and legs weren't shaking. The patient's face turned a little bit red which occurred after both the first and second vaccine and only lasted a short time. The patient took Prednisone once a day, Benadryl every 6 hours by mouth. Outcome of the event odd tightness in his throat/same type pressure in his throat was recovering, face turned a little bit red was recovered on 10Mar2021, and for all other events, it was not recovered. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Bee sting hypersensitivity; MS (Verbatim: MS)
- Andere Medikamente
- GILENYA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 17.02.2021
- Beginn
- 17.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Blister
Condition aggravated
Eczema
Nipple disorder
Inappropriate schedule of product administration
Rash
Pruritus
Rash erythematous
Symptomtext
Skin rashes that have spread from my arms all the way down to my legs. I have eczema on my hands, specifically dyshidrotic eczema. These rashes however are different never had them prior; Inappropriate schedule of vaccine administered; This is a spontaneous report from a Contactable Consumer (patient). A 20-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 17Feb2021 (Batch/Lot Number: EL0203) as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm Right on 17Feb2021 10:30 (Batch/Lot Number: EL9269) as DOSE 1, SINGLE for covid-19 immunisation at the age of 20-year-old. Medical history included allergies to Latex, Dust, Pollen, mice, roaches, cats, dogs; Eczema, IBS, scoliosis, Anxiety, Depression and dyshidrotic eczema (eczema on hands). There were no concomitant medications. The patient experienced skin rashes that have spread from the arms all the way down to the legs on 24Feb2021 with outcome of not recovered, inappropriate schedule of vaccine administered on 17Feb2021 with outcome of unknown. Therapeutic measures were taken as a result of skin included topical steroids, phototherapy, steroid injections. The event resulted in Doctor or other healthcare professional office/clinic visit. No COVID prior vaccination and unknown if COVID tested post vaccination. The clinical course was reported: Skin rashes that have spread from the arms all the way down to the legs. The patient has eczema on the hands, specifically dyshidrotic eczema. These rashes however are different never had them prior and first flare up started the first 2 weeks of the vaccination. Within the last few months, it continues to spread to other parts of the body and flares up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to animal; Anxiety; Depression; Dust allergy; Dyshidrotic eczema (I have eczema on my hands, specifically dyshidrotic eczema.); Eczema; Irritable bowel syndrome; Latex allergy; Pollen allergy; Scoliosis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 12.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Condition aggravated
Pain
Feeling hot
Herpes zoster
Rash
Symptomtext
shingles rash; shingles rash; sharp piercing pain across my upper left chest; heat attack; Had throbbing and soreness in left upper chest; This is a spontaneous report from a contactable consumer (patient herself). A 66-years-old non-pregnant female patient received second dose of bnt162b2 (Solution injection, Batch/Lot Number: EL9269), via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 12:15 (at the age of 66-years-old) as single dose for covid-19 immunisation. Patient previously received first dose of bnt162b2 (Solution injection, Batch/Lot Number: EL3249), via an unspecified route of administration, administered in Arm Left on 19Jan2021 at 17:00 as single dose for covid-19 immunisation. Medical history included shingles. Patient had no known allergies. Concomitant medications included lorazepam, valacyclovir, atorvastatin and trazodone. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with covid prior vaccination. Patient was not tested for covid post vaccination. On 12Feb2021 at 12:15, patient experienced sharp piercing pain across her upper left chest. For the following two months pain would come and go without any pattern. She was having a heat attack. Had throbbing and soreness in left upper chest and also dull pain at various times for two months after shot. Doctors were giving her many tests. Two months after shot broke out in a shingles rash in that exact same. The outcome of the events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Shingles
- Andere Medikamente
- LORAZEPAM; VALACYCLOVIR HCL; ATORVASTATIN; TRAZODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 12.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Condition aggravated
Pain
Feeling hot
Herpes zoster
Rash
Symptomtext
shingles rash; shingles rash; sharp piercing pain across my upper left chest; heat attack; Had throbbing and soreness in left upper chest; This is a spontaneous report from a contactable consumer (patient herself). A 66-years-old non-pregnant female patient received second dose of bnt162b2 (Solution injection, Batch/Lot Number: EL9269), via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 12:15 (at the age of 66-years-old) as single dose for covid-19 immunisation. Patient previously received first dose of bnt162b2 (Solution injection, Batch/Lot Number: EL3249), via an unspecified route of administration, administered in Arm Left on 19Jan2021 at 17:00 as single dose for covid-19 immunisation. Medical history included shingles. Patient had no known allergies. Concomitant medications included lorazepam, valacyclovir, atorvastatin and trazodone. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with covid prior vaccination. Patient was not tested for covid post vaccination. On 12Feb2021 at 12:15, patient experienced sharp piercing pain across her upper left chest. For the following two months pain would come and go without any pattern. She was having a heat attack. Had throbbing and soreness in left upper chest and also dull pain at various times for two months after shot. Doctors were giving her many tests. Two months after shot broke out in a shingles rash in that exact same. The outcome of the events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Shingles
- Andere Medikamente
- LORAZEPAM; VALACYCLOVIR HCL; ATORVASTATIN; TRAZODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 16.09.2021
- Impfdatum
- 06.02.2021
- Beginn
- 15.09.2021
- Tage bis Beginn
- 221,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Dyspnoea
Nausea
Pyrexia
SARS-CoV-2 test positive
Symptomtext
9/15/2021 presented to EC with with shortness of breath, cough and fever with nausea.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 09/15/21 SARS-CoV-2 (COVID-19) by NAA - DETECTED
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 15.09.2021
- Impfdatum
- 12.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia oral
Maternal exposure during breast feeding
Paraesthesia
Paraesthesia ear
Paraesthesia oral
Symptomtext
Around 1 week following 2nd Pfizer covid shot, developed a numb/tingling sensation in top of tongue. Gradually progressed over the course of 10days. Numbness and tingling tip of tongue to right lateral side of tongue. By day 7 of 10 right side of cheek radiating up to side of right ear was tingling. No motor deficits occurred only sensory. By day 10 symptoms resolved. I took ibuprofen 200mgx2 three times a day on day 8-10.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Primary care visit for assessment. No labs or tests run. Prednisone given but I did not take it due to breastfeeding.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Pelvic interstitial cystitis
- Andere Medikamente
- Prenatal
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 10.09.2021
- Impfdatum
- 11.02.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 209,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
COVID-19
Chest pain
Cough
Dyspnoea
Fall
Musculoskeletal chest pain
Pleuritic pain
Symptomtext
Presented with SOB, cough and was admitted for COVID-19 viral infection. He has been coughing with progressive dyspnea and pleuritic chest pain component x1 day with chest wall pain since fall couple weeks ago. No fevers chills rigors loss of taste or smell nausea vomiting abdominal pain or diarrhea. No dysuria or hematuria. He received full dose aspirin, azithromycin, Decadron in the ED. He was continued on zinc, vitamin D3, decadron, famotidine and monitored overnight with no need for oxygen. He was found safe for discharge with continued supplements and decadron.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- significant PMH of CAD, paroxysmal atrial fibrillation, HTN, HLD, s/p TAVR, bladder cancer
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 12.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Migraine
Pain
Symptomtext
Chills; body pain; migraine; headache; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 55 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Lot Number: EL9269) via intramuscular route, administered in Left Arm on 12Feb2021 at 17:30 (at the age of 55-year-old) as a Dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications within 2 weeks after vaccination were reported as none. No known allergies were reported. Vaccination facility type was reported as Other. The patient had not received any other vaccine within 4 weeks prior to Covid vaccination. The patient was not diagnosed with Covid prior to vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Lot Number: EL9262) via intramuscular route, administered in Left Arm on 26Jan2021 (at the age of 55-year-old) as a Dose 1, single for COVID-19 immunization. She mentioned that with her first dose (26Jan2021) she did not have any reaction, but with her second dose (12Feb2021) well past a few hours she began to feel chills, body pain and migraine, headache. Since vaccination the patient was not tested for Covid. No treatment medications received for the events. The outcome of the events was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information was expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 08.02.2021
- Beginn
- 26.08.2021
- Tage bis Beginn
- 199,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Adenovirus test
Aortic arteriosclerosis
Asthenia
Bordetella test negative
COVID-19
Chest X-ray
Chlamydia test negative
Condition aggravated
Decreased appetite
Diarrhoea
Dizziness
Early satiety
Enterovirus test negative
Essential hypertension
Human metapneumovirus test
Human rhinovirus test
Hyponatraemia
Hypophagia
Symptomtext
ED to Hosp-Admission Current 9/2/2021 - present (6 days) Essential hypertension, Hypothyroid, Hyponatremia, COVID-19, Diarrhea Chief Complaint Patient presents with ? Weakness - Generalized History of Present Illness Patient is a remarkable 86-year-old female in excellent health, past medical history significant for hypothyroidism and hypertension, active and independent in activities of daily living, works and engages in social activities. Patient has been generally unwell for 1 week's time. Her closest dance partner had upper respiratory symptoms 1 week ago. She is fully vaccinated against COVID-19. She does not routinely mask in public or in dance halls. She has had 1 week of lethargy, malaise, nausea, poor appetite, poor p.o. intake, early satiety, and diffuse watery diarrhea. She has had no upper respiratory symptoms, has not been short of breath or coughing, no fevers. She is generally weak and lightheaded. She saw her primary care physician on 830, had a rapid Covid test in the office which was negative, and in her vaccination status this was thought to be accurate. Repeat Covid is positive today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 6,0
- Labordaten
- 09/02/21 1659 Respiratory virus detection panel Collected: 09/02/21 1549 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected X-ray chest 2 views [3300995824] Resulted: 09/02/21 1524 Order Status: Completed Updated: 09/02/21 1525 Narrative: XR CHEST 2 VW IMPRESSION: Stable chest with no acute cardiopulmonary process. END OF IMPRESSION: INDICATION: weakness Weakness. TECHNIQUE: PA and lateral projections of the chest are acquired. COMPARISON: 10/7/2019 FINDINGS: No focal consolidation or pulmonary edema. There is mild scoliosis of the thoracic spine unchanged from prior study. No pneumothorax or pleural effusion. Normal cardiomediastinal silhouette. Atherosclerosis of the aortic arch. Surgical clips are noted of the lower chest.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Non-Hospital Atrophic vaginitis Postmenopausal atrophic vaginitis Sebaceous cyst Vaginal dysplasia Pelvic pain Thyroid disorder Onychomycosis
- Andere Medikamente
- amLODIPine (NORVASC) 5 mg tablet cholecalciferol, vitamin D3, 25 mcg (1,000 unit) tablet levothyroxine (SYNTHROID) 100 mcg tablet metoprolol tartrate (LOPRESSOR) 25 mg tablet
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 07.09.2021
- Impfdatum
- 25.02.2021
- Beginn
- 07.09.2021
- Tage bis Beginn
- 194,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
SARS-CoV-2 test positive
Symptomtext
pt is hospitalized with covid + pna
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 07.09.2021
- Impfdatum
- 13.02.2021
- Beginn
- 13.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Migraine
Symptomtext
Migraine type headache; This is a spontaneous report from a contactable consumer(patient). A 50-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL9269), via an Intramuscular route of administration on 13Feb2021 at 10:00(at the age of 50-years-old) administered in Arm Right as a single dose for COVID-19 immunisation. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL9261), via an Intramuscular route of administration on 26Jan2021 at 20:00(at the age of 50-years-old) administered in Upper right arm as a single dose for COVID-19 immunisation. Medical history included epstein barr virus positive mucocutaneous ulcer from 2010 and ongoing, Penicillin allergies from an unknown date and unknown if ongoing , Low thryoid function from 2015 and ongoing , thyroid from an unknown date and unknown if ongoing, Chronic pain from an unknown date and unknown if ongoing. Concomitant medication(s) included tramadol taken for pain from an unspecified start date and ongoing; cyanocobalamin (B12) taken for epstein barr virus positive mucocutaneous ulcer from an unspecified start date and ongoing; levothyroxine sodium (LEVOTHYROXINE) taken for thyroid disorder from an unspecified start date and ongoing; liothyronine sodium (LIOTHYRONINE) taken for thyroid disorder from an unspecified start date and ongoing. On 13Feb2021 at 22:00, the patient experienced Migraine type headache. The patient had received advil as a treatment medication. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Epstein Barr virus positive mucocutaneous ulcer; Thyroid function decreased
- Vorgeschichte
- Medical History/Concurrent Conditions: Chronic pain; Penicillin allergy; Thyroid disorder
- Andere Medikamente
- TRAMADOL; B12 [CYANOCOBALAMIN]; LEVOTHYROXINE [LEVOTHYROXINE SODIUM]; LIOTHYRONINE [LIOTHYRONINE SODIUM]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 03.09.2021
- Impfdatum
- 08.03.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 170,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anaemia
Anticoagulant therapy
Asthenia
Blood creatinine normal
Blood test
COVID-19
COVID-19 pneumonia
Chest X-ray normal
Condition aggravated
Cough
Decreased appetite
Dyspnoea
Fall
Haemoglobin decreased
Hyponatraemia
Leukocytosis
Lymphocyte count decreased
Lymphopenia
Symptomtext
Hospitalized (admitted 8.28); COVID-19 exposure and symptoms 8.25.21; COVID-19 positive 8.28.21 (fully vaccinated) Currently still admitted to the hospital. CHIEF COMPLAINT COVID ASSESSMENT AND PLAN Covid pneumonia - patient presenting with cough, SOB, fevers, weakness for the last 3 days. Husband is also Covid positive. Fully vaccinated with Pfizer. - satting well on room air but did have episode of desaturation to 88%, recovered quickly - Covid positive 8/28 - CXR negative for acute process - started on decadron, continue - does not currently qualify for Remdesivir - prn cough meds - monitor on pulse ox Mechanical falls - notes she has had 3 mechanical falls in the last 3 days. Last fall was yesterday and she states they were from "getting tripped up" not really from weakness. Had to call sister to help with getting her off the floor. Denies hitting head and not on AC. - PT/OT eval Essential HTN - continue home Norvasc Crohn's disease - holing home Imuran and Humera with acute infection Epilepsy - continue home Lamictal Anxiety - home ativan PRN Chronic anemia - hgb 10.3 which is around recent baseline Hx SDH with chronic R sided weakness HDL - continue home ASA and stain Hx DVT/PE - not currently on AC Diet: general VTE Prophylaxis: Lovenox Code status: Full code per discussion with patient and sister at bedside Above assessment and plan discussed with Dr. whose insight is reflected above. HISTORY OF PRESENT ILLNESS Patient is a 71 y.o. female with past medical history significant for Crohn disease on chronic anemia depression, anxiety, subdural hematoma with chronic right-sided weakness, epilepsy, hypertension, history of DVT/PE who presented emergency department complaints of cough, shortness of breath and weakness. Patient states that her husband was found to be COVID positive recently. She was seen at urgent care a few days ago and was negative but states that she has had worsening symptoms. Cough has been productive and she has been having intermittent shortness of breath. Has been having fevers at home with most recent being this morning. She also notes a decreased appetite and minor sore throat. Patient notes that she is fully vaccinated with Pfizer. Per patient and sister at bedside, they noted patient had 3 mechanical falls in the last 3 days. Last fall was yesterday. Patient states that these falls were secondary to ?getting tripped up? and not necessarily from weakness. She does have chronic right-sided from her prior stroke. Patient states that she had to call her sister for assistance getting off the floor has her husband is currently weak with COVID and was unable to help. Patient denies having had any of her falls. Patient is also not currently on any anticoagulation. Denies any chills, lightheadedness/dizziness, loss of taste or smell, chest pain, abdominal pain, nausea/vomiting, diarrhea urinary symptoms. Upon arrival to emergency department, patient was tachypneic. Baseline blood work was obtained showing minor hyponatremia of 132, slight bump in her creatinine to 0.99, minor leukocytosis of 12.8 with lymphopenia, stable chronic anemia. COVID PCR was positive. CXR was obtained was negative for acute process. Patient was stable on room air for most of her stay in the ER. She did have 1 episode of desaturation to 88% but did recover quickly. Patient was then started on Decadron. She was then admitted to General Medicine under observation for further evaluation and management.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- COVID-19 symptoms (8.25.21) found to be COVID-19 positive 8.28.21 Husband tested positive for COVID 8.25.21
- Vorgeschichte
- Epileptic seizure (HCC) Pseudothrombocytopenia Risk for falls, due to Physical deconditioning H/O: GI bleed Age-related osteoporosis without current pathological fracture Adnexal mass Renal stone Chronic midline low back pain without sciatica High risk medication use Cognitive impairment Spinal stenosis Nodule of neck
- Andere Medikamente
- amLODIPine (NORVASC) 10 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 10 MG tablet azaTHIOprine (IMURAN) 50 MG tablet AZO-CRANBERRY PO Calcium Citrate-Vitamin D3 1000-400 LIQD c
- Allergien
- Gabapentin Penicillins Rash Tizanidine
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 02.09.2021
- Impfdatum
- 19.02.2021
- Beginn
- 06.08.2021
- Tage bis Beginn
- 168,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19 pneumonia
SARS-CoV-2 test positive
Symptomtext
Patient symptoms onset was on 8/6, she was hospitalize at Hospital in city from 8/10 through 8/16 and diagnosed with COVID pneumonia. She will be in isolation until 8/26. PUI other underlying condition/risk factors lung cancer, melanoma and previously suffered a stroke.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD and Diabetes Mellitus
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 95,0
- Geschlecht
- M
- Eingang
- 01.09.2021
- Impfdatum
- 06.02.2021
- Beginn
- 06.08.2021
- Tage bis Beginn
- 181,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19 pneumonia
SARS-CoV-2 test positive
Symptomtext
Case completed Covid vaccine series on 2/6/2021, and was admitted to hospital 8/6/2021 for Covid pneumonia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 6,0
- Labordaten
- SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection (SARS Coronavirus 2 RNA) Detected; Ordered Test: SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection (SARS Coronavirus 2) Ordered Test Codes: 94309-2 (LN LOINC)/2019nCoV (L LOCAL) Status: Final; Accession Number: 1575543; Specimen Source: Other; Specimen Site: Specimen Collection Date/Time: 2021-08-03 00:00:00.0. GISAID ID (GISAID ID) 3845062 Final; SARS-CoV-2 Vaccine Status (SARS-CoV-2 Vaccine Status) No Answer Given Final; SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing (Sequencing Results) B.1.617.2 NA Final; Ordered Test: SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing; Ordered Test Codes: 96741-4 (LN LOINC)/ Status: Final; Accession Number: 1575543; Specimen Source: Other; Specimen Site: Specimen Collection Date/Time: 2021-08-03 00:00:00.0; SARS-CoV-2 RNA Resp Ql NAA+probe DETECTED Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe; Ordered Test Codes: 94500-6 (LN LOINC)/ Status: Final Accession Number: 212210156LP-198922; Specimen Source: SOFT TISSUE SAMPLE; Specimen Site: ENTIRE NASOPHARYNX(181200003) Specimen Collection Date/Time: 2021-08-09 17:46:00.0; SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection (SARS Coronavirus 2 RNA) Detected; Ordered Test: SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection (SARS Coronavirus 2) Ordered Test Codes: 94309-2 (LN LOINC)/2019nCoV (L LOCAL) Status: Final; Accession Number:1492828; Specimen Source: Other; Specimen Site: Specimen Collection Date/Time: 2021-08-09 00:00:00.0.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Arthritis; Back pain; BPH (benign prostatic hyperplasia) CAD (coronary artery disease) past PCI / stents; CHF (congestive heart failure) (HCC) details unclear; Environmental allergies; GERD (gastroesophageal reflux disease) 7/5/2012; History of esophageal stricture; 7/5/2012 Hypercholesteremic; 7/5/2012 Hypertension; PMR (polymyalgia rheumatica) (HCC) 7/5/2012; Subdural hematoma (HCC) 2012 and basilar skull fracture, hospitalization
- Andere Medikamente
- acetaminophen (TYLENOL) 325 mg tablet, Take 650 mg by mouth every 8 hours as needed for Pain. aspirin 81 mg EC table Take 324 mg by mouth Daily. Indications: CAD; atorvaSTATin (LIPITOR) 40 mg tablet Take 20 mg by mouth nightly. azelastine 0
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 01.09.2021
- Impfdatum
- 25.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Asthma
Body temperature increased
Condition aggravated
Fatigue
Goitre
Hypersensitivity
Oropharyngeal pain
Pharyngeal swelling
Sinusitis
Thirst
Symptomtext
After coming home from the vaccine, I had no issues for 6-8 hours. I then started feeling extremely weak tired and thirsty. I checked my temperature, and I was actually running a temperature. To me, it felt like I needed fluids. It felt like my body needed more fluids to process the vaccine. I started drinking a lot more. I was basically on a liquid diet, soups, fluids etc. After about 3 days, I was fine. I did develop a sinus infection after but that is normal for me. I have allergies so that is something I was going to deal with regardless of the vaccine. My asthma and allergies were also on peak for that time of year. Last week, I had a sore throat and honestly thought I had COVID. My doctor looked at me and said I had no symptoms of COVID at all. My throat was so swollen in the front. After tests were done, it all came back normal. My thyroid is still swollen, and I concerns me, but I am not sure what the reason for this is. I do not know if it is from the vaccine at all but nothing else has changed nor have I done anything different since. This is the only thing that concerns me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- Allergy symptoms
- Vorgeschichte
- Yes, heart issues; high blood pressure; allergic asthma
- Andere Medikamente
- Yes, prescriptions
- Allergien
- white potatoes; beef; pork
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 01.09.2021
- Impfdatum
- 11.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Malaise
Mobility decreased
Pain
Rheumatoid arthritis
Symptomtext
she got very ill; ad severe pain and mobility problems; ad severe pain and mobility problems; flare of her rheumatoid arthritis; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female received second dose of BNT162B2 (lot number EL9269) on 11Feb2021 (at age of 77-year-old) at single dose on left arm for Covid-19 immunization. Co-suspect product included tofacitinib citrate (XELJANZ) from unspecified date and ongoing at 5 mg twice daily for rheumatoid Arthritis. Medical history included ongoing rheumatoid Arthritis. Concomitant medications included ongoing methotrexate for rheumatoid Arthritis, ongoing hydroxychloroquine, prednisone from unspecified date and Jul2021, folic acid. Historical vaccine included first dose of BNT162B2 (lot number EL1283) on 22Jan2021 (at age of 77-year-old) on left arm for Covid-19 immunization. She was taking xeljanz 5 mg twice daily for years for severe rheumatoid Arthritis. Her Dr. wants her to have a booster dose of the Pfizer covid vaccine and wants her to be off xeljanz for a week after the booster dose. asking for pfizer's recommendations on when to stop xeljanz. Added she received a 2nd dose of pfizer covid vaccine on 11Feb and 12 days later she experienced a flare of her rheumatoid arthritis on 23Feb2021 which lasted till end of May2021. States with the flare, she got very ill, had severe pain and mobility problems especially in her shoulders and knees. She was treated with high doses of prednisone, received coritisone shots, took aleve and tylenol. She got cortisone shots in her shoulder and knees, and they made no difference. She took Aleve and Tylenol more often than normal. She took high doses of Prednisone, and none of that helped. Finally, she was given Meloxicam 15 mg which helped almost immediately. States at the time of her pfizer covid vaccine doses, she was taking xeljanz, methotrexate, hydroxychloroquine and prednisone. she has since weaned off prednisone as of Jul2021. states no one told her to stop those medications before/after the covid vaccines. she was told by a provider that because she was on so many immunosuppressants, she had 'a blunted effectiveness' of the vaccine. States this was general information she was told and not due to any presenting. She recovered completely from her flare up. She just never fully recovers with her rheumatoid arthritis. She did go down to her normal degree of Rheumatoid Arthritis. This was an extreme flare, and she did recover. She continued to take Xeljanz, Methotrexate, Hydroxychloroquine, and prednisone when she got the COVID vaccine. She also takes folic acid. She is on Methotrexate 2.5mg seven tablets, once a week. NDC:68382-775-01. Medication is in a pharmacy bottle so she is unable to provide Lot number. Expiration is 31May2022. Her Hydroxychloroquine NDC is 43598-0721-01, and it is good until May2022. She doesn't have the lot. She has no information on the Prednisone because she is not taking it anymore. She doesn't have NDC/lot/expiration. She called because she wanted information on what to do for the booster. Should she stop her immunosuppressant drugs? She didn't get anymore information than she already had. She is afraid to go off her medications for it because she never has. She will have a flare up. Her doctor thinks she needs the booster though. Caller was referred to her doctor. The action taken for tofacitinib citrate was dose not changed. The outcome of the event flare of her rheumatoid arthritis was recovered in May2021 (duration reported as 67 days). The outcome of other events was unknown. The Seriousness was no.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Rheumatoid arthritis (taking xeljanz 5 mg twice daily for years for severe rheumatoid Arthritis).
- Vorgeschichte
- -
- Andere Medikamente
- Methotrexate; Hydroxychloroquine; Prednisone; Folic Acid; Xeljanz
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 31.08.2021
- Impfdatum
- 12.02.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 152,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chest X-ray abnormal
Chills
Cough
Dyspnoea
Lung opacity
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Pt came to ER with SOB, cough, and covid positive, onset 1 week prior. Fever and chills since 7/4/21. Covid positive on 7/9/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 8,0
- Labordaten
- Chest xray: airspace opacities in the lungs demonstrating a perihilar predilection. 7/15/21: Covid test-positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM, HTN
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 29.08.2021
- Impfdatum
- 28.08.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Nausea
Pallor
Pyrexia
Tremor
Symptomtext
Shivering, trembling 101.2 degrees Fahrenheit fever Pale lips and face Temporary spots on right hand Nausea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Possibly fibromyalgia or similar illness (still testing with rheumatologist) that started developing recently. Experiences flair-ups of pain at random times and after strenuous labor.
- Vorgeschichte
- Hashimoto?s hypothermia Eczema Low blood pressure
- Andere Medikamente
- Levothyroxine 88 mcg Duloxetine 60 mg Methylprednisolone 4 mg
- Allergien
- Penicillin Some fruits Tree nuts Peanuts Cinnamon Silicone Soy Chocolate
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 29.08.2021
- Impfdatum
- 01.02.2020
- Beginn
- 01.02.2020
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Hypoaesthesia
Paraesthesia
Symptomtext
Burning in both right and left feet; Tingling in both right,left feet and hands; Local burning sensation in thighs; Numbness in left little finger, 5th digit; This is a spontaneous report from a non contactable consumer, the patient. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EL9269) via an unspecified route of administration on an unknown date in Feb2020 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Feb2020 the patient experienced burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger was unknown at the time of this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 29.08.2021
- Impfdatum
- 04.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Blood test
Chest X-ray
Chest scan
Dyspnoea
Echocardiogram
Computerised tomogram normal
Inflammation
Interstitial lung disease
Laboratory test normal
Electrocardiogram
Fatigue
Pulmonary function test
Red blood cell count increased
Pulmonary function test normal
SARS-CoV-2 test negative
X-ray normal
SARS-CoV-2 test
Symptomtext
High red blood count; Feeling tired; Interstitial lung disease; Trouble breathing/Shortness of breath; The initial safety information received was reporting only non-serious adverse drug reactions. Upon receipt of follow-up information on 09Aug2021, this case now contains serious adverse reactions. This is a spontaneous report from a contactable consumer (patient). A 76-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EL 9269), dose 2 intramuscular, administered in left arm on 04Feb2021 13:15 (at the age of 76-year-old) as dose 2, single for COVID-19 immunization. Medical history included High cholesterol and high blood pressure. Concomitant medications included montelukast sodium (SINGULAIR); ezetimibe, simvastatin (VYTORIN); amlodipine; meloxicam; and an unspecified vitamin. The patient previously received the first dose of bnt162b2 (lot no.: EL8982), via intramuscular on administered in left arm on 04Jan2021 (at the age of 76-year-old) as single dose for COVID-19 immunization. On 08Feb2021 the patient experienced shortness of breath/ trouble breathing and Interstitial lung disease. On 11Feb2021, the patient experienced feeling tired. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal swab: negative on 14Jun2021 and negative on 15Mar2021, EKG: Normal on 12Feb2021, Chest X-ray: Normal on 22Feb2021, Echocardiogram: Normal on 26Feb2021, CT Chest scan: Interstitial lung disease on 26Feb2021, Blood tests: High red blood count on 03Mar2021, Pulmonary function test: Diffusing capacity of 58/0, Inflammation of lungs oxygen not getting to lungs although lungs are okay on 15Mar2021. The adverse events shortness of breath/ trouble breathing, Interstitial lung disease and feeling tired resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events shortness of breath/ trouble breathing and feeling tired which included prednisone. Treatment for Interstitial lung disease included Mycophenolate. The outcome of High red blood count was unknown and the remaining events was recovering. The events shortness of breath/ trouble breathing, and Interstitial lung disease were assessed as serious (Persistent/significant disability/incapacity). The reporter consider that the Pfizer product had a casual effect to the adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210303; Test Name: Blood tests; Result Unstructured Data: Test Result:High red blood count; Test Date: 20210226; Test Name: CT Chest scan; Result Unstructured Data: Test Result:Interstitial lung disease; Test Date: 20210222; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Test Date: 20210226; Test Name: Echocardiogram; Result Unstructured Data: Test Result:Normal; Test Date: 20210212; Test Name: EKG; Result Unstructured Data: Test Result:Normal; Test Date: 20210315; Test Name: Pulmonary function test; Result Unstructured Data: Test Result:Diffusing capacity of 58/0; Comments: Inflammation of lungs oxygen not getting to lungs although lungs are ok; Test Date: 20210315; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Test Date: 20210614; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high; High cholesterol
- Andere Medikamente
- SINGULAIR; VYTORIN; AMLODIPINE; MELOXICAM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 29.08.2021
- Impfdatum
- 04.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Blood test
Chest X-ray
Chest scan
Dyspnoea
Echocardiogram
Computerised tomogram normal
Inflammation
Interstitial lung disease
Laboratory test normal
Electrocardiogram
Fatigue
Pulmonary function test
Red blood cell count increased
Pulmonary function test normal
SARS-CoV-2 test negative
X-ray normal
SARS-CoV-2 test
Symptomtext
High red blood count; Feeling tired; Interstitial lung disease; Trouble breathing/Shortness of breath; The initial safety information received was reporting only non-serious adverse drug reactions. Upon receipt of follow-up information on 09Aug2021, this case now contains serious adverse reactions. This is a spontaneous report from a contactable consumer (patient). A 76-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EL 9269), dose 2 intramuscular, administered in left arm on 04Feb2021 13:15 (at the age of 76-year-old) as dose 2, single for COVID-19 immunization. Medical history included High cholesterol and high blood pressure. Concomitant medications included montelukast sodium (SINGULAIR); ezetimibe, simvastatin (VYTORIN); amlodipine; meloxicam; and an unspecified vitamin. The patient previously received the first dose of bnt162b2 (lot no.: EL8982), via intramuscular on administered in left arm on 04Jan2021 (at the age of 76-year-old) as single dose for COVID-19 immunization. On 08Feb2021 the patient experienced shortness of breath/ trouble breathing and Interstitial lung disease. On 11Feb2021, the patient experienced feeling tired. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal swab: negative on 14Jun2021 and negative on 15Mar2021, EKG: Normal on 12Feb2021, Chest X-ray: Normal on 22Feb2021, Echocardiogram: Normal on 26Feb2021, CT Chest scan: Interstitial lung disease on 26Feb2021, Blood tests: High red blood count on 03Mar2021, Pulmonary function test: Diffusing capacity of 58/0, Inflammation of lungs oxygen not getting to lungs although lungs are okay on 15Mar2021. The adverse events shortness of breath/ trouble breathing, Interstitial lung disease and feeling tired resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events shortness of breath/ trouble breathing and feeling tired which included prednisone. Treatment for Interstitial lung disease included Mycophenolate. The outcome of High red blood count was unknown and the remaining events was recovering. The events shortness of breath/ trouble breathing, and Interstitial lung disease were assessed as serious (Persistent/significant disability/incapacity). The reporter consider that the Pfizer product had a casual effect to the adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210303; Test Name: Blood tests; Result Unstructured Data: Test Result:High red blood count; Test Date: 20210226; Test Name: CT Chest scan; Result Unstructured Data: Test Result:Interstitial lung disease; Test Date: 20210222; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Test Date: 20210226; Test Name: Echocardiogram; Result Unstructured Data: Test Result:Normal; Test Date: 20210212; Test Name: EKG; Result Unstructured Data: Test Result:Normal; Test Date: 20210315; Test Name: Pulmonary function test; Result Unstructured Data: Test Result:Diffusing capacity of 58/0; Comments: Inflammation of lungs oxygen not getting to lungs although lungs are ok; Test Date: 20210315; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Test Date: 20210614; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high; High cholesterol
- Andere Medikamente
- SINGULAIR; VYTORIN; AMLODIPINE; MELOXICAM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 11.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Asthenia
Condition aggravated
Diarrhoea
Dizziness
Fatigue
Headache
Myalgia
Nausea
Swelling face
Vaccination site pain
Symptomtext
Headache (this morning and radiated to neck and upper back); swelling on left side of face; Injection site pain; Muscle pain; Joint pain (Especially in jaw, lower extremities, ankles, and wrists); Severe nausea and diarrhea; Severe nausea and diarrhea; Dizziness; Tiredness; Injection site pain was reported as worsened.; Weakness; This is a spontaneous report from a contactable consumer (patient) or other non HCP. A 21-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9269, Expiration date was not reported), dose 2 via an unspecified route of administration, administered in arm left on 11Feb2021 at 10:00 (age at vaccination: 21-year-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history included did have allergy to heat and will get swelling and heat hives from an unknown date and unknown if ongoing. There were no concomitant medications. Historical vaccine included previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date in Jan2021 (age at vaccination: 21-year-old) (Batch/Lot Number: EL1283) as DOSE 1, SINGLE for covid-19 immunization and had no adverse reaction. Prior vaccinations within 4 weeks: no, only first COVID-19 Vaccine dose. AEs follow prior vaccinations was none. family medical history was none. History of all previous immunizations was not provided. Additional vaccines administered on same date of Pfizer suspect was none. On 11Feb2021, patient experienced injection site pain, tiredness, muscle pain, joint pain, severe nausea and diarrhea, dizziness, on 12Feb2021, patient experienced swelling on left side of face and headache and on an unspecified date in Feb2021, patient experienced injection site pain was reported as worsened and weakness. Patient wanted to report side effects for COVID-19 Vaccine, thought she fell close to severe allergic reaction and this was unexpected. About separate events, patient stated, injection site pain: Occurred immediately after COVID-19 Vaccine and was worse than yesterday. Tiredness: Hard to say when it started. Set in three hours after the COVID-19 Vaccine, generally still tired, much worse in the evening. Headache: This morning and radiated to neck and upper back. Had gone away. Took about roughly three to four hours. Muscle Pain: Began immediately after COVID-19 Vaccine. Still had muscle pain specifically in that arm. Did have points in her arms, legs, and chest where she has sharp muscle pains. Had not recognized this recently. May have faded away. Joint Pain: Especially in jaw, lower extremities, ankles, and wrists. Began immediately after COVID-19 Vaccine. Had gotten better. Had not noticed as much. Severe nausea and diarrhea: Had three bouts of that. Did not know if directly related to COVID-19 Vaccine. Started three hours after the COVID-19 Vaccine. Had since stopped. Nausea only lasted for an hour. Diarrhea faded out as well. Dizziness: Began after bouts of nausea and diarrhea. Associated movement with bit of dizziness. Did not know when that stopped. Just laid down to rest and it faded. Weakness: Began after bouts of nausea and diarrhea. Lasted significantly longer. Was much weaker this morning. Had since faded. Twenty-four hours after vaccination had swelling on left side of face. Had since gone away. Was crying at the time and not sure if this contributed to swelling. Had not experienced something like this so she was not sure. Injection site: left arm. Clarified these symptoms occurred after the second dose of the COVID-19 Vaccine. Patient also wanted to know if she should be concerned for these adverse reactions. The events did not result in emergency room/ physician office visit. The outcome of the event injection site pain and tiredness was not recovered, outcome of event events headache recovered on 12Feb2021, outcome of event events nausea recovered on 11Feb2021 and outcome of event events diarrhea, swelling on left side of face recovered on Feb2021, outcome of event events events muscle pain, joint pain, dizziness and weakness was recovering and event injection site pain was reported as worsened was unknown. Follow-up attempts completed. No further information expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Heat sensitivity (Does have allergy to heat and will get swelling. Will get heat hives.); Swelling (Does have allergy to heat and will get swelling. Will get heat hives.); Urticaria heat (Does have allergy to heat and will get swelling. Will get heat hives.)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 28.08.2021
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
Arthralgia
Blood pressure measurement
Blood test
Feeling abnormal
Feeling cold
Headache
Heart rate
Heart rate increased
Hypertension
Nervousness
Pain
Pyrexia
Somnolence
Tremor
Symptomtext
he felt awful; Headache; he was very cold; hands were trembling; stomach felt like it was shaking; Nervous; blood pressure was extremely high; pulse was high; high fever; His shoulder initially was very sore; shooting pains throughout the body; really sleepy; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 80-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269), via an unspecified route of administration on 09Feb2021 14:00 (at the age of 80-year-old) as dose 2, single for covid-19 immunisation. Medical history included prostate cancer from an unknown date and unknown if ongoing Verbatim: Prostate cancer, patient's medical history (including any illness at time of vaccination) Prostate Cancer, mild version so far, blood pressure abnormal from an unknown date and unknown if ongoing, blood cholesterol from an unknown date and unknown if ongoing, neuropathy peripheral from an unknown date and unknown if ongoing. Concomitant medications included lisinopril taken for blood pressure abnormal, start and stop date were not reported; gabapentin taken for neuropathy peripheral, start and stop date were not reported; atorvastatin taken for blood cholesterol, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported, lot of vitamins and minerals. Patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3249), via an unspecified route of administration on 21Jan2021 (at the age of 80-year-old) as dose 1, single for covid-19 immunisation and experienced sore. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Feb2021, patient experienced really sleepy. On 10Feb2021, patient experienced shooting pains throughout the body, he felt awful, headache, he was very cold, hands were trembling, stomach felt like it was shaking, nervous, blood pressure was extremely high, pulse was high, high fever, his shoulder initially was very sore. Clinical course: evening he was getting really sleepy and sat in the chair. Two hours later he felt ok. He stayed up until 12:30. At 5:30AM, he felt awful. He had a headache. He was very cold. His hands were trembling. His stomach felt like it was shaking. He was nervous. His blood pressure was extremely high. His pulse was high. After he took his blood pressure he went to bed and 2 hours later he didn't have the trembling, but he still felt awful. He had a high fever between 101 and 102. Later that afternoon he took two Tylenol. This morning he took two Tylenol and feels good now. His shoulder initially was very sore. When he got the first shot it was sore where the shot was for a couple of days. This time it was his entire shoulder and it was the size of a softball. He had shooting pains throughout the body. He slept an awful lot yesterday. Right now he is tired from sleeping too much. Yesterday he didn't want to eat anything and just drank liquids, water, and V8. The patient underwent lab tests and procedures which included blood pressure measurement: extremely high on 10Feb2021, blood test: everything was fine on Dec2020 Relevant Tests: prior to his COVID vaccine he had bloodwork in Dec2020 and everything was fine, heart rate: high on 10Feb2021, pyrexia: fever between 101 and 102 on 10Feb2021. Therapeutic measures were taken as a result of shooting pains throughout the body, he felt awful, headache, he was very cold, hands were trembling, stomach felt like it was shaking, nervous, blood pressure was extremely high, pulse was high, high fever, his shoulder initially was very sore included tylenol. He took two of the 500mg when he went to bed early at 10:30PM and again at 7:30AM today. The outcome of the event really sleepy was unknown, hands were trembling was recovered on 10Feb2021 and the remaining events were recovering. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210210; Test Name: blood pressure; Result Unstructured Data: Test Result:extremely high; Test Date: 202012; Test Name: bloodwork; Result Unstructured Data: Test Result:everything was fine; Comments: Relevant Tests: prior to his COVID vaccine he had bloodwork in Dec2020 and everything was fine.; Test Date: 20210210; Test Name: pulse; Result Unstructured Data: Test Result:high; Test Date: 20210210; Test Name: fever; Result Unstructured Data: Test Result:fever between 101 and 102
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure abnormal (Patient's Medical History (including any illness at time of vaccination) Blood Pressure); Cholesterol (Patient's Medical History (including any illness at time of vaccination) Cholesterol); Neuropathy (Patient's Medical History (including any illness at time of vaccination)Mild Neuropathy); Prostate cancer (Medical History including any illness at time of vaccination Prostate Cancer, mild version so far)
- Andere Medikamente
- LISINOPRIL; GABAPENTIN; ATORVASTATIN; BABY ASPIRIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 07.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Chills
Headache
Laboratory test
Migraine
Neck pain
Pain
Pyrexia
Symptomtext
She had 101 fever; Body aches; Chills; Pain in the neck; Headache/intense headache; She had migraine; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 39-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9269, Expiration Date: May2021) via an unspecified route of administration on 07Feb2021 (at the age of 39-years-old) as dose 2, single for COVID-19 immunisation. Medical history included none. There were no concomitant medications. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247, Expiration date: May2021) via an unknown route of administration on 17Jan2021 as dose 1, single for COVID-19 immunisation and she had very mild side effects just body aches and stomach upset that subsided within 36 hours. After second dose, patient wanted to call instead of doing the self reporting thing and say it was awesome that they came up with the vaccine. She feels so fortunate to received it she works in a school setting but her side effects were pretty severe so she did want to report because if her feed back can help someone later she wants to report what she experienced. The second vaccine was the one she had the severe reaction to. It was sunday 07Feb2021. She got it in the afternoon. She felt fine until she went to bed, she went to bed at 10 PM, she woke up at 1 AM so that would has been monday morning on unknown date, experienced she had 101 fever. She was not too worried. She did not want to take pain killers because there were mixed reviews that it may mitigate the effects of the immune response so she just drank fluids. She started to get some body aches and headache and chills on unknown date. She ended up feeling better on monday morning. She went to work thinking it was over. Then she started feel lousy so she went home she was there a few days, her fever broke monday night but she had an intense headache. She said she had a 27 hour labor with her son she was not a baby, she has a pretty high pain threshold but this was a severe headache, she tried not to take pain killer she held off on even Tylenol and it got a little better then last night, Tuesday night she woke up in the middle of the night with excruciating pain in her neck it was like her whole neck was locked up on unknown date and she put a call in to her doctor to make sure he did not think it was something else. She ended up taking Tylenol and put more heat on it and it was tolerable enough for her to report to work today for the first time since monday. That morning it was a very intense pain in the neck, one of those things that she was not anticipating it being that strong. It was still worth it she would still do it all over she was not complaining but she did want to log it in one of her co-workers said if you feel that it was that severe you should probably let them know because they want to know. She was a single mom so she was cooking dinner too. The vaccine card just said May2021 it does not said anything else, she was assuming that was the expiration. She said for both first and second doses expiration was May2021. She just wanted to call because she thought they need to know. She really did not want complain she thinks it was amazing that they came up with the vaccine so quickly and she feels so luckily and fortunate to be a recipient. She said she was currently taking a low dose of Tylenol to get through the day she tried to come off of one dose and her headache started coming back and it was not as intense it was like a nagging kind of like at the base of her head, top of her neck area. She said at its height it was like someone was pressing her head in a press and it would not stop. She does not get a lot of headaches but she had migraines on unknown date and other headaches and this felt like a different type of headache. She said thank you again and she hopes, she was looking forward to being to protected she still plans on doing social distancing she was not going to be going out in a crowd any time soon but she thinks she would feel a lot safer having been vaccinated. She will not be clubbing anytime soon. Treatment was received for the events neck and headache as Tylenol. The patient underwent lab tests and procedures which included body temperature: 101 (she had 101 fever), laboratory test: normal (She just had normal labs a few months ago. She was perfectly healthy and it coincided with the timing of the vaccine) on unknown date. The outcome of the events was reported as unknown. Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: she had 101 fever; Test Name: labs; Result Unstructured Data: Test Result:Normal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 08.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Dyspnoea
Headache
Influenza like illness
Pain
Pyrexia
Symptomtext
Difficulty breathing; Extreme flu-like symptoms; Dizzy; Fever; Splitting headache; The worst body aches ever; This is a spontaneous report from a non-contactable consumer (patient). A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9269) via an unspecified route, administered in Right Arm on 08Feb2021 at 07:00 PM (36-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient's medical history included asthma. The patient had known allergies of Erythromycin. The patient's concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3249) via an unspecified route of administration on 15Jan2021 at 08:00 PM (36-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. Facility type Vaccine was reported as other. The patient had not received an other vaccine within four weeks prior to covid-19 vaccination. The patient was not diagnosed with covid prior to vaccination. The patient was not tested for Covid post vaccination. On 10Feb2021 at 03:00 PM, the patient had experienced extreme flu-like symptoms, dizzy, difficulty breathing, worst body aches ever, fever and splitting headache. No treatment medications were received by the patient for the resulted events. The outcome of the events was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information was expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 28.01.2021
- Beginn
- 28.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Bone pain
Lymphadenopathy
Migraine
Pain of skin
Pyrexia
Symptomtext
fever of 103 for 2.5 days; migraine; worst bone pain I have ever had; My skin hurt to go though; lymph nodes in armpit are still very swollen; This is a spontaneous report from a non-contactable other hcp (patient). A 42-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9269) via an unspecified route of administration, administered in right arm on 28Jan2021 at 14:30 (at the age of 42-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included Hashimoto's, covid prior vaccination. Patient had known allergies to antihistamine and narcotics. The concomitant medications were not reported. The patient previously received first dose of (BNT162B2, Solution for injection, Lot Number: EK9231) via an unspecified route of administration, administered in left arm on 05Jan2021 at 12:30 for covid-19 immunisation. No other vaccine in four weeks. No other medications in two weeks. No covid tested post vaccination. On 28Jan2021 at 19:00, the patient experienced fever of 103 for 2.5 days and reported a migraine (never had one before), and the worst bone pain she ever had. The patient reported my skin hurt to go though, and 2 weeks later lymph nodes in armpit were still very swollen. The patient underwent lab tests included fever 103 on 28Jan2021 (for 2.5 days). Patient did not receive any treatment. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210128; Test Name: fever; Result Unstructured Data: Test Result:103; Comments: for 2.5 days
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19 (If covid prior vaccination: Yes); Drug allergy (Allergies to Antihistamine and narcotics); Hashimoto's disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 28.08.2021
- Impfdatum
- 05.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ageusia
Anosmia
Headache
Paraesthesia oral
Pyrexia
Rhinorrhoea
Symptomtext
lost his sense of taste; cannot feel anything in his mouth; lost his sense of taste and smell; runny nose; fever; headache; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 37-year-old male patient reported that they received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EL9269), via unspecified route of administration in right arm on 05Feb2021 14:25 (at the age of 37 years) as a DOSE 1, SINGLE for COVID-19 immunization. Patient had no medical history and had not received concomitant medications (Other Products). Patient was not administered with any other additional Vaccines on Same Date of the Pfizer Suspect. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient reported that he had a very slight headache on 10Feb2021 that was no big deal. Patient stated that he received the Pfizer vaccine 10 days ago, on Friday before, then six days later on 11Feb2021 he had a fever which he knew was a side effect of the vaccine. The day before the fever was very brief, maybe two hours in the night. Then a couple of days later on 13Feb2021 he had a runny nose. It was a crazy runny nose, he had to breathe out of his mouth and was using lots of paper. On 14Feb2021 patient woke up and lost his sense of smell and on 15Feb2021 lost his sense of taste and he cannot feel anything in his mouth. He wanted to know if these are reported adverse events (AEs) associated with the vaccine. Then he noticed he could not smell anything. He put perfume up to his nose and could smell nothing. He thought maybe he lost his sense of smell due to the runny nose but the next day on 15Feb2021 he lost his sense of taste and he was concerned about that and was querying were these all are part of the side effects of the vaccine or something else and queried for was that the vaccine working on him. Patient reported that his wife cooks and puts in lots of flavors but he can smell or taste nothing, perfume nothing. He can't smell or taste cheese or ham. He doesn't taste or smell coffee. He can only tell hot or cold. He was scheduled to receive the second dose of the vaccine on 26Feb2021. Patient had not attended any physician or emergency room (ER) visit for the experienced events. Outcome of event headache was recovered on 10Feb2021, fever was recovered on 11Feb2021, runny nose recovered on 14Feb2021, lost his sense of taste and smell was not recovered, cannot feel anything in his mouth was unknown. Follow-up attempts completed. No further information expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 01.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Blood pressure increased
Burning sensation
Depression
Dizziness
Cerebral disorder
Confusional state
Mental impairment
Pain
Tachyphrenia
Dyspnoea
Fatigue
Irritability
Language disorder
Muscular weakness
Nausea
Thought blocking
Symptomtext
great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided. She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Lyme disease (She also reports having chronic Lyme disease.)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 27.08.2021
- Impfdatum
- 26.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Blood test
Cardiac disorder
Dizziness
Electrocardiogram abnormal
Feeling hot
Heart rate increased
Heart rate irregular
Hyperhidrosis
Tremor
Symptomtext
After the first shot I started getting really hot and sweaty and I started shaking and I almost passed out. The EMT checked my heart and I had a rapid heartbeat. About 10 minutes it passed. After the second shot the same thing happened but it messed with the beating of my heart. There was an ER doctor there and he looked to my EKG and he saw some damage in my heart. He said it was probably because of the 2 heart attacks I have had in the past. Within 20 minutes he let me go but the next day I called my cardiologist and I went to see him. He told me the shot interfered with my heart beat and within a month it should go away, which it did. They had to put me back on a medication to help with my heartbeat.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- EKG- some damage in my heart Echocardiogram- I do not have the results Blood work- I do not have the results
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic back pain; high blood pressure; I have had 2 heart attacks
- Andere Medikamente
- Corgard; regular vitamin; vitamin C; Lisinopril; Gabapentin; Tylenol
- Allergien
- Eggs; flu shot; Keflex
- Vorherige Impfungen
- flu shot, I had a burning and hurting sensation in my arm, they had to give me Benadryl and the doctor said I was allergic to th
- Staat
- FL
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 27.08.2021
- Impfdatum
- 09.03.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 136,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Dyspnoea
Fall
Fatigue
SARS-CoV-2 test positive
Symptomtext
8/4/21: Admitted to Hospital due to weakness and frequent falls. Patient tested positive for COVID-19 1 week ago, his 1st symptoms began 2 days prior, which included some mild shortness of breath, on Friday the 30th the patient got a regeneron infusion for COVID. Patient stated after receiving infusion on Friday he spent most of the subsequent weekend in bed secondary to increased fatigue. Note: patient previously vaccinated with Pfizer COVID-19 vaccine on 2/16/21 and 3/9/2021. 8/5/21: discharged.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- Patient reported testing positive for COVID 07/28/2021 prior to admission and tested positive in-patient on 08/03/21.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM, neuropathy, hypertension, hyperlipidemia, CAD status post CABG, prostate CA. Degeneration, intervertebral disc
- Andere Medikamente
- Duloxetine, ezetimibe, metformin, montelukast, pregabalin
- Allergien
- Lipitor, sulfonamides, tetracycline
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 26.08.2021
- Impfdatum
- 09.03.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 167,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Dyspnoea
COVID-19
Chest X-ray
Respiratory viral panel
SARS-CoV-2 test positive
Symptomtext
Patient presented to ER with dyspnea after her dialysis. She was diagnosed with COVID pneumonia and is currently still being treated inpatient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 26.08.2021
- Impfdatum
- 09.03.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 167,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Dyspnoea
COVID-19
Chest X-ray
Respiratory viral panel
SARS-CoV-2 test positive
Symptomtext
Patient presented to ER with dyspnea after her dialysis. She was diagnosed with COVID pneumonia and is currently still being treated inpatient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 19.08.2021
- Impfdatum
- 03.02.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood gases
Blood pressure increased
Blood test
Chest pain
Dyspnoea
Electrocardiogram
Fibrin D dimer
Heart rate increased
Pharyngeal swelling
Pulmonary function test
SARS-CoV-2 test
Thyroid function test
Symptomtext
Shortness of breath starting less than 24 hours after vaccine. Shortness of breath is still currently experienced intermittently to this day. Air hunger and feelings of not being able to breathe correctly. Throat swelling. Chest pains that occurred infrequently throughout first few months after vaccine. Elevated heart rate and blood pressures. Normal blood pressure prior to vaccine was 100s/70s. Now blood pressure consistently 130/80s. Tx- I was prescribed Prednisone for 5 days, 6 weeks after my first shot by my PCP. This did not help my breathing issues or change any other symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 2 EKG + COVID 19 swab + Blood labs and DDimer (02/05/2021) Pulmonary function tests + Arterial blood gas (around May 4th 2021) Thyroid tests (End of May 2021, I believe the 26th)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth Control Pill
- Allergien
- Codeine, pet dander, dust
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 19.08.2021
- Impfdatum
- 09.02.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 182,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
COVID-19 pneumonia
Chest pain
Cough
Dyspnoea
Dyspnoea exertional
Oxygen saturation decreased
SARS-CoV-2 test positive
Symptomtext
64 Y female with history of HTN, obesity BMI>40yr, hypothyroidism, and psoriasis presenting with SOB and CP since 7/31 admitted for COVID PNA. Patient Active Hospital Problem List: #CORONAVIRUS COVID-19 PNEUMONIA Pt was vaccinated w/ COVID Pfizer vaccine in Jan/Feb 2021. Became symptomatic on 7/31 and tested COVID + on 8/3. Has started to experience progressively worsening DOE with continuous dry cough. Desatted to 89% on RA in the ED on 8/10/21. S/p decadron 6 mg x1 in ED. Admitted for COVID PNA. She was started on supplemental O2, Remdesivir, and prednisone 6mg daily. She remained stable on 1-2L NC at rest. S/p a 5 day course of Remdesivir; however, she still required 1-2L NC at rest. She was discharged with home O2 and to complete a total 10 day course of prednisone 6mg with referral to the oxygen clinic. Pt discharged on 8/14/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Psoriasis
- Vorgeschichte
- PMH of prediabetes (A1c 5.8 on 1/26/21), hypothyroidism, obesity, HTN
- Andere Medikamente
- Prior to Admission Medications Outpatient Home Medications Taking? Albuterol (PROAIR/PROVENTIL/VENTOLIN) 90 mcg/actuation Inhl HFAA Sig: Inhale 2 Puffs by mouth every 4 hours as needed for quick relief of asthma symptoms . 100 days supply
- Allergien
- Influenza Virus Vaccines Anaphylaxis Not Specified 10/15/2020 patient states she had difficulty breathing after flu vaccine Latex Anaphylaxis Not Specified 4/18/2018
- Vorherige Impfungen
- Flu vaccine- per pt difficulty breathing other details not known
- Staat
- KY
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 18.08.2021
- Impfdatum
- 16.01.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 214,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19 pneumonia
Symptomtext
Hospitalized for pneumonia due to COVID-19 virus.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
